Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AGRP,Agouti-related protein,40058,-0.199702354093155,0.00498604662474807,-0.209475005477662,-0.189929702708649,0
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FGFBP1,Fibroblast growth factor-binding protein 1,39913,0.134237228643299,0.00293655232857504,0.128481586079292,0.139992871207306,0
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GCG,Pro-glucagon,39477,-0.518818012330539,0.0112617293980865,-0.540891001950788,-0.496745022710289,0
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LDLR,Low-density lipoprotein receptor,39882,-0.215170753605439,0.00483924598577061,-0.224655675737549,-0.205685831473328,0
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MFGE8,Lactadherin,39858,-0.215809228769238,0.00392242420367784,-0.223497180208447,-0.20812127733003,0
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRAP1,Proline-rich acidic protein 1,37437,-0.148136269764757,0.00374237769734957,-0.155471330051562,-0.140801209477952,0
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PON3,Serum paraoxonase/lactonase 3,39931,0.101913628888701,0.0026316161520953,0.096755661230594,0.107071596546808,1.11254168111307e-308
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NPY,Pro-neuropeptide Y,40030,-0.235968774014345,0.00620211226166879,-0.248124914047215,-0.223812633981474,1.96546980854056e-303
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PLA2G7,Platelet-activating factor acetylhydrolase,39858,0.107722776264893,0.00285342695755333,0.102130059428088,0.113315493101697,7.56291837135435e-299
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IGSF9,Protein turtle homolog A,37437,-0.287351683600206,0.00770875929779846,-0.302460851823891,-0.272242515376521,1.21974484365582e-289
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PYY,Peptide YY,37021,-0.297472339370831,0.00868971448614125,-0.314504179763667,-0.280440498977994,4.11471502806343e-246
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRSS8,Prostasin,39805,-0.123714736936005,0.00379063171370194,-0.131144375094861,-0.11628509877715,3.16773309945993e-226
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ASGR1,Asialoglycoprotein receptor 1,39749,-0.0891747367459861,0.00275384511558001,-0.0945722731725229,-0.0837772003194493,8.04665785822912e-223
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TMPRSS15,Enteropeptidase,39788,-0.272815030365443,0.00843989104061705,-0.289357216805053,-0.256272843925834,4.43148877556328e-222
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCN1,CCN family member 1,39758,-0.227540522490335,0.0072439446391325,-0.241738653983035,-0.213342390997636,3.56970515041597e-210
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LPL,Lipoprotein lipase,39868,0.139477972928632,0.00448858430122607,0.130680347698229,0.148275598159035,6.71632446898045e-206
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GPR37,Prosaposin receptor GPR37,39585,-0.186962510954196,0.00609332217643876,-0.198905422420016,-0.175019599488376,7.55526676854703e-201
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,APOF,Apolipoprotein F,37445,0.0749718719405057,0.00246189922453246,0.0701465494604221,0.0797971944205893,4.27319946160069e-197
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CES1,Liver carboxylesterase 1,39854,-0.226659197165085,0.00756671421743896,-0.241489957031265,-0.211828437298904,7.28587450774768e-192
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD4,T-cell surface glycoprotein CD4,39839,-0.0796551453273629,0.00275241996527341,-0.0850498884592988,-0.074260402195427,1.55056977483654e-179
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,C9,Complement component C9,37445,0.143768879573923,0.00506451589132696,0.133842428426922,0.153695330720924,2.92641120440051e-172
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RARRES2,Retinoic acid receptor responder protein 2,39949,-0.125895003488515,0.00451123304102429,-0.134737020248923,-0.117052986728108,2.0751394570209e-167
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCL27,C-C motif chemokine 27,39868,-0.166358241969813,0.00596754102911706,-0.178054622386882,-0.154661861552744,4.80249772783033e-167
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IGFBP1,Insulin-like growth factor-binding protein 1,40017,0.32666450312543,0.0117296335785703,0.303674421311433,0.349654584939428,9.24470957796988e-167
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PTH,Parathyroid hormone,37039,-0.21008669189833,0.00763764223976537,-0.22505647068827,-0.195116913108389,5.23654881355275e-162
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADIPOQ,Adiponectin,37453,0.172543332998261,0.00632043582214335,0.16015527878686,0.184931387209662,8.47525433955671e-160
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,APOM,Apolipoprotein M,39908,0.0689683051677708,0.00254972506547422,0.0639708440394414,0.0739657662961003,1.30366176126655e-157
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VMO1,Vitelline membrane outer layer protein 1 homolog,39788,-0.171787576882193,0.00635982914097776,-0.184252841998509,-0.159322311765876,3.69478645841619e-157
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,OXT,Oxytocin-neurophysin 1,40009,-0.357191830489402,0.0132483381058243,-0.383158573176818,-0.331225087801986,1.2112051344626e-156
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NOS3,"Nitric oxide synthase, endothelial",39489,-0.131371994683558,0.00487915777859371,-0.140935143929602,-0.121808845437514,3.9745853503527e-156
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MAMDC4,Apical endosomal glycoprotein,37368,-0.139984418510071,0.00533877607757742,-0.150448419622123,-0.12952041739802,7.5604695469835e-148
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SMOC1,SPARC-related modular calcium-binding protein 1,40030,-0.0818190053629734,0.00312874453263174,-0.0879513446469316,-0.0756866660790152,1.11814012952382e-147
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FURIN,Furin,39913,-0.0835655819654459,0.00324170744988871,-0.0899193285672278,-0.0772118353636641,1.27971854232737e-143
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL1RN,Interleukin-1 receptor antagonist protein,39820,-0.131712630578482,0.00511891606260776,-0.141745706061193,-0.121679555095771,4.33067823192888e-143
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PLTP,Phospholipid transfer protein,39976,0.0880501080301505,0.00343979271398814,0.0813081143107338,0.0947921017495673,1.08686039926648e-141
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PPY,Pancreatic prohormone,39826,-0.23983429595634,0.00959385671156392,-0.258638255111005,-0.221030336801675,2.49375637543007e-135
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ACY1,Aminoacylase-1,39868,-0.147931076103859,0.00591990414485211,-0.159534088227769,-0.136328063979949,3.12306685076957e-135
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DEFB4A_DEFB4B,Beta-defensin 4A,39585,-0.346828522504949,0.0138833511011892,-0.374039890663279,-0.319617154346618,4.11764361543163e-135
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,39749,-0.0746799024290993,0.00304126784376786,-0.0806407874028843,-0.0687190174553143,1.01963416998444e-130
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCL16,C-C motif chemokine 16,40052,-0.122513095531457,0.00500463137061983,-0.132322173017872,-0.112704018045042,5.51076174455842e-130
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CXCL13,C-X-C motif chemokine 13,40009,-0.136875259653434,0.00564633711421961,-0.147942080397305,-0.125808438909564,1.53263383956159e-127
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,39477,-0.144128984947088,0.00599713142346253,-0.155883362537074,-0.132374607357101,2.3498705099652e-125
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MVK,Mevalonate kinase,39587,-0.181479766989718,0.00759896784108658,-0.196373743958247,-0.166585790021188,7.4509269865884e-124
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,39683,-0.106315570413342,0.00446434593862599,-0.115065688453049,-0.0975654523736355,3.45259073371607e-123
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MXRA8,Matrix remodeling-associated protein 8,37124,0.0689586216150405,0.0028960032552558,0.0632824552347391,0.0746347879953419,9.353599832634e-123
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,40030,-0.0773006412756633,0.00325547831371557,-0.0836813787705458,-0.0709199037807808,1.54271391972585e-122
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLUL1,Clusterin-like protein 1,39840,0.103204948209968,0.00434619499304005,0.0946864060236097,0.111723490396327,1.58506784819702e-122
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CA14,Carbonic anhydrase 14,40030,0.0794182450201264,0.00337317831581522,0.0728068155211286,0.0860296745191243,1.52880470537593e-120
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SLC39A5,Zinc transporter ZIP5,39866,-0.119271769088758,0.00508058721695538,-0.12922972003399,-0.109313818143525,7.54302809842619e-120
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NHLRC3,NHL repeat-containing protein 3,36838,-0.0723473250661556,0.00307719561541142,-0.078378628472362,-0.0663160216599492,9.8844993781476e-120
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CTSD,Cathepsin D,38721,-0.0880805257604291,0.00377492435116913,-0.0954793774887206,-0.0806816740321376,2.71153640621949e-118
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PGF,Placenta growth factor,40058,-0.0575136957351003,0.00247419822068955,-0.0623631242476518,-0.0526642672225488,1.32270200032161e-117
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,39585,-0.188244291979398,0.00810728268184348,-0.204134566035812,-0.172354017922985,2.71829883640984e-117
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GDF15,Growth/differentiation factor 15,40052,-0.0946188830620007,0.00407835326425792,-0.102612455459946,-0.0866253106640552,3.65906555648464e-117
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GUSB,Beta-glucuronidase,39919,-0.130438918787012,0.00564980362036856,-0.141512533882934,-0.11936530369109,4.77875974939947e-116
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCL23,C-C motif chemokine 23,39931,-0.0910473747230241,0.00395557528961237,-0.0988003022906643,-0.0832944471553838,2.27088107502106e-115
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,F7,Coagulation factor VII,39899,-0.0658689878188501,0.00288208420006314,-0.0715178728509738,-0.0602201027867263,8.57771222922479e-114
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HHEX,Hematopoietically-expressed homeobox protein HHEX,37388,-0.168680939387117,0.00739264282693851,-0.183170519327917,-0.154191359446318,4.1497043893555e-113
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RTN4R,Reticulon-4 receptor,40030,-0.0726028749849503,0.00318748570546938,-0.0788503469676703,-0.0663554030022303,4.58288580957309e-113
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GSTA1,Glutathione S-transferase A1,39841,-0.18579346692216,0.00817173249215196,-0.201810062606778,-0.169776871237542,1.19778984597152e-112
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ACE2,Angiotensin-converting enzyme 2,39585,-0.108770375638261,0.00478850066630532,-0.118155836944219,-0.0993849143323026,2.04088887535759e-112
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SIT1,Signaling threshold-regulating transmembrane adapter 1,39587,-0.118733833044755,0.00526660046349535,-0.129056369953205,-0.108411296136304,8.5706466302108e-111
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,UPB1,Beta-ureidopropionase,37437,-0.199067079976503,0.00887547916378159,-0.216463019137515,-0.181671140815491,1.97830426548417e-109
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LGALS4,Galectin-4,39862,-0.113667984998133,0.00507543413519931,-0.123615835903123,-0.103720134093142,2.06790889616441e-109
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FTCD,Formimidoyltransferase-cyclodeaminase,37368,-0.182519314733569,0.00813940391204147,-0.198472546401171,-0.166566083065968,2.24176327309564e-109
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PSRC1,Proline/serine-rich coiled-coil protein 1,39477,-0.127079261524521,0.00570052449927237,-0.138252289543094,-0.115906233505947,2.12834920836289e-108
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,INHBC,Inhibin beta C chain,39858,-0.0888674479767211,0.00399044396002189,-0.096688718138364,-0.0810461778150782,3.16340505400366e-108
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AMBP,Protein AMBP,40003,-0.0413164776376206,0.00186013628935004,-0.0449623447647467,-0.0376706105104945,1.08484093933339e-107
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FGF21,Fibroblast growth factor 21,40011,-0.252947925385433,0.0114773729705217,-0.275443576407656,-0.23045227436321,4.45112776861068e-106
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MUC13,Mucin-13,39489,-0.106625181072032,0.00487794846363768,-0.116185960060762,-0.0970644020833021,2.34185844330606e-104
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GIP,Gastric inhibitory polypeptide,37043,-0.0920664233094643,0.00421543000812321,-0.100328666125386,-0.0838041804935428,6.60771293528072e-104
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IGSF8,Immunoglobulin superfamily member 8,39868,-0.0632580720017145,0.00290942444788232,-0.0689605439195638,-0.0575556000838651,2.53205208686311e-103
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,39913,-0.072717049221233,0.00335314240633844,-0.0792892083376563,-0.0661448901048097,8.23373393789836e-103
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VWA1,von Willebrand factor A domain-containing protein 1,40011,-0.0885388664046236,0.00411361889096612,-0.0966015594309172,-0.08047617337833,2.48549954940689e-101
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HGF,Hepatocyte growth factor,40058,-0.0703344050008031,0.00327534412462384,-0.0767540794850659,-0.0639147305165404,6.93842354261359e-101
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IGFBP4,Insulin-like growth factor-binding protein 4,39585,-0.0820512908506509,0.00382484453430529,-0.0895479861378892,-0.0745545955634125,1.20150704974476e-100
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CRELD1,Protein disulfide isomerase CRELD1,37124,-0.0769029970161137,0.00359728835450605,-0.0839536821909456,-0.0698523118412819,1.02088712370153e-99
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NTRK3,NT-3 growth factor receptor,40009,0.043529182037788,0.00205488326519147,0.0395016108380127,0.0475567532375633,2.9465560848517e-98
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRCP,Lysosomal Pro-X carboxypeptidase,39948,-0.0634794956776342,0.00299842957895645,-0.0693564176523888,-0.0576025737028796,3.84802755270609e-98
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TFF3,Trefoil factor 3,39839,-0.0986378668299836,0.00467618070394957,-0.107803181009725,-0.0894725526502424,1.92873408312931e-97
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VPS37A,Vacuolar protein sorting-associated protein 37A,39788,-0.161447192586594,0.00766056567135797,-0.176461901302456,-0.146432483870733,2.85322823073076e-97
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,39749,-0.10949475201954,0.00521008796742169,-0.119706524435687,-0.099282979603394,9.68327695406887e-97
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,39587,-0.0844897353804189,0.00403374765950502,-0.0923958807930488,-0.0765835899677891,4.19683862909836e-96
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CPM,Carboxypeptidase M,39955,-0.069494799111851,0.00332226392349226,-0.0760064364018958,-0.0629831618218061,6.92113146569161e-96
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD300LG,CMRF35-like molecule 9,39858,0.073775408599268,0.0035331464121826,0.0668504416313901,0.0807003755671459,1.49666858212271e-95
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DNAJB1,DnaJ homolog subfamily B member 1,39788,-0.174740781782845,0.00837573380438587,-0.191157220039441,-0.158324343526249,2.19542899803995e-95
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SMAD1,Mothers against decapentaplegic homolog 1,39477,-0.16544213566154,0.00797379871552875,-0.181070781143976,-0.149813490179103,2.37481152621835e-94
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KITLG,Kit ligand,39868,0.0740956772359728,0.00357648776074164,0.0670857612249192,0.0811055932470264,4.12706470117974e-94
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EPHA1,Ephrin type-A receptor 1,39904,-0.0666080879045451,0.00321939830929181,-0.072918108590757,-0.0602980672183331,7.19854973950792e-94
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RBP5,Retinol-binding protein 5,39788,-0.111641371692348,0.00540053631493866,-0.122226422869628,-0.101056320515068,1.04222411824882e-93
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,39788,-0.0600375136792041,0.00290527795022323,-0.0657318584616416,-0.0543431688967666,1.20745815699241e-93
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DSG2,Desmoglein-2,39858,0.0530110527994419,0.00257441667328144,0.0479651961198103,0.0580569094790736,5.24203518317457e-93
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,F9,Coagulation factor IX,39908,-0.0361730689389011,0.00175715163201465,-0.0396170861376498,-0.0327290517401524,5.7803896202402e-93
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CA5A,"Carbonic anhydrase 5A, mitochondrial",39585,-0.179748196757113,0.00877354460522816,-0.19694434418336,-0.162552049330866,4.41852081970194e-92
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AMOT,Angiomotin,37124,-0.0819789867714317,0.00399932228379474,-0.0898176584476694,-0.074140315095194,5.90234017703529e-92
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KRT18,"Keratin, type I cytoskeletal 18",39788,-0.160505109036728,0.00784999035692866,-0.175891090136308,-0.145119127937148,9.68421959004233e-92
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SERPINF1,Pigment epithelium-derived factor,37254,-0.0504331196734471,0.00247514415275093,-0.0552844022128389,-0.0455818371340553,6.50793975655671e-91
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL17RB,Interleukin-17 receptor B,39644,0.105529247715371,0.0051972701099485,0.0953425982998722,0.11571589713087,1.66759859008432e-90
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD74,HLA class II histocompatibility antigen gamma chain,40009,-0.0662691226732571,0.00326739870700937,-0.0726732241389954,-0.0598650212075187,2.47203972303031e-90
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,COL18A1,Collagen alpha-1(XVIII) chain,39893,-0.0441369432760277,0.00217679213366084,-0.048403455858003,-0.0398704306940525,2.82363854162921e-90
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CPA2,Carboxypeptidase A2,39933,-0.125557264987949,0.00621992093696812,-0.137748310024406,-0.113366219951491,1.65796055813535e-89
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CHI3L1,Chitinase-3-like protein 1,39545,-0.146159615403265,0.00727209412847632,-0.160412919895079,-0.131906310911451,9.89635407908587e-89
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCL15,C-C motif chemokine 15,40052,-0.0839021556294962,0.00418649218188412,-0.0921076803059891,-0.0756966309530034,2.82910054318624e-88
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CRIP2,Cysteine-rich protein 2,39749,-0.0692020394008047,0.0034652957602933,-0.0759940190909796,-0.0624100597106298,1.19141832689904e-87
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GSTA3,Glutathione S-transferase A3,39477,-0.147355137222433,0.00738574017282933,-0.161831187961179,-0.132879086483688,1.79107346177073e-87
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CTSO,Cathepsin O,40058,-0.0575141605906013,0.00289200341798556,-0.063182487289853,-0.0518458338913496,5.70719398634006e-87
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NOMO1,Nodal modulator 1,39858,-0.0454536265571141,0.00229094293048302,-0.0499438747008609,-0.0409633784133674,1.45750342592026e-86
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MCAM,Cell surface glycoprotein MUC18,39931,0.0627124245423117,0.00316191031948117,0.0565150803161286,0.0689097687684948,1.64743994114545e-86
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MME,Neprilysin,39788,-0.150713991778852,0.00759973682047204,-0.165609475946978,-0.135818507610727,1.75714674659098e-86
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GHR,Growth hormone receptor,37124,-0.0551168020801548,0.00278920499185699,-0.0605836438641945,-0.0496499602961151,1.10207444992399e-85
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RNASET2,Ribonuclease T2,39974,-0.0485177263125433,0.0024631024596067,-0.0533454071333724,-0.0436900454917141,2.26982809792769e-85
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,APOD,Apolipoprotein D,36780,0.082890281868792,0.00420367341235757,0.0746510819805712,0.0911294817570129,2.67048518355584e-85
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,40058,-0.0689565551747012,0.00350678841251176,-0.0758298604632243,-0.0620832498861782,4.32573968780464e-85
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NECTIN2,Nectin-2,39846,-0.0535042655044402,0.00272618333014586,-0.0588475848315261,-0.0481609461773543,9.1954590488032e-85
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NOTCH3,Neurogenic locus notch homolog protein 3,40052,0.0640152887398078,0.00328220586416693,0.0575821652460407,0.070448412233575,9.3143948976368e-84
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NRP1,Neuropilin-1,39949,0.0521775098916974,0.00267941559231059,0.0469258553307686,0.0574291644526261,1.68337141062135e-83
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SEMA3F,Semaphorin-3F,39868,-0.0479871706606849,0.00246675300687843,-0.0528220065541666,-0.0431523347672032,2.48673832037795e-83
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ANGPTL7,Angiopoietin-related protein 7,40030,-0.0699189292453866,0.00359899966359522,-0.0769729685860332,-0.0628648899047399,4.01158084128659e-83
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDKN1A,Cyclin-dependent kinase inhibitor 1,39788,-0.199387959618667,0.0102961303442122,-0.219568375093323,-0.179207544144011,1.34583355774319e-82
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IGFBPL1,Insulin-like growth factor-binding protein-like 1,39868,-0.060902888555554,0.00317937596980603,-0.0671344654563739,-0.0546713116547342,6.9730954680954e-81
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FETUB,Fetuin-B,39908,-0.0623652726088313,0.00325860431321496,-0.0687521370627326,-0.0559784081549299,9.53900969026459e-81
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MEP1A,Meprin A subunit alpha,37382,-0.132908938595249,0.00694171541668876,-0.146514700811959,-0.119303176378539,1.20630110487622e-80
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,37437,-0.130832021841345,0.00688608178523209,-0.1443287421404,-0.11733530154229,1.84378749776477e-79
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KIT,Mast/stem cell growth factor receptor Kit,39908,0.0527806619451346,0.00278453600913359,0.0473229713672328,0.0582383525230364,2.94935895898e-79
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GRP,Gastrin-releasing peptide,37043,-0.0959179061414637,0.0050587057369695,-0.105832969385924,-0.0860028428970035,4.03586753191898e-79
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,39585,-0.0995774141495612,0.0052640429242221,-0.109894938281036,-0.0892598900180859,6.2631541096057e-79
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NFASC,Neurofascin,40058,-0.0506044864388162,0.00267894311577931,-0.0558552149457437,-0.0453537579318888,9.71657425025299e-79
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SKAP1,Src kinase-associated phosphoprotein 1,39713,-0.131277837600055,0.00696252568392445,-0.144924387940547,-0.117631287259563,1.92939635728457e-78
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL10RB,Interleukin-10 receptor subunit beta,39931,-0.0507617679212289,0.00270996638591079,-0.0560733020376141,-0.0454502338048438,1.82923377288994e-77
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DPY30,Protein dpy-30 homolog,39979,-0.107222740250294,0.00572724232052665,-0.118448135198526,-0.0959973453020617,2.18537409156137e-77
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GLA,Alpha-galactosidase A,37088,-0.0686972383967278,0.00366778551408965,-0.0758860980043435,-0.0615083787891121,2.81355610884506e-77
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SCG2,Secretogranin-2,39949,-0.0562391867655963,0.00300839865808494,-0.0621356481354427,-0.0503427253957498,3.63149212763093e-77
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MENT,Protein MENT,37124,0.0402741826322334,0.0021566746091086,0.0360471003983805,0.0445012648660863,7.73669430933941e-77
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SELE,E-selectin,40052,-0.0897693423218584,0.00481604086151037,-0.0992087824104187,-0.0803299022332981,9.72655137315694e-77
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD5,T-cell surface glycoprotein CD5,40003,-0.0591885518084498,0.0031785045603972,-0.0654184207468283,-0.0529586828700713,1.36303369207292e-76
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SCLY,Selenocysteine lyase,39984,-0.0882746358110665,0.00475699504167664,-0.0975983460927527,-0.0789509255293803,4.44945085409427e-76
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADGRG1,Adhesion G-protein coupled receptor G1,39788,-0.096757174698849,0.0052618631124163,-0.107070426399185,-0.0864439229985131,9.65115921697184e-75
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ELN,Elastin,37437,-0.0598559281671665,0.00325754703667157,-0.0662407203590428,-0.0534711359752902,1.67664220816376e-74
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CST3,Cystatin-C,39897,-0.0471685951826289,0.00257295729600798,-0.0522115914828045,-0.0421255988824532,2.61566584054274e-74
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL18R1,Interleukin-18 receptor 1,40058,-0.0575281280939557,0.00315005664131078,-0.0637022391109248,-0.0513540170769865,9.03175951556603e-74
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CXADR,Coxsackievirus and adenovirus receptor,39866,-0.0888722303211864,0.00490504449256584,-0.0984861175266155,-0.0792583431157574,1.20974203610272e-72
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CSF1,Macrophage colony-stimulating factor 1,39931,-0.0457024232715988,0.00253493134164294,-0.050670888701219,-0.0407339578419787,5.89189402497123e-72
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FAM20A,Pseudokinase FAM20A,37437,-0.0489982404723791,0.0027409559284334,-0.0543705140921086,-0.0436259668526496,1.1617906173632e-70
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,37124,-0.0849654076612685,0.00475837883542697,-0.0942918301787054,-0.0756389851438317,1.73294900910083e-70
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CTSZ,Cathepsin Z,39865,-0.0535614298554256,0.00300562394411294,-0.059452452785887,-0.0476704069249643,2.34634746601253e-70
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MTSS1,Protein MTSS 1,37382,-0.19108061111525,0.0107246602363513,-0.212100945178499,-0.170060277052002,3.30769507576946e-70
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KLRB1,Killer cell lectin-like receptor subfamily B member 1,40058,-0.0619517745503292,0.00349609554975963,-0.0688041218278581,-0.0550994272728004,1.32663694561211e-69
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TGFB1,Transforming growth factor beta-1 proprotein,40040,-0.0660174685492478,0.00372767402908014,-0.0733237096462449,-0.0587112274522507,1.58683689899349e-69
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CPB1,Carboxypeptidase B,40052,-0.0982782220112779,0.00556112527029258,-0.109178027541051,-0.0873784164815045,3.05758691408051e-69
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HAO1,Hydroxyacid oxidase 1,40030,-0.220448827470592,0.0124807953761698,-0.244911186407885,-0.195986468533299,3.60270289321207e-69
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LECT2,Leukocyte cell-derived chemotaxin-2,37437,-0.110696079011891,0.00626537662560815,-0.122976217198083,-0.0984159408256994,4.38747360689241e-69
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,UMOD,Uromodulin,40012,0.0900093907743074,0.00510216600455792,0.0800091454053739,0.100009636143241,5.25515592827841e-69
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,37021,-0.116905837926272,0.00663243150842409,-0.129905403682783,-0.103906272169761,9.50705892165098e-69
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FGFR2,Fibroblast growth factor receptor 2,39913,-0.0366085662261977,0.00208655176258565,-0.0406982076808656,-0.0325189247715298,2.81494741611957e-68
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LSP1,Lymphocyte-specific protein 1,39866,-0.0686707751327032,0.00391513312397767,-0.0763444360556994,-0.0609971142097069,3.09123306860579e-68
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NPPC,C-type natriuretic peptide,39866,-0.0776174291029795,0.00442536053119646,-0.0862911357441245,-0.0689437224618344,3.12334167767751e-68
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDH2,Cadherin-2,39868,-0.0595535596043682,0.00339904861571933,-0.0662156948911781,-0.0528914243175583,4.30287607419767e-68
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NCS1,Neuronal calcium sensor 1,40030,-0.0476068301312535,0.00272176011995244,-0.0529414799663603,-0.0422721802961467,7.0472459360465e-68
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,OCLN,Occludin,37411,-0.0728217021367822,0.00417676117582736,-0.0810081540414038,-0.0646352502321605,2.42860697001783e-67
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AGR3,Anterior gradient protein 3,39464,-0.0993822138648678,0.00571388908728251,-0.110581436475942,-0.0881829912537941,3.99623975860355e-67
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",37043,-0.0971222147054408,0.00558224676565145,-0.108063418366118,-0.086181011044764,4.75058816518177e-67
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IGSF3,Immunoglobulin superfamily member 3,39788,-0.0596088226864668,0.00343213141943867,-0.0663358002685666,-0.052881845104367,5.9757039731294e-67
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,37085,-0.0650940870177407,0.00375576939447637,-0.0724553950309144,-0.057732779004567,1.47053060032901e-66
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BPIFB1,BPI fold-containing family B member 1,39786,0.105921211149796,0.00613026284809222,0.0939058959675348,0.117936526332056,2.74945025000717e-66
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,39858,-0.0458331638958968,0.00265991515456108,-0.0510465975988365,-0.0406197301929571,6.11034000459759e-66
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FAM3B,Protein FAM3B,39788,-0.0597578254609258,0.00347866957185153,-0.0665760178217548,-0.0529396331000968,1.50167236391209e-65
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PIGR,Polymeric immunoglobulin receptor,39677,-0.0604747639557687,0.00352215063371954,-0.0673781791978591,-0.0535713487136784,1.7507828644291e-65
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BTN3A2,Butyrophilin subfamily 3 member A2,39866,-0.061119881846796,0.00356346568051611,-0.0681042745806076,-0.0541354891129845,2.33730412924948e-65
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PON1,Serum paraoxonase/arylesterase 1,37445,0.0426602149380249,0.00248718430636913,0.0377853336975414,0.0475350961785084,2.94994979885566e-65
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HJV,Hemojuvelin,37411,-0.0740038476965788,0.00431920576480826,-0.082469490995603,-0.0655382043975546,4.03292257646566e-65
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLEC4M,C-type lectin domain family 4 member M,37410,0.0804421987491962,0.00469735178226669,0.0712353892559535,0.089649008242439,4.66594456438543e-65
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NPC2,NPC intracellular cholesterol transporter 2,37268,-0.049422015470769,0.002892121434918,-0.0550905734832083,-0.0437534574583297,8.7587378551716e-65
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,S100P,Protein S100-P,39585,-0.0869074558507167,0.00509014094269372,-0.0968841320983964,-0.076930779603037,8.93230220571425e-65
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,37114,-0.0785143781443904,0.00461205111482201,-0.0875539983294415,-0.0694747579593392,2.63789126850772e-64
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,F11R,Junctional adhesion molecule A,39858,-0.0928158687418942,0.00548115723317017,-0.103558936918908,-0.0820728005648807,9.13100678190968e-64
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL16,Pro-interleukin-16,40058,-0.0675416774007454,0.00399138182738108,-0.0753647857824123,-0.0597185690190785,1.09371059807355e-63
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KYNU,Kynureninase,40058,-0.0744282582138589,0.00440703072012002,-0.0830660384252942,-0.0657904780024237,1.90700261663373e-63
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KHK,Ketohexokinase,37043,-0.106546944365884,0.00630378283090114,-0.11890235871445,-0.094191530017318,2.01912044718822e-63
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CTBS,Di-N-acetylchitobiase,37296,-0.0453901516084962,0.00268622510570601,-0.05065515281568,-0.0401251504013124,2.12126943033233e-63
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AREG,Amphiregulin,39788,-0.0764895683506974,0.00453261016640024,-0.0853734842768419,-0.067605652424553,2.42321732819544e-63
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TGFA,Protransforming growth factor alpha,39866,-0.074841685990022,0.00444737332957366,-0.0835585377159863,-0.0661248342640576,5.26788735490454e-63
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HEG1,Protein HEG homolog 1,37124,-0.0443024014519047,0.00263664574731164,-0.0494702271166355,-0.0391345757871739,1.03901912366308e-62
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,39885,-0.0474346598639831,0.00284296694839791,-0.053006875082843,-0.0418624446451232,5.62399810073985e-62
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CXCL6,C-X-C motif chemokine 6,40058,-0.123844785898348,0.00744244596142291,-0.138431979982737,-0.109257591813959,1.15565272176398e-61
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",39913,-0.0555725729497829,0.00334782991765968,-0.0621343195883959,-0.04901082631117,2.27832847104989e-61
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADAMTSL2,ADAMTS-like protein 2,37437,-0.0511876375268035,0.00308500048563008,-0.0572342384786384,-0.0451410365749685,3.16502311397006e-61
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,40009,-0.0839958700715313,0.00506731030588261,-0.0939277982710612,-0.0740639418720014,3.3270063531053e-61
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TIMP1,Metalloproteinase inhibitor 1,39698,-0.0441848087094435,0.00267431763197318,-0.0494264712681109,-0.0389431461507761,8.23483437734299e-61
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",37388,-0.0613525922668534,0.00373711486614735,-0.0686773374045022,-0.0540278471292046,5.48173098187919e-60
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EFCAB14,EF-hand calcium-binding domain-containing protein 14,37382,-0.0413138748505658,0.00252307225098785,-0.046259096462502,-0.0363686532386296,1.09188796454247e-59
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADGRG2,Adhesion G-protein coupled receptor G2,39868,0.042540931329729,0.00260212699517251,0.0374407624191909,0.0476411002402671,1.35447567974434e-59
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,39477,-0.106779233840386,0.00655752240522364,-0.119631977754624,-0.0939264899261476,3.96851867460195e-59
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PTS,6-pyruvoyl tetrahydrobiopterin synthase,39419,-0.086069760489185,0.00529525654081505,-0.0964484633091826,-0.0756910576691875,6.38370070033814e-59
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LGALS9,Galectin-9,39859,-0.049470796843645,0.00305102835728687,-0.0554508124239273,-0.0434907812633627,1.16945992290578e-58
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PXN,Paxillin,39489,-0.0811723122082326,0.00501262273061386,-0.0909970527602357,-0.0713475716562294,1.67504579798435e-58
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PSIP1,PC4 and SFRS1-interacting protein,39866,-0.0990195766514266,0.00612983418917082,-0.111034051662201,-0.0870051016406518,3.08688989048909e-58
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRSS2,Trypsin-2,39931,-0.0803653877100739,0.00498633753221459,-0.0901386092732145,-0.0705921661469333,5.50795224591488e-58
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LRP11,Low-density lipoprotein receptor-related protein 11,39868,-0.0544031503862396,0.00337696004011242,-0.06102199206486,-0.0477843087076193,6.18439044551328e-58
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AFM,Afamin,37453,-0.0297395801325917,0.00184617003322226,-0.0333580733977074,-0.0261210868674761,7.58838919472175e-58
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EGLN1,Egl nine homolog 1,39866,-0.0831641875286484,0.00517414309527088,-0.0933055079953794,-0.0730228670619175,1.11480930489246e-57
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PSME1,Proteasome activator complex subunit 1,39738,-0.0574655302397315,0.00358338815772857,-0.0644889710288795,-0.0504420894505835,2.00185376265361e-57
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ITGAV,Integrin alpha-V,40030,0.0256988958870247,0.00160337160748436,0.0225562875363553,0.028841504237694,2.25230808990982e-57
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,39788,0.0307575862290291,0.00192067730918968,0.0269930587030173,0.0345221137550408,2.85921603122053e-57
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PLA2G15,Phospholipase A2 group XV,39913,-0.0410022787358329,0.00256398038382182,-0.0460276802881237,-0.0359768771835422,4.03441722997948e-57
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GPRC5C,G-protein coupled receptor family C group 5 member C,37368,-0.088768242738312,0.00554849006400955,-0.0996432832637707,-0.0778932022128533,4.36604446920751e-57
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AGR2,Anterior gradient protein 2 homolog,39364,-0.154924804341331,0.00971535489833407,-0.173966899942066,-0.135882708740596,8.53634761523583e-57
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",39477,-0.128243709232749,0.00805606709829,-0.144033600745398,-0.112453817720101,1.30597922070533e-56
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FLI1,Friend leukemia integration 1 transcription factor,39477,-0.170101906143377,0.0106871876678267,-0.191048793972317,-0.149155018314437,1.35759275819529e-56
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,POSTN,Periostin,37437,0.0573950084455682,0.0036129186642957,0.0503136878635487,0.0644763290275878,2.54441553422492e-56
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NUCB2,Nucleobindin-2,39995,-0.0575384236432778,0.00363515374494544,-0.0646633249833709,-0.0504135223031847,5.23541204870845e-56
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EFNA4,Ephrin-A4,39720,-0.0424151773688968,0.00268448672776142,-0.0476767713553092,-0.0371535833824845,8.27534404447472e-56
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CANT1,Soluble calcium-activated nucleotidase 1,39816,-0.0305368096792039,0.00193300167120037,-0.0343254929547566,-0.0267481264036512,8.55413744996e-56
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ITGA11,Integrin alpha-11,39866,0.0521153451052057,0.00329919623856074,0.0456489204776267,0.0585817697327847,8.69455657257345e-56
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,39885,-0.0485956829718842,0.00308436381856921,-0.0546410360562798,-0.0425503298874885,1.64305952333235e-55
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GPD1,Glycerol-3-phosphate dehydrogenase,37368,-0.0800390692834454,0.00509306444324095,-0.0900214755921976,-0.0700566629746931,3.6569967472846e-55
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CXCL10,C-X-C motif chemokine 10,39931,-0.100012367396623,0.00639261750143359,-0.112541897699433,-0.0874828370938133,9.11256681260678e-55
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IGFBP2,Insulin-like growth factor-binding protein 2,40012,0.0941087821824354,0.00602381438864877,0.0823021059806838,0.105915458384187,1.2783650112825e-54
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VEGFA,Vascular endothelial growth factor A,39993,-0.0863002541565365,0.00553002005434729,-0.0971390934630572,-0.0754614148500158,1.66431484089899e-54
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SHBG,Sex hormone-binding globulin,37445,0.0782461839690318,0.00502247357334157,0.0684021357652823,0.0880902321727813,2.96842402519953e-54
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SRP14,Signal recognition particle 14 kDa protein,39788,-0.0900607807252186,0.00579013086437697,-0.101409437219397,-0.0787121242310397,3.72855678744775e-54
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GGT1,Glutathione hydrolase 1 proenzyme,39826,-0.0749688593920812,0.00482199841609901,-0.0844199762876353,-0.0655177424965272,4.13888627294871e-54
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SPINK1,Serine protease inhibitor Kazal-type 1,39858,-0.0604651835125904,0.0038927217541643,-0.0680949181507525,-0.0528354488744284,5.15330983658809e-54
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SULT2A1,Bile salt sulfotransferase,39866,-0.084149527673961,0.00541979253032597,-0.0947723210333998,-0.0735267343145221,5.69569718462541e-54
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TFPI,Tissue factor pathway inhibitor,39843,0.0472109674017776,0.00305302488707607,0.0412270386231085,0.0531948961804467,1.49039249111396e-53
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RELT,Tumor necrosis factor receptor superfamily member 19L,39858,-0.0398793874311549,0.00258049959604031,-0.044937166639394,-0.0348216082229159,1.72296135172891e-53
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AGRN,Agrin,39931,-0.0485441426606768,0.00316489237090712,-0.0547473317076548,-0.0423409536136989,1.00194309297056e-52
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,OMD,Osteomodulin,39931,0.0646748385805942,0.004219213080422,0.0564051809429671,0.0729444962182213,1.16038625983581e-52
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LBR,Delta(14)-sterol reductase LBR,40009,-0.0991752198684883,0.0064789503331022,-0.111873962521369,-0.086476477215608,1.59743323813625e-52
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RRM2,Ribonucleoside-diphosphate reductase subunit M2,39477,-0.0752959814856964,0.00493645346079493,-0.0849714302688545,-0.0656205327025384,3.73284990833277e-52
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,39749,-0.10938378546626,0.00718909342445118,-0.123474408578185,-0.0952931623543361,6.50557618355172e-52
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SCARB2,Lysosome membrane protein 2,39486,-0.0424657900689563,0.00279425112883163,-0.0479425222814663,-0.0369890578564463,8.60910848007749e-52
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,39788,-0.0575973037673107,0.00380014428357283,-0.0650455865631134,-0.0501490209715079,1.56746614756981e-51
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MEGF9,Multiple epidermal growth factor-like domains protein 9,40002,-0.0310494103686816,0.0020549249510338,-0.0350770632727078,-0.0270217574646553,3.12919551261467e-51
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RNASE6,Ribonuclease K6,37386,-0.0407017279451768,0.00269332418675755,-0.0459806433512216,-0.035422812539132,3.52673841556993e-51
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GAST,Gastrin,37388,-0.170732267799463,0.0113105968607514,-0.192901037646536,-0.148563497952391,4.55662552609094e-51
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDHR2,Cadherin-related family member 2,39788,-0.106790417665913,0.00708268238735216,-0.120672475145123,-0.0929083601867028,5.1083657285292e-51
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",39763,-0.152543798589745,0.0101410605862041,-0.172420277338705,-0.132667319840785,8.68283738861799e-51
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RNASE4,Ribonuclease 4,37051,-0.0381034304907865,0.00253362878828722,-0.0430693429158294,-0.0331375180657435,1.07101274789966e-50
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SERPIND1,Heparin cofactor 2,37424,-0.0412529431327,0.00274410295860699,-0.0466313849315697,-0.0358745013338303,1.13650956904458e-50
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DMP1,Dentin matrix acidic phosphoprotein 1,37043,0.0884043641111201,0.00590642875451726,0.0768277637522662,0.0999809644699739,3.09540907434631e-50
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ELOA,Elongin-A,39788,-0.0741418436281966,0.00496276495116173,-0.0838688629324736,-0.0644148243239196,3.97656395101179e-50
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SMNDC1,Survival of motor neuron-related-splicing factor 30,37382,-0.0868307642928414,0.00581653558608569,-0.0982311740415693,-0.0754303545441134,5.39601477477982e-50
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MET,Hepatocyte growth factor receptor,39879,0.0281559606539166,0.00189650091384256,0.0244388188627852,0.031873102445048,1.56976227483908e-49
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,B4GALT1,"Beta-1,4-galactosyltransferase 1",39931,-0.0386650973505041,0.00260874600140387,-0.0437782395132557,-0.0335519551877526,2.25916837442443e-49
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LATS1,Serine/threonine-protein kinase LATS1,37056,-0.124016936949729,0.00839007615449789,-0.140461486212545,-0.107572387686913,4.76384582285606e-49
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD2AP,CD2-associated protein,39868,-0.0907058656685474,0.00615297702888652,-0.102765700645165,-0.0786460306919298,7.26607408943511e-49
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ALDH1A1,Retinal dehydrogenase 1,39858,-0.0748314275241726,0.00510362735839725,-0.0848345371466312,-0.064828317901714,2.31157977855352e-48
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,39749,-0.0552058424036174,0.00376742484256277,-0.0625899950950405,-0.0478216897121944,2.64483967326362e-48
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,APOC1,Apolipoprotein C-I,37424,0.0534538624697737,0.00364900706636456,0.0463018086196992,0.0606059163198482,3.19699321754126e-48
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD209,CD209 antigen,39885,0.0551969747184522,0.00377184943161315,0.0478041498324904,0.062589799604414,3.49095487592026e-48
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GRPEL1,"GrpE protein homolog 1, mitochondrial",39788,-0.0868344275145328,0.00595845793769053,-0.0985130050724063,-0.0751558499566594,8.43316398407088e-48
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CRHBP,Corticotropin-releasing factor-binding protein,39862,-0.0396395984176344,0.002722328369522,-0.0449753620218976,-0.0343038348133713,1.00528211924371e-47
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VSIG4,V-set and immunoglobulin domain-containing protein 4,39831,-0.0538068625145787,0.00369897166414812,-0.061056846976309,-0.0465568780528483,1.24055730676796e-47
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AP3S2,AP-3 complex subunit sigma-2,37388,-0.0666471851267852,0.00458739889833807,-0.0756384869675279,-0.0576558832860426,1.82486370450644e-47
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EGFR,Epidermal growth factor receptor,40052,0.0226020364694401,0.00155762163034837,0.0195490980739573,0.0256549748649229,2.05926083957425e-47
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PAXX,Protein PAXX,37124,-0.0650639899871261,0.00448331480685303,-0.0738512870085581,-0.0562766929656942,2.32847884646417e-47
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLEC4D,C-type lectin domain family 4 member D,39866,-0.0853328270048555,0.00588525028955473,-0.0968679175723827,-0.0737977364373282,2.43730848147587e-47
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CPA1,Carboxypeptidase A1,40052,-0.0829791487075538,0.00574492847183518,-0.0942392085123507,-0.0717190889027568,5.36725033761108e-47
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FUOM,Fucose mutarotase,37124,-0.0894629865492693,0.00619404481691664,-0.101603314390426,-0.0773226587081127,6.26228570224973e-47
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GPKOW,G-patch domain and KOW motifs-containing protein,39489,-0.0381200431968565,0.00264302671622517,-0.0433003755606578,-0.0329397108330552,7.42738653348967e-47
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GSN,Gelsolin,37383,0.026255304018001,0.00182015500518926,0.0226878002078301,0.0298228078281719,8.0446962971669e-47
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SORD,Sorbitol dehydrogenase,39963,-0.0958866447230952,0.00665232345008386,-0.10892519868526,-0.0828480907609309,8.2628619358122e-47
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MLN,Promotilin,39866,-0.124050037497634,0.00865269772642454,-0.141009325041426,-0.107090749953842,2.50287630779216e-46
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,39858,-0.0484667726081325,0.00338107485341691,-0.0550936793208296,-0.0418398658954354,2.57045302434453e-46
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LAT2,Linker for activation of T-cells family member 2,39788,-0.173081002027921,0.0120960072934984,-0.196789176323178,-0.149372827732664,3.71856706800539e-46
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FGF23,Fibroblast growth factor 23,40008,-0.0811455604250952,0.00567289487743573,-0.0922644343848692,-0.0700266864653212,3.94850341634937e-46
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CREG1,Protein CREG1,39660,-0.0521309540911208,0.00364851014331036,-0.0592820339720091,-0.0449798742102325,5.01059256708651e-46
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HLA_E,,39866,-0.0379772602904387,0.00266033870036238,-0.043191524143149,-0.0327629964377285,5.96828854316502e-46
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,OSM,Oncostatin-M,39785,-0.0990541755084647,0.00694063496101236,-0.112657820032049,-0.0854505309848805,6.3115664962109e-46
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SIAE,Sialate O-acetylesterase,39875,-0.0653586081349711,0.00458069283873117,-0.0743367660988842,-0.056380450171058,6.59417118469402e-46
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,STC1,Stanniocalcin-1,40009,-0.0579467585953723,0.00407085110285466,-0.0659256267569674,-0.0499678904337771,1.05678111986451e-45
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CFI,Complement factor I,37453,-0.0276769409501311,0.00194648692560029,-0.0314920553243077,-0.0238618265759546,1.48292183145349e-45
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",39788,-0.0607345610600527,0.00427974929688686,-0.0691228696819509,-0.0523462524381544,1.96635446915771e-45
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD27,CD27 antigen,39913,-0.0534799484200997,0.0037767013681255,-0.0608822831016257,-0.0460776137385738,3.01197432763102e-45
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EEF1D,Elongation factor 1-delta,37437,-0.125977868113153,0.00889491353349584,-0.143411898638805,-0.108543837587502,3.26068992649545e-45
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDCP1,CUB domain-containing protein 1,39749,-0.0685208222259333,0.00484579631289584,-0.0780185829992092,-0.0590230614526575,4.02743673305083e-45
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NCAM2,Neural cell adhesion molecule 2,39858,0.0366309597578319,0.00259557161336968,0.0315436393956274,0.0417182801200365,5.88827100491272e-45
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CHMP6,Charged multivesicular body protein 6,37437,-0.0780237869171537,0.0055276979981226,-0.088858074993474,-0.0671894988408334,6.37250269794299e-45
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SMAD2,Mothers against decapentaplegic homolog 2,37368,-0.0952585970432688,0.00675844124851742,-0.108505141890363,-0.0820120521961746,8.49336215502288e-45
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MYH9,Myosin-9,37437,-0.152766507036084,0.0108507312631599,-0.174033940311877,-0.131499073760291,1.05560059818611e-44
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADM,Pro-adrenomedullin,40030,-0.0359586735424309,0.00255668985843812,-0.0409697856649696,-0.0309475614198922,1.15000543927857e-44
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,XCL1,Lymphotactin,40030,-0.0748192449030016,0.00532706472566342,-0.0852602917653019,-0.0643781980407013,1.50810496464625e-44
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SNAP29,Synaptosomal-associated protein 29,39913,-0.124315569196664,0.0088634301279792,-0.141687892247503,-0.106943246145825,1.98607783921061e-44
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DNAJC6,Putative tyrosine-protein phosphatase auxilin,37043,-0.116154003430407,0.00829213940600454,-0.132406596666175,-0.0999014101946376,2.90219297736086e-44
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ABL1,Tyrosine-protein kinase ABL1,39788,-0.092861907829493,0.00664488572875256,-0.105885883857848,-0.079837931801138,4.03894765682569e-44
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PVR,Poliovirus receptor,40009,-0.0504861049247722,0.00361354016996012,-0.0575686436578941,-0.0434035661916504,4.20992371551102e-44
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,39429,-0.118027886685598,0.00845367555504656,-0.13459709077349,-0.101458682597707,4.91850492822841e-44
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CALCA,Calcitonin,39713,-0.0826334545555252,0.00592192159606601,-0.0942404208838145,-0.0710264882272358,5.42826410629031e-44
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EZR,Ezrin,40009,-0.0325535962066971,0.0023337950993217,-0.0371278346013676,-0.0279793578120266,5.75809908712076e-44
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FAM3C,Protein FAM3C,39846,-0.0392409885622216,0.00281458013916417,-0.0447575656349834,-0.0337244114894598,6.35915636521355e-44
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AGXT,Serine--pyruvate aminotransferase,39868,-0.105528779336273,0.00756989951387126,-0.12036578238346,-0.0906917762890851,6.48387585003455e-44
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL18BP,Interleukin-18-binding protein,39931,-0.0399313471551933,0.00287512651331397,-0.0455665951212887,-0.0342960991890979,1.32761859663569e-43
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EPO,Erythropoietin,39866,-0.104102329939007,0.00750165772627394,-0.118805579082503,-0.0893990807955096,1.55529319207386e-43
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CNTN1,Contactin-1,40052,0.035901295890174,0.00258916324593407,0.0308265359281432,0.0409760558522048,1.80433715288992e-43
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NUMB,Protein numb homolog,37056,-0.114467426575272,0.00825292872733924,-0.130643166880857,-0.0982916862696868,1.94415980194321e-43
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GZMA,Granzyme A,40058,-0.045533899256972,0.00328665237918393,-0.0519757379201725,-0.0390920605937715,2.12207500123223e-43
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SELPLG,P-selectin glycoprotein ligand 1,39866,-0.0374423339603191,0.00270320855975518,-0.0427406227374392,-0.0321440451831989,2.23013234061226e-43
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ERP44,Endoplasmic reticulum resident protein 44,39758,-0.0348788007178128,0.00252737402336249,-0.0398324538036033,-0.0299251476320224,4.48894437821793e-43
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,39979,-0.077130622162803,0.00558955824970914,-0.088086156332233,-0.0661750879933731,4.53774487659601e-43
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NPL,N-acetylneuraminate lyase,37437,-0.0591394842935613,0.00428951374332975,-0.0675469312304876,-0.050732037356635,5.94162002397739e-43
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ZBTB16,Zinc finger and BTB domain-containing protein 16,39477,-0.0950905196752211,0.00690051940668779,-0.108615537712329,-0.081565501638113,5.98141437826642e-43
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADH1B,All-trans-retinol dehydrogenase,37124,-0.101847667188426,0.00739777489126438,-0.116347305975304,-0.0873480284015475,7.89221416539472e-43
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,YTHDF3,YTH domain-containing family protein 3,39587,-0.113922578501507,0.00828647374367487,-0.130164067039109,-0.097681089963904,9.24974703529429e-43
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ENO3,Beta-enolase,37043,-0.0811005476139605,0.00589956480192633,-0.0926636946257361,-0.0695374006021849,1.04756628175108e-42
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SEL1L,Protein sel-1 homolog 1,37043,-0.0420598135325721,0.00306026896793722,-0.048057940709729,-0.0360616863554151,1.09186522096408e-42
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDH1,Cadherin-1,39315,-0.0537807420061479,0.0039217573731204,-0.0614673864574639,-0.0460940975548319,1.49720413205124e-42
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DTYMK,Thymidylate kinase,37437,-0.0917979231509841,0.00669469569209378,-0.104919526707488,-0.0786763195944803,1.65056686527858e-42
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DCTN1,Dynactin subunit 1,40030,-0.086542085854797,0.00631766595133706,-0.0989247111194176,-0.0741594605901763,1.79097916610483e-42
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL18,Interleukin-18,39795,-0.0605723429493104,0.00442195488213484,-0.0692393745182947,-0.0519053113803262,1.81360551556086e-42
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLEC4A,C-type lectin domain family 4 member A,39866,0.0462312792997756,0.00337792483246926,0.0396105466281358,0.0528520119714154,2.12412131088182e-42
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,39788,-0.0574006736711018,0.00424238789051396,-0.0657157539365092,-0.0490855934056945,1.75670022995441e-41
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,37056,-0.0590216018353221,0.0043709723639175,-0.0675887076686005,-0.0504544960020438,2.81844442650546e-41
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ERMAP,Erythroid membrane-associated protein,37056,-0.0585306745641957,0.0043476450588981,-0.067052058879636,-0.0500092902487554,4.84192150299377e-41
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PILRA,Paired immunoglobulin-like type 2 receptor alpha,39858,-0.0542276676108205,0.00403712539959351,-0.0621404333940238,-0.0463149018276172,6.52044808866524e-41
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,APLP1,Amyloid-like protein 1,39868,0.0668603421122603,0.00497955999801591,0.0571004045161491,0.0766202797083715,6.99544130306353e-41
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BECN1,Beclin-1,37043,-0.0793762979222268,0.00591666362485209,-0.0909729586269369,-0.0677796372175168,9.05264674045103e-41
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",37437,-0.0989096224331728,0.00738107566971632,-0.113376530745817,-0.0844427141205288,1.08995468535601e-40
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD79B,B-cell antigen receptor complex-associated protein beta chain,40058,-0.0545106543909517,0.00407040902344058,-0.0624886560768952,-0.0465326527050081,1.10934903782534e-40
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HYOU1,Hypoxia up-regulated protein 1,40052,-0.0279587525049873,0.00208838473198107,-0.0320519865796702,-0.0238655184303044,1.17329765490473e-40
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IDUA,Alpha-L-iduronidase,40030,-0.0596227155867636,0.00445939477452484,-0.0683631293448322,-0.0508823018286949,1.48397382569766e-40
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,39931,0.0499561378856983,0.00374242737047382,0.0426209802395696,0.057291295531827,1.98175509235659e-40
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GFRA1,GDNF family receptor alpha-1,40011,-0.0348517904526386,0.00261390847913546,-0.0399750510717441,-0.0297285298335331,2.42456821647588e-40
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PARP1,Poly [ADP-ribose] polymerase 1,39866,-0.0709551947740386,0.00532291268330828,-0.0813881036333228,-0.0605222859147544,2.53631968739579e-40
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,THBS2,Thrombospondin-2,39858,-0.0466774679244853,0.00350219977281961,-0.0535417794792117,-0.0398131563697588,2.60861920045524e-40
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FUS,RNA-binding protein FUS,39455,-0.0508715184499403,0.00382060896369237,-0.0583599120187774,-0.0433831248811033,3.13894025036064e-40
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,YES1,Tyrosine-protein kinase Yes,39788,-0.14759272753222,0.0110859040575142,-0.169321099484948,-0.125864355579492,3.16762956510062e-40
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD274,Programmed cell death 1 ligand 1,39749,-0.0432122686354826,0.00326156675424056,-0.0496049394737941,-0.0368195977971711,7.44654523629659e-40
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RNF149,E3 ubiquitin-protein ligase RNF149,37043,-0.0381548374562189,0.00287933677395492,-0.0437983375331706,-0.0325113373792673,7.97375980707587e-40
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PLAUR,Urokinase plasminogen activator surface receptor,39757,-0.0343922757774264,0.00260228205477199,-0.0394927486047795,-0.0292918029500733,1.14538648658381e-39
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BCAN,Brevican core protein,39749,0.0426911496694987,0.00323620525754455,0.0363481873647114,0.049034111974286,1.57988623358412e-39
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RBKS,Ribokinase,39504,-0.0636272305884054,0.00482306938395027,-0.0730804465809479,-0.0541740145958629,1.58048038273458e-39
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CKB,Creatine kinase B-type,37437,0.0746162625945059,0.00567041340381738,0.0635022523230238,0.085730272865988,2.63267081607816e-39
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,39931,-0.0543799737253584,0.00414077936277095,-0.0624959012763894,-0.0462640461743273,3.40047739058932e-39
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CEP20,Centrosomal protein 20,39477,-0.094402960844763,0.00718795870147644,-0.108491359899657,-0.0803145617898691,3.41503332224605e-39
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NFKBIE,NF-kappa-B inhibitor epsilon,39477,-0.0629266614803556,0.00479819151709235,-0.0723311168538566,-0.0535222061068546,4.36644351527962e-39
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SH2D1A,SH2 domain-containing protein 1A,39866,-0.0721242447088298,0.00550133089401282,-0.082906853261095,-0.0613416361565647,4.56785673870184e-39
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SERPINA5,Plasma serine protease inhibitor,37283,-0.0405717229627447,0.00310575822996236,-0.0466590090934709,-0.0344844368320184,9.18461377665736e-39
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KRT19,"Keratin, type I cytoskeletal 19",39842,-0.082991377443076,0.00635870315992537,-0.0954544356365297,-0.0705283192496223,9.81516692712838e-39
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TOP2B,DNA topoisomerase 2-beta,37056,-0.10143589206536,0.00776777240439364,-0.116660725977971,-0.0862110581527484,9.86967659180658e-39
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCL21,C-C motif chemokine 21,39931,-0.0496063203577196,0.00380507748810912,-0.0570642722344135,-0.0421483684810257,1.18561508030539e-38
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,APOA1,Apolipoprotein A-I,37453,0.034716971942146,0.00266580335426498,0.0294919973677866,0.0399419465165054,1.53794163169439e-38
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DKK1,Dickkopf-related protein 1,40009,-0.0753898290515054,0.00580436548451168,-0.0867663854011483,-0.0640132727018625,2.2146075023068e-38
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IMMT,MICOS complex subunit MIC60,37368,-0.0554872478799151,0.00428201096211478,-0.06387998936566,-0.0470945063941701,3.56367680388273e-38
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FSTL3,Follistatin-related protein 3,39803,-0.037701909575008,0.0029169906275038,-0.0434192112049154,-0.0319846079451005,5.05411619849047e-38
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PSME2,Proteasome activator complex subunit 2,39666,-0.0454260542441541,0.00352037950105379,-0.0523259980662196,-0.0385261104220887,6.66227718706853e-38
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HEPH,Hephaestin,37437,-0.0331360150505321,0.00256913935100112,-0.0381715281784943,-0.0281005019225699,7.73302674194105e-38
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SCAMP3,Secretory carrier-associated membrane protein 3,39788,-0.105877012233797,0.00822273946693671,-0.121993581588993,-0.0897604428786008,9.46377789308671e-38
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DNER,Delta and Notch-like epidermal growth factor-related receptor,39821,0.0317733729061869,0.00246855545229056,0.0269350042196974,0.0366117415926764,1.00659983978585e-37
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ULBP2,UL16-binding protein 2,39749,-0.0456574160766499,0.00355077484298696,-0.0526169347689043,-0.0386978973843955,1.18829322438447e-37
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,37021,-0.0702753100028837,0.0054768257056281,-0.0810098883859148,-0.0595407316198527,1.83401969476585e-37
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,YOD1,Ubiquitin thioesterase OTU1,37021,-0.0767095023562254,0.00598528648472721,-0.0884406638662907,-0.0649783408461601,2.2216520646923e-37
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PBLD,Phenazine biosynthesis-like domain-containing protein,39489,-0.064246279631584,0.00501571854304543,-0.074077087975953,-0.0544154712872149,2.25111643219185e-37
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IPCEF1,Interactor protein for cytohesin exchange factors 1,39720,-0.111492766340746,0.00870776215756505,-0.128559980169574,-0.0944255525119189,2.38894864869688e-37
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FYB1,FYN-binding protein 1,39836,-0.114212760721272,0.00892243458056525,-0.13170073249918,-0.0967247889433644,2.48109113339361e-37
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,THOP1,Thimet oligopeptidase,39798,-0.0378539684730666,0.0029604153057576,-0.0436563824723515,-0.0320515544737817,2.96543145457761e-37
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PLAT,Tissue-type plasminogen activator,40002,-0.0616341471086287,0.00482070518936984,-0.0710827292797936,-0.0521855649374638,3.00329564265449e-37
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MZB1,Marginal zone B- and B1-cell-specific protein,39908,-0.0610925417130663,0.00478030337338523,-0.0704619363249014,-0.0517231471012313,3.2183145186869e-37
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,COL6A3,Collagen alpha-3(VI) chain,40052,-0.0397261488959172,0.00311387133208364,-0.0458293367068011,-0.0336229610850332,4.25549240636962e-37
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SUOX,"Sulfite oxidase, mitochondrial",37411,-0.0783252376173688,0.00613706231911831,-0.0903538797628407,-0.0662965954718969,4.33227371476499e-37
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CES3,Carboxylesterase 3,39788,-0.0853998520657651,0.00669715141465246,-0.0985262688384839,-0.0722734352930463,4.63148032290193e-37
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TXLNA,Alpha-taxilin,39749,-0.110424125388329,0.00867398133040784,-0.127425128795929,-0.0934231219807301,6.06470917359352e-37
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCL3,C-C motif chemokine 3,39866,-0.0777502797743397,0.00610759477198464,-0.0897211655274296,-0.0657793940212498,6.07739347684191e-37
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CPE,Carboxypeptidase E,39906,0.0477498571018266,0.00375244936557068,0.040395056345308,0.0551046578583451,6.47785011985631e-37
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ARF6,ADP-ribosylation factor 6,37382,-0.132190602665737,0.0103922238815061,-0.152559361473489,-0.111821843857985,7.43096472426973e-37
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,39866,0.0479894086772916,0.0037760154324643,0.0405884184296616,0.0553903989249217,7.93889124102797e-37
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD72,B-cell differentiation antigen CD72,37124,-0.0515440138418125,0.00405686797530958,-0.0594954750734192,-0.0435925526102057,9.04067089075245e-37
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TIMP4,Metalloproteinase inhibitor 4,39858,0.0484410247817045,0.00381575350385022,0.040962147914158,0.0559199016492509,9.47911019208797e-37
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL12A_IL12B,Interleukin-12,39788,-0.0908971144033451,0.00716630621100697,-0.104943074576919,-0.0768511542297715,1.09197519807448e-36
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AP1G2,AP-1 complex subunit gamma-like 2,37368,-0.0989720220850165,0.00780310181693996,-0.114266101646219,-0.0836779425238142,1.17836798205679e-36
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ASPN,Asporin,37437,0.0333859894121439,0.00263276110503397,0.0282257776462773,0.0385462011780105,1.21618800883313e-36
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HAVCR1,Hepatitis A virus cellular receptor 1,40003,-0.0738751738581792,0.00583303553936999,-0.0853079235153444,-0.062442424201014,1.38046062937454e-36
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",39885,0.0409027058554606,0.00323503199653358,0.0345620431422548,0.0472433685686664,1.81059006489234e-36
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,39931,-0.0510386510674663,0.00404057177227977,-0.0589581717411346,-0.0431191303937979,2.10713080446806e-36
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",37043,-0.0863840498733156,0.0068475629467239,-0.0998052732488945,-0.0729628264977368,2.81722333875758e-36
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BMPER,BMP-binding endothelial regulator protein,37124,-0.0277001326265653,0.00219605830590985,-0.0320044069061486,-0.023395858346982,2.87060074417349e-36
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LAT,Linker for activation of T-cells family member 1,40058,-0.092862886150144,0.00738167200067398,-0.107330963271465,-0.078394809028823,4.00349770753196e-36
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CHL1,Neural cell adhesion molecule L1-like protein,39900,0.0381873312528724,0.00303691240677207,0.0322349829355991,0.0441396795701456,4.3219371438669e-36
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CTSS,Cathepsin S,36543,-0.0299540299704964,0.00238237687387832,-0.0346234886432979,-0.0252845712976949,4.86416958870339e-36
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CXCL17,C-X-C motif chemokine 17,40058,-0.0524643621461816,0.00417596876996355,-0.0606492609353102,-0.044279463357053,4.94121751510548e-36
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TTR,Transthyretin,37309,-0.0308759020387569,0.00245905501772911,-0.0356956498735059,-0.0260561542040078,5.86186314887028e-36
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,STAB2,Stabilin-2,37437,-0.0343294961858106,0.00273428248356323,-0.0396886898535945,-0.0289703025180267,5.89440003053289e-36
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SNAPIN,SNARE-associated protein Snapin,37411,-0.0711868597554264,0.00567160806649533,-0.0823032115657572,-0.0600705079450955,6.18392347275555e-36
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PDCD5,Programmed cell death protein 5,40009,-0.0706918589518336,0.0056381828590916,-0.0817426973556531,-0.0596410205480141,6.79196157215117e-36
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",39788,-0.119074997367598,0.00950000592612559,-0.137695008982804,-0.100454985752392,7.16492762432383e-36
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PTGDS,Prostaglandin-H2 D-isomerase,39762,-0.034613392546495,0.00276218914752788,-0.0400272832756497,-0.0291995018173404,7.44850588074538e-36
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CTSE,Cathepsin E,37124,-0.0647099284016401,0.00516226382187707,-0.0748279654925191,-0.054591891310761,7.64942770769905e-36
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SARG,Specifically androgen-regulated gene protein,37390,-0.134029696589245,0.0106945923911785,-0.154991097675955,-0.113068295502536,7.84052013287149e-36
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,37366,-0.100261480724306,0.008009957343641,-0.115960997117842,-0.0845619643307693,9.502769581505e-36
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CXCL9,C-X-C motif chemokine 9,39931,-0.0791845878113333,0.00633862467033929,-0.0916082921651983,-0.0667608834574683,1.2026957411846e-35
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,39585,-0.0584583090947228,0.00468033987175997,-0.0676317752433724,-0.0492848429460733,1.24655192144342e-35
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SERPINE1,Plasminogen activator inhibitor 1,40052,-0.0821681723996051,0.00658368041706826,-0.0950721860170589,-0.0692641587821513,1.3891731990754e-35
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PLXNB2,Plexin-B2,39984,-0.0286128938450052,0.00229485736406528,-0.0331108142785731,-0.0241149734114372,1.62162382339615e-35
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SHISA5,Protein shisa-5,37437,-0.0278776475953362,0.00223533425147542,-0.032258902728228,-0.0234963924624443,1.67417179579371e-35
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PNLIPRP1,Inactive pancreatic lipase-related protein 1,37388,-0.0941980701724406,0.00755586330806267,-0.109007562256243,-0.0793885780886378,1.77251498310894e-35
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCL7,C-C motif chemokine 7,39866,-0.0704188274224415,0.00567116836550007,-0.0815343174188216,-0.0593033374260613,3.07146739155359e-35
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD248,Endosialin,37437,0.0478679410127268,0.00386881697639162,0.0402850597389992,0.0554508222864544,5.66365078707124e-35
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD40,Tumor necrosis factor receptor superfamily member 5,39859,-0.060500779223612,0.00489826760339535,-0.0701013837262669,-0.0509001747209571,6.8980443416708e-35
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SERPINH1,Serpin H1,37169,-0.155281658554824,0.0125712306261924,-0.179921270582161,-0.130642046527487,7.36192507876169e-35
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PALM2,Paralemmin-2,37388,-0.0456357439282372,0.00369575390681464,-0.0528794215855939,-0.0383920662708805,7.67746183020547e-35
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CRELD2,Protein disulfide isomerase CRELD2,39908,-0.0624809230102067,0.00506400826047689,-0.0724063792007414,-0.052555466819672,8.10887598489325e-35
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HAVCR2,Hepatitis A virus cellular receptor 2,39858,-0.040355230995483,0.0032718009647136,-0.0467679608863217,-0.0339425011046444,8.52517353621415e-35
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NCAN,Neurocan core protein,40009,0.0440087903806863,0.00357016925086043,0.0370112586489998,0.0510063221123727,9.31116916417555e-35
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SORCS2,VPS10 domain-containing receptor SorCS2,39477,-0.0409769335781466,0.00332926362577291,-0.0475022902846615,-0.0344515768716317,1.18580624103264e-34
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ARSA,Arylsulfatase A,39858,-0.0535662346415826,0.00437588021515444,-0.0621429598632853,-0.0449895094198799,2.66449695031634e-34
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CGREF1,Cell growth regulator with EF hand domain protein 1,39868,-0.0497929536310271,0.00407492086179343,-0.0577797985201422,-0.0418061087419119,3.47876725226103e-34
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TGFBR2,TGF-beta receptor type-2,39913,-0.0353217842777121,0.00289699467009936,-0.0409998938311068,-0.0296436747243173,4.81643014170305e-34
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SIRPB1,Signal-regulatory protein beta-1,39835,-0.0524404317697548,0.00430599274666388,-0.060880177553216,-0.0440006859862936,5.7252775761419e-34
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FMNL1,Formin-like protein 1,39489,-0.0721965708200965,0.00593012941790847,-0.0838196244791971,-0.0605735171609959,6.05190849588136e-34
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,WFDC2,WAP four-disulfide core domain protein 2,39017,-0.0424420514929537,0.00348628740368401,-0.0492751748041744,-0.0356089281817331,6.15867597741033e-34
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MDK,Midkine,39843,-0.0598742306432859,0.00492130387827201,-0.069519986244699,-0.0502284750418728,6.63348846584557e-34
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CXCL11,C-X-C motif chemokine 11,40009,-0.0920175093500922,0.00757060213149174,-0.106855889527816,-0.0771791291723684,7.62295146691527e-34
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RETN,Resistin,39790,-0.0482002228932444,0.00396819436597504,-0.0559778838505554,-0.0404225619359333,8.43248999878505e-34
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LAMP2,Lysosome-associated membrane glycoprotein 2,39383,-0.0227205517016618,0.00187412588167194,-0.0263938384297388,-0.0190472649735848,1.12879862782206e-33
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL12B,Interleukin-12 subunit beta,40058,-0.0617463238728796,0.00509472358930687,-0.0717319821079211,-0.0517606656378382,1.16229274359139e-33
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CNTN3,Contactin-3,39858,-0.038504957506661,0.00317721311867472,-0.0447322952192635,-0.0322776197940586,1.17512105756604e-33
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,39862,-0.0443563017170673,0.00366924606353896,-0.0515480240016036,-0.0371645794325309,1.69674530368947e-33
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PSMG3,Proteasome assembly chaperone 3,39866,-0.0583836231764654,0.00483679518759319,-0.0678637417441481,-0.0489035046087828,2.10620133229213e-33
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NT5C1A,Cytosolic 5'-nucleotidase 1A,37388,-0.0361033451761185,0.00299318696201463,-0.0419699916216672,-0.0302366987305699,2.49034550382923e-33
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FEN1,Flap endonuclease 1,39477,-0.0732069010505568,0.00607406172137361,-0.085112062024449,-0.0613017400766645,2.648159518119e-33
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",37358,-0.128129157806061,0.0106730474481509,-0.149048330804437,-0.107209984807685,4.93080737640742e-33
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ZBTB17,Zinc finger and BTB domain-containing protein 17,39585,-0.0472270853765801,0.00393682462178685,-0.0549432616352823,-0.0395109091178779,5.18114210920945e-33
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SBSN,Suprabasin,37420,0.0397455269721208,0.00331407213761105,0.0332499455824032,0.0462411083618385,5.67931569052395e-33
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SNCA,Alpha-synuclein,37124,-0.136111986683967,0.0113490825411692,-0.158356188464659,-0.113867784903276,5.71026430616818e-33
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,39841,-0.0716500753790344,0.00597822436046138,-0.0833673951255387,-0.05993275563253,5.88316376710939e-33
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TDRKH,Tudor and KH domain-containing protein,39489,-0.0994086747525508,0.00830097387637998,-0.115678583550256,-0.083138765954846,6.64936186964074e-33
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDC27,Cell division cycle protein 27 homolog,39477,-0.0715186339601796,0.00597302354161153,-0.0832257601017382,-0.059811507818621,6.80676156433769e-33
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ASAH2,Neutral ceramidase,39749,-0.0609104084621269,0.00509686827090141,-0.0709002702730936,-0.0509205466511601,8.91229992539432e-33
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DNAJA2,DnaJ homolog subfamily A member 2,40009,-0.0956136181241221,0.00800902921115792,-0.111311315377992,-0.0799159208702526,1.02699281533693e-32
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,39788,-0.0325066216007921,0.00272696562255116,-0.0378514742209924,-0.0271617689805918,1.27484396105383e-32
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MFAP5,Microfibrillar-associated protein 5,40052,-0.0466237441807141,0.00391581577771205,-0.0542987431050297,-0.0389487452563985,1.49649996173054e-32
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CEP85,Centrosomal protein of 85 kDa,39477,-0.0740671938530156,0.00622108749446711,-0.0862605253421712,-0.0618738623638601,1.52626528791547e-32
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NAA80,N-alpha-acetyltransferase 80,37039,-0.140766719046124,0.0118284229177466,-0.163950427964908,-0.117583010127341,1.72111635711186e-32
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AKR7L,Aflatoxin B1 aldehyde reductase member 4,37056,-0.0820796956951878,0.00689737843597734,-0.0955985574297034,-0.0685608339606723,1.73230934045272e-32
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SPINT2,Kunitz-type protease inhibitor 2,39931,-0.0475578232735321,0.00399848413619798,-0.0553948521804801,-0.039720794366584,1.74131714137947e-32
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MTSS2,Protein MTSS 2,37368,-0.115716953919955,0.00973965602383883,-0.134806679726679,-0.0966272281132308,2.15379415465258e-32
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCL5,C-C motif chemokine 5,39931,-0.116747299798969,0.00984104565704822,-0.136035749286783,-0.0974588503111544,2.50478994960088e-32
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,37382,-0.163361249478105,0.0137787904749904,-0.190367678809086,-0.136354820147123,2.89434350044387e-32
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BST2,Bone marrow stromal antigen 2,40009,-0.0613518146444781,0.00517887800384766,-0.0715024155320195,-0.0512012137569367,3.04965995568041e-32
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SIGLEC7,Sialic acid-binding Ig-like lectin 7,39868,-0.0323225733427355,0.00273387730813291,-0.037680972866676,-0.026964173818795,4.03965169014659e-32
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCN4,CCN family member 4,40030,-0.0459936237314934,0.00389819164208568,-0.0536340793499813,-0.0383531681130054,5.36186576742586e-32
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,INSL5,Insulin-like peptide INSL5,37382,-0.11177070195367,0.00947388344502095,-0.130339513505912,-0.0932018904014294,5.74947994398291e-32
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IGF2R,Cation-independent mannose-6-phosphate receptor,39858,-0.0269292179240164,0.0022853965890289,-0.0314085952385131,-0.0224498406095198,6.45883385327092e-32
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GFER,FAD-linked sulfhydryl oxidase ALR,39477,-0.0744084432112682,0.00631469459500219,-0.0867852446174725,-0.0620316418050639,6.49063122465234e-32
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DCXR,L-xylulose reductase,39913,-0.0616944189344154,0.00524020549291017,-0.0719652217005193,-0.0514236161683115,7.24783325093123e-32
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SCPEP1,Retinoid-inducible serine carboxypeptidase,36995,-0.0586670667806607,0.00498540840907763,-0.0684384672624529,-0.0488956662988685,8.26568760662868e-32
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KRT5,"Keratin, type II cytoskeletal 5",39489,-0.0577919221812815,0.004916451594753,-0.0674281673069973,-0.0481556770555656,9.07801473531613e-32
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FABP4,"Fatty acid-binding protein, adipocyte",40052,-0.0554507305563202,0.00472484556066376,-0.0647114278552212,-0.0461900332574192,1.11998591152404e-31
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LEP,Leptin,39868,-0.0773200896035423,0.00659784683839221,-0.0902518694067911,-0.0643883098002936,1.3713221388724e-31
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ITGBL1,Integrin beta-like protein 1,37437,-0.0408499491202181,0.00348600429764496,-0.0476825175436022,-0.034017380696834,1.45788135692535e-31
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FLT4,Vascular endothelial growth factor receptor 3,39913,-0.0387049729617566,0.00330804954800739,-0.0451887500758511,-0.0322211958476622,1.70606590556215e-31
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RBFOX3,RNA binding protein fox-1 homolog 3,37411,-0.0423383244879274,0.00362223954935381,-0.0494379140046609,-0.0352387349711939,2.06639341590811e-31
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNFSF14,Tumor necrosis factor ligand superfamily member 14,39749,-0.0653545615627898,0.00559376782913153,-0.0763183465078877,-0.054390776617692,2.0815861954208e-31
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL15,Interleukin-15,39866,-0.036893782078123,0.00316015827878105,-0.0430876923045339,-0.0306998718517121,2.30156639219378e-31
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MTDH,Protein LYRIC,37056,-0.105630488967082,0.00904698954077146,-0.123362588466995,-0.0878983894671704,2.41746442089857e-31
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NCAM1,Neural cell adhesion molecule 1,39931,0.0339937709070214,0.00292107670293142,0.0282684605692758,0.0397190812447669,3.54699512870573e-31
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLEC1B,C-type lectin domain family 1 member B,40009,-0.108889459660083,0.00937223333035755,-0.127259036987584,-0.0905198823325825,4.42226170702101e-31
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SIGLEC10,Sialic acid-binding Ig-like lectin 10,39866,-0.0370696413740581,0.00319406332103449,-0.0433300054832857,-0.0308092772648305,5.12581396403957e-31
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NFKB1,Nuclear factor NF-kappa-B p105 subunit,37021,-0.0848666879426104,0.00731172606035633,-0.0991976710209088,-0.070535704864312,5.37926655408243e-31
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,B2M,Beta-2-microglobulin,37453,-0.034917169352496,0.00300871194791234,-0.0408142447704042,-0.0290200939345878,5.41844580693503e-31
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PILRB,Paired immunoglobulin-like type 2 receptor beta,39868,-0.064007680128253,0.0055293417965326,-0.0748451900494569,-0.0531701702070491,7.23689198733266e-31
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PAK4,Serine/threonine-protein kinase PAK 4,39489,-0.069288520155028,0.00599103080912937,-0.0810309405409216,-0.0575460997691345,8.23871770095621e-31
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNF,Tumor necrosis factor,39555,-0.0426389224724783,0.0036904948377737,-0.0498722923545147,-0.0354055525904418,9.41480135176063e-31
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,C19orf12,Protein C19orf12,39489,-0.0730282049965073,0.00632126058086603,-0.0854178757350047,-0.0606385342580099,9.52704285148016e-31
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLEC6A,C-type lectin domain family 6 member A,39477,-0.0522150259410838,0.00452652482732683,-0.0610870146026444,-0.0433430372795232,1.16525872316468e-30
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ESAM,Endothelial cell-selective adhesion molecule,40052,-0.0351025818364014,0.00304365326001428,-0.0410681422260294,-0.0291370214467734,1.18456880896542e-30
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CA6,Carbonic anhydrase 6,39817,0.0713211323840582,0.00619157048715832,0.0591856542292279,0.0834566105388885,1.39699120339482e-30
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SSNA1,Sjoegren syndrome nuclear autoantigen 1,37382,-0.0569074930741682,0.00494146942584638,-0.0665927731488271,-0.0472222129995093,1.51566017164332e-30
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ATP6V1G1,V-type proton ATPase subunit G 1,37043,-0.0819589079209309,0.00711981126936555,-0.0959137380088874,-0.0680040778329744,1.61729376662412e-30
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FAS,Tumor necrosis factor receptor superfamily member 6,40002,-0.0357054192482193,0.00310440670249907,-0.0417900563851174,-0.0296207821113211,1.7038809491048e-30
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ACAN,Aggrecan core protein,39730,0.0315618288677427,0.00274512487915138,0.026181384104606,0.0369422736308794,1.79475713744847e-30
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD300E,CMRF35-like molecule 2,39991,-0.0429357651668794,0.00374255779944304,-0.0502711784537878,-0.035600351879971,2.38340950708171e-30
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DEFA1_DEFA1B,Neutrophil defensin 1,39537,-0.0559670583428845,0.00488941082786844,-0.0655503035655067,-0.0463838131202624,3.22462801402104e-30
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,37124,-0.0310557518347486,0.00271308318991916,-0.0363733948869902,-0.0257381087825071,3.38676093753187e-30
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCN2,CCN family member 2,39880,-0.0651105282181239,0.00569477497746964,-0.0762722871739644,-0.0539487692622834,3.72810719041277e-30
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL4R,Interleukin-4 receptor subunit alpha,39866,-0.0397846025338132,0.00348129545482885,-0.0466079416252778,-0.0329612634423487,3.96070891527091e-30
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NFX1,Transcriptional repressor NF-X1,37021,-0.0751668628567169,0.00657735488689089,-0.088058478435023,-0.0622752472784108,4.19500206508463e-30
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PTPRB,Receptor-type tyrosine-protein phosphatase beta,37437,-0.0326679228839642,0.00286056909804096,-0.0382746383161245,-0.0270612074518039,4.55276029602345e-30
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IFNGR2,Interferon gamma receptor 2,39749,-0.0577472493637983,0.00506781786296298,-0.0676801723752058,-0.0478143263523909,5.79568871613562e-30
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KLK14,Kallikrein-14,40030,0.0500532489750571,0.00439300118452702,0.0414429666533841,0.0586635312967301,5.83715068745555e-30
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HBEGF,Proheparin-binding EGF-like growth factor,39984,-0.0802832394482191,0.00705060451280461,-0.0941024242933161,-0.066464054603122,6.33654637056778e-30
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ANG,Angiogenin,39843,-0.0374638345697775,0.00329144084361066,-0.0439150586232544,-0.0310126105163006,6.68626311951417e-30
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,A1BG,Alpha-1B-glycoprotein,37453,-0.0190132970453147,0.00166988546831561,-0.0222862725632133,-0.0157403215274161,6.70814198336745e-30
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL7R,Interleukin-7 receptor subunit alpha,39858,0.057652481887798,0.00506801579622054,0.0477191709272057,0.0675857928483903,7.19331711107557e-30
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MAPK9,Mitogen-activated protein kinase 9,39866,-0.0481091981884253,0.00422953104516331,-0.0563990790369454,-0.0398193173399052,7.28755385136078e-30
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,39749,-0.0491954683833201,0.00432514702712679,-0.0576727565564886,-0.0407181802101516,7.32709291183167e-30
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,37437,-0.0848620688794912,0.00745923853544366,-0.0994821764089608,-0.0702419613500216,7.45112577426965e-30
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SPOCK1,Testican-1,39749,0.0280988062552702,0.00247090239577411,0.0232558375595529,0.0329417749509874,7.53040504764401e-30
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PTP4A3,Protein tyrosine phosphatase type IVA 3,37056,-0.0574712237571306,0.00505461697105619,-0.0673782730204008,-0.0475641744938605,8.11450459871328e-30
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LDLRAP1,Low density lipoprotein receptor adapter protein 1,37411,-0.108801238284246,0.00957171955245737,-0.127561808607062,-0.0900406679614293,8.33515498668167e-30
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,COCH,Cochlin,37437,-0.0507571155441425,0.00446795497056059,-0.0595143072864413,-0.0419999238018438,8.98705796874488e-30
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GLB1,Beta-galactosidase,39749,-0.0465841647805561,0.00410432351985026,-0.0546286388794626,-0.0385396906816496,9.65186874730762e-30
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EREG,Proepiregulin,39713,-0.0881990092087835,0.00777255481297672,-0.103433216642218,-0.0729648017753492,9.93878495524921e-30
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,REN,Renin,39868,-0.0726595446145778,0.00642059417132823,-0.0852439091903811,-0.0600751800387744,1.40611902018243e-29
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SIGLEC1,Sialoadhesin,39931,-0.0460029872547327,0.00406654782537978,-0.0539734209924771,-0.0380325535169883,1.47135065643225e-29
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CEBPB,CCAAT/enhancer-binding protein beta,39585,-0.0410058294262689,0.00362865104315935,-0.0481179854708612,-0.0338936733816766,1.69399334352695e-29
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GAL,Galanin peptides,39931,0.0707881092315401,0.00626547210333728,0.058507783908999,0.0830684345540811,1.73164791550964e-29
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL6,Interleukin-6,39788,-0.0779036755473139,0.00689720734613143,-0.0914222019457314,-0.0643851491488963,1.79885904714434e-29
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TANK,TRAF family member-associated NF-kappa-B activator,39587,-0.0777922368936876,0.00689723586261901,-0.0913108191844209,-0.0642736546029544,2.16680773992598e-29
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AMN,Protein amnionless,39587,-0.0523397548918192,0.0046410883004571,-0.0614362879607152,-0.0432432218229233,2.19832878777398e-29
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ERBIN,Erbin,39788,-0.11275561722899,0.0100073784400957,-0.132370078971577,-0.0931411554864023,2.45882720699255e-29
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PTPRS,Receptor-type tyrosine-protein phosphatase S,40052,0.0267352531594703,0.00237849889738794,0.0220733953205899,0.0313971109983506,3.31279632331328e-29
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SNCG,Gamma-synuclein,39749,-0.0709739886917905,0.0063252275504414,-0.0833714346906556,-0.0585765426929253,4.148336297465e-29
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PPP1R9B,Neurabin-2,40058,-0.103336441816307,0.00922468457170565,-0.12141682357685,-0.0852560600557638,5.08675486365404e-29
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HNMT,Histamine N-methyltransferase,39669,-0.0503343354326616,0.00450321240694753,-0.0591606317502788,-0.0415080391150444,6.74927687117445e-29
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,S100A4,Protein S100-A4,39913,-0.0618264618174301,0.00553188383834923,-0.0726689541405946,-0.0509839694942656,6.80278908754448e-29
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,OGFR,Opioid growth factor receptor,39788,-0.035569777464496,0.00318385437819751,-0.0418101320457631,-0.0293294228832289,7.1642447299863e-29
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DTNB,Dystrobrevin beta,37348,-0.0479532209990457,0.00429526075489844,-0.0563719320786466,-0.0395345099194448,8.16202040151658e-29
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,F10,Coagulation factor X,37445,-0.0289478241855831,0.00259384560321402,-0.0340317615678826,-0.0238638868032836,8.51861907179424e-29
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TFF2,Trefoil factor 2,39908,-0.0619775470392876,0.00555554481335512,-0.0728664148734636,-0.0510886792051116,8.54442785686828e-29
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ANGPTL1,Angiopoietin-related protein 1,39617,-0.0318064340953524,0.00285208660403676,-0.0373965238392645,-0.0262163443514404,8.9736633332969e-29
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD83,CD83 antigen,39866,-0.0356331778822791,0.00319557968083375,-0.0418965140567133,-0.029369841707845,9.06137009251387e-29
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,39788,-0.0487295915323149,0.00437657700297458,-0.0573076824581451,-0.0401515006064847,1.09147255411902e-28
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FGR,Tyrosine-protein kinase Fgr,39489,-0.0610950090541479,0.00549199265778267,-0.071859314663402,-0.0503307034448939,1.22291138257985e-28
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCL14,C-C motif chemokine 14,39843,-0.042140606818079,0.00379101948132793,-0.0495710050014818,-0.0347102086346763,1.33649441121612e-28
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SRPK2,SRSF protein kinase 2,39866,-0.0910382828669524,0.00818994492233969,-0.107090574914738,-0.0749859908191666,1.3366768264734e-28
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD80,T-lymphocyte activation antigen CD80,37437,-0.0363958684982189,0.00327899739006385,-0.0428227033827441,-0.0299690336136938,1.66933976496543e-28
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PENK,Proenkephalin-A,37124,-0.0316321179535447,0.00285083813031797,-0.0372197606889679,-0.0260444752181215,1.75599346311149e-28
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GH1,Somatotropin,39846,0.19494585860341,0.0175865462691007,0.160476227915972,0.229415489290847,1.8847179410487e-28
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,40058,-0.107533789171953,0.00970419955628531,-0.126554020302272,-0.0885135580416339,1.95934494070324e-28
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CTSF,Cathepsin F,39913,-0.0436057389585652,0.00393535854755375,-0.0513190417117705,-0.0358924362053598,1.97792102612392e-28
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ECHS1,"Enoyl-CoA hydratase, mitochondrial",37043,-0.105442687139281,0.00952537507938378,-0.124112422294873,-0.0867729519836891,2.34732017811908e-28
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,37169,-0.122776044747428,0.011103087629618,-0.144538096501479,-0.101013992993377,2.66802937892509e-28
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VPS53,Vacuolar protein sorting-associated protein 53 homolog,39788,-0.0825666844526868,0.00747706708646177,-0.0972217359421519,-0.0679116329632217,3.01214684639769e-28
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CEP43,Centrosomal protein 43,39476,-0.0749592387969119,0.00679898290129198,-0.0882852452834442,-0.0616332323103797,3.67475316517217e-28
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SHMT1,"Serine hydroxymethyltransferase, cytosolic",39908,-0.0932860675648199,0.00846617066581151,-0.10987976206981,-0.0766923730598294,3.91749856156093e-28
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TPP1,Tripeptidyl-peptidase 1,39767,-0.0498454408601919,0.00453321090095751,-0.0587305342260686,-0.0409603474943152,5.0610087054176e-28
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PTGR1,Prostaglandin reductase 1,37437,-0.0855067468967478,0.00778383766605742,-0.10076306872222,-0.0702504250712753,5.9059478259083e-28
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SELP,P-selectin,39931,-0.0614376624409755,0.00559565480494946,-0.0724051458586765,-0.0504701790232746,6.02577534795757e-28
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MMP1,Interstitial collagenase,39314,-0.098083593498654,0.00894521967900716,-0.115616224069508,-0.0805509629277999,7.13868787589215e-28
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD300C,CMRF35-like molecule 6,40009,-0.035433316280987,0.00323769739513607,-0.0417792031754536,-0.0290874293865203,8.88941892132793e-28
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD63,CD63 antigen,39720,-0.0548188286141041,0.0050125470601404,-0.0646434208519793,-0.0449942363762289,9.70693971745287e-28
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PQBP1,Polyglutamine-binding protein 1,39477,-0.0582837171120332,0.00533152318291854,-0.0687335025505535,-0.0478339316735128,1.02233131640967e-27
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,39858,-0.0270013794234054,0.00247123633799159,-0.0318450026458689,-0.0221577562009419,1.08148333986614e-27
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BACH1,Transcription regulator protein BACH1,39866,-0.0788193590855624,0.00722140484065542,-0.092973312573247,-0.0646654055978778,1.22723606241743e-27
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ANGPTL2,Angiopoietin-related protein 2,39877,-0.0417595443713971,0.0038302923457703,-0.0492669173691069,-0.0342521713736873,1.40251042352076e-27
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CFH,Complement factor H,36763,-0.0251342488663971,0.00230453356391071,-0.0296511346516621,-0.0206173630811321,1.41662890812911e-27
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD300A,CMRF35-like molecule 8,37124,-0.0308346632487121,0.00283036649892236,-0.0363821815865999,-0.0252871449108242,1.60600671044907e-27
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SERPINA4,Kallistatin,37241,-0.0249102967917812,0.00228923807381525,-0.0293972034164591,-0.0204233901671033,1.84073834520556e-27
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",37382,-0.109085088951393,0.0100265670213646,-0.128737160313267,-0.089433017589518,1.87349572967177e-27
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PGLYRP1,Peptidoglycan recognition protein 1,39962,-0.0443778616480033,0.00408334514594689,-0.0523812181340592,-0.0363745051619474,2.0384427567668e-27
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",39587,-0.0632112010161174,0.005819863684842,-0.0746181338384077,-0.0518042681938271,2.20466301238917e-27
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL12RB1,Interleukin-12 receptor subunit beta-1,39587,-0.0389925979231218,0.00359120408585324,-0.0460313579313941,-0.0319538379148494,2.28962945494645e-27
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SPINK4,Serine protease inhibitor Kazal-type 4,39866,-0.0655720418255888,0.00604728108134904,-0.0774247127450329,-0.0537193709061447,2.67208759039744e-27
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RASSF2,Ras association domain-containing protein 2,39477,-0.0582227860074474,0.00536951433167021,-0.068747034097521,-0.0476985379173738,2.68701690356218e-27
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TARBP2,RISC-loading complex subunit TARBP2,39489,-0.083888853856084,0.00775502333030358,-0.099088699583479,-0.068689008128689,3.55563122487751e-27
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,39749,-0.0562686881849862,0.00520377851664805,-0.0664680940776164,-0.0460692822923561,3.71214680248594e-27
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GOLM2,Protein GOLM2,40009,-0.0232859556074663,0.00215545797932459,-0.0275106532469425,-0.0190612579679901,4.11272182031222e-27
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DAAM1,Disheveled-associated activator of morphogenesis 1,37124,-0.0874120243712865,0.00809097734893162,-0.103270339975193,-0.0715537087673806,4.28888431176873e-27
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FCN1,Ficolin-1,37430,-0.0594063234495394,0.0055075942809668,-0.0702012082402343,-0.0486114386588444,5.14413647383863e-27
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCL25,C-C motif chemokine 25,40058,-0.0523408809783796,0.00485684239061717,-0.0618602920639892,-0.0428214698927699,5.47376986645729e-27
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ALPI,Intestinal-type alkaline phosphatase,37056,-0.127424823238724,0.0118264978684941,-0.150604759060972,-0.104244887416475,5.87940526145215e-27
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,39469,-0.0618083978483199,0.00574125630739293,-0.07306126021081,-0.0505555354858298,6.21692057603767e-27
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CNTN5,Contactin-5,39897,0.0377107408073129,0.0035040061445964,0.030842888763904,0.0445785928507219,6.4171829599022e-27
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",39788,-0.0341482666194575,0.00317510514203102,-0.0403714726978383,-0.0279250605410767,6.9428534867153e-27
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KCTD5,BTB/POZ domain-containing protein KCTD5,37165,-0.0460269803709714,0.00427937472648407,-0.0544145548348802,-0.0376394059070626,7.19674057526213e-27
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DDT,D-dopachrome decarboxylase,37437,-0.0421069832460881,0.00392235600028825,-0.0497948010066531,-0.0344191654855232,8.91658132767262e-27
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SPARCL1,SPARC-like protein 1,39871,0.0284793932564096,0.0026552844999427,0.0232750356365219,0.0336837508762973,9.51949161705533e-27
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GCC1,GRIP and coiled-coil domain-containing protein 1,37388,-0.113734109391409,0.0106139578933436,-0.134537466862362,-0.0929307519204556,1.10127601078639e-26
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ISM1,Isthmin-1,39866,-0.0415861514888059,0.00388421066804333,-0.0491992043981708,-0.033973098579441,1.16845650533246e-26
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ICAM4,Intercellular adhesion molecule 4,39866,0.0546415405540649,0.00510800878771763,0.0446298433301383,0.0646532377779915,1.28997848690527e-26
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,37382,-0.0310022593912889,0.00289846707730481,-0.0366832548628063,-0.0253212639197715,1.35616965148601e-26
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,39868,-0.0661926047094684,0.00619288642500682,-0.0783306621024817,-0.054054547316455,1.41648908005953e-26
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,37437,0.0269427411318214,0.00252599219233065,0.0219917964348533,0.0318936858287895,1.86446075355738e-26
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LAMP3,Lysosome-associated membrane glycoprotein 3,40040,-0.0520767539000943,0.00488983893258729,-0.0616608382079654,-0.0424926695922232,2.13267365234888e-26
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SLITRK1,SLIT and NTRK-like protein 1,37056,0.0332598368524127,0.00312338659504975,0.0271379991261152,0.0393816745787102,2.26370395616353e-26
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,39749,-0.0979186888501745,0.00921379565851096,-0.115977728340856,-0.079859649359493,2.72315256221312e-26
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FARSA,Phenylalanine--tRNA ligase alpha subunit,37039,-0.0711787746796841,0.00672192312516279,-0.0843537440050032,-0.058003805354365,4.26423998804328e-26
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,37388,-0.0901225285390702,0.00851409156390837,-0.106810148004331,-0.0734349090738097,4.41884852350208e-26
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NCF2,Neutrophil cytosol factor 2,39843,-0.0855327397006631,0.0080895839115718,-0.101388324167344,-0.0696771552339824,4.83642640075113e-26
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,REG4,Regenerating islet-derived protein 4,39885,-0.0483568144145347,0.00457774034491691,-0.0573291854905719,-0.0393844433384976,5.35821796702646e-26
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PLSCR3,Phospholipid scramblase 3,37373,-0.0615265851757172,0.00582300199342502,-0.0729396690828303,-0.0501135012686042,5.4027134130554e-26
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,39985,-0.0288360246914735,0.0027320306342796,-0.0341908047346615,-0.0234812446482855,5.86595264548131e-26
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL32,Interleukin-32,39866,0.0439529462629313,0.00417206648412859,0.0357756959540392,0.0521301965718233,7.23673302703758e-26
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DAG1,Dystroglycan,39931,-0.0497139573203059,0.00472752948271502,-0.0589799151064274,-0.0404479995341845,8.85505667428326e-26
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TJAP1,Tight junction-associated protein 1,39913,-0.0849665741742516,0.00808426846678258,-0.100811740369145,-0.0691214079793577,9.40802718572171e-26
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EPPK1,Epiplakin,37043,-0.0768322793869537,0.00731095112734727,-0.0911617435965544,-0.062502815177353,9.90271583874311e-26
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,37388,-0.0422988723820359,0.00403095677700878,-0.0501995476649731,-0.0343981970990987,1.16096673155534e-25
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TXNDC5,Thioredoxin domain-containing protein 5,40009,-0.0699727626046149,0.00667433407910703,-0.0830544573996647,-0.0568910678095651,1.23864939264532e-25
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,STAT5B,Signal transducer and activator of transcription 5B,39788,-0.140626303780987,0.0134134556077667,-0.16691667677221,-0.114335930789765,1.24038371756673e-25
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PLIN1,Perilipin-1,39489,-0.0353284278288943,0.00337290203377376,-0.0419393158150908,-0.0287175398426977,1.37954823448054e-25
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BSG,Basigin,40040,-0.0198209802161217,0.00189541300188887,-0.0235359896998239,-0.0161059707324196,1.63541744715135e-25
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",39858,-0.0474296216965793,0.00453574738934665,-0.0563196865796987,-0.0385395568134599,1.64737768157597e-25
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FGF19,Fibroblast growth factor 19,39931,-0.0778520958895797,0.00745356125711704,-0.0924610759535291,-0.0632431158256303,1.86435723563064e-25
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TFF1,Trefoil factor 1,39789,-0.076480980951921,0.00732793063258151,-0.0908437249917808,-0.0621182369120613,2.03134249354387e-25
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CTRB1,Chymotrypsinogen B,39858,-0.0542980109319416,0.00520648385635939,-0.064502719290406,-0.0440933025734772,2.20660510403539e-25
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,39913,-0.0960288173861488,0.00921496811965327,-0.114090154900669,-0.0779674798716284,2.39646930901167e-25
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",39788,0.0434664793772476,0.00417239915425441,0.035288577034909,0.0516443817195862,2.4850831210163e-25
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NUDT5,ADP-sugar pyrophosphatase,39858,-0.0522906830675544,0.00502755469115115,-0.0621446902622107,-0.0424366758728982,2.95886674335534e-25
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ICAM1,Intercellular adhesion molecule 1,39822,-0.0287952048788541,0.0027723717570936,-0.0342290535227575,-0.0233613562349506,3.43671216862731e-25
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HSPB6,Heat shock protein beta-6,40030,-0.0379136190566617,0.00365081574668656,-0.0450692179201674,-0.0307580201931561,3.48311786236465e-25
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CHAD,Chondroadherin,37124,0.0512519230692629,0.00493465090949977,0.0415800072866434,0.0609238388518825,3.58095425300968e-25
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCL11,Eotaxin,40058,-0.0386042986902895,0.0037199961271231,-0.0458954910994508,-0.0313131062811283,3.76317390867506e-25
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,USP8,Ubiquitin carboxyl-terminal hydrolase 8,39585,-0.097830151552349,0.00942939740069586,-0.116311770457713,-0.0793485326469851,3.883110044969e-25
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,WARS,"Tryptophan--tRNA ligase, cytoplasmic",39858,-0.0380107814854282,0.00366396013948956,-0.0451921433588277,-0.0308294196120287,3.90240882664346e-25
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IQGAP2,Ras GTPase-activating-like protein IQGAP2,39788,-0.0553066020910303,0.00533212149592853,-0.0657575602230502,-0.0448556439590104,3.98304324602729e-25
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PLEKHO1,Pleckstrin homology domain-containing family O member 1,37388,-0.0703816182271801,0.00679018975800349,-0.0836903901528669,-0.0570728463014933,4.43182180800022e-25
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LYN,Tyrosine-protein kinase Lyn,39788,-0.0853884089097267,0.00825053641353402,-0.101559460280253,-0.0692173575392,5.05286558069789e-25
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FABP1,"Fatty acid-binding protein, liver",39862,-0.0943518909002125,0.00912098692663382,-0.112229025276415,-0.0764747565240102,5.31485866063502e-25
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NADK,NAD kinase,39868,-0.0538002382368443,0.00520348854751873,-0.063999075789981,-0.0436014006837076,5.60999806889312e-25
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,37411,-0.0482789521694423,0.00467568820211785,-0.0574433010455932,-0.0391146032932913,6.68117968682425e-25
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CSTB,Cystatin-B,39619,-0.0426840590147837,0.00413510496390179,-0.0507888647440312,-0.0345792532855361,6.70196715152227e-25
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LCN2,Neutrophil gelatinase-associated lipocalin,39372,-0.0365800302393707,0.00354927570257876,-0.043536610616425,-0.0296234498623163,7.93273925097021e-25
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TAX1BP1,Tax1-binding protein 1,37388,-0.0636191087602799,0.00617351742781417,-0.0757192029187957,-0.0515190146017641,8.248298573858e-25
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NBN,Nibrin,39587,-0.0516527420716802,0.00501994407488306,-0.061491832458451,-0.0418136516849094,9.41446854728272e-25
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ATG16L1,Autophagy-related protein 16-1,37382,-0.086399703698197,0.00841897806353777,-0.102900900702731,-0.069898506693663,1.2801425020539e-24
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EPHA2,Ephrin type-A receptor 2,39248,-0.029352104897197,0.00286438998153737,-0.0349663092610102,-0.0237379005333837,1.46029134906589e-24
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SLMAP,Sarcolemmal membrane-associated protein,37382,-0.083977614316005,0.00820110588713983,-0.100051781854799,-0.0679034467772109,1.6161562594012e-24
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ANGPT2,Angiopoietin-2,40030,-0.0379635479665159,0.00371064444404932,-0.0452364110768526,-0.0306906848561792,1.71060255932263e-24
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RAB6A,Ras-related protein Rab-6A,39866,0.0460702247516913,0.00450936621627713,0.0372318669677881,0.0549085825355945,1.9866797339523e-24
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADGRD1,Adhesion G-protein coupled receptor D1,37124,-0.038828919861389,0.00380873748077954,-0.0462940453237169,-0.0313637943990611,2.57408088030698e-24
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NCR1,Natural cytotoxicity triggering receptor 1,39835,-0.035236841020797,0.003458878316351,-0.042016242520845,-0.0284574395207491,2.67937536379388e-24
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ANXA2,Annexin A2,36879,-0.0695416770406095,0.00683260002293887,-0.0829335730855696,-0.0561497809956493,3.06626861147466e-24
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LGALS8,Galectin-8,40009,-0.060585306134945,0.00595818990353444,-0.0722633583458725,-0.0489072539240175,3.24538139838129e-24
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BOC,Brother of CDO,39585,0.0231501535192936,0.0022768054654047,0.0186876148071004,0.0276126922314869,3.27957883495339e-24
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PDGFB,Platelet-derived growth factor subunit B,39931,-0.0847545450455578,0.00834686931763765,-0.101114408908128,-0.0683946811829881,3.75980184610575e-24
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AP3B1,AP-3 complex subunit beta-1,37382,-0.0762541909739659,0.00751419795511133,-0.0909820189659841,-0.0615263629819477,4.12575421627338e-24
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AXIN1,Axin-1,39866,-0.0943470107814082,0.00930032561505429,-0.112575648986915,-0.0761183725759018,4.14724567886473e-24
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RNF41,E3 ubiquitin-protein ligase NRDP1,39477,-0.0664254235198408,0.00655688506245994,-0.0792769182422623,-0.0535739287974193,4.79417858969158e-24
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ERBB4,Receptor tyrosine-protein kinase erbB-4,39913,0.023476751688483,0.00231781733853095,0.0189338297049623,0.0280196736720036,4.86103873626932e-24
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SLA2,Src-like-adapter 2,37411,-0.104485420006108,0.0103307671881947,-0.12473372369497,-0.0842371163172467,5.82446749070272e-24
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NBL1,Neuroblastoma suppressor of tumorigenicity 1,39913,-0.0251273927196876,0.00248551027840724,-0.0299989928653658,-0.0202557925740094,5.91119186474194e-24
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HPSE,Heparanase,37306,-0.0929714490912023,0.00920300831421875,-0.111009345387071,-0.0749335527953336,6.56821126124351e-24
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,40040,-0.0353550463740609,0.00350444462041335,-0.042223757830071,-0.0284863349180507,7.29749872886683e-24
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,USP25,Ubiquitin carboxyl-terminal hydrolase 25,37368,-0.0718283781327926,0.00711756253294025,-0.0857788006973555,-0.0578779555682297,7.30368071068937e-24
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LRRN1,Leucine-rich repeat neuronal protein 1,39587,0.0383908857552736,0.00380920828863131,0.0309248375095562,0.0458569340009909,8.12747164820793e-24
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD6,T-cell differentiation antigen CD6,40040,-0.0514846487173866,0.00511064161814847,-0.0615015062889576,-0.0414677911458156,8.46068386608658e-24
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EHBP1,EH domain-binding protein 1,37437,-0.0739862794810578,0.00734292652399269,-0.0883784154680834,-0.0595941434940321,8.5642240578604e-24
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EIF4B,Eukaryotic translation initiation factor 4B,39749,-0.0568798879983312,0.00565524168150394,-0.0679641616940789,-0.0457956143025834,9.9841793415413e-24
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PDLIM7,PDZ and LIM domain protein 7,39931,-0.12368251109541,0.0123059523736479,-0.14780217774776,-0.09956284444306,1.07253533134351e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SCGB3A2,Secretoglobin family 3A member 2,39908,0.0755690820592635,0.00751888351541361,0.0608320703690528,0.0903060937494742,1.07335157292481e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TSPAN8,Tetraspanin-8,37382,-0.0964343119659412,0.00959278779956842,-0.115236176053095,-0.0776324478787871,1.08157411244279e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NFE2,Transcription factor NF-E2 45 kDa subunit,37043,-0.07344953840961,0.00730868603551883,-0.0877745630392269,-0.0591245137799931,1.12215345687548e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,39477,-0.0443784495614656,0.0044199733751838,-0.0530415973768259,-0.0357153017461054,1.19410713494048e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AKT1S1,Proline-rich AKT1 substrate 1,39489,-0.0658745514075284,0.00656111004280726,-0.0787343270914306,-0.0530147757236261,1.19733182089579e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ZHX2,Zinc fingers and homeoboxes protein 2,37388,-0.0306085475360037,0.00304796068144263,-0.0365825504716312,-0.0246345446003761,1.20196800100046e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,STK11,Serine/threonine-protein kinase STK11,39585,-0.0715453550787445,0.0071273699511243,-0.0855150001829481,-0.0575757099745409,1.22095046179242e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VEGFC,Vascular endothelial growth factor C,39913,-0.0543012506469245,0.00541108798852637,-0.0649069831044362,-0.0436955181894128,1.25336419963785e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SNAP23,Synaptosomal-associated protein 23,39868,-0.0849821102692147,0.0084793462595202,-0.101601628937874,-0.0683625916005551,1.42823016025282e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,36764,-0.0487147959340033,0.00486378821584329,-0.0582478208370562,-0.0391817710309504,1.58300477458134e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NSFL1C,NSFL1 cofactor p47,40009,-0.0633719517501303,0.00633042319168699,-0.0757795812058368,-0.0509643222944238,1.6018327149633e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CKAP4,Cytoskeleton-associated protein 4,39991,-0.0247739748764806,0.00247510890272697,-0.0296251883258255,-0.0199227614271357,1.62563940157451e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TRIM5,Tripartite motif-containing protein 5,39866,-0.0842035934302817,0.00841262277318263,-0.10069233406572,-0.0677148527948437,1.62845611233663e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NPDC1,Neural proliferation differentiation and control protein 1,39868,-0.0287004663829694,0.00287579575757702,-0.0343370260678204,-0.0230639066981185,2.18228026993816e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNIP1,TNFAIP3-interacting protein 1,37388,-0.0860944541334141,0.00863153827124809,-0.10301226914506,-0.0691766391217679,2.37532028713645e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,39749,-0.0684531340075741,0.0068779668553247,-0.0819339490440105,-0.0549723189711377,2.87612350123522e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AP2B1,AP-2 complex subunit beta,37039,-0.0478525817805381,0.00481168736574186,-0.0572834890173922,-0.0384216745436841,3.19901640089456e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BANK1,B-cell scaffold protein with ankyrin repeats,39866,-0.102888236842275,0.0103615479395377,-0.123196870803769,-0.0825796028807814,3.60354767083004e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VSIG2,V-set and immunoglobulin domain-containing protein 2,37368,-0.0518423554098978,0.00521948313386222,-0.0620725423522678,-0.0416121684675279,3.61058090821272e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TALDO1,Transaldolase,37415,-0.0433868808898316,0.0043727610930359,-0.0519574926321819,-0.0348162691474812,4.00145680499422e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IRAK1,Interleukin-1 receptor-associated kinase 1,39587,-0.0680212871833403,0.00686169320426887,-0.0814702058637073,-0.0545723685029734,4.26376506312902e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HCLS1,Hematopoietic lineage cell-specific protein,40058,-0.0541425915375539,0.0054623089309959,-0.0648487170423059,-0.043436466032802,4.29377606574722e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,37124,-0.0209751819615183,0.00211709723644935,-0.025124692544959,-0.0168256713780776,4.64291847230693e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RNASE1,Ribonuclease pancreatic,37445,-0.0217174186442513,0.00219297114135531,-0.0260156420813077,-0.0174191952071949,4.82576721990593e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL1RAP,Interleukin-1 receptor accessory protein,39858,0.0413311999230495,0.00417626354136795,0.0331457233819683,0.0495166764641307,5.0106866602409e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CTSL,Cathepsin L1,39868,-0.023045072620229,0.00232881478825175,-0.0276095496052025,-0.0184805956352556,5.06378711470949e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCL4,C-C motif chemokine 4,39882,-0.0599690086178164,0.00606865424221975,-0.0718635709325671,-0.0480744463030657,5.80989334022163e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BTN2A1,Butyrophilin subfamily 2 member A1,39931,-0.0240318049364325,0.00243292144725159,-0.0288003309730456,-0.0192632788998194,6.04272231359041e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,WDR46,WD repeat-containing protein 46,37368,-0.0348610300193806,0.0035291309459659,-0.0417781266734738,-0.0279439333652875,6.19715454037604e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SORT1,Sortilin,39846,-0.0358792972193639,0.00363651095204992,-0.0430068586853817,-0.028751735753346,6.76750853089718e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SH3GLB2,Endophilin-B2,37388,-0.0639072500258212,0.00647698553794042,-0.0766021416801845,-0.051212358371458,6.92601363959224e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,REG1B,Lithostathine-1-beta,40052,-0.0522059244079896,0.00529533595216238,-0.0625847828742279,-0.0418270659417513,7.27944950784411e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HDGFL2,Hepatoma-derived growth factor-related protein 2,37388,-0.0604388490867629,0.00613145121871287,-0.0724564934754402,-0.0484212046980857,7.61847798622776e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD302,CD302 antigen,39788,-0.027878021417885,0.00283199259971899,-0.0334287269133342,-0.0223273159224357,8.4551768337811e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,OSCAR,Osteoclast-associated immunoglobulin-like receptor,39885,-0.0317525395770442,0.00322669364720601,-0.038076859125568,-0.0254282200285205,8.73438674711652e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CBS,Cystathionine beta-synthase,37043,-0.0491678128473904,0.00499923725434005,-0.0589663178658969,-0.0393693078288839,9.52199757822608e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",37411,-0.074648349382894,0.00759574415484522,-0.0895360079263906,-0.0597606908393973,1.01938625155321e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCL22,C-C motif chemokine 22,39686,-0.0480171770548283,0.00490365132581264,-0.057628333653421,-0.0384060204562355,1.41073912078854e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",39866,-0.0935789165278126,0.00956336943217365,-0.112323120614873,-0.0748347124407523,1.50852808701971e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DSC2,Desmocollin-2,39673,-0.0317461543118566,0.00324513826600191,-0.0381066253132204,-0.0253856833104929,1.54815723417842e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,37437,-0.0611495143586133,0.00625959353629508,-0.0734183176897517,-0.0488807110274749,1.81500087330159e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,39998,-0.0286938804160904,0.00293998777188969,-0.0344562564489942,-0.0229315043831866,1.93099187487196e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RARRES1,Retinoic acid receptor responder protein 1,39477,-0.0321809069362599,0.00330406419849402,-0.0386568727653082,-0.0257049411072116,2.36144840349998e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EGFL7,Epidermal growth factor-like protein 7,39477,-0.0374271722644096,0.0038451996726892,-0.0449637636228804,-0.0298905809059387,2.51186208395078e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FCAR,Immunoglobulin alpha Fc receptor,39866,-0.0443255888095589,0.0045611214266101,-0.0532653868057147,-0.0353857908134031,2.90779627540636e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NCK2,Cytoplasmic protein NCK2,39931,-0.100488882451431,0.0103509376397813,-0.120776720225402,-0.0802010446774594,3.20218213476968e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HIP1R,Huntingtin-interacting protein 1-related protein,37365,-0.0398281691428203,0.00410287213269672,-0.0478697985229058,-0.0317865397627347,3.31429769447574e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BCR,Breakpoint cluster region protein,39866,-0.0868497622928096,0.00896081555749683,-0.104412960785503,-0.0692865638001159,3.74527418374327e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",37026,-0.0758857188657721,0.00782912284848875,-0.0912307996488101,-0.0605406380827342,3.83813190193193e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ARSB,Arylsulfatase B,39788,-0.0521830264403746,0.00538831750622893,-0.0627441287525833,-0.0416219241281659,4.03934480538024e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FOXO1,Forkhead box protein O1,39866,-0.0810858334100377,0.00838180759719516,-0.0975141763005402,-0.0646574905195352,4.46822970463343e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,STIP1,Stress-induced-phosphoprotein 1,39826,-0.0610062007771793,0.00630936179883633,-0.0733725499028985,-0.0486398516514601,4.68642793839326e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GBP1,Guanylate-binding protein 1,37376,-0.0601745032305513,0.00622186690166154,-0.0723693623578079,-0.0479796441032947,4.69963222270605e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SNRPB2,U2 small nuclear ribonucleoprotein B'',37388,-0.0382908020777433,0.00396000370129944,-0.0460524093322902,-0.0305291948231964,4.79426054810144e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDH15,Cadherin-15,39973,-0.0504631061979214,0.00522389227849294,-0.0607019350637676,-0.0402242773320752,5.11272536744685e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ARHGEF1,Rho guanine nucleotide exchange factor 1,37388,-0.0857387348419953,0.0088801318167616,-0.103143793202848,-0.0683336764811425,5.50551844191567e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LETM1,Mitochondrial proton/calcium exchanger protein,37411,-0.0496000961554455,0.00513853719627986,-0.059671629060154,-0.039528563250737,5.64158899364774e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,COL3A1,Collagen alpha-1(III) chain,37437,-0.0219380802442601,0.00227293568129712,-0.0263930341796024,-0.0174831263089177,5.67826527192408e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL1R2,Interleukin-1 receptor type 2,39830,-0.018408670730921,0.00190994935222934,-0.0221521714612905,-0.0146651700005515,6.32090044212865e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCL19,C-C motif chemokine 19,40009,-0.108618988941026,0.0112705543230153,-0.130709275414136,-0.0865287024679158,6.36593629135565e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ANKRD54,Ankyrin repeat domain-containing protein 54,39477,-0.0531034205750249,0.00551069636166568,-0.0639043854438896,-0.0423024557061602,6.45673837973354e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TCTN3,Tectonic-3,37437,-0.0277750026612651,0.00288564628544875,-0.0334308693807446,-0.0221191359417855,7.3476787243309e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,39477,-0.0733196323249796,0.00763305193306003,-0.0882804141137773,-0.058358850536182,8.70239814668062e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IKBKG,NF-kappa-B essential modulator,39866,-0.0862774204332587,0.00898252991230731,-0.103883179061381,-0.0686716618051364,8.71699855351589e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,37169,-0.040745906186293,0.0042423551113694,-0.0490609222045771,-0.032430890168009,8.99935385624455e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ANGPT1,Angiopoietin-1,39794,-0.0790309268867178,0.0082343543926113,-0.0951702614962359,-0.0628915922771996,9.36026238639922e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HEXIM1,Protein HEXIM1,39866,-0.0763222308191838,0.00795854477068684,-0.09192097856973,-0.0607234830686376,1.00787685366549e-21
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,QDPR,Dihydropteridine reductase,39790,-0.0406218188752018,0.0042367403770012,-0.0489258300141241,-0.0323178077362794,1.02799088524212e-21
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MSR1,Macrophage scavenger receptor types I and II,40009,-0.0426424482350892,0.00445120789533676,-0.0513668157099493,-0.0339180807602292,1.10848235512616e-21
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TRIM24,Transcription intermediary factor 1-alpha,37135,-0.061072198208619,0.00639350461163635,-0.0736034672474262,-0.0485409291698117,1.48888171451104e-21
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ATP6AP2,Renin receptor,39477,-0.037901076162246,0.00397448708570004,-0.0456910708502181,-0.0301110814742739,1.6971157339069e-21
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NIT2,Omega-amidase NIT2,37377,-0.0703814507623907,0.00738034503309721,-0.0848469270272612,-0.0559159744975201,1.72882164406529e-21
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,39866,-0.03430168828279,0.00360358614328045,-0.0413647171236197,-0.0272386594419604,1.99690055351587e-21
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RAPGEF2,Rap guanine nucleotide exchange factor 2,37169,-0.0500488106759353,0.00526161125905459,-0.0603615687436823,-0.0397360526081884,2.18561282578851e-21
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SDCCAG8,Serologically defined colon cancer antigen 8,37368,-0.106443658587523,0.011201532410245,-0.128398662111604,-0.0844886550634431,2.38695569315895e-21
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DAB2,Disabled homolog 2,40030,-0.103221997562564,0.010869217786647,-0.124525664424392,-0.0819183307007354,2.46180176425162e-21
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RFC4,Replication factor C subunit 4,37368,-0.0198625665117016,0.00209143657125479,-0.023961782191361,-0.0157633508320422,2.5156623105288e-21
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BGN,Biglycan,39448,0.110288703553018,0.0116361211870289,0.0874819060264416,0.133095501079595,2.95342002230227e-21
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PDGFA,Platelet-derived growth factor subunit A,40052,-0.0661852352231625,0.00700288382540599,-0.0799108875209583,-0.0524595829253668,3.79967121159606e-21
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CNST,Consortin,39868,-0.0993830157811717,0.0105344704767531,-0.120030577915608,-0.0787354536467357,4.47419933151341e-21
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD48,CD48 antigen,39908,-0.0266188533229894,0.00282167668555017,-0.0321493396266678,-0.0210883670193111,4.48883334855857e-21
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PLA2G10,Group 10 secretory phospholipase A2,39749,-0.0542556455340488,0.00575345851677724,-0.0655324242269322,-0.0429788668411654,4.6509038005053e-21
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BID,BH3-interacting domain death agonist,39866,-0.0606781557481855,0.0064481454888469,-0.0733165209063254,-0.0480397905900456,5.61150076217082e-21
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,APOA2,Apolipoprotein A-II,37445,0.0439057020633521,0.00466534926942574,0.0347616174952777,0.0530497866314266,5.69121968829467e-21
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,APP,Amyloid-beta precursor protein,39829,-0.0610521211911235,0.0064902976473819,-0.073773104579992,-0.048331137802255,5.80188852056443e-21
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AGT,Angiotensinogen,37445,-0.0206438026572178,0.00219680429459633,-0.0249495390746266,-0.016338066239809,6.4851809860938e-21
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MNDA,Myeloid cell nuclear differentiation antigen,39841,-0.0891849690838518,0.00950266751695073,-0.107810197417075,-0.0705597407506284,7.10254934904832e-21
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,OTUD7B,OTU domain-containing protein 7B,37411,-0.0590191945530845,0.0062917161659008,-0.0713509582382501,-0.0466874308679189,7.59688573270293e-21
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ARHGEF12,Rho guanine nucleotide exchange factor 12,39866,-0.0948728685248941,0.0101300307849116,-0.114727728863321,-0.0750180081864674,8.55453129161678e-21
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CASP10,Caspase-10,39489,-0.0652323173280845,0.00696725379938575,-0.0788881347748805,-0.0515764998812884,8.80935983368746e-21
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DPP4,Dipeptidyl peptidase 4,39575,0.027365278164953,0.00292747337412302,0.0216274303516719,0.0331031259782341,1.01332472403723e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KAZN,Kazrin,37382,-0.095369101226122,0.0102040601418575,-0.115369059104163,-0.0753691433480814,1.04898638331583e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ITGA5,Integrin alpha-5,39858,-0.0225782395534064,0.0024171070612122,-0.0273157693933823,-0.0178407097134305,1.07711834989294e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GOLGA3,Golgin subfamily A member 3,37411,-0.0711445708068309,0.00761865212931461,-0.0860771289802875,-0.0562120126333742,1.13025179791091e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RABEP1,Rab GTPase-binding effector protein 1,37124,-0.0711228288741474,0.00763720663908058,-0.0860917538867454,-0.0561539038615495,1.4401443624662e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IDS,Iduronate 2-sulfatase,40058,0.00817022976744684,0.000878251249086062,0.00644885731923816,0.00989160221565553,1.53846173422109e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SEZ6L2,Seizure 6-like protein 2,39788,0.0217830503756889,0.00234199547532311,0.0171927392440556,0.0263733615073222,1.56733425609761e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FABP5,Fatty acid-binding protein 5,39972,-0.0618087819699579,0.00664564385231298,-0.0748342439204914,-0.0487833200194245,1.5713344380813e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IDO1,"Indoleamine 2,3-dioxygenase 1",37043,-0.0579280974726215,0.00622920935677829,-0.0701373478119069,-0.045718847133336,1.63144953407928e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PCBP2,Poly(rC)-binding protein 2,37411,-0.0660469701930973,0.00711394744934104,-0.0799903071938057,-0.0521036331923888,1.87427530811591e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,METAP2,Methionine aminopeptidase 2,40011,-0.0522326387218025,0.00562820444429294,-0.0632639194326167,-0.0412013580109884,1.89606232668375e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ATXN3,Ataxin-3,37388,-0.0555821751789076,0.00600329452530441,-0.0673486324485042,-0.043815717909311,2.37840826344522e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,JAM3,Junctional adhesion molecule C,37124,-0.0459113851978896,0.00495899367033161,-0.0556310127917396,-0.0361917576040397,2.39396584468331e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KLRD1,Natural killer cells antigen CD94,40058,-0.0412036631038344,0.00445547757374269,-0.04993639914837,-0.0324709270592987,2.56957016477023e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SEPTIN8,Septin-8,37357,-0.0288468846736322,0.00311881402327966,-0.0349597601592603,-0.022734009188004,2.59410669721967e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SFRP4,Secreted frizzled-related protein 4,37124,-0.0376206400548647,0.00406734652550478,-0.045592639244854,-0.0296486408648753,2.59751871639026e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PNLIP,Pancreatic triacylglycerol lipase,37445,-0.0554949510312314,0.00600115079204853,-0.0672572065836466,-0.0437326954788163,2.63864876793703e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FOLR1,Folate receptor alpha,39809,-0.024667698801017,0.00267032028019511,-0.0299015265501994,-0.0194338710518346,2.82861033157074e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CTSC,Dipeptidyl peptidase 1,39856,-0.0384341915282456,0.00416736745123353,-0.0466022317326633,-0.0302661513238278,3.25257269923186e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PECAM1,Platelet endothelial cell adhesion molecule,39858,-0.0269868154738726,0.00292704416310306,-0.0327238220335546,-0.0212498089141906,3.33925792617285e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,S100A14,Protein S100-A14,37411,-0.0461153897421447,0.00501018162627841,-0.0559353457296504,-0.036295433754639,3.93470755634233e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PPBP,Platelet basic protein,37371,-0.0765163171050641,0.00831871072095627,-0.0928209901181384,-0.0602116440919898,4.17002568268362e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,37124,-0.0525764731734797,0.00571755139940526,-0.0637828739163141,-0.0413700724306454,4.27705059663624e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KRT8,"Keratin, type II cytoskeletal 8",36991,-0.058771695564024,0.00639486079434685,-0.0713056227209439,-0.0462377684071042,4.49255205687882e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,WASHC3,WASH complex subunit 3,37388,-0.0681656713428433,0.00742307296011081,-0.0827148943446605,-0.0536164483410261,4.79586779126935e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FGFBP3,Fibroblast growth factor-binding protein 3,37388,0.0329452728188174,0.00358796842740743,0.0259128547010988,0.039977690936536,4.83109194647448e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CXCL5,C-X-C motif chemokine 5,39805,-0.101993000333023,0.0111110888080801,-0.12377073439686,-0.0802152662691862,4.85679412796368e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MMP8,Neutrophil collagenase,39985,-0.0640595063216012,0.00698511681210691,-0.0777503352733308,-0.0503686773698717,5.24823385087163e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HSPA1A,Heat shock 70 kDa protein 1A,39904,-0.063841573898531,0.00696253685497908,-0.07748814613429,-0.050195001662772,5.3272851039186e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BTD,Biotinidase,37453,-0.0184034402780536,0.0020099705117183,-0.0223429824810215,-0.0144638980750858,6.14007045030137e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCN5,CCN family member 5,39858,-0.034271413240278,0.00375146973828336,-0.0416242939273134,-0.0269185325532426,7.27768831376803e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,POF1B,Protein POF1B,37056,-0.0404278638854298,0.00442901069835432,-0.0491087248542042,-0.0317470029166553,7.98140026342306e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SYTL4,Synaptotagmin-like protein 4,37437,-0.0645603640820504,0.00707332010735731,-0.0784240714924707,-0.05069665667163,7.99986421027399e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MMP9,Matrix metalloproteinase-9,39843,-0.0538733574519244,0.00590607241003013,-0.0654492593755834,-0.0422974555282653,8.26034852518693e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MAN2B2,Epididymis-specific alpha-mannosidase,37437,-0.0525881335257494,0.00576671952537763,-0.0638909037954895,-0.0412853632560092,8.61390668821319e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",39788,-0.0301926937239015,0.00331375129287864,-0.0366876462579436,-0.0236977411898593,9.08721348288358e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TACSTD2,Tumor-associated calcium signal transducer 2,38022,0.0274137477159574,0.00300843542024726,0.0215172142922727,0.033310281139642,9.13194524400168e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADD1,Alpha-adducin,37124,-0.0615383993286831,0.00676123616938427,-0.0747904222206762,-0.0482863764366899,1.01515146204985e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,37411,-0.0587143439182693,0.00645130427721455,-0.0713589003016098,-0.0460697875349288,1.01688547803852e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,COLEC12,Collectin-12,39862,-0.0220171817728655,0.00242113788039285,-0.0267626120184355,-0.0172717515272955,1.06719981700534e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PCDH17,Protocadherin-17,39868,-0.0310144209364889,0.00341078819480882,-0.0376995657983142,-0.0243292760746636,1.07398479902935e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RILP,Rab-interacting lysosomal protein,39984,-0.0525477457299963,0.00578606937677474,-0.0638884417084748,-0.0412070497515179,1.18966098402602e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,STAT2,Signal transducer and activator of transcription 2,37056,-0.0699910178791285,0.00771614204738718,-0.0851146562920074,-0.0548673794662496,1.3474804502098e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,USO1,General vesicular transport factor p115,39788,-0.0793328032338364,0.00875288113251603,-0.0964884502535678,-0.062177156214105,1.40597576937271e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PZP,Pregnancy zone protein,37453,-0.0488485335728185,0.00538851358030218,-0.0594100201902107,-0.0382870469554262,1.4103788248287e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NRP2,Neuropilin-2,39858,0.0251754311910351,0.00278054711375407,0.0197255588480771,0.0306253035339931,1.53240165225464e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,39713,-0.0988275968350134,0.0109204055249505,-0.120231591663916,-0.0774236020061104,1.59546714328818e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,QPCT,Glutaminyl-peptide cyclotransferase,39862,-0.023345531550533,0.00258088035297939,-0.0284040570423726,-0.0182870060586934,1.65664864015721e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CFC1,Cryptic protein,39477,-0.041183983649442,0.00455470950053338,-0.0501112142704875,-0.0322567530283966,1.71482844587129e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PLXNA4,Plexin-A4,39866,-0.0715688427751192,0.00791869871343717,-0.087089492253456,-0.0560481932967823,1.7755020864093e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ABCA2,ATP-binding cassette sub-family A member 2,37021,-0.0325111426012809,0.00359664689092518,-0.0395605705074942,-0.0254617146950675,1.79468936841221e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,COL5A1,Collagen alpha-1(V) chain,37124,-0.0350003154439994,0.00387651467791276,-0.0425982842127084,-0.0274023466752904,1.97205114052007e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL2RA,Interleukin-2 receptor subunit alpha,39732,-0.034483418605409,0.0038276001995755,-0.041985514996577,-0.026981322214241,2.30871462357707e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IGBP1,Immunoglobulin-binding protein 1,37411,-0.0533060258749764,0.00592177080614964,-0.0649126966550297,-0.0416993550949232,2.51485081599005e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GORASP2,Golgi reassembly-stacking protein 2,37382,-0.0418263435282843,0.00464692477220261,-0.0509343160818014,-0.0327183709747672,2.53468667320687e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",39758,-0.0656155023984256,0.00729838897884667,-0.0799203447969651,-0.0513106599998861,2.73556327864895e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GIGYF2,GRB10-interacting GYF protein 2,37411,-0.0675400357699737,0.00751689965353015,-0.0822731590908928,-0.0528069124490546,2.9227189125242e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FCRLB,Fc receptor-like B,39477,-0.0507136854884436,0.005646851305998,-0.0617815140481997,-0.0396458569286875,2.98752924574404e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CMIP,C-Maf-inducing protein,37368,-0.0728890582151776,0.00811904010880452,-0.0888023768284345,-0.0569757396019208,3.13017309290616e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DYNLT1,Dynein light chain Tctex-type 1,37039,-0.0702787874884641,0.00783534136553592,-0.0856360565649145,-0.0549215184120137,3.37747233357619e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SIGLEC6,Sialic acid-binding Ig-like lectin 6,40030,-0.0289063222060556,0.00322478409634671,-0.0352268990348952,-0.0225857453772161,3.47341820650014e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ING1,Inhibitor of growth protein 1,39453,-0.0392930776490108,0.00439005215505665,-0.0478975798729218,-0.0306885754250997,3.9315800743678e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KDR,Vascular endothelial growth factor receptor 2,39913,-0.0222581770947037,0.00248754901049217,-0.0271337731552684,-0.0173825810341391,4.01441309952398e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KLF4,Krueppel-like factor 4,36991,-0.0346498552497347,0.00387307019949358,-0.0422410728407421,-0.0270586376587273,4.16128068987167e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MPHOSPH8,M-phase phosphoprotein 8,39585,-0.0659847489540758,0.00738634132009648,-0.0804619779414649,-0.0515075199666867,4.58348186046488e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PF4,Platelet factor 4,37385,-0.0843837886370752,0.0094503791754628,-0.102906531820982,-0.0658610454531681,4.8404031919166e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RBPMS2,RNA-binding protein with multiple splicing 2,37043,-0.0902766555626126,0.0101104652776354,-0.110093167506778,-0.0704601436184472,4.86033585955271e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SLAMF6,SLAM family member 6,39477,-0.0328721909684069,0.00368357652057624,-0.0400920009487364,-0.0256523809880775,4.98947980029894e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TCOF1,Treacle protein,37437,-0.0265845028360963,0.00298123603521624,-0.0324277254651201,-0.0207412802070724,5.38227956320399e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DNMBP,Dynamin-binding protein,39749,-0.0538699097943743,0.00604669095282281,-0.065721424061907,-0.0420183955268416,5.69879439657677e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SAMD9L,Sterile alpha motif domain-containing protein 9-like,39866,-0.0634776264214535,0.00714229674643849,-0.077476528044473,-0.0494787247984341,6.90029130956986e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,C1RL,Complement C1r subcomponent-like protein,37432,-0.0167350317508486,0.00188341239085196,-0.0204265200369185,-0.0130435434647788,7.15607294391759e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ATG4A,Cysteine protease ATG4A,39477,-0.0510223808849589,0.0057444948436345,-0.0622815907784825,-0.0397631709914353,7.27311875275072e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TRIM40,E3 ubiquitin ligase TRIM40,37039,-0.0630888762163949,0.00713282956688095,-0.0770692221674816,-0.0491085302653083,1.03181255855134e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SERPINA9,Serpin A9,39715,-0.0625266913842729,0.00708853286848545,-0.0764202158065044,-0.0486331669620414,1.2526800708962e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DOK2,Docking protein 2,39868,-0.105517895881308,0.0119687625222855,-0.128976670424988,-0.0820591213376286,1.30506804992114e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NT5E,5'-nucleotidase,39913,-0.0474434623099555,0.00538837043550615,-0.0580046683635475,-0.0368822562563634,1.44264372158232e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,39749,-0.0330736949236636,0.00375730127111462,-0.0404380054150482,-0.0257093844322789,1.47350633975268e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NGRN,Neugrin,37388,-0.0183767605784152,0.00208884709613901,-0.0224709008868477,-0.0142826202699828,1.56566769874111e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CRTAC1,Cartilage acidic protein 1,40052,0.0257961981721848,0.00293559428630026,0.0200424333710363,0.0315499629733333,1.68191276888663e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",37411,-0.0692080547831707,0.00788505963175275,-0.0846627716614061,-0.0537533379049353,1.87583199458266e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,37368,-0.0415080251054755,0.00473695637999309,-0.0507924596102619,-0.032223590600689,2.13318706674037e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ESYT2,Extended synaptotagmin-2,37388,-0.0706567881644201,0.00806672894493594,-0.0864675768964945,-0.0548459994323456,2.20079873549107e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,STAMBP,STAM-binding protein,39713,-0.0549778576757853,0.00627990054164397,-0.0672864627374075,-0.0426692526141632,2.25232299801783e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,40030,-0.025376126110541,0.00289918442407808,-0.031058527581734,-0.0196937246393479,2.28262972297708e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GLO1,Lactoylglutathione lyase,39585,-0.0492719684342374,0.0056296771453949,-0.0603061356392114,-0.0382378012292634,2.30210263677757e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RPL14,60S ribosomal protein L14,37043,-0.0347503313718062,0.00397020609342537,-0.0425319353149199,-0.0269687274286924,2.33243485381306e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IGFBP6,Insulin-like growth factor-binding protein 6,39825,-0.0235390076878224,0.00269360507823801,-0.0288184736411689,-0.0182595417344759,2.58554702647303e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CFHR4,Complement factor H-related protein 4,37409,0.0615550874484373,0.00705144263343861,0.0477342598868976,0.075375915009977,2.85584056027748e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BIRC2,Baculoviral IAP repeat-containing protein 2,39477,-0.054297952651043,0.00622376492222618,-0.0664965318986063,-0.0420993734034797,2.94498065988298e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EPHB4,Ephrin type-B receptor 4,40052,-0.0199815675302607,0.00229109533452882,-0.0244721143859372,-0.0154910206745842,3.01064861858435e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,39749,-0.0668637656659299,0.00766797297918662,-0.0818929927051357,-0.0518345386267241,3.05668651618708e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SNX15,Sorting nexin-15,37124,-0.0460061343148211,0.00528316402950653,-0.0563611358126539,-0.0356511328169883,3.45326240205653e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDC42BPB,Serine/threonine-protein kinase MRCK beta,37382,-0.0872799659519765,0.0100380163999148,-0.10695447809581,-0.0676054538081434,3.86604046586682e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RABGAP1L,Rab GTPase-activating protein 1-like,39587,-0.0504418275818833,0.0058103643254939,-0.0618301416598513,-0.0390535135039152,4.28935687725125e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MTUS1,Microtubule-associated tumor suppressor 1,37169,-0.0476036547854874,0.00548360191712043,-0.0583515145430435,-0.0368557950279314,4.37165840851286e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TP53I3,Quinone oxidoreductase PIG3,36874,-0.0455492918158494,0.00525043173876923,-0.0558401380238371,-0.0352584456078617,4.60831620237478e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SH2B3,SH2B adapter protein 3,39477,-0.0834106139283772,0.00961853447369846,-0.102262941496826,-0.0645582863599282,4.66364674254326e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,APCS,Serum amyloid P-component,37333,-0.0295674068559542,0.00341034840081109,-0.0362516897215439,-0.0228831239903644,4.81415433981249e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CPXM2,Inactive carboxypeptidase-like protein X2,37437,-0.020356465370989,0.00234930473204143,-0.0249611026457902,-0.0157518280961878,5.02569298389169e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DLK1,Protein delta homolog 1,40052,-0.0470690814493918,0.00543858149439556,-0.0577287011784071,-0.0364094617203765,5.40205832877723e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,OGA,Protein O-GlcNAcase,37382,-0.0603752984513899,0.00697812712968375,-0.0740524276255701,-0.0466981692772098,5.622322019727e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD207,C-type lectin domain family 4 member K,39496,-0.0317537781617353,0.00367112806048229,-0.0389491891602806,-0.02455836716319,5.66382691960663e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SPARC,SPARC,39913,-0.0593808742482994,0.00687306499260179,-0.0728520816337989,-0.0459096668627998,6.16221391209125e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SEC31A,Protein transport protein Sec31A,37043,-0.0652815797304004,0.00756121050118793,-0.0801015523127288,-0.0504616071480721,6.61309694914073e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DNM3,Dynamin-3,37411,-0.0465032678969106,0.00538645818647234,-0.0570607259423964,-0.0359458098514248,6.61570697991835e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AZI2,5-azacytidine-induced protein 2,37411,-0.0469201040620462,0.00544071125745081,-0.0575838981266498,-0.0362563099974426,7.1837402925856e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RAB27B,Ras-related protein Rab-27B,37437,-0.0692402666981567,0.00803096422254274,-0.0849809565743404,-0.0534995768219729,7.32273520264654e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CST7,Cystatin-F,39882,-0.0774417956008437,0.00898969891032007,-0.095061605465071,-0.0598219857366163,7.67039408160402e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EVI5,Ecotropic viral integration site 5 protein homolog,37056,-0.0766743888031391,0.0089277452030717,-0.0941727694011597,-0.0591760082051186,9.80598985324884e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SLC16A1,Monocarboxylate transporter 1,39489,-0.0485242282170227,0.00565728983656576,-0.0596125162966916,-0.0374359401373538,1.06135704802964e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CARHSP1,Calcium-regulated heat-stable protein 1,39489,-0.0422560013811528,0.00493231152627567,-0.0519233319726531,-0.0325886707896525,1.15831913438691e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LEPR,Leptin receptor,39868,0.025803258188329,0.00301542293274673,0.0198930292401454,0.0317134871365126,1.26111101900794e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SERPINB8,Serpin B8,40058,-0.0459422521572564,0.00537230642240053,-0.0564719727451614,-0.0354125315693513,1.32009064479429e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GASK1A,Golgi-associated kinase 1A,37021,-0.0358071370811171,0.00418987441083624,-0.0440192909263561,-0.0275949832358781,1.41214939021162e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,39866,-0.0506959850382927,0.0059400796567903,-0.0623385411656017,-0.0390534289109837,1.53147710809241e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,37411,-0.0707596401851801,0.008295255496094,-0.0870183409575244,-0.0545009394128359,1.61550461533844e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",37043,-0.0311278337620416,0.00365113609498294,-0.0382840605082082,-0.023971607015875,1.68553556533713e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,39585,-0.046995952995882,0.00551391885124581,-0.0578032339443238,-0.0361886720474402,1.69205241117947e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,37043,-0.0642076755553664,0.00755022927402507,-0.0790061249324555,-0.0494092261782773,2.02621589010945e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CTSB,Cathepsin B,39847,0.0425012162269627,0.00500332496570842,0.0326946992941742,0.0523077331597512,2.15904452900572e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MMP12,Macrophage metalloelastase,39900,-0.0414236919140727,0.00489767014748173,-0.0510231254031369,-0.0318242584250085,2.95582012709814e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNXB,Tenascin-X,39858,0.0211995727387943,0.00250778694724213,0.0162843103221997,0.0261148351553889,3.0679327341622e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCL2,C-C motif chemokine 2,39720,-0.0425921424903044,0.00503915731917084,-0.0524688908358793,-0.0327153941447296,3.10336806722955e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BMP10,Bone morphogenetic protein 10,37124,0.0234210448785062,0.0027715879380751,0.017988732519879,0.0288533572371334,3.20318806647064e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCL8,C-C motif chemokine 8,40003,-0.0496881305591744,0.00588507961711517,-0.0612228866087201,-0.0381533745096286,3.35078322991629e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SUSD2,Sushi domain-containing protein 2,39858,0.0231612037282867,0.0027479673754231,0.0177751876724575,0.028547219784116,3.79646867043072e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FABP2,"Fatty acid-binding protein, intestinal",39868,0.0639218810992446,0.00759457261952329,0.0490365187649789,0.0788072434335102,4.19329819455522e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VASN,Vasorin,39642,0.0224833567962241,0.00267232927308415,0.0172455914209792,0.027721122171469,4.3207813252878e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MOCS2,Molybdopterin synthase catalytic subunit,37124,-0.056069436321712,0.00667381065279077,-0.0691501052011819,-0.0429887674422421,4.85689093211468e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,37043,0.0172616768915879,0.00205507879166095,0.0132337224599324,0.0212896313232433,4.93825926979758e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TREML2,Trem-like transcript 2 protein,39858,-0.0271132934143995,0.0032320603294748,-0.0334481316601701,-0.0207784551686289,5.31425714086906e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CIT,Citron Rho-interacting kinase,37039,-0.0372834917997709,0.00444633406461063,-0.0459983065664077,-0.0285686770331341,5.57373884245986e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,39585,0.017500789229541,0.00208900701617614,0.0134063354778358,0.0215952429812462,5.8551944599142e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNFSF10,Tumor necrosis factor ligand superfamily member 10,40058,0.021233199886775,0.00253478299290897,0.0162650252206735,0.0262013745528766,5.88270888763245e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DDX58,Antiviral innate immune response receptor RIG-I,39477,-0.046711181010414,0.00557620864989943,-0.0576405499642169,-0.0357818120566111,5.89284357770806e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IMPACT,Protein IMPACT,37388,-0.0454405949906812,0.00542538578058006,-0.0560743511206181,-0.0348068388607443,6.03351199621197e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNFSF13,Tumor necrosis factor ligand superfamily member 13,39931,-0.0214570951855203,0.00256300931254763,-0.0264805934381137,-0.016433596932927,6.1350733171589e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IFNG,Interferon gamma,39587,-0.093226291247939,0.0111529682727941,-0.115086109062615,-0.0713664734332627,6.85626155352018e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GMPR,GMP reductase 1,40058,-0.0404620798263652,0.00484203812424042,-0.0499524745498764,-0.030971685102854,6.98405628736212e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LARP1,La-related protein 1,37368,-0.0524607071896693,0.00627828106814318,-0.06476613808323,-0.0401552762961087,7.12253152888285e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TPR,Nucleoprotein TPR,37021,-0.0384319501320167,0.00460885390589089,-0.0474653037875628,-0.0293985964764706,8.25110251271454e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TREM2,Triggering receptor expressed on myeloid cells 2,39862,-0.0419158285080986,0.00503627240777133,-0.0517869224273305,-0.0320447345888668,9.27849325927902e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SUGP1,SURP and G-patch domain-containing protein 1,37382,-0.0327120839454765,0.0039356083681627,-0.0404258763470754,-0.0249982915438776,1.03166437127648e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BAG4,BAG family molecular chaperone regulator 4,37056,-0.0406592342378831,0.00489194976420921,-0.0502474557757332,-0.0310710127000331,1.03714388963072e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SH3BP1,SH3 domain-binding protein 1,37382,-0.0390575786980942,0.00470202006427971,-0.0482735380240824,-0.029841619372106,1.07827506392748e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,WFDC1,WAP four-disulfide core domain protein 1,37123,-0.0427791270886575,0.00515415311773061,-0.0528812671994095,-0.0326769869779055,1.1417599841394e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCL13,C-C motif chemokine 13,40024,-0.0556809562586037,0.00671429156221925,-0.0688409677205534,-0.042520944796654,1.19133136973723e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DLL1,Delta-like protein 1,39913,-0.0229630260397292,0.0027695613896297,-0.0283913663634034,-0.017534685716055,1.208907135317e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BRAP,BRCA1-associated protein,37249,-0.0895665870604349,0.0108065961881356,-0.110747515589181,-0.0683856585316891,1.25909974693366e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MYDGF,Myeloid-derived growth factor,37437,-0.0821426517335288,0.00992032900321111,-0.101586496579823,-0.062698806887235,1.3434455252647e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TADA3,Transcriptional adapter 3,37368,-0.0321265566119464,0.00388027131525464,-0.0397318883898455,-0.0245212248340473,1.352763724218e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,COL1A1,Collagen alpha-1(I) chain,40052,0.0199520749024788,0.00241484310430764,0.0152189824180359,0.0246851673869218,1.53886806572684e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDA,Cytidine deaminase,37422,-0.0375534013235652,0.00454451724623222,-0.0464606551261804,-0.0286461475209501,1.54561668047866e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PON2,Serum paraoxonase/arylesterase 2,39585,-0.0276606677655194,0.00334904872617921,-0.0342248032688307,-0.0210965322622082,1.58137963043488e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FOXO3,Forkhead box protein O3,39477,-0.0787038499328104,0.00953371236367553,-0.0973899261656145,-0.0600177737000064,1.63506285552465e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SEMA7A,Semaphorin-7A,40002,-0.0216233400047557,0.00262539310318492,-0.0267691104869981,-0.0164775695225132,1.91211087277975e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SIGLEC8,Sialic acid-binding Ig-like lectin 8,37043,-0.0371906820877358,0.00451555160036239,-0.0460411632244461,-0.0283402009510255,1.94522159632358e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TIMP3,Metalloproteinase inhibitor 3,39931,-0.103896228007031,0.0126385716819534,-0.12866782850366,-0.0791246275104028,2.17865462306454e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SERPINA12,Serpin A12,39405,-0.0948826452080574,0.0115569535534493,-0.117534274172818,-0.0722310162432968,2.38407225928777e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRSS22,Brain-specific serine protease 4,37056,-0.0270520264537534,0.00329614179744424,-0.0335124643767441,-0.0205915885307627,2.47323421391638e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FKBPL,FK506-binding protein-like,37382,-0.0478557416011075,0.00583819439534329,-0.0592986026159804,-0.0364128805862347,2.68477623119861e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,THY1,Thy-1 membrane glycoprotein,40009,-0.0215658982009205,0.00263332725854132,-0.0267272196276615,-0.0164045767741795,2.81521843159542e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NAGK,N-acetyl-D-glucosamine kinase,37026,-0.0462763270672471,0.00564936942082528,-0.0573490911320646,-0.0352035630024295,2.81845471033287e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SOST,Sclerostin,39846,-0.0305804487303404,0.0037340885280386,-0.037899262245296,-0.0232616352153847,2.81879265463987e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LAYN,Layilin,39713,-0.025764989266137,0.00314606991240353,-0.0319312862944479,-0.019598692237826,2.81946145570038e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,37382,-0.0521810160820861,0.00638257266814275,-0.0646908585116459,-0.0396711736525263,3.20586831707837e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LGALS3BP,Galectin-3-binding protein,37453,-0.0241005694319792,0.00295215111621752,-0.0298867856197656,-0.0183143532441929,3.5324347791006e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TREH,Trehalase,37437,-0.060163004335383,0.00737522791164612,-0.0746184510422094,-0.0457075576285566,3.72064168996028e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GIPC2,PDZ domain-containing protein GIPC2,37388,-0.0229195087600448,0.00281180735341177,-0.0284306511727319,-0.0174083663473578,3.91916886539342e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ASAH1,Acid ceramidase,37340,-0.0377472066892436,0.00463219242713347,-0.0468263038464252,-0.028668109532062,3.9945920322778e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDH3,Cadherin-3,40009,-0.0275180259783241,0.00337781022910057,-0.0341385340273612,-0.020897517929287,4.0110467708797e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD46,Membrane cofactor protein,39777,-0.0225399987685244,0.00276771132523872,-0.0279647129659923,-0.0171152845710565,4.10850746781037e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ITGB1,Integrin beta-1,39862,0.01726275356198,0.00212138422507066,0.0131048404808415,0.0214206666431185,4.32959451256717e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KYAT1,Kynurenine--oxoglutarate transaminase 1,39850,-0.044908176648886,0.00552708747466391,-0.0557412680992272,-0.0340750851985447,4.79377143006241e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,37411,0.020465720042275,0.00251887059652514,0.0155287336730857,0.0254027064114643,4.86025333135243e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SERPINE2,Glia-derived nexin,37437,-0.0513457997822935,0.0063246921691931,-0.063742196433912,-0.038949403130675,5.13191433334957e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VAMP5,Vesicle-associated membrane protein 5,39585,-0.0416856442009125,0.00514106664041852,-0.0517621348161328,-0.0316091535856922,5.50586154724778e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SMOC2,SPARC-related modular calcium-binding protein 2,39931,-0.0298628063520677,0.00370205902824373,-0.0371188420474255,-0.02260677065671,7.73834894671884e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DGKA,Diacylglycerol kinase alpha,37056,-0.0432979203235207,0.00536967531349165,-0.0538224839379644,-0.0327733567090771,8.05538506080909e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CBLIF,Cobalamin binding intrinsic factor,39846,-0.0539472833331918,0.00669663374080051,-0.0670726854651608,-0.0408218812012228,8.44354649834284e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PLIN3,Perilipin-3,39868,-0.0337347692604052,0.00419111172120958,-0.0419493482339759,-0.0255201902868344,8.92028544610302e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AHSP,Alpha-hemoglobin-stabilizing protein,39836,-0.0669050493597949,0.00831974156278233,-0.0832117428228482,-0.0505983558967415,9.47490656941282e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD160,CD160 antigen,40058,-0.0351848662773208,0.00437660469779933,-0.0437630114850075,-0.0266067210696341,9.65391673277884e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DFFA,DNA fragmentation factor subunit alpha,40058,-0.0531344883998461,0.0066155301438307,-0.0661009274817543,-0.0401680493179379,1.02625510901174e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MITD1,MIT domain-containing protein 1,39749,-0.0761187123969245,0.00947983199734276,-0.0946991831117163,-0.0575382416821327,1.04641578944313e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,S100A12,Protein S100-A12,39615,-0.0584892716653718,0.00729789357776552,-0.0727931430777922,-0.0441854002529514,1.18245934031113e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLIP2,CAP-Gly domain-containing linker protein 2,39866,-0.0885355640973975,0.0110476943153054,-0.110189044955396,-0.0668820832393989,1.18698314374204e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD36,Platelet glycoprotein 4,37056,-0.0358690497554787,0.00448085463308753,-0.0446515248363302,-0.0270865746746271,1.29454701379973e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FCN2,Ficolin-2,39810,-0.0316974427932635,0.00396114064725044,-0.0394612784618744,-0.0239336071246526,1.30671572586002e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MAP2,Microtubule-associated protein 2,37388,-0.0360972575133432,0.00451203485487899,-0.044940845828906,-0.0272536691977804,1.34250002631404e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SCARF1,Scavenger receptor class F member 1,40052,-0.0333740259257218,0.00417395514418831,-0.0415549780083309,-0.0251930738431127,1.37389635414619e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PDGFC,Platelet-derived growth factor C,39477,-0.022743350695609,0.00284750428437475,-0.0283244590929835,-0.0171622422982345,1.47701817531714e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL1R1,Interleukin-1 receptor type 1,39826,-0.0175039598793989,0.00219210844895139,-0.0218004924393436,-0.0132074273194542,1.50044037440369e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDHR5,Cadherin-related family member 5,39868,-0.0302060224993587,0.00378508637229993,-0.0376247917890666,-0.0227872532096509,1.55838226815151e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BAP18,Chromatin complexes subunit BAP18,37388,-0.0509010004157852,0.00637943691047196,-0.0634046967603102,-0.0383973040712601,1.59437786917729e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CEMIP2,Cell surface hyaluronidase,37056,-0.0250242429628945,0.00313764163220681,-0.0311740205620199,-0.0188744653637692,1.64214802731691e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ESM1,Endothelial cell-specific molecule 1,39862,0.0264971950542386,0.00332375196153382,0.0199826412096323,0.0330117488988449,1.6649710187019e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PACS2,Phosphofurin acidic cluster sorting protein 2,37021,-0.0487680029370119,0.00612102647213268,-0.0607652148223919,-0.0367707910516318,1.75466966868087e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,P4HB,Protein disulfide-isomerase,39776,-0.0302340938845577,0.0037958826552346,-0.0376740238888175,-0.0227941638802979,1.76366486282395e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HTRA2,"Serine protease HTRA2, mitochondrial",39913,-0.0477562240242001,0.00599622770255965,-0.0595088303212171,-0.0360036177271832,1.7711232001271e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FCRL5,Fc receptor-like protein 5,39858,-0.0433848604564314,0.00545033937683835,-0.0540675256350346,-0.0327021952778282,1.83464781199132e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NUB1,NEDD8 ultimate buster 1,39866,-0.0654306795232316,0.00822231818827731,-0.0815464231722551,-0.049314935874208,1.86942034490425e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AAMDC,Mth938 domain-containing protein,37043,-0.0417624640452923,0.00524932383278531,-0.0520511387575515,-0.031473789333033,1.92468109216943e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD28,T-cell-specific surface glycoprotein CD28,39477,-0.0273234154859354,0.00343801861235326,-0.0340619319661478,-0.020584899005723,2.03348793312605e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PCDH9,Protocadherin-9,37382,-0.0258847943904434,0.0032597592950891,-0.032273922608818,-0.0194956661720687,2.16816691179535e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PTPRF,Receptor-type tyrosine-protein phosphatase F,40052,0.0221408779786854,0.00279119497839395,0.0166701358210333,0.0276116201363376,2.28903114607719e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HYAL1,Hyaluronidase-1,39747,-0.0176614913312574,0.00222803121180942,-0.0220284325064039,-0.013294550156111,2.39421292128362e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NXPH3,Neurexophilin-3,37056,0.0230686658348936,0.00291162015974906,0.0173618903217855,0.0287754413480018,2.50418070746697e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VNN1,Pantetheinase,37445,-0.0562068298066151,0.00710551087780064,-0.0701336311271043,-0.0422800284861258,2.76489186661342e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCL17,C-C motif chemokine 17,39836,-0.0695371528415832,0.00879295560061786,-0.0867713458187942,-0.0523029598643722,2.77936318030633e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD34,Hematopoietic progenitor cell antigen CD34,39945,0.0185249701635722,0.00234346141258495,0.0139317857949057,0.0231181545322387,2.85292123350398e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NIT1,Deaminated glutathione amidase,37043,-0.0365834552453577,0.00462746935157546,-0.0456532951744456,-0.0275136153162698,2.8749046155884e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FAM13A,Protein FAM13A,37382,-0.0525007788197982,0.00664557989765866,-0.0655261154192092,-0.0394754422203872,3.00096740502324e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CASC3,Protein CASC3,37039,-0.0325062381412179,0.00411850796859431,-0.0405785137596628,-0.0244339625227731,3.18924624413995e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LMNB2,Lamin-B2,37388,-0.021136257958108,0.00267978078619486,-0.02638862829905,-0.0158838876171661,3.32348948374367e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SLC27A4,Long-chain fatty acid transport protein 4,39489,-0.051921370503517,0.00660256497693418,-0.064862397858308,-0.038980343148726,3.96815242164276e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,40034,-0.0203594298622225,0.00259138008535192,-0.0254385348295122,-0.0152803248949327,4.19382451460197e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SYAP1,Synapse-associated protein 1,37124,-0.0442788965997481,0.00564234964568731,-0.0553379019052952,-0.033219891294201,4.56450965273357e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,WASF1,Wiskott-Aldrich syndrome protein family member 1,39585,-0.0719056147694248,0.00916629951176108,-0.0898715618124765,-0.0539396677263731,4.62246305661114e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ERBB3,Receptor tyrosine-protein kinase erbB-3,39809,-0.0147386864686045,0.00187971007096454,-0.018422918207695,-0.011054454729514,4.75331693938876e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",37382,-0.113435583393111,0.0144661979642053,-0.141789331402953,-0.0850818353832686,4.78695976241157e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NELL1,Protein kinase C-binding protein NELL1,39913,0.0311686569012213,0.0039820375127157,0.0233638633762986,0.0389734504261441,5.29329366473892e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,OMG,Oligodendrocyte-myelin glycoprotein,39788,0.0494901015888349,0.00633614181076235,0.0370712636397407,0.0619089395379291,6.03679280443002e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MMP7,Matrilysin,39563,-0.0375799119628255,0.0048138441059398,-0.0470150464104675,-0.0281447775151835,6.24244518228155e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADGRF5,Adhesion G protein-coupled receptor F5,37437,-0.0218165851104293,0.00279712504298419,-0.0272989501946783,-0.0163342200261803,6.6593224071014e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,REEP4,Receptor expression-enhancing protein 4,37411,-0.0477339572290753,0.00612318513149178,-0.0597354000867992,-0.0357325143713514,6.87567443453566e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,39587,-0.0424856660737566,0.00545143459488264,-0.0531704778797265,-0.0318008542677866,6.92455896402655e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SPRY2,Protein sprouty homolog 2,39587,-0.0704424379047502,0.00903985697473873,-0.0881605575752381,-0.0527243182342623,6.98242887702327e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CSPG4,Chondroitin sulfate proteoglycan 4,37437,0.0250519429973888,0.00321553632736831,0.0187494917957469,0.0313543941990307,7.13435986769004e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ORM1,Alpha-1-acid glycoprotein 1,37389,-0.015157145511305,0.00194590648111691,-0.0189711222142941,-0.0113431688083159,7.23006683860944e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,37382,-0.0826719186059333,0.0106165385157446,-0.103480334096793,-0.0618635031150738,7.35433130806591e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LZTFL1,Leucine zipper transcription factor-like protein 1,37124,-0.0551002735727761,0.00707797872059754,-0.0689731118651473,-0.0412274352804049,7.50132902314168e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,37056,-0.034551741959267,0.00443842024407343,-0.0432510456376509,-0.025852438280883,7.5072276405944e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CETN2,Centrin-2,39489,-0.051370923982666,0.00661041295679985,-0.0643273333779938,-0.0384145145873383,8.2553994761989e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,37437,-0.0474432505957254,0.00610536878192308,-0.0594097734082947,-0.0354767277831562,8.361326788028e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",40052,-0.0218926640180679,0.00282535570354312,-0.0274303611970124,-0.0163549668391234,9.83654109549238e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,UROD,Uroporphyrinogen decarboxylase,37124,-0.0527109429863195,0.00680625538524076,-0.0660512035413914,-0.0393706824312476,1.02911770426517e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RGCC,Regulator of cell cycle RGCC,37411,-0.0575199035475247,0.00743740007353512,-0.0720972076916536,-0.0429425994033959,1.11663668000706e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LY96,Lymphocyte antigen 96,39749,-0.0266312370438611,0.00344588490752653,-0.0333851714626131,-0.0198773026251091,1.15377301161999e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SIRT2,NAD-dependent protein deacetylase sirtuin-2,39788,-0.0669258533562638,0.00866053032170938,-0.0839004927868141,-0.0499512139257134,1.16023676188982e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ARHGEF10,Rho guanine nucleotide exchange factor 10,37411,-0.0709986718016173,0.00919685900969694,-0.0890245154606233,-0.0529728281426113,1.24569228554098e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SKAP2,Src kinase-associated phosphoprotein 2,39931,-0.0783414687166375,0.0101537350425227,-0.098242789399982,-0.058440148033293,1.27523066084754e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GIT1,ARF GTPase-activating protein GIT1,37056,-0.073849145430325,0.00957345121495599,-0.0926131098116387,-0.0550851810490113,1.30708815441598e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CXCL16,C-X-C motif chemokine 16,40034,-0.0174799243739772,0.00226670800005367,-0.0219226720540823,-0.013037176693872,1.31462307312658e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FOXJ3,Forkhead box protein J3,37056,-0.0339137736678911,0.00439857928536229,-0.0425349890672011,-0.025292558268581,1.3462850446074e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CPXM1,Probable carboxypeptidase X1,39913,-0.0509649588439627,0.00662034577489684,-0.0639408365627605,-0.0379890811251649,1.45964643974425e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RRAS,Ras-related protein R-Ras,37039,-0.0995413533551402,0.0129361166502355,-0.124896141989602,-0.0741865647206786,1.51720186059852e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GET3,ATPase GET3,37437,-0.0421905087851617,0.00548633092327195,-0.0529437173947747,-0.0314373001755487,1.57091672936943e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,OPHN1,Oligophrenin-1,37388,-0.0812777931686552,0.0105837621283161,-0.102021966940155,-0.0605336193971556,1.70675469795754e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LTA,Lymphotoxin-alpha,39866,-0.0295430171439613,0.00385351997208284,-0.0370959162892437,-0.0219901179986789,1.86864828455816e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CPPED1,Serine/threonine-protein phosphatase CPPED1,40009,-0.0490272871354423,0.00639677145061752,-0.0615649591786527,-0.036489615092232,1.89874882250003e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VAMP8,Vesicle-associated membrane protein 8,37056,-0.0664384531856057,0.00867332576554592,-0.0834381716860757,-0.0494387346851358,1.9872568116187e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD7,T-cell antigen CD7,37037,-0.0321108194220554,0.00419254740125566,-0.0403282123285165,-0.0238934265155943,2.00394087018362e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LRP1,Prolow-density lipoprotein receptor-related protein 1,39788,0.0197920488969216,0.00258628990217963,0.0147229206886495,0.0248611771051937,2.08070757722737e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PEBP1,Phosphatidylethanolamine-binding protein 1,39858,-0.0429569354679471,0.00562481570524157,-0.0539815742502206,-0.0319322966856736,2.34803582728221e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ENTR1,Endosome-associated-trafficking regulator 1,37043,-0.0447992868194311,0.00588045583805152,-0.056324980262012,-0.0332735933768501,2.74464434863738e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BPIFA2,BPI fold-containing family A member 2,36593,0.0812939707180357,0.0106760481560422,0.060368916332193,0.102219025103878,2.83111939909924e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD163,Scavenger receptor cysteine-rich type 1 protein M130,39931,-0.0316037839791247,0.00415445119625437,-0.0397465083237833,-0.0234610596344661,2.95542565510456e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,37056,-0.0270173107761787,0.00355202561627584,-0.0339792809840793,-0.020055340568278,3.0141883514035e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MPO,Myeloperoxidase,39858,-0.0335856628349965,0.00442194876118553,-0.0422526824069202,-0.0249186432630729,3.24216250760848e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CNTN4,Contactin-4,39858,0.0176731985351641,0.00232804650297247,0.0131102273893381,0.0222361696809901,3.33806086297435e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,COMMD1,COMM domain-containing protein 1,37043,-0.0462035049651665,0.0060884776608102,-0.0581369211803545,-0.0342700887499785,3.44842602038311e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MCFD2,Multiple coagulation factor deficiency protein 2,39788,-0.0332104708571426,0.00437900371632886,-0.0417933181411472,-0.0246276235731381,3.5344016572244e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",39788,-0.0517023472256572,0.0068286490338977,-0.0650864993320967,-0.0383181951192177,3.89450785840668e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BCL2L15,Bcl-2-like protein 15,37056,-0.0419684393613317,0.00554213287247014,-0.0528310197913732,-0.0311058589312902,3.90065855971382e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DNAJB2,DnaJ homolog subfamily B member 2,37124,-0.0395694841996357,0.00522869832805223,-0.0498177329226181,-0.0293212354766533,4.04751920939282e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",39842,-0.0467404415894775,0.0061813234567808,-0.0588558355647678,-0.0346250476141871,4.19856033469051e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NID1,Nidogen-1,39892,-0.0277562633125709,0.00367277098941648,-0.0349548944518272,-0.0205576321733146,4.33679896163394e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RBP2,Retinol-binding protein 2,39788,0.0563042323065256,0.00745911325053823,0.0416843703354706,0.0709240942775805,4.64504770812818e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RAB33A,Ras-related protein Rab-33A,37021,-0.0496779987382629,0.00658026636021075,-0.0625753208042759,-0.0367806766722498,4.65507209176283e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ACP5,Tartrate-resistant acid phosphatase type 5,39919,-0.0244413644366493,0.00324022905412828,-0.0307922133827408,-0.0180905154905579,4.83449893977488e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL19,Interleukin-19,39419,-0.0504596565009064,0.00669802071834722,-0.063587777108867,-0.0373315358929459,5.21024237226488e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,UBAC1,Ubiquitin-associated domain-containing protein 1,39788,-0.0252795117315958,0.00335770355175108,-0.0318606106930279,-0.0186984127701637,5.39418793646486e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CMC1,COX assembly mitochondrial protein homolog,37437,-0.0668237978165021,0.00887885482592831,-0.0842263532753216,-0.0494212423576826,5.55344269996921e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,STX8,Syntaxin-8,39866,-0.035795592034694,0.00476086962463112,-0.045126896498971,-0.026464287570417,5.8246208321856e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NEXN,Nexilin,37445,-0.0507348790129109,0.00675117012707138,-0.0639671724619708,-0.037502585563851,6.04770110861225e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FAM3D,Protein FAM3D,37382,-0.0614380039844554,0.00818398229983729,-0.0774786092921365,-0.0453973986767743,6.42277192029948e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GMPR2,GMP reductase 2,37124,-0.0492774076759783,0.00657646675288088,-0.0621672825116248,-0.0363875328403318,7.15803242635949e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LGALS3,Galectin-3,39901,-0.0215214729464101,0.00287436934464534,-0.0271552368619149,-0.0158877090309052,7.3913058823799e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD164,Sialomucin core protein 24,39858,-0.0191334534879488,0.00255773064743118,-0.0241466055569139,-0.0141203014189837,7.77987539091966e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,39506,-0.0573938795151944,0.00768340692566548,-0.0724533570894987,-0.04233440194089,8.4522124886111e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PKD2,Polycystin-2,37021,-0.0436039249345646,0.00583820292434071,-0.0550468026662724,-0.0321610472028568,8.60729465016327e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,40009,-0.0407459234927151,0.00545918899857009,-0.0514459339299125,-0.0300459130555177,8.83859452781466e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DDR1,Epithelial discoidin domain-containing receptor 1,40009,-0.0169495165642582,0.00227192443250823,-0.0214024884519744,-0.0124965446765421,9.06267689262968e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,STK24,Serine/threonine-protein kinase 24,39489,-0.0452324151637286,0.00607370392959585,-0.0571368748657364,-0.0333279554617207,1.00274036611918e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SOD3,Extracellular superoxide dismutase,37445,0.0444649997668023,0.00597347861013517,0.0327569816909373,0.0561730178426672,1.03759379029397e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,36846,-0.0240677029419258,0.00323324882519235,-0.0304048706393028,-0.0177305352445488,1.039773722505e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TSC22D1,TSC22 domain family protein 1,37411,-0.0495435209119058,0.00665605292625399,-0.0625893846473636,-0.036497657176448,1.04055037762236e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,39977,-0.0748175518225488,0.0100586242166933,-0.0945324552872676,-0.0551026483578299,1.07240876956762e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ZNRD2,Protein ZNRD2,37382,-0.0495573147333136,0.00666227204288079,-0.0626153679373599,-0.0364992615292673,1.0796680166913e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PAGR1,PAXIP1-associated glutamate-rich protein 1,37043,-0.0317708370374183,0.00427275958740055,-0.0401454458287234,-0.0233962282461132,1.10458664670942e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HGFAC,Hepatocyte growth factor activator,37318,0.0206722184908096,0.00278031380024419,0.015222803442331,0.0261216335392882,1.10707840180098e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RWDD1,RWD domain-containing protein 1,40009,-0.0462738753395726,0.0062273168744283,-0.0584794164134521,-0.0340683342656931,1.13349129490385e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LRRC59,Leucine-rich repeat-containing protein 59,37437,-0.0339968331234099,0.0045761197959801,-0.0429660279235309,-0.0250276383232889,1.15789772371261e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNR,Tenascin-R,39749,0.030406946625886,0.00409354411539807,0.0223836001597058,0.0384302930920662,1.15826223141189e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PCYT2,Ethanolamine-phosphate cytidylyltransferase,37382,-0.0559038572193738,0.00752920267816067,-0.0706610944685687,-0.0411466199701789,1.19578131872483e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,39477,-0.0475820444070741,0.0064101049553156,-0.0601458501194927,-0.0350182386946556,1.20418809997774e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LTBP2,Latent-transforming growth factor beta-binding protein 2,40052,0.0223232087683954,0.00300858926596867,0.0164263738070968,0.028220043729694,1.23086866917461e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",39866,-0.069693235145243,0.00941293508084247,-0.0881425879036943,-0.0512438823867918,1.38728082142785e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PPP1R2,Protein phosphatase inhibitor 2,39868,-0.0583277570513715,0.00788325997101433,-0.0737789465945596,-0.0428765675081835,1.44083521453451e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,37368,-0.0259780411937436,0.00351154202912227,-0.0328606635708233,-0.0190954188166639,1.46511562249523e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TP53,Cellular tumor antigen p53,39477,-0.0319030082014134,0.00431349024767297,-0.0403574490868524,-0.0234485673159744,1.47361979822772e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CRKL,Crk-like protein,39881,-0.0771892158478691,0.0104454351363036,-0.0976622687150241,-0.0567161629807141,1.54349508347228e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FBP1,"Fructose-1,6-bisphosphatase 1",39868,-0.0524032143534416,0.00709962751543139,-0.0663184842836871,-0.0384879444231961,1.64668674254724e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DCTN2,Dynactin subunit 2,39788,-0.0683315735015032,0.00925845848220894,-0.0864781521266328,-0.0501849948763737,1.65540672140317e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL10,Interleukin-10,39587,-0.0569445052718068,0.00772330494614619,-0.0720821829662533,-0.0418068275773603,1.75037042718386e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SART1,U4/U6.U5 tri-snRNP-associated protein 1,37021,-0.025838957553761,0.00350570276871416,-0.0327101349804407,-0.0189677801270812,1.80063426068364e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LGMN,Legumain,39931,-0.0258163566480613,0.00350404194306884,-0.0326842788564763,-0.0189484344396464,1.82169798822242e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VEGFD,Vascular endothelial growth factor D,40024,0.0255403771617467,0.00346806659159168,0.018742966642227,0.0323377876812663,1.86458979730708e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,39866,-0.0728702964350817,0.00990403295050679,-0.092282201018075,-0.0534583918520884,1.96267543153389e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FABP3,"Fatty acid-binding protein, heart",37437,-0.0353661735864858,0.00480617716650905,-0.0447862808328436,-0.0259460663401281,1.96689807005857e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TMSB10,Thymosin beta-10,39858,-0.0554378699692329,0.00754068255273081,-0.0702176077725853,-0.0406581321658805,2.04954341864231e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,APOBR,Apolipoprotein B receptor,37043,0.0306873196289714,0.00417690470234367,0.0225005864123778,0.038874052845565,2.14775527548895e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HMOX2,Heme oxygenase 2,39489,-0.0338974830663972,0.00461470979486508,-0.0429423142643328,-0.0248526518684616,2.15061749002481e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,37056,-0.0262470858245585,0.00357668053339398,-0.0332573796700107,-0.0192367919791063,2.28811293953376e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AKR1C4,Aldo-keto reductase family 1 member C4,39585,-0.0376635009504486,0.0051390939465197,-0.0477361250856272,-0.02759087681527,2.43469181347454e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GOT1,"Aspartate aminotransferase, cytoplasmic",37437,-0.0302025266993858,0.00412623714528058,-0.0382899515041358,-0.0221151018946359,2.6262932100019e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PPCDC,Phosphopantothenoylcysteine decarboxylase,40009,-0.033699277678767,0.0046065397841499,-0.0427280956557008,-0.0246704597018332,2.68404956689498e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TSNAX,Translin-associated protein X,37021,-0.0280975240153739,0.00384294549455259,-0.035629697184697,-0.0205653508460508,2.79526661949759e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MINK1,Misshapen-like kinase 1,37388,-0.0665497186503007,0.00910899084106374,-0.0844033406987856,-0.0486960966018157,2.90752600042879e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ST13,Hsc70-interacting protein,37124,-0.0396129241360791,0.00542402539645333,-0.0502440139131276,-0.0289818343590305,2.96955667746638e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PCDH7,Protocadherin-7,37382,-0.024050090699122,0.00329490655300509,-0.030508107543012,-0.017592073855232,3.056979460827e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DNAJB6,DnaJ homolog subfamily B member 6,37013,-0.0612649987210125,0.00840096857330704,-0.0777308971246943,-0.0447991003173307,3.21390360632472e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TIA1,Nucleolysin TIA-1 isoform p40,39374,-0.0872431609540532,0.0119791980769724,-0.110722389184919,-0.0637639327231874,3.42445674836754e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,C3,Complement C3,36816,-0.032896067534616,0.00452291336008903,-0.0417609777203905,-0.0240311573488414,3.71234435218364e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AHNAK,Neuroblast differentiation-associated protein AHNAK,37043,-0.022340423269085,0.0030724896668911,-0.0283625030161916,-0.0163183435219785,3.76636509161772e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SLAMF8,SLAM family member 8,39477,-0.0368596682754829,0.00508086457357351,-0.046818162839687,-0.0269011737112788,4.21758914571939e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GYS1,"Glycogen [starch] synthase, muscle",39585,-0.0658483028234248,0.00908708793541468,-0.0836589951768375,-0.048037610470012,4.48004930027583e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD226,CD226 antigen,37056,-0.0297822127489095,0.00411072394926021,-0.0378392316894596,-0.0217251938083595,4.56431306163506e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DKK4,Dickkopf-related protein 4,39718,-0.0319746193265569,0.00442110512163561,-0.0406399853649627,-0.0233092532881511,4.9669042568082e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KLB,Beta-klotho,39489,0.0519223693184225,0.00718563623937536,0.0378385222892468,0.0660062163475982,5.2096267763074e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ALPP,"Alkaline phosphatase, placental type",39788,-0.0744764268250391,0.0103081424375529,-0.0946803860026428,-0.0542724676474355,5.23762363508496e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ECI2,Enoyl-CoA delta isomerase 2,37021,-0.0437900263745079,0.00606397427370642,-0.0556754159509725,-0.0319046367980433,5.43053722788155e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SERPINA7,Thyroxine-binding globulin,37453,-0.0131187164450283,0.00181791922521196,-0.0166818381264437,-0.00955559476361282,5.62375562526333e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDH17,Cadherin-17,39868,-0.046771631531679,0.00648542647617673,-0.0594830674249854,-0.0340601956383726,5.7684972970327e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,39931,0.0303469456284322,0.0042085705805891,0.0220981472904776,0.0385957439663868,5.81228111588993e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCT5,T-complex protein 1 subunit epsilon,39477,-0.0315397952687204,0.0043740948984659,-0.0401130212697136,-0.0229665692677272,5.82649768694393e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NID2,Nidogen-2,39858,-0.0510507830409367,0.00709232921431609,-0.0649517483009962,-0.0371498177808771,6.38033318235841e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CSNK2A1,Casein kinase II subunit alpha,37411,0.0317630701058578,0.00441258227379433,0.023114408849221,0.0404117313624947,6.41792862085671e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CAPG,Macrophage-capping protein,39739,-0.0408018589953016,0.00567149128695854,-0.0519179819177403,-0.0296857360728628,6.56328723175515e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SGSH,N-sulphoglucosamine sulphohydrolase,37265,-0.038918427948124,0.00541229401768405,-0.0495265242227847,-0.0283103316734632,6.78537942153021e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SCRIB,Protein scribble homolog,37043,-0.0637204749331936,0.00886399982538212,-0.0810939145909426,-0.0463470352754447,6.8942727622242e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,S100G,Protein S100-G,37411,0.0317108079978963,0.00441145352295693,0.0230643590929007,0.0403572569028918,6.90418443779995e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IFT20,Intraflagellar transport protein 20 homolog,37039,-0.0307382895378581,0.00427837643073889,-0.0391239073421063,-0.0223526717336099,7.1043053316229e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TXNDC9,Thioredoxin domain-containing protein 9,37388,-0.0377957978542792,0.00526996017817455,-0.0481249198035013,-0.0274666759050571,7.77884626546964e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CETN3,Centrin-3,37382,-0.0554780945286025,0.0077494111907729,-0.0706669404625174,-0.0402892485946876,8.54566226249098e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,37382,-0.0625857229664315,0.00874292636547274,-0.079721858642758,-0.0454495872901049,8.58092039092189e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,37382,-0.0207003830831203,0.00289230959551454,-0.0263693098903288,-0.0150314562759118,8.66854143392775e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TBCC,Tubulin-specific chaperone C,39749,-0.0567168786523734,0.00793393065218346,-0.072267382730653,-0.0411663745740938,9.14501022959258e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RAB11FIP3,Rab11 family-interacting protein 3,37437,-0.0754188056788636,0.0105521371133418,-0.0961009944210135,-0.0547366169367136,9.30505654190665e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TRAF2,TNF receptor-associated factor 2,39866,-0.0493810958282078,0.00693522600651926,-0.0629741388009856,-0.03578805285543,1.12246123434731e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,STX4,Syntaxin-4,39788,-0.0411829331955111,0.00578682880633484,-0.0525251176559274,-0.0298407487350948,1.15282155484495e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AZU1,Azurocidin,39344,-0.0531847132999588,0.00747494524316915,-0.0678356059765704,-0.0385338206233473,1.16764977375811e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TGFBI,Transforming growth factor-beta-induced protein ig-h3,39805,-0.0186067188278198,0.00261686643889794,-0.0237357770480598,-0.0134776606075799,1.20700100803374e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ASPSCR1,Tether containing UBX domain for GLUT4,37411,-0.0473425574292647,0.00665792322502874,-0.0603920869503211,-0.0342930279082084,1.2123299668757e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CHMP1A,Charged multivesicular body protein 1a,39749,-0.0552614929813099,0.0077728125500233,-0.0704962055793555,-0.0400267803832642,1.21344818342576e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLEC3B,Tetranectin,37138,0.0147692373209252,0.00207770012239659,0.0106969450810279,0.0188415295608225,1.2334563674314e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CA2,Carbonic anhydrase 2,39821,-0.047016093451896,0.00662554078455799,-0.0600021533896297,-0.0340300335141624,1.33636924548865e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ARHGAP25,Rho GTPase-activating protein 25,39477,-0.0418202831878656,0.00589741273842097,-0.0533792121551707,-0.0302613542205605,1.38561841402842e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CHRDL2,Chordin-like protein 2,39868,-0.0389740160770021,0.00549906560548405,-0.0497521846637509,-0.0281958474902534,1.42368049344669e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BAG6,Large proline-rich protein BAG6,39585,-0.0254692964663894,0.00359944172527561,-0.0325242022479296,-0.0184143906848492,1.54747596661225e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,UBXN1,UBX domain-containing protein 1,37124,-0.0481980074763623,0.00681186174830007,-0.0615492565030304,-0.0348467584496941,1.56275134080155e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCDC80,Coiled-coil domain-containing protein 80,39868,-0.0225398575920991,0.00318886967422253,-0.0287900421535753,-0.016289673030623,1.63327845361752e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SPTLC1,Serine palmitoyltransferase 1,37388,-0.0247724738124484,0.00350426374915962,-0.0316408307608013,-0.0179041168640956,1.63425388691254e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ICAM2,Intercellular adhesion molecule 2,40052,-0.0215848339126232,0.0030564724664695,-0.0275755199469034,-0.015594147878343,1.70784736694372e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PHACTR2,Phosphatase and actin regulator 2,37411,-0.0794018403637436,0.0112537829971705,-0.101459255038198,-0.0573444256892893,1.80244641634756e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",37411,-0.0325348764693438,0.00461949027143902,-0.0415890774013642,-0.0234806755373233,1.97275885335126e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PDCD1,Programmed cell death protein 1,39998,-0.0281262913816272,0.00399562906659053,-0.0359577243521446,-0.0202948584111097,2.01038719776219e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ATRAID,All-trans retinoic acid-induced differentiation factor,37382,-0.0187181361452853,0.00265894364284359,-0.0239296656852587,-0.0135066066053118,2.01963029881895e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,40009,0.030578205171304,0.00434930697066741,0.0220535635087959,0.0391028468338121,2.13893268516157e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EFNA1,Ephrin-A1,39826,-0.0180750276828444,0.00257161064986227,-0.0231153845565745,-0.0130346708091144,2.16933810121197e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CXCL8,Interleukin-8,39750,-0.0453006698060419,0.00644918595537772,-0.0579410742785822,-0.0326602653335016,2.23954551613217e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,37056,-0.0330200842907913,0.0047026735995509,-0.042237324545911,-0.0238028440356715,2.30150323995589e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,37056,-0.0394857365808678,0.00562896976602737,-0.0505185173222814,-0.0284529558394541,2.41615679067403e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MAVS,Mitochondrial antiviral-signaling protein,39477,-0.0633366016605789,0.00904374182524411,-0.0810623356380573,-0.0456108676831004,2.60085188670405e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ABRAXAS2,BRISC complex subunit Abraxas 2,37021,-0.0457530192031952,0.00653864317137868,-0.0585687598190974,-0.032937278587293,2.73520930397087e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,37411,-0.0732830830058558,0.0104778739206119,-0.0938197158902551,-0.0527464501214564,2.79526633419168e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,F12,Coagulation factor XII,37453,-0.0283837007039504,0.00406468030407366,-0.0363504740999348,-0.020416927307966,3.02343117152447e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DLG4,Disks large homolog 4,37388,-0.0490565874759061,0.0070297313801453,-0.0628348609809909,-0.0352783139708213,3.12361747406725e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,39749,-0.0645377286749434,0.00926297786699007,-0.0826931652942439,-0.0463822920556428,3.35822575877947e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,OGN,Mimecan,39858,-0.0268418334097096,0.00385305398454411,-0.034393819219416,-0.0192898476000031,3.3787661220859e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TTF2,Transcription termination factor 2,37039,-0.0336762804962399,0.0048337097447462,-0.0431503515959425,-0.0242022093965374,3.39236584827888e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ITGAM,Integrin alpha-M,39858,0.0214360522917636,0.0030778041979735,0.0154035560637355,0.0274685485197916,3.41863116126837e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PTGES2,Prostaglandin E synthase 2,36961,-0.0379679157467737,0.00545363275749358,-0.0486570359514611,-0.0272787955420862,3.51586724079842e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TBC1D23,TBC1 domain family member 23,39788,-0.0610625949812934,0.00879148832028477,-0.0782939120890516,-0.0438312778735353,3.91296217198934e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IRAK4,Interleukin-1 receptor-associated kinase 4,39866,-0.0710581796076301,0.0102311070827514,-0.0911111494898229,-0.0510052097254373,3.92171049762145e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HS1BP3,HCLS1-binding protein 3,37043,-0.0624611441671633,0.00899895266963596,-0.0800990913996498,-0.0448231969346769,4.07733702375485e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLSTN2,Calsyntenin-2,40058,0.0266822069610382,0.00384663194703447,0.0191428083448506,0.0342216055772258,4.17103448503241e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AARSD1,Alanyl-tRNA editing protein Aarsd1,39788,-0.0369503043702885,0.0053294640939826,-0.0473960539944944,-0.0265045547460826,4.27191306652556e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,37382,-0.0342182022018863,0.00493660450741481,-0.0438939470364194,-0.0245424573673533,4.35198487351585e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GLOD4,Glyoxalase domain-containing protein 4,39832,-0.0241862690701569,0.00349114676187743,-0.0310289167234367,-0.0173436214168772,4.43484189100307e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VSNL1,Visinin-like protein 1,37388,-0.0256465865362339,0.0037033882398756,-0.0329052274863901,-0.0183879455860777,4.55117214474899e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PGA4,Pepsin A-4,37445,-0.0422556733340896,0.00610262573041345,-0.0542168197657,-0.0302945269024792,4.58212264749116e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GPI,Glucose-6-phosphate isomerase,37445,-0.0321476141947954,0.00465848370504868,-0.0412782422566908,-0.0230169861329,5.3974048412884e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,YJU2,Splicing factor YJU2,37368,-0.0219413660897658,0.00318331251005417,-0.028180658609472,-0.0157020735700597,5.72040574015723e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VSTM1,V-set and transmembrane domain-containing protein 1,39489,-0.0324755869931086,0.00471257747337111,-0.041712238840916,-0.0232389351453012,5.74146140151632e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD300LF,CMRF35-like molecule 1,40030,-0.04010563225912,0.00582575021284602,-0.0515241026762982,-0.0286871618419418,6.02496552254399e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BLVRB,Flavin reductase,39858,-0.0432756149414411,0.00629257004413064,-0.0556090522279371,-0.0309421776549451,6.32752297875382e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ATP5IF1,"ATPase inhibitor, mitochondrial",39931,-0.0738128591882501,0.0107428543096856,-0.0948688536352339,-0.0527568647412662,6.61497480254532e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IGLC2,Immunoglobulin lambda constant 2,37422,-0.0164130809169519,0.00239168134037021,-0.0211007763440776,-0.0117253854898263,7.05694254111305e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NAMPT,Nicotinamide phosphoribosyltransferase,39477,-0.0342203846692732,0.00498754739790289,-0.0439959775691629,-0.0244447917693836,7.08684253182892e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GLRX,Glutaredoxin-1,39771,-0.03756231693198,0.00547755601530965,-0.048298326721987,-0.0268263071419731,7.26570564901942e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TRIM58,E3 ubiquitin-protein ligase TRIM58,37368,-0.0573746862462421,0.00837384194486083,-0.0737874164581693,-0.0409619560343149,7.61625193488414e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,COMT,Catechol O-methyltransferase,39403,-0.0567629984562883,0.0083017075344982,-0.0730343452239048,-0.0404916516886719,8.35838510204137e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,37027,-0.0244341545901247,0.00357453275292348,-0.0314402387858547,-0.0174280703943947,8.52469979202174e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",39587,-0.0482513177811408,0.00706194207674972,-0.0620927242515702,-0.0344099113107113,8.64589798859838e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,39846,-0.0756242896260571,0.0110737894918288,-0.0973289170300416,-0.0539196622220727,8.85120556063924e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRTN3,Myeloblastin,39421,-0.0308171420625905,0.00451335614134829,-0.0396633200996331,-0.0219709640255478,8.92999750159764e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PARK7,Parkinson disease protein 7,39858,-0.0349513231319982,0.00512132829626317,-0.044989126592674,-0.0249135196713224,9.12983076889344e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GDNF,Glial cell line-derived neurotrophic factor,39489,-0.0255062799923219,0.00374144533983775,-0.0328395128584039,-0.0181730471262399,9.62125165921191e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NOTCH2,Neurogenic locus notch homolog protein 2,37437,0.0145187372507176,0.00213026460790908,0.0103434186192158,0.0186940558822194,9.79263219087985e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SPRR3,Small proline-rich protein 3,37388,-0.0437515856765992,0.00642292711755505,-0.0563405228270071,-0.0311626485261913,1.00470350472401e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,37368,-0.0559138852800261,0.00821371282595673,-0.0720127624189013,-0.0398150081411509,1.03586318295154e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VPS28,Vacuolar protein sorting-associated protein 28 homolog,37169,-0.044816826750106,0.0065985666209556,-0.0577500173271789,-0.031883636173033,1.15363734144687e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,XIAP,E3 ubiquitin-protein ligase XIAP,37056,-0.0390234850062862,0.0057461969639053,-0.0502860310555406,-0.0277609389570318,1.15979137589387e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DDHD2,Phospholipase DDHD2,37411,-0.0445133474261917,0.00655523705273134,-0.0573616120495451,-0.0316650828028383,1.16400178320749e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PSAP,Prosaposin,37347,-0.0186136225690309,0.00274207852621145,-0.0239880964804053,-0.0132391486576564,1.183344336954e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BOLA2_BOLA2B,BolA-like protein 2,37043,-0.0365869791333978,0.00539225887866488,-0.047155806535581,-0.0260181517312146,1.2096684285922e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GUCA2A,Guanylin,39796,-0.021329315677099,0.00314730386651647,-0.0274980312554713,-0.0151606000987267,1.26987449725239e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SOD1,Superoxide dismutase [Cu-Zn],39487,-0.0320869272050155,0.00473601953643974,-0.0413695254964374,-0.0228043289135936,1.28775438958764e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,39477,-0.0392076610685911,0.0057888880767419,-0.0505538816990052,-0.0278614404381769,1.30716085268905e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AIF1,Allograft inflammatory factor 1,39477,-0.0348831197726185,0.00515405052192828,-0.044985058795598,-0.0247811807496391,1.35130764756021e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CXCL1,Growth-regulated alpha protein,39839,-0.0626003834048454,0.00925445750641646,-0.0807391201174217,-0.0444616466922692,1.38556128022763e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MDH1,"Malate dehydrogenase, cytoplasmic",37397,-0.0266956538558922,0.00395130364682496,-0.0344402090036692,-0.0189510987081153,1.47484839360853e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,40009,-0.0293095528173894,0.00434445190425475,-0.0378246785497287,-0.0207944270850501,1.56671097852911e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD244,Natural killer cell receptor 2B4,40058,-0.0175915390382645,0.00260806922427062,-0.0227033547178349,-0.0124797233586941,1.58157932246198e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TMPRSS5,Transmembrane protease serine 5,39667,0.0250447370268531,0.00371302251773988,0.0177672128920829,0.0323222611616232,1.58217516806905e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,WIF1,Wnt inhibitory factor 1,40030,0.0220597317852896,0.00327064628890095,0.0156492650590438,0.0284701985115355,1.58472230665392e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCL18,C-C motif chemokine 18,39715,-0.0464900205661567,0.00689383996971087,-0.06000194690679,-0.0329780942255234,1.59732913150671e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CWC15,Spliceosome-associated protein CWC15 homolog,37324,-0.0405151346067638,0.0060085973815658,-0.0522919854746328,-0.0287382837388948,1.61630681527593e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FIS1,Mitochondrial fission 1 protein,39855,-0.05135699051419,0.00762813432489468,-0.0663081337909836,-0.0364058472373964,1.72356453448276e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EGF,Pro-epidermal growth factor,39808,-0.0681365073265279,0.0101234982544068,-0.0879785639051652,-0.0482944507478906,1.74807532365095e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ZFYVE19,Abscission/NoCut checkpoint regulator,37382,-0.0599275782788327,0.00892069231880414,-0.0774121352236889,-0.0424430213339766,1.91845877517919e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,YWHAQ,14-3-3 protein theta,37124,-0.0489212627763293,0.00728786787398255,-0.0632054838093351,-0.0346370417433235,1.98827009548071e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TRIM21,E3 ubiquitin-protein ligase TRIM21,39866,-0.0492272773281629,0.00733614884008795,-0.0636061290547353,-0.0348484256015906,2.00831312234497e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MRC1,Macrophage mannose receptor 1,37445,-0.0181302525343096,0.0027019884623221,-0.0234261499204609,-0.0128343551481583,2.02382828788932e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,37124,-0.0566898150480494,0.00844935657718806,-0.073250553939338,-0.0401290761567608,2.0340730959499e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RALY,RNA-binding protein Raly,37368,-0.0319949851420852,0.00477093706562351,-0.0413460217907073,-0.0226439484934632,2.07663873058413e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DBNL,Drebrin-like protein,39931,-0.0608975862914993,0.00908233791280382,-0.0786989686005948,-0.0430962039824039,2.08035019318605e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FSHB,Follitropin subunit beta,37043,0.043025760863472,0.00642806976206625,0.0304267441298221,0.0556247775971218,2.2683647666888e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NTRK2,BDNF/NT-3 growth factors receptor,39868,0.0166907691463896,0.00249499230271781,0.0118005842330626,0.0215809540597165,2.3102731942757e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LEFTY2,Left-right determination factor 2,40011,-0.0348117987488902,0.00520677531400164,-0.0450170783643334,-0.0246065191334469,2.37086039029146e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,OPLAH,5-oxoprolinase,37043,-0.0455592694536206,0.0068149369548101,-0.0589165458850484,-0.0322019930221928,2.39880593932682e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ZBP1,Z-DNA-binding protein 1,37056,-0.027001734973172,0.00404184317584776,-0.0349237475978336,-0.0190797223485104,2.47594409461765e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,COMP,Cartilage oligomeric matrix protein,39729,0.0218413561845535,0.00327077827181403,0.015430630771798,0.028252081597309,2.50736770627934e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SLAMF1,Signaling lymphocytic activation molecule,39587,-0.038127775071268,0.00571634481640543,-0.0493318109114227,-0.0269237392311134,2.64410512625081e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GIMAP8,GTPase IMAP family member 8,36962,-0.0324090227931638,0.00486128225396683,-0.0419371360109388,-0.0228809095753888,2.71982362813266e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AMPD3,AMP deaminase 3,37388,-0.0462522408127673,0.0069429191377759,-0.0598603623228081,-0.0326441193027266,2.80980593613407e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",37169,-0.0325390165059886,0.00489477067890807,-0.0421327670366484,-0.0229452659753288,3.09293498285762e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",39713,-0.0626410089812825,0.00942824231840356,-0.0811203639253535,-0.0441616540372115,3.15277768486392e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TSPAN1,Tetraspanin-1,39585,-0.0261064209928802,0.00393089880319478,-0.033810982647142,-0.0184018593386184,3.21042999891863e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,37437,0.0210570493690484,0.00317529449851994,0.0148334721519493,0.0272806265861475,3.44802858291119e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FGL1,Fibrinogen-like protein 1,37445,-0.0402540460345083,0.0060782622527172,-0.052167440049834,-0.0283406520191825,3.66149286890871e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GRN,Progranulin,39787,-0.0159463434130791,0.00241037805802262,-0.0206706844068035,-0.0112220024193548,3.81577260067716e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RTBDN,Retbindin,39788,-0.0189075354401709,0.00286285893683616,-0.0245187389563698,-0.013296331923972,4.1169608692279e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FCER2,Low affinity immunoglobulin epsilon Fc receptor,39858,-0.0307528191103827,0.00466341067095375,-0.039893104025452,-0.0216125341953133,4.40084212701412e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MIF,Macrophage migration inhibitory factor,39826,-0.0438826526779189,0.00665545483058272,-0.056927344145861,-0.0308379612099768,4.4309186952882e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD58,Lymphocyte function-associated antigen 3,39835,0.0111952134821153,0.00169883293878315,0.00786550092210036,0.0145249260421303,4.5375805203518e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GIMAP7,GTPase IMAP family member 7,37124,0.0210825435719294,0.00320100959117572,0.014808564773225,0.0273565223706338,4.68183082280785e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LYPD8,Ly6/PLAUR domain-containing protein 8,39477,-0.0337680800410254,0.00512891828758577,-0.0438207598846935,-0.0237154001973573,4.73008579911172e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MAX,Protein max,39489,-0.0677278665633829,0.0102952259336492,-0.0879065093933353,-0.0475492237334305,4.90083004973481e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,APOE,Apolipoprotein E,37453,-0.0467739103663933,0.0071095019375972,-0.0607085341640838,-0.0328392865687028,4.90732663491515e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TWF2,Twinfilin-2,37437,-0.05444103307244,0.00828268230266236,-0.0706750903856582,-0.0382069757592218,5.11553327566948e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MARS1,"Methionine--tRNA ligase, cytoplasmic",37088,-0.0557074418636137,0.00848189370513638,-0.072331953525681,-0.0390829302015464,5.29705003805173e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLEC4G,C-type lectin domain family 4 member G,39866,-0.0212283456325253,0.00324071257139501,-0.0275801422724595,-0.0148765489925911,5.90859959669188e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CRLF1,Cytokine receptor-like factor 1,39931,-0.0166675361064603,0.00254655201662724,-0.0216587780590497,-0.011676294153871,6.12391002161087e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PHLDB1,Pleckstrin homology-like domain family B member 1,37382,-0.0341904348085429,0.00522584760573238,-0.0444330961157784,-0.0239477735013074,6.2650712692003e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,37124,-0.0270329879880103,0.00413740146976125,-0.0351422948687423,-0.0189236811072782,6.64595158632802e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MYOC,Myocilin,39858,0.029254881771119,0.00448427832108829,0.020465696261786,0.0380440672804521,7.0569083899067e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,39932,-0.0714650301307176,0.0109667345088097,-0.0929598297679845,-0.0499702304934506,7.40934401498829e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DBI,Acyl-CoA-binding protein,39793,-0.0507890546129369,0.00780806466959809,-0.0660928613653492,-0.0354852478605247,8.01718890268378e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ITPA,Inosine triphosphate pyrophosphatase,37021,-0.0432241018194376,0.00664441911123197,-0.0562471632774523,-0.030201040361423,8.03303788023014e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,C8B,Complement component C8 beta chain,37453,0.019325349071705,0.00297282182587142,0.013498618292997,0.025152079850413,8.27515935172178e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ALDH2,"Aldehyde dehydrogenase, mitochondrial",37368,-0.0324537353097353,0.0049980616904465,-0.0422499362230105,-0.0226575343964602,8.69337132772707e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IFNLR1,Interferon lambda receptor 1,39866,-0.0237024774279807,0.00365213233287322,-0.0308606568004122,-0.0165442980555492,8.83365553795858e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADA,Adenosine deaminase,40058,-0.0220070081049655,0.00339547946292832,-0.028662147852305,-0.015351868357626,9.35823781522059e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BCL2,Apoptosis regulator Bcl-2,37382,-0.0321710663506857,0.00496333579406145,-0.0418992045070462,-0.0224429281943253,9.38143813247483e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ICA1,Islet cell autoantigen 1,39587,-0.0507620400737065,0.00783267189065873,-0.0661140769793976,-0.0354100031680154,9.3946750880623e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TRIAP1,TP53-regulated inhibitor of apoptosis 1,40030,-0.0402304675815608,0.0062124945244498,-0.0524069568494824,-0.0280539783136392,9.70718773077662e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,OPTC,Opticin,39788,0.0278745651336712,0.00430796628454117,0.0194309512159705,0.0363181790513719,1.00549708325965e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NECAP2,Adaptin ear-binding coat-associated protein 2,37021,-0.0411402662999065,0.0063651967678347,-0.0536160519648625,-0.0286644806349504,1.06045649466556e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,COL9A1,Collagen alpha-1(IX) chain,39866,0.0275060383531887,0.00426861340181193,0.0191395560856373,0.0358725206207401,1.19856755840508e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DPEP1,Dipeptidase 1,39713,0.0297801524315092,0.00462393475926626,0.0207172403033474,0.0388430645596711,1.22560574458261e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DNAJB14,DnaJ homolog subfamily B member 14,37382,-0.0410445969360145,0.00637589337630275,-0.0535413479535679,-0.0285478459184611,1.25585611028489e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HARS1,"Histidine--tRNA ligase, cytoplasmic",39858,-0.0487415427364407,0.00758198550863312,-0.0636022343333617,-0.0338808511395198,1.32431978430498e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,37043,-0.0297862613459796,0.00463645535416726,-0.0388737138401474,-0.0206988088518118,1.36975037097524e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,37388,-0.0389593195646008,0.00606865112121953,-0.0508538757621911,-0.0270647633670106,1.41039377323359e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ANXA10,Annexin A10,39489,-0.0490590365950289,0.00764981401069306,-0.0640526720559872,-0.0340654011340705,1.4668257169144e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD69,Early activation antigen CD69,39785,-0.0548758718912091,0.00857702748247532,-0.0716868457568607,-0.0380648980255575,1.61813313872317e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PDCD6,Programmed cell death protein 6,39868,0.0435226064182177,0.00680536538804016,0.030184090257659,0.0568611225787764,1.64634114058855e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,37043,0.0219701275701523,0.00344067341837562,0.0152264076701361,0.0287138474701686,1.76666494199386e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PLPBP,Pyridoxal phosphate homeostasis protein,39868,-0.0424319489118717,0.00665033817773237,-0.0554666117402271,-0.0293972860835162,1.81453797870366e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CTHRC1,Collagen triple helix repeat-containing protein 1,37437,-0.0167924328252716,0.0026329111004311,-0.0219529385821165,-0.0116319270684266,1.85354837151263e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PDLIM5,PDZ and LIM domain protein 5,37411,-0.0749932236906934,0.0117640270134292,-0.0980507166370146,-0.0519357307443722,1.89148038493864e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD99,CD99 antigen,39858,0.0118984236272322,0.00186858757525956,0.00823599197972344,0.0155608552747409,1.97240315644252e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RNASEH2A,Ribonuclease H2 subunit A,37411,-0.030840911934223,0.00484501245034132,-0.040337136336892,-0.0213446875315541,2.00929403225961e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SPINK6,Serine protease inhibitor Kazal-type 6,40030,-0.0335445688178187,0.00527595089012273,-0.0438854325624593,-0.0232037050731782,2.09858745281797e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TF,Serotransferrin,37453,-0.0136155368684328,0.00214128098992994,-0.0178124476086955,-0.00941862612817011,2.10119172851742e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PDCD1LG2,Programmed cell death 1 ligand 2,39788,-0.019080491585999,0.00300450410586852,-0.0249693196335013,-0.0131916635384967,2.20246922977617e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CTF1,Cardiotrophin-1,39585,-0.0524795610338048,0.00826498350313868,-0.0686789286999566,-0.036280193367653,2.21759479918664e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,37411,-0.0419343438501701,0.00660878960114524,-0.0548875714684148,-0.0289811162319255,2.29146171650004e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LAP3,Cytosol aminopeptidase,39587,-0.0301017421927931,0.00474960188792373,-0.0394109618931237,-0.0207925224924626,2.39508544324532e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LCAT,Phosphatidylcholine-sterol acyltransferase,37445,-0.0135672025728948,0.00214606078840284,-0.0177734817181644,-0.00936092342762524,2.66428897141647e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BAX,Apoptosis regulator BAX,39456,-0.0564882299754833,0.00893861794303076,-0.0740079211438236,-0.038968538807143,2.69411938296268e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LYAR,Cell growth-regulating nucleolar protein,39477,-0.0317434457790483,0.00503666510635742,-0.0416153093875088,-0.0218715821705877,3.00791493258142e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADA2,Adenosine deaminase 2,39782,-0.0253936778483739,0.00403149999327366,-0.0332954178351902,-0.0174919378615575,3.07798730309575e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TPD52L2,Tumor protein D54,37124,-0.0675060856850234,0.0107176504561497,-0.0885126805790768,-0.0464994907909699,3.09848294648393e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ACYP1,Acylphosphatase-1,37073,-0.0405572769272374,0.00644902795078049,-0.0531973717107671,-0.0279171821437076,3.29800186165218e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EIF4E,Eukaryotic translation initiation factor 4E,37056,-0.0562387047486887,0.00894334159299512,-0.0737676542709591,-0.0387097552264182,3.31012652350772e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SDC1,Syndecan-1,39868,-0.0243581879092624,0.00388037350550606,-0.0319637199800543,-0.0167526558384705,3.53421613213805e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MCEMP1,Mast cell-expressed membrane protein 1,37056,-0.0554001207076029,0.00884570498981953,-0.0727377024876492,-0.0380625389275566,3.895085948275e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,37368,-0.0230848266003454,0.00369477488047621,-0.0303265853660787,-0.015843067834612,4.28315769158926e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LONP1,"Lon protease homolog, mitochondrial",37043,-0.0536074317533398,0.00858582220448385,-0.0704356432741281,-0.0367792202325515,4.40408598817637e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SMS,Spermine synthase,36991,-0.0393812404506922,0.00630763315484492,-0.0517442014341882,-0.0270182794671961,4.41275536115487e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ATXN2L,Ataxin-2-like protein,37411,-0.0294297849700893,0.00472065772365434,-0.0386822741084518,-0.0201772958317268,4.67397590540874e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LGALS7_LGALS7B,Galectin-7,39822,-0.0246669768578288,0.00397115729695638,-0.0324504451598633,-0.0168835085557943,5.37698835334943e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SPART,Spartin,37124,-0.0475688346088315,0.00766288450397241,-0.0625880882366175,-0.0325495809810456,5.53706258113129e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,39868,-0.0505572770706693,0.00815075068555165,-0.0665327484143505,-0.0345818057269881,5.68387051656758e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLTA,Clathrin light chain A,39585,-0.0281102884290274,0.0045340198657979,-0.0369969673659913,-0.0192236094920635,5.79242964227426e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PPME1,Protein phosphatase methylesterase 1,39788,-0.0362000778396822,0.00585041841879025,-0.047666897940511,-0.0247332577388533,6.25788597635732e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LIF,Leukemia inhibitory factor,39489,-0.031016413707325,0.00501386682408749,-0.0408435926825365,-0.0211892347321135,6.31960382759193e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,39477,-0.0515546484238588,0.00833617138543784,-0.067893544339317,-0.0352157525084006,6.38701144733188e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,JAM2,Junctional adhesion molecule B,40009,-0.015130106822942,0.0024472149979106,-0.0199266482188468,-0.0103335654270373,6.45774436179489e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LGALS1,Galectin-1,39868,-0.0202315058523266,0.00327446637153503,-0.0266494599405353,-0.0138135517641179,6.62512332158456e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,THTPA,Thiamine-triphosphatase,37345,-0.0534552103189569,0.00866047729643314,-0.0704297458199659,-0.036480674817948,6.92248686313277e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,37382,-0.0717988204033214,0.0116379521760364,-0.0946092066683528,-0.04898843413829,7.05186701107117e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PDAP1,28 kDa heat- and acid-stable phosphoprotein,37437,-0.0594570204239013,0.00968201544561312,-0.078433770697303,-0.0404802701504996,8.43038062296814e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SMAD3,Mothers against decapentaplegic homolog 3,37368,-0.0306623570275377,0.00500322951012523,-0.0404686868673832,-0.0208560271876923,9.11712541195564e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TOR1AIP1,Torsin-1A-interacting protein 1,37043,-0.0303813396602001,0.00495937062339566,-0.0401017060820556,-0.0206609732383446,9.26529832514723e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD200R1,Cell surface glycoprotein CD200 receptor 1,39809,-0.0207109904350809,0.00338125850541519,-0.0273382571056946,-0.0140837237644671,9.26765870553068e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,UNC79,Protein unc-79 homolog,36962,-0.0339308395341996,0.00554320085861683,-0.0447955132170886,-0.0230661658513106,9.55464850870266e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,REG1A,Lithostathine-1-alpha,39804,-0.0277777880536151,0.00453919822016751,-0.0366746165651435,-0.0188809595420868,9.60426735386821e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IST1,IST1 homolog,37287,-0.0599216596170821,0.00979718224133404,-0.0791241368100968,-0.0407191824240674,9.84850227192341e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FUT8,"Alpha-(1,6)-fucosyltransferase",39749,-0.0343912333639884,0.00563460538997209,-0.0454350599283337,-0.0233474067996432,1.06131278818052e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LPP,Lipoma-preferred partner,37021,-0.0401619733216844,0.00658231248987907,-0.0530633058018474,-0.0272606408415215,1.08026814078222e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CHCHD6,MICOS complex subunit MIC25,37368,-0.0173771166359371,0.00284880734565857,-0.0229607790334279,-0.0117934542384463,1.09109852054372e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,37411,-0.0355173290306338,0.00582864517220833,-0.0469414735681621,-0.0240931844931054,1.13404137602297e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GTPBP2,GTP-binding protein 2,37039,-0.0483826024357421,0.00795267197068091,-0.0639698394982767,-0.0327953653732075,1.20605389588211e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DSCAM,Down syndrome cell adhesion molecule,37411,-0.0210781348244355,0.0034651220644222,-0.027869774070703,-0.014286495578168,1.21173627568498e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,37437,-0.0238215445360364,0.003917679225624,-0.0315001958182594,-0.0161428932538133,1.23003225581406e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CENPF,Centromere protein F,37169,-0.0322360473345653,0.00530514257835022,-0.0426341267881317,-0.0218379678809988,1.262835513642e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SERPING1,Plasma protease C1 inhibitor,37424,0.011204798399016,0.00184508917242998,0.00758842362105325,0.0148211731769788,1.29082724221494e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GRAP2,GRB2-related adapter protein 2,39868,-0.0761503254702177,0.012547707711191,-0.100743832584152,-0.0515568183562834,1.31722040491818e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SERPINI2,Serpin I2,37382,-0.0339739727186344,0.00561902656280335,-0.044987264781729,-0.0229606806555399,1.52172158475961e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FCRL6,Fc receptor-like protein 6,39866,-0.0389005449550847,0.00644108196596015,-0.0515250656083666,-0.0262760243018028,1.58067482951677e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DNPEP,Aspartyl aminopeptidase,37388,-0.0349989452309703,0.00579474088109506,-0.0463566373579166,-0.023641253104024,1.58372899495053e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RBM17,Splicing factor 45,37411,-0.0454502227941526,0.00752753610775933,-0.0602041935653609,-0.0306962520229443,1.60251839904367e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TBCA,Tubulin-specific chaperone A,37124,-0.0512052010588648,0.00848827925985407,-0.0678422284081788,-0.0345681737095508,1.65780970675059e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,STX7,Syntaxin-7,37056,-0.0291950010552191,0.0048436334815996,-0.0386885226791543,-0.0197014794312839,1.70955982722051e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MICALL2,MICAL-like protein 2,37039,-0.0403037876849883,0.00668672982575549,-0.053409778143469,-0.0271977972265075,1.7103696782563e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PADI4,Protein-arginine deiminase type-4,39456,-0.0413173826390001,0.0068646040839029,-0.0547720066434498,-0.0278627586345504,1.79536986417234e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",37124,-0.0618358699960648,0.0102739003217956,-0.0819727146267841,-0.0416990253653454,1.80423835828246e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GFRAL,GDNF family receptor alpha-like,36942,0.0366710004132377,0.00611045981584501,0.0246944991741815,0.048647501652294,2.00860343084842e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ANXA3,Annexin A3,39985,-0.0408763998752233,0.0068172561283163,-0.0542382218867233,-0.0275145778637234,2.06527175182737e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SORBS1,Sorbin and SH3 domain-containing protein 1,37411,-0.0222593733944993,0.00372217556757889,-0.0295548375069539,-0.0149639092820447,2.2846579457654e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DMD,Dystrophin,37043,-0.0304348120512972,0.005090884461644,-0.0404129455961195,-0.020456678506475,2.31312276729156e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PTN,Pleiotrophin,39585,-0.0292854300461911,0.00490683940239024,-0.038902835274876,-0.0196680248175062,2.44907870161539e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BDNF,Brain-derived neurotrophic factor,37437,-0.0482549295901198,0.00808572978119858,-0.064102959961269,-0.0324068992189706,2.46295597670922e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BMP6,Bone morphogenetic protein 6,39568,-0.0242883298533705,0.00407124117430028,-0.0322679625549991,-0.016308697151742,2.48621830264996e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,39904,-0.0295433188739821,0.00495473581885006,-0.0392546010789282,-0.019832036669036,2.53397491034258e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,37437,-0.05199814780635,0.00873656155373583,-0.0691218084516722,-0.0348744871610277,2.71770155055574e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,37411,-0.0456326898723204,0.00767123992961715,-0.06066832013437,-0.0305970596102708,2.77210328992345e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,37169,-0.062100654636493,0.01044753924196,-0.0825778315507345,-0.0416234777222515,2.85030356800372e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HMBS,Porphobilinogen deaminase,40030,-0.0249079710931279,0.00419507157249878,-0.0331303113752255,-0.0166856308110303,2.9543929352446e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TBCB,Tubulin-folding cofactor B,39749,-0.0586915423361495,0.00989502012499349,-0.0780857817811368,-0.0392973028911623,3.06554033856135e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FLT3LG,Fms-related tyrosine kinase 3 ligand,40058,-0.0192959353332758,0.00325399692299934,-0.0256737693023546,-0.0129181013641971,3.09248186485171e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NME3,Nucleoside diphosphate kinase 3,39885,0.0137754401955365,0.00232678014864657,0.00921495110418924,0.0183359292868838,3.27743764472724e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SPAG1,Sperm-associated antigen 1,37411,-0.0339293560594279,0.00573121578372653,-0.0451625389955319,-0.0226961731233239,3.2953294428499e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TCL1A,T-cell leukemia/lymphoma protein 1A,39730,-0.0548300922206204,0.00926747196643649,-0.072994337274836,-0.0366658471664049,3.35828868190678e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DHPS,Deoxyhypusine synthase,37368,-0.0237437377229863,0.00401758696695033,-0.031618208178209,-0.0158692672677637,3.50459453220609e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SCGB3A1,Secretoglobin family 3A member 1,37124,0.0141997111086171,0.00240286617554165,0.00949009340455549,0.0189093288126788,3.51592629218888e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TMED8,Protein TMED8,37382,-0.0599701374801337,0.0101619351530779,-0.0798875303801663,-0.0400527445801011,3.68949881569257e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CSF3R,Granulocyte colony-stimulating factor receptor,37056,-0.018131174957742,0.00307241015871102,-0.0241530988688156,-0.0121092510466684,3.69525369897615e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LY9,T-lymphocyte surface antigen Ly-9,39699,-0.0163358169087507,0.00276867736867221,-0.0217624245513482,-0.0109092092661532,3.70410220389074e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCL20,C-C motif chemokine 20,40058,-0.0485388549515337,0.00822821557329939,-0.0646661574752005,-0.0324115524278669,3.72828238613435e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SERPINB1,Leukocyte elastase inhibitor,39811,-0.0515555384900381,0.00873999209332802,-0.068685922992961,-0.0344251539871152,3.73542120258773e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ASS1,Argininosuccinate synthase,37021,-0.0462321008706433,0.00783801582430511,-0.0615946118862813,-0.0308695898550053,3.75954456495856e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TACC3,Transforming acidic coiled-coil-containing protein 3,39788,-0.0673322012484217,0.011428040204985,-0.0897311600501923,-0.0449332424466511,3.89616002967167e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL22RA1,Interleukin-22 receptor subunit alpha-1,39587,-0.0247732764319663,0.00420523543650685,-0.0330155378875197,-0.0165310149764128,3.91568914712323e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GGCT,Gamma-glutamylcyclotransferase,37430,-0.0278211964441415,0.00472361859368009,-0.0370794888877544,-0.0185629040005285,3.9580142353327e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KLRF1,Killer cell lectin-like receptor subfamily F member 1,37056,-0.0245258081590077,0.00416408163720792,-0.0326874081679352,-0.0163642081500801,3.95962608032075e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PKN3,Serine/threonine-protein kinase N3,37169,-0.043860281846307,0.00747544748065763,-0.0585121589083959,-0.029208404784218,4.5363105324789e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD200,OX-2 membrane glycoprotein,39866,0.014726396770486,0.00251243936907944,0.00980201560709032,0.0196507779338817,4.68021448125725e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,39846,-0.0180951102063015,0.00308841201788981,-0.0241483977613655,-0.0120418226512374,4.74718059001462e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PPL,Periplakin,37056,-0.0184166984702919,0.00314879521565661,-0.0245883370929789,-0.012245059847605,5.06836071697384e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PTPRH,Receptor-type tyrosine-protein phosphatase H,37382,-0.0280023060663203,0.00478788794538753,-0.0373865664392799,-0.0186180456933607,5.07268491795376e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,OLFM4,Olfactomedin-4,36654,-0.0705607870637595,0.0120854388423998,-0.094248247194863,-0.0468733269326559,5.39525320050326e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,39477,-0.056107928865267,0.00961388911914968,-0.0749511515388003,-0.0372647061917336,5.44850954013582e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RHOC,Rho-related GTP-binding protein RhoC,39672,-0.0672220000852047,0.0115221945711753,-0.0898055014447083,-0.0446384987257011,5.51280668735814e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BCL2L1,Bcl-2-like protein 1,37388,-0.057263028656657,0.00981938990978076,-0.0765090328798272,-0.0380170244334867,5.61425649631769e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GFAP,Glial fibrillary acidic protein,39453,0.0248906223308848,0.00427030869088228,0.0165208172967556,0.0332604273650141,5.69420072556026e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,39931,0.0242701549373476,0.00416427858175963,0.0161081689170987,0.0324321409575964,5.710888489814e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BOLA1,BolA-like protein 1,36991,-0.0314989077430492,0.00540437558508717,-0.04209148388982,-0.0209063315962783,5.72724618682484e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ERI1,3'-5' exoribonuclease 1,37169,-0.0191290795746915,0.00329198020104122,-0.0255813607687323,-0.0126767983806507,6.35934474040457e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CACYBP,Calcyclin-binding protein,37088,-0.0591916586067821,0.0101922678826184,-0.0791685036567142,-0.03921481355685,6.48673750339981e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VNN2,Vascular non-inflammatory molecule 2,39788,-0.0262169473587206,0.00451657534162921,-0.0350694350283139,-0.0173644596891274,6.57437772580493e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ANXA11,Annexin A11,39829,-0.0379028818579101,0.00652995691839137,-0.0507015974179572,-0.025104166297863,6.57979088382479e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MYO9B,Unconventional myosin-IXb,39587,-0.0373774443304207,0.00645537630949892,-0.0500299818970386,-0.0247249067638028,7.16749723370158e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EBI3_IL27,Interleukin-27,40011,-0.0173760181409502,0.00300525129034104,-0.0232663106700186,-0.0114857256118817,7.52320490060353e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CRISP2,Cysteine-rich secretory protein 2,40030,0.0316190600124292,0.00547239734283205,0.0208931612204784,0.04234495880438,7.7022014017513e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CES2,Cocaine esterase,39788,-0.0305528279877601,0.00528809883466129,-0.0409175017036962,-0.0201881542718239,7.71617955465288e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GRSF1,G-rich sequence factor 1,36874,-0.0457785586747163,0.00793213160688815,-0.0613255366242171,-0.0302315807252155,8.04644839275399e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MGLL,Monoglyceride lipase,39908,-0.0490134165047999,0.00853098561465692,-0.0657341483095274,-0.0322926847000723,9.33992219715628e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PLXNB3,Plexin-B3,39812,-0.0267329733827408,0.00465395228929099,-0.0358547198697512,-0.0176112268957305,9.40705591135293e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,39913,0.0254339195741782,0.00442927509439613,0.0167525403891618,0.0341152987591947,9.51270874104393e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PDIA4,Protein disulfide-isomerase A4,37437,-0.0345872611705548,0.00602408898974536,-0.0463944755904557,-0.0227800467506539,9.58541292898663e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,XRCC4,DNA repair protein XRCC4,39489,-0.0208350417247121,0.00362953015517301,-0.0279489208288512,-0.013721162620573,9.61922029343699e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AK1,Adenylate kinase isoenzyme 1,39868,-0.0351036932838356,0.00611879210392432,-0.0470965258075272,-0.0231108607601439,9.80923850009658e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PSG1,Pregnancy-specific beta-1-glycoprotein 1,39749,0.0618741209153847,0.0107911058920847,0.0407235533668986,0.0830246884638707,9.99849601889528e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ELAC1,Zinc phosphodiesterase ELAC protein 1,37411,-0.0481558705203983,0.00840159911187367,-0.0646230047796707,-0.0316887362611259,1.01516536866835e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDH5,Cadherin-5,40052,0.0170574930227813,0.00297778662797717,0.011221031231946,0.0228939548136165,1.03276479069586e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PI3,Elafin,39594,-0.0295821969138045,0.00517141747432957,-0.0397181751634905,-0.0194462186641186,1.08252254929215e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ATOX1,Copper transport protein ATOX1,39913,-0.0406354842755692,0.00710442133974743,-0.0545601501014741,-0.0267108184496642,1.08583326545132e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,L1CAM,Neural cell adhesion molecule L1,39913,0.0159390649940101,0.00278934288713665,0.0104719529352223,0.0214061770527979,1.12129034167506e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SLC51B,Organic solute transporter subunit beta,37021,-0.0424473446202923,0.00743004216731913,-0.0570102272682378,-0.0278844619723468,1.13449086357491e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,39477,-0.0242559339690904,0.00424964734521862,-0.0325852427657189,-0.0159266251724619,1.16556706926565e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EHD3,EH domain-containing protein 3,37043,-0.0659647856298558,0.011556194513194,-0.0886149268757161,-0.0433146443839955,1.16654349000301e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRDX1,Peroxiredoxin-1,39434,0.050609397431912,0.00886824081167869,0.0332276454410217,0.0679911494228022,1.17205448920463e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ITGAL,Integrin alpha-L,37056,-0.0239323636156192,0.00419460773146395,-0.0321537947692885,-0.0157109324619499,1.18489780748874e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CNPY4,Protein canopy homolog 4,39788,-0.0421583872645354,0.00739073057700658,-0.0566442191954682,-0.0276725553336025,1.18949386858843e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CGA,Glycoprotein hormones alpha chain,39858,0.049198173360875,0.00863801442189656,0.0322676650939577,0.0661286816277922,1.25142043638868e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SEZ6L,Seizure 6-like protein,39913,0.0149630533649904,0.00262752533081416,0.00981310371659463,0.0201130030133862,1.25728615287717e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,37169,-0.0212828603450745,0.00373885065164621,-0.0286110076223011,-0.0139547130678479,1.27945171036593e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AHSG,Alpha-2-HS-glycoprotein,37445,-0.0148952623718799,0.00261703734396793,-0.020024655566057,-0.00976586917770272,1.2841750282042e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ACVRL1,Serine/threonine-protein kinase receptor R3,39720,-0.0128996815229149,0.00226692701896124,-0.017342858480079,-0.00845650456575089,1.28994504857364e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,39489,-0.0357318246889059,0.00628971859482928,-0.0480596731347713,-0.0234039762430405,1.36303343415226e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TMEM106A,Transmembrane protein 106A,37368,-0.0396643779291276,0.00698684958873421,-0.0533586031230467,-0.0259701527352086,1.39894452456105e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,37031,-0.015579762028977,0.0027450055202559,-0.0209599728486786,-0.0101995512092755,1.41055434223439e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SMTN,Smoothelin,37342,-0.0535198371577685,0.00945008913868155,-0.0720420118695844,-0.0349976624459527,1.51414968721176e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,OTUD6B,Deubiquitinase OTUD6B,37382,-0.0324071413568453,0.00572679720758076,-0.0436316638837036,-0.0211826188299871,1.55475556802319e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KLRK1,NKG2-D type II integral membrane protein,37388,-0.0246272990045809,0.00435571902011463,-0.0331645082840055,-0.0160900897251562,1.59912718611916e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SEMA4D,Semaphorin-4D,40009,-0.0165078312639538,0.00292329575959385,-0.0222374909527577,-0.0107781715751499,1.66027175169939e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SLITRK2,SLIT and NTRK-like protein 2,40030,-0.0212772116992553,0.00376839886564797,-0.0286632734759253,-0.0138911499225853,1.66769439184545e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CSNK1D,Casein kinase I isoform delta,37056,-0.03577666862067,0.0063445087929284,-0.0482119058548097,-0.0233414313865304,1.74553143979491e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PLG,Plasminogen,37162,-0.0125298144256817,0.00222210040828785,-0.0168851312259259,-0.00817449762543751,1.74799949268258e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PPP3R1,Calcineurin subunit B type 1,39749,-0.0228469199135357,0.00405492291385238,-0.0307945688246863,-0.014899271002385,1.78684075938269e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DGCR6,Protein DGCR6,36991,-0.0240160327003766,0.00426201464412194,-0.0323695814028556,-0.0156624839978976,1.787605778389e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CSDE1,Cold shock domain-containing protein E1,37021,-0.0661677249281235,0.0117466831784655,-0.0891912239579158,-0.0431442258983311,1.80849860998025e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DKK3,Dickkopf-related protein 3,40052,0.0157938768925952,0.00280531566648711,0.0102954581862805,0.0212922955989099,1.8321897299326e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SLIT2,Slit homolog 2 protein,39489,-0.0283685020256321,0.00503967664651927,-0.0382462682528099,-0.0184907357984543,1.8433776305613e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LTBR,Tumor necrosis factor receptor superfamily member 3,39786,-0.014692316328752,0.00261065117237152,-0.0198091926266002,-0.00957544003090382,1.85558985598101e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ELOB,Elongin-B,37021,-0.0216650618924302,0.00384993298419417,-0.0292109305414508,-0.0141191932434097,1.86694556486633e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CFB,Complement factor B,37220,-0.0182082430356548,0.00324063217990621,-0.024559882108271,-0.0118566039630386,1.96208273867899e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DRG2,Developmentally-regulated GTP-binding protein 2,39788,-0.0310440057319345,0.00552743638779944,-0.0418777810520214,-0.0202102304118476,1.98295045435171e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GRK5,G protein-coupled receptor kinase 5,39585,-0.0289934140645674,0.00516259622901624,-0.0391121026734392,-0.0188747254556955,1.98675348626397e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FGF2,Fibroblast growth factor 2,39866,-0.0365570793869932,0.00651149565935419,-0.0493196108793274,-0.023794547894659,2.00709830593505e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MAGED1,Melanoma-associated antigen D1,39477,-0.026519309525785,0.00473217596236904,-0.0357943744120283,-0.0172442446395416,2.12949941654423e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CRYZL1,Quinone oxidoreductase-like protein 1,37043,-0.0509579255283815,0.00909265589070207,-0.0687795310741576,-0.0331363199826055,2.13297050975075e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EDF1,Endothelial differentiation-related factor 1,37411,-0.0378958309903754,0.00676950426767742,-0.0511640593550231,-0.0246276026257277,2.21021463204787e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CASP7,Caspase-7,37388,-0.046312199193301,0.00827747384822067,-0.0625360479358135,-0.0300883504507885,2.24945438284589e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,F2R,Proteinase-activated receptor 1,39908,-0.031912114323208,0.0057056600193531,-0.0430952079611401,-0.0207290206852759,2.26739161223096e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RSPO3,R-spondin-3,40030,-0.0147105616110162,0.00263071474944862,-0.0198667625199355,-0.00955436070209693,2.28298299825184e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,OLR1,Oxidized low-density lipoprotein receptor 1,39721,-0.0320286495939635,0.00572998185295156,-0.0432594140257486,-0.0207978851621785,2.31262530010532e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NUDC,Nuclear migration protein nudC,40058,-0.0351265822935288,0.00628823620194638,-0.0474515252493437,-0.0228016393377139,2.35990285289508e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",37437,-0.0481304555322623,0.00861604412542795,-0.0650179020181011,-0.0312430090464235,2.36629817789541e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MSRA,Mitochondrial peptide methionine sulfoxide reductase,39913,-0.0395905218466945,0.00709324731100814,-0.0534932865762704,-0.0256877571171185,2.42397429824418e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DXO,Decapping and exoribonuclease protein,37388,-0.0248736741829585,0.00446203400886783,-0.0336192608403395,-0.0161280875255776,2.52969741833265e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MYBPC1,"Myosin-binding protein C, slow-type",37437,-0.0372196722846545,0.00669546216444847,-0.0503427781269735,-0.0240965664423355,2.76535461301812e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LACTB2,Endoribonuclease LACTB2,39868,-0.0360859801763869,0.00650869410517945,-0.0488430206225386,-0.0233289397302352,2.99843343519036e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,39908,-0.0415332379873327,0.00749694860098941,-0.056227257245272,-0.0268392187293935,3.07193448845086e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BIN2,Bridging integrator 2,39858,-0.0484970499211644,0.00876045282299513,-0.0656675374542348,-0.0313265623880939,3.14491057798097e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,39477,-0.0369129502768194,0.00666941470188937,-0.0499850030925226,-0.0238408974611163,3.16850180947806e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BLNK,B-cell linker protein,37056,-0.0212436215074268,0.00383846512651066,-0.0287670131553877,-0.0137202298594659,3.1824156409825e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VCAM1,Vascular cell adhesion protein 1,39908,-0.0144145195389576,0.00260931084591459,-0.0195287687969502,-0.00930027028096501,3.36015507432893e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ROBO2,Roundabout homolog 2,40009,0.0122587228615057,0.00221958427666499,0.00790833767924235,0.0166091080437691,3.38439376644465e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CERT,Ceramide transfer protein,39489,-0.0331653004475514,0.00601902983729502,-0.0449625989286497,-0.0213680019664532,3.64352385497411e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PLAU,Urokinase-type plasminogen activator,39858,0.0153771909810496,0.00279308096659879,0.00990275228651596,0.0208516296755832,3.73875588025702e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD59,CD59 glycoprotein,39173,-0.0113562767888188,0.00206373084232293,-0.0154011892397718,-0.0073113643378659,3.79829070632768e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DOK1,Docking protein 1,37388,-0.0740492043130284,0.0134659669973571,-0.100442499627848,-0.0476559089982085,3.88902964820756e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PEPD,Xaa-Pro dipeptidase,37445,0.0138609460767315,0.00252271388270271,0.00891642686663416,0.0188054652868288,3.98967040504598e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VWC2,Brorin,39684,-0.0206599417177376,0.00376167037644699,-0.0280328156555737,-0.0132870677799015,4.03018295131288e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CRYM,Ketimine reductase mu-crystallin,36991,-0.0413775335035133,0.00754475917726599,-0.0561652614909547,-0.026589805516072,4.22847287346747e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",39866,-0.0445426795229122,0.00812362739924086,-0.0604649892254243,-0.0286203698204001,4.24258580299542e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL13RA1,Interleukin-13 receptor subunit alpha-1,39597,-0.0121019314013134,0.00220768942163999,-0.0164290026677278,-0.007774860134899,4.27694926196989e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ATP6V1F,V-type proton ATPase subunit F,39453,-0.0353990193063768,0.00646471658005158,-0.0480698638032779,-0.0227281748094757,4.42457352640399e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",39866,-0.0235087022187324,0.00429611491848416,-0.0319290874589613,-0.0150883169785034,4.51454554690654e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,39749,-0.0155640689870693,0.00284861491111698,-0.0211473542128586,-0.00998078376128002,4.73239889055994e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD14,Monocyte differentiation antigen CD14,39564,-0.0218911497080891,0.00401403086443568,-0.029758650202383,-0.0140236492137951,5.00898476222884e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ATRN,"Attractin, Isoform 2",37453,-0.0087078762011009,0.00159797924170442,-0.0118399155148416,-0.00557583688736025,5.14479603646574e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ITGB1BP2,Integrin beta-1-binding protein 2,39585,-0.0596086040899032,0.0109495815960762,-0.0810697840182125,-0.0381474241615938,5.29028664410371e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,39755,-0.0128110502051126,0.00235392848777118,-0.0174247500411441,-0.00819735036908112,5.33421456345448e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VPS4B,Vacuolar protein sorting-associated protein 4B,37368,-0.0505045103582435,0.00928784808273041,-0.0687086926003951,-0.0323003281160919,5.49118083323879e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HSPA2,Heat shock-related 70 kDa protein 2,37368,-0.0180104380655674,0.00331636845108959,-0.024510520229703,-0.0115103559014318,5.7081742726256e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DNAJC9,DnaJ homolog subfamily C member 9,37382,-0.0404458853593824,0.00745118923488303,-0.0550502162597532,-0.0258415544590117,5.79358346520648e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD99L2,CD99 antigen-like protein 2,39858,-0.0127697967903733,0.00235287431774043,-0.0173814304531446,-0.00815816312760209,5.80398152960423e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,THBD,Thrombomodulin,39868,-0.0144029647735468,0.00265695534857775,-0.0196105972567592,-0.00919533229033444,6.0174024433964e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD8A,T-cell surface glycoprotein CD8 alpha chain,40009,-0.0248803862157443,0.00459891863092855,-0.0338942667323643,-0.0158665056991244,6.39038372617263e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FCRL2,Fc receptor-like protein 2,39990,-0.0244301280168714,0.00452347375516875,-0.0332961365770022,-0.0155641194567406,6.73045094712621e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",37388,-0.0519255568157674,0.00961698949390725,-0.0707748562238256,-0.0330762574077092,6.80096600593087e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CIAPIN1,Anamorsin,39913,-0.0332712204915684,0.00616274103812631,-0.045350192926296,-0.0211922480568408,6.80527959690329e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRSS27,Serine protease 27,39818,-0.0211539496183609,0.00392169194251115,-0.0288404658256827,-0.013467433411039,6.98537801442483e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GPA33,Cell surface A33 antigen,39788,-0.0691750957898645,0.0128280096544866,-0.0943179947126583,-0.0440321968670708,7.04730488515875e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,37056,-0.0172987182638927,0.0032108920188897,-0.0235920666209165,-0.0110053699068689,7.26662213714612e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CXCL3,C-X-C motif chemokine 3,39859,-0.0496456386263485,0.00924543220435294,-0.0677666857468803,-0.0315245915058167,7.99476129512427e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LACRT,Extracellular glycoprotein lacritin,37339,-0.0253934472201945,0.00473023924154751,-0.0346647161336276,-0.0161221783067614,8.07895603332277e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GBP4,Guanylate-binding protein 4,39489,-0.0255506986584195,0.00477415148794414,-0.03490803557479,-0.016193361742049,8.82719012927062e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HSPB1,Heat shock protein beta-1,39617,-0.0363835056622009,0.00680128429791217,-0.0497140228861088,-0.0230529884382931,8.94270446452479e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,37021,-0.0144890132670108,0.00271003208658669,-0.0198006761567207,-0.00917735037730089,9.12015411504061e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SERPINB6,Serpin B6,39970,-0.0313810175716306,0.00587413207555605,-0.0428943164397205,-0.0198677187035407,9.30530575444367e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SDHB,Succinate dehydrogenase,37382,-0.0367760060931777,0.00688924850721102,-0.0502789331673113,-0.0232730790190441,9.54045861835898e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GM2A,Ganglioside GM2 activator,37178,-0.0188925652429749,0.00354788179777655,-0.0258464135666169,-0.0119387169193328,1.02578621659659e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,37411,-0.052051561165171,0.0097857889215714,-0.071231707451451,-0.0328714148788911,1.05941706025209e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SPINK2,Serine protease inhibitor Kazal-type 2,37124,-0.0190453160143387,0.00358071957898323,-0.0260635263891459,-0.0120271056395316,1.06120586982255e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MBL2,Mannose-binding protein C,37257,0.0559980001473033,0.010550937714851,0.0353181622261953,0.0766778380684112,1.12976079026577e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NOS1,"Nitric oxide synthase, brain",39489,-0.0279640591672363,0.00527162239101307,-0.0382964390536219,-0.0176316792808507,1.14434279863369e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,37093,0.0255536367209133,0.00481721568916666,0.0161118939701466,0.0349953794716799,1.14709318011181e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LPA,Apolipoprotein(a),37186,0.091464051406589,0.0172591005229114,0.0576362143816826,0.125291888431495,1.17991837412353e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ERP29,Endoplasmic reticulum resident protein 29,37124,-0.0621542562249462,0.0117303992600719,-0.0851458387746871,-0.0391626736752053,1.18585760306801e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD40LG,CD40 ligand,40058,-0.0402663772142199,0.00760109328559822,-0.0551645200539924,-0.0253682343744473,1.1896987582443e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SELENOP,Selenoprotein P,37453,0.0115464658074087,0.0021799210498813,0.00727382054964132,0.015819111065176,1.19729413829256e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MYL4,Myosin light chain 4,37043,-0.0269973209678286,0.00510146203967946,-0.0369961865656003,-0.0169984553700569,1.22874291733683e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,STC2,Stanniocalcin-2,39831,-0.0136686439992225,0.00258470709845032,-0.0187346699121852,-0.00860261808625992,1.25101703321429e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PPIB,Peptidyl-prolyl cis-trans isomerase B,39837,-0.0496141244893541,0.00939262485534936,-0.0680236692058389,-0.0312045797728694,1.29285380485637e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,B4GAT1,"Beta-1,4-glucuronyltransferase 1",39858,0.0125623076141469,0.00238032527730928,0.00789687007062074,0.0172277451576731,1.32624477208565e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SIL1,Nucleotide exchange factor SIL1,37043,-0.0172835140794808,0.00328015525532858,-0.0237126183799248,-0.0108544097790368,1.39243383499799e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PI16,Peptidase inhibitor 16,37445,0.012313983801987,0.00234384456331547,0.00772004845788866,0.0169079191460853,1.51282146662062e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CSF2,Granulocyte-macrophage colony-stimulating factor,37021,-0.0180358145752841,0.00344117642656335,-0.0247805203713483,-0.01129110877922,1.62022377307127e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ARAF,Serine/threonine-protein kinase A-Raf,37169,-0.034466172295323,0.00658256319633134,-0.0473679961601325,-0.0215643484305136,1.66610444395344e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CTRC,Chymotrypsin-C,39856,0.0315714500860255,0.00603390817862767,0.0197449900559153,0.0433979101161358,1.69491662435608e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCDC134,Coiled-coil domain-containing protein 134,37368,-0.0249225674762741,0.00477296871211019,-0.0342775861520101,-0.0155675488005381,1.80009745492612e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,S100A11,Protein S100-A11,39703,-0.0231583189982671,0.00443777392882066,-0.0318563558987556,-0.0144602820977786,1.82698709686381e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DENR,Density-regulated protein,37056,-0.0296130353077094,0.00567424571704968,-0.0407345569131267,-0.018491513702292,1.82768060050841e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CALB2,Calretinin,39489,-0.0148661765940197,0.00284954567521615,-0.0204512861174434,-0.00928106707059608,1.84133452041648e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CASP3,Caspase-3,40052,-0.0452024158836607,0.00869038348110175,-0.0622355675066201,-0.0281692642607013,2.00171408680426e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SWAP70,Switch-associated protein 70,37382,-0.0183346043955221,0.00352467297472295,-0.0252429634259791,-0.0114262453650651,2.00263091202382e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CAT,Catalase,37252,-0.0269813712623981,0.00518708269873303,-0.0371480533519148,-0.0168146891728814,2.00444243206077e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ENAH,Protein enabled homolog,39587,-0.024337196112599,0.00468725500774267,-0.0335242159277746,-0.0151501762974233,2.10405902214404e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,COL2A1,Collagen alpha-1(II) chain,37043,-0.0410686990405474,0.0079097440932387,-0.0565717974632952,-0.0255656006177995,2.10955274132127e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL17A,Interleukin-17A,39558,-0.021462884241446,0.0041368035350445,-0.0295710191701332,-0.0133547493127587,2.14890269008747e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SNX9,Sorting nexin-9,39868,-0.0351498403433164,0.00677584418382545,-0.0484304949436142,-0.0218691857430185,2.1571045037395e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ACRBP,Acrosin-binding protein,37368,-0.0195255005007831,0.00376607420247538,-0.0269070059376349,-0.0121439950639314,2.19631846562799e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,37056,-0.0408060766889252,0.00788445744097715,-0.0562596132732404,-0.02535254010461,2.30627807632095e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,STX16,Syntaxin-16,39477,-0.0294289340570977,0.00569631056376466,-0.0405937027620764,-0.018264165352119,2.41693003841334e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DYNLT3,Dynein light chain Tctex-type 3,37368,-0.0221637277283215,0.00429102378767044,-0.0305741343521555,-0.0137533211044874,2.43680745750117e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DPP7,Dipeptidyl peptidase 2,39754,-0.0303616233793301,0.00588059970083321,-0.0418875987929632,-0.018835647965697,2.45935104161317e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MESD,LRP chaperone MESD,39858,-0.0615352382033904,0.0119266489306152,-0.0849114701073961,-0.0381590062993847,2.50604030432843e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AKR1B10,Aldo-keto reductase family 1 member B10,37039,-0.0308517496167503,0.00598075642600826,-0.0425740322117265,-0.0191294670217741,2.52544856263226e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADAMTSL4,ADAMTS-like protein 4,37043,-0.0122728408961787,0.00237920780435371,-0.016936088192712,-0.00760959359964545,2.52718922361249e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CASP1,Caspase-1,39489,-0.0336252779844931,0.00653095579419392,-0.0464259513411132,-0.0208246046278731,2.65622871709929e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KIFBP,KIF-binding protein,39788,-0.041758846913733,0.0081118071752577,-0.057657988977238,-0.0258597048502279,2.6654052067583e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TBL1X,F-box-like/WD repeat-containing protein TBL1X,39477,-0.0427908951936984,0.00831912903024607,-0.0590963880929807,-0.0264854022944161,2.72675445640453e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD86,T-lymphocyte activation antigen CD86,37382,0.0147694337690582,0.00287739462448759,0.00912974030506248,0.0204091272330538,2.89239928410759e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,C2,Complement C2,39908,-0.0118558873231968,0.0023126148445605,-0.0163886124185353,-0.00732316222785819,2.98425513996812e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ARL13B,ADP-ribosylation factor-like protein 13B,37021,-0.0349065906554889,0.00681078061661295,-0.0482557206640502,-0.0215574606469275,3.01439267704492e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SAA4,Serum amyloid A-4 protein,37453,-0.0165432151867632,0.0032374965908103,-0.0228887085047514,-0.010197721868775,3.26736728019702e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,39587,-0.0210328620647727,0.00411982185910588,-0.0291077129086202,-0.0129580112209252,3.34152119116791e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RCOR1,REST corepressor 1,39585,-0.0223537009459146,0.00437941223762921,-0.0309373489316678,-0.0137700529601613,3.35947396697831e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLGN,Calmegin,37039,-0.0218746849911524,0.00429027847416864,-0.0302836308005229,-0.0134657391817818,3.46804634261801e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCN3,CCN family member 3,40042,-0.0160993349842676,0.00316144936559605,-0.0222957757408359,-0.00990289422769939,3.57547386117269e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GLYR1,Putative oxidoreductase GLYR1,37368,-0.0297854786415173,0.00585438185622097,-0.0412600670797104,-0.0183108902033242,3.67248567838409e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VASH1,Tubulinyl-Tyr carboxypeptidase 1,39866,-0.0407362687405072,0.00800961643184727,-0.0564351169469279,-0.0250374205340866,3.69981540397813e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,37368,-0.0538856884091508,0.0105962992492525,-0.0746544349376858,-0.0331169418806159,3.71900509849738e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,STX6,Syntaxin-6,39477,-0.0338520191610682,0.00666714966283077,-0.0469196325002165,-0.0207844058219199,3.86966072715096e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FUCA1,Tissue alpha-L-fucosidase,39928,-0.0400290972304169,0.00788467075591654,-0.0554830519120133,-0.0245751425488205,3.88082549223136e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EDN1,Endothelin-1,37043,-0.0140072907694224,0.00276084208075546,-0.0194185412477031,-0.0085960402911417,3.95757346950569e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDC37,Hsp90 co-chaperone Cdc37,39913,-0.0414503252481079,0.00817197277264645,-0.057467391882495,-0.0254332586137209,3.97512803757541e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,UROS,Uroporphyrinogen-III synthase,37039,-0.0341397968158873,0.00673647047297868,-0.0473432789429255,-0.020936314688849,4.07665513905121e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SCRG1,Scrapie-responsive protein 1,37437,-0.0131026065677454,0.00259380715058243,-0.0181864685828869,-0.00801874455260379,4.44054439165609e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MED18,Mediator of RNA polymerase II transcription subunit 18,39477,-0.037950027087398,0.00751645978278343,-0.0526822882616535,-0.0232177659131424,4.49309394696182e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CTSV,Cathepsin L2,39967,0.0201838365362395,0.00399935432359671,0.0123451020619899,0.028022571010489,4.54228531050382e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RPE,Ribulose-phosphate 3-epimerase,37169,-0.0352714722146839,0.0069996496730561,-0.0489907855738738,-0.0215521588554939,4.74026144950044e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,STXBP3,Syntaxin-binding protein 3,39477,-0.0217629179114628,0.00432025618262927,-0.0302306200294162,-0.0132952157935094,4.77129241975035e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SIGLEC5,Sialic acid-binding Ig-like lectin 5,39858,-0.058293702451746,0.0115845193886393,-0.0809993604534791,-0.0355880444500129,4.90565381456113e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NEK7,Serine/threonine-protein kinase Nek7,37169,-0.0365817753945834,0.00728152876923656,-0.0508535717822871,-0.0223099790068797,5.12854198854217e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CST5,Cystatin-D,39559,-0.0266060213249121,0.0052995263934741,-0.0369930930561214,-0.0162189495937029,5.21146146749999e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",37437,-0.0364298064128795,0.00726839418583448,-0.0506758590171151,-0.0221837538086439,5.45216749625867e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CRYBB1,Beta-crystallin B1,37437,-0.03267817236776,0.0065297725924676,-0.0454765266489965,-0.0198798180865235,5.67118372428479e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,F11,Coagulation factor XI,37249,0.0153442552407461,0.00307140587017289,0.00932429973520721,0.0213642107462849,5.93187812612944e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SUSD1,Sushi domain-containing protein 1,39585,-0.0236128736211366,0.00473966155480555,-0.0329026102685554,-0.0143231369737177,6.36068548376327e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PAM,Peptidyl-glycine alpha-amidating monooxygenase,39956,-0.0135058631590838,0.00271307520706382,-0.0188234905649289,-0.00818823575323869,6.48872842971394e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",37411,-0.020398940190009,0.00409844493568274,-0.0284318922639472,-0.0123659881160709,6.52898299549325e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PLB1,"Phospholipase B1, membrane-associated",37388,0.0292110666414375,0.00587265513340098,0.0177006625799716,0.0407214707029034,6.63622433083936e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FHIT,Bis(5'-adenosyl)-triphosphatase,39489,-0.036106855455818,0.0072703960765957,-0.0503568317659456,-0.0218568791456904,6.89679554728809e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NACC1,Nucleus accumbens-associated protein 1,37368,-0.0267940996875003,0.005397337603621,-0.0373728813905975,-0.0162153179844032,6.97839142282269e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SELL,L-selectin,37453,0.0110156667639081,0.00222021011487837,0.00666405493874649,0.0153672785890697,7.07814668582654e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TDP1,Tyrosyl-DNA phosphodiesterase 1,37368,-0.0334774266942817,0.00677489362595771,-0.0467562182011588,-0.0201986351874046,7.84948584004027e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,37043,-0.0207073133427053,0.00419351285820928,-0.0289265985447955,-0.0124880281406151,7.99190438919788e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,USP28,Ubiquitin carboxyl-terminal hydrolase 28,37388,-0.0174789981881825,0.00354281495271365,-0.0244229154955012,-0.0105350808808637,8.16679805387846e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NAP1L4,Nucleosome assembly protein 1-like 4,37362,-0.0196526402186219,0.00398516370178125,-0.0274635610741132,-0.0118417193631307,8.25917385302928e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ERBB2,Receptor tyrosine-protein kinase erbB-2,39913,-0.0120575722377568,0.00244742214970788,-0.0168545196511843,-0.0072606248243294,8.44879818396122e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LAMP1,Lysosome-associated membrane glycoprotein 1,37097,-0.0136864824309531,0.00277838517738632,-0.0191321173786302,-0.00824084748327589,8.49194460517631e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PTPRM,Receptor-type tyrosine-protein phosphatase mu,39845,-0.0116724461582552,0.0023721591363499,-0.016321878065501,-0.00702301425100944,8.71381054914821e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",37437,-0.0144170700831535,0.00293614357898772,-0.0201719114979694,-0.00866222866833757,9.20389711081991e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PDZD2,PDZ domain-containing protein 2,37021,-0.0288885228881202,0.00588332351205487,-0.0404198369717478,-0.0173572088044927,9.20572904636286e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,APRT,Adenine phosphoribosyltransferase,39738,-0.023074233535831,0.00469961071495323,-0.0322854705371393,-0.0138629965345226,9.20667305093066e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",39477,-0.0387952362142979,0.00791159013195139,-0.0543019528729226,-0.0232885195556732,9.50442749796879e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,37382,-0.0158912366976288,0.00324464860108852,-0.0222507479557623,-0.00953172543949535,9.80983525686111e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLEC5A,C-type lectin domain family 5 member A,39818,-0.0135651383714102,0.00277006406960256,-0.0189944639478312,-0.0081358127949892,9.82389452561053e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VAV3,Guanine nucleotide exchange factor VAV3,36991,-0.0479374163995928,0.00979238162298551,-0.0671304843806444,-0.0287443484185412,9.92830598398723e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,C1QA,Complement C1q subcomponent subunit A,39971,-0.0109694391835337,0.00224196011123309,-0.0153636810015505,-0.00657519736551679,1.00377150294645e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,39868,-0.0233203277187153,0.0047730317677127,-0.0326754699834322,-0.0139651854539984,1.03978330387753e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RP2,Protein XRP2,39788,-0.0199335428943626,0.00408073492268898,-0.027931783342833,-0.0119353024458922,1.04543360089813e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FSTL1,Follistatin-related protein 1,37043,-0.0110092689997046,0.00225366138630011,-0.0154264453168529,-0.00659209268255641,1.04612267375234e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MTIF3,"Translation initiation factor IF-3, mitochondrial",37382,-0.0419557295074397,0.00860079143180029,-0.0588132807137682,-0.0250981783011111,1.08318932671043e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ROBO1,Roundabout homolog 1,39885,-0.0112339746285415,0.00230563257366096,-0.0157530144729169,-0.00671493478416598,1.11301861564045e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,JPT2,Jupiter microtubule associated homolog 2,37382,-0.0422147761553504,0.00867130179757178,-0.0592105276785911,-0.0252190246321097,1.13815700455766e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CIRBP,Cold-inducible RNA-binding protein,37382,-0.0460831324285615,0.0094676570996737,-0.064639740343922,-0.0275265245132011,1.14336897643433e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GNAS,Neuroendocrine secretory protein 55,37411,-0.0431339843264233,0.00888710509573285,-0.0605527103140597,-0.0257152583387869,1.22623693622657e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DCN,Decorin,39585,0.0102728990540554,0.00211731790172377,0.00612295596667686,0.014422842141434,1.23490151357727e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SMARCA2,Probable global transcription activator SNF2L2,39489,-0.0349231269428598,0.0072010018583764,-0.0490370905852775,-0.020809163300442,1.24801169484347e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MERTK,Tyrosine-protein kinase Mer,40058,-0.0120120998603,0.00247711926989775,-0.0168672536292996,-0.00715694609130046,1.25097561555176e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FCRL1,Fc receptor-like protein 1,39868,-0.0207633339250464,0.00428984063085055,-0.0291714215615134,-0.0123552462885793,1.30972278185385e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD22,B-cell receptor CD22,40058,-0.0189547874064224,0.00391949037314199,-0.0266369885377807,-0.0112725862750641,1.33672177168568e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GGT5,Glutathione hydrolase 5 proenzyme,39749,-0.0108320517739773,0.00224318926152803,-0.0152287027265723,-0.00643540082138238,1.38593997208326e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RLN2,Prorelaxin H2,37095,-0.067179401488306,0.0139380330522373,-0.0944979462706911,-0.0398608567059209,1.45252787497546e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,C4BPB,C4b-binding protein beta chain,39913,0.0186491749600148,0.00387097462733671,0.0110620646904348,0.0262362852295948,1.46552638344608e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DDC,Aromatic-L-amino-acid decarboxylase,39846,-0.022877202444513,0.00475195586012646,-0.0321910359303609,-0.0135633689586652,1.49089722420609e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,C7orf50,Uncharacterized protein C7orf50,37388,-0.0103548501329329,0.00215088476803624,-0.0145705842782839,-0.00613911598758187,1.49368120719985e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KLK13,Kallikrein-13,39490,-0.0198189294868765,0.00412916194667527,-0.02791208690236,-0.0117257720713929,1.60335961889075e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SLAMF7,SLAM family member 7,39866,-0.0270487803339012,0.0056380454421631,-0.0380993494005408,-0.0159982112672615,1.62069420433967e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NEFL,Neurofilament light polypeptide,39438,-0.0203718113356902,0.00424726535318655,-0.0286964514279359,-0.0120471712434446,1.62993859463442e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AMFR,E3 ubiquitin-protein ligase AMFR,39489,-0.0303135394454413,0.00632015705982328,-0.0427010472826949,-0.0179260316081877,1.63091898807519e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MMP10,Stromelysin-2,39857,0.0274935345332976,0.00573645911315882,0.0162500746715064,0.0387369943950889,1.65971248613876e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,YAP1,Transcriptional coactivator YAP1,37388,-0.011986556853402,0.0025026192617591,-0.0168916906064499,-0.00708142310035422,1.68882219658636e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DNAJC21,DnaJ homolog subfamily C member 21,37388,-0.0180180912144147,0.003773692967859,-0.0254145294314183,-0.0106216529974111,1.81899318306653e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BCHE,Cholinesterase,37208,-0.0129445283258402,0.00271141966454469,-0.0182589108683478,-0.00763014578333257,1.8244868550825e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TST,Thiosulfate sulfurtransferase,39455,-0.035591384241549,0.00747187276248238,-0.0502362548560144,-0.0209465136270835,1.92088423602203e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SV2A,Synaptic vesicle glycoprotein 2A,37039,-0.0287473101566852,0.00603688196862023,-0.0405795988151808,-0.0169150214981895,1.93775342963644e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ALCAM,CD166 antigen,40052,-0.00902045748517533,0.00189594759927112,-0.0127365147797467,-0.00530440019060393,1.97445197559493e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EFCAB2,Dynein regulatory complex protein 8,37169,-0.0163918118607189,0.00344564799114091,-0.0231452819233551,-0.00963834179808273,1.98307934364302e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,37043,-0.0248508842891168,0.0052247361825404,-0.035091367206896,-0.0146104013713376,1.99173198939047e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GAS2,Growth arrest-specific protein 2,37169,-0.0247703657166891,0.00520997129399793,-0.034981909452925,-0.0145588219804532,2.0110687202467e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SCGN,Secretagogin,39587,-0.0200077331294632,0.00420934574431718,-0.0282580507883249,-0.0117574154706015,2.02024946001049e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL17C,Interleukin-17C,39587,-0.0308255305495499,0.00648811678314369,-0.0435422394445116,-0.0181088216545883,2.04125765429794e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DCTN6,Dynactin subunit 6,39489,-0.0329595672543738,0.00693794982458401,-0.0465579489105585,-0.0193611855981892,2.0459582932628e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,36962,-0.0316476488305951,0.00666303725218593,-0.0447072018448795,-0.0185880958163106,2.05844768492742e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL15RA,Interleukin-15 receptor subunit alpha,39587,-0.0158937912118388,0.00334986426487362,-0.0224595251709911,-0.00932805725268651,2.10747266397689e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MILR1,Allergin-1,39587,-0.022934414897529,0.00483491648191557,-0.0324108512020835,-0.0134579785929745,2.11904110094624e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SEZ6,Seizure protein 6 homolog,37039,0.014494061717807,0.00305570758797705,0.00850487484537195,0.020483248590242,2.12495236479611e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CHM,Rab proteins geranylgeranyltransferase component A 1,37039,-0.0285546107981994,0.00602416073906421,-0.0403619658467652,-0.0167472557496335,2.1593734778175e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ARHGAP45,Rho GTPase-activating protein 45,37124,-0.0385138627676444,0.00813267772497261,-0.0544539111085907,-0.0225738144266981,2.20568327112624e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FOLR2,Folate receptor beta,40009,-0.0133103905106091,0.00281443630741071,-0.0188266856731341,-0.00779409534808408,2.27169247803479e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RNASE3,Eosinophil cationic protein,39791,-0.0496265427358512,0.0105006823561926,-0.0702078801539887,-0.0290452053177137,2.30908285836166e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",37437,-0.02502038516809,0.00529826171846347,-0.0354049781362784,-0.0146357921999016,2.35437021182428e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,37124,-0.028115528379674,0.00595926506337514,-0.0397956879038893,-0.0164353688554588,2.40661318922193e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,UNC5D,Netrin receptor UNC5D,37056,0.0123128755056519,0.00261108080057275,0.00719515713652926,0.0174305938747745,2.43437973210539e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FDX1,"Adrenodoxin, mitochondrial",37021,-0.0293410560901569,0.00622626386146768,-0.0415445332586335,-0.0171375789216802,2.47242805453123e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SDK2,Protein sidekick-2,37124,-0.0171636165646572,0.00364905017158384,-0.0243157549009616,-0.0100114782283529,2.58211055621215e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TBC1D5,TBC1 domain family member 5,39866,-0.0357886915734888,0.00761397116511947,-0.0507120750571229,-0.0208653080898546,2.61818403648869e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LAMB1,Laminin subunit beta-1,37043,-0.0140488682762739,0.00298988614206421,-0.0199090451147197,-0.00818869143782803,2.64343435809777e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PARD3,Partitioning defective 3 homolog,37169,-0.0341871805008332,0.00727641662116792,-0.0484489570783223,-0.0199254039233441,2.6489140475188e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PROC,Vitamin K-dependent protein C,39908,-0.0118299926010447,0.00252119996062971,-0.0167715445238789,-0.00688844067821047,2.72503624960176e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LPCAT2,Lysophosphatidylcholine acyltransferase 2,39788,-0.0175570352029605,0.00374206643596054,-0.0248914854174432,-0.0102225849884779,2.73060000469448e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NFYA,Nuclear transcription factor Y subunit alpha,37021,-0.0174014656480224,0.00371199786585336,-0.0246769814650949,-0.0101259498309498,2.78795872990209e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL7,Interleukin-7,39866,-0.0298595198286597,0.00637182128834859,-0.0423482895538229,-0.0173707501034964,2.80639309500464e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,C2CD2L,Phospholipid transfer protein C2CD2L,39453,-0.0191097236691857,0.00408772671101403,-0.0271216680227732,-0.0110977793155982,2.96556121860951e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NUDT16,U8 snoRNA-decapping enzyme,37366,-0.0404726271096475,0.00867232870441318,-0.0574703913702974,-0.0234748628489977,3.08761969962532e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,37021,0.00922548566062587,0.00197777005484058,0.00534905635313834,0.0131019149681134,3.12277447199809e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,F3,Tissue factor,39931,0.012358905736599,0.00265400183224892,0.00715706214539112,0.0175607493278069,3.23880559494069e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,37388,-0.0220853129096498,0.0047457020832668,-0.0313868889928527,-0.0127837368264468,3.29044608878704e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KLK10,Kallikrein-10,39856,-0.0178675989332482,0.00384546374866582,-0.0254047078806332,-0.0103304899858632,3.40455198858279e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CFHR2,Complement factor H-related protein 2,37364,-0.0256605783411095,0.00552761281965344,-0.0364946994676303,-0.0148264572145888,3.47875437752665e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PLA2G1B,Phospholipase A2,40031,0.0185098353369076,0.00398974306356834,0.0106899389323136,0.0263297317415015,3.52237952607119e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MAPKAPK2,MAP kinase-activated protein kinase 2,37169,-0.0334655308871117,0.00722304142962745,-0.0476226920891815,-0.0193083696850419,3.63535290005287e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PSMD9,26S proteasome non-ATPase regulatory subunit 9,39788,-0.02430388627949,0.00525958201781504,-0.0346126670344075,-0.0139951055245725,3.85114982030965e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",39453,-0.0211923940232915,0.00458879008980549,-0.0301864225993103,-0.0121983654472728,3.8999437258645e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",37043,-0.020817879840875,0.00451011059556966,-0.0296576966081916,-0.0119780630735585,3.95232351598906e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GMFG,Glia maturation factor gamma,37437,-0.0325969009465618,0.00706768439061281,-0.0464495623521629,-0.0187442395409607,4.02252847727967e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AK2,"Adenylate kinase 2, mitochondrial",37388,-0.0481364248635042,0.0104671601440278,-0.0686520587457987,-0.0276207909812098,4.2877422825157e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RAB10,Ras-related protein Rab-10,37437,-0.0241211402081022,0.00525245540288514,-0.034415952797757,-0.0138263276184473,4.42209443068973e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,37382,-0.0215732121700905,0.00470306623692135,-0.0307912219944564,-0.0123552023457247,4.53584856639893e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EPHB6,Ephrin type-B receptor 6,39713,-0.0135391727796863,0.00295348735096873,-0.019328007987585,-0.00775033757178759,4.59360405006982e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AKAP12,A-kinase anchor protein 12,37124,0.00947634523485482,0.00207082577947456,0.00541752670708468,0.013535163762625,4.77978673403828e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDNF,Cerebral dopamine neurotrophic factor,39788,-0.0140808114082584,0.00308451677771752,-0.0201264642925847,-0.00803515852393202,5.03236807513181e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CRADD,Death domain-containing protein CRADD,39713,-0.0340374158892413,0.00745864484986346,-0.0486563597949737,-0.019418471983509,5.06890029891065e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CSF1R,Macrophage colony-stimulating factor 1 receptor,37445,-0.0176890885773264,0.00387692540494533,-0.0252878623710193,-0.0100903147836336,5.09521708547946e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,37411,-0.0296584315798974,0.00650908800279607,-0.0424162440653777,-0.0169006190944171,5.24760697506284e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADGRE1,Adhesion G protein-coupled receptor E1,37382,-0.0239243719955334,0.00527050228571649,-0.0342545564755377,-0.013594187515529,5.69291709115898e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GCLM,Glutamate--cysteine ligase regulatory subunit,37021,-0.01967739145466,0.00433679503723316,-0.028177509727637,-0.0111772731816831,5.74800286386519e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,APOA4,Apolipoprotein A-IV,37453,-0.0157012866653991,0.00347334825696238,-0.0225090492490454,-0.00889352408175288,6.22134647965682e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RAB44,Ras-related protein Rab-44,37368,-0.0187253186316558,0.00414291493382369,-0.0268454319019502,-0.0106052053613614,6.24116509110656e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MPI,Mannose-6-phosphate isomerase,39788,-0.0380782766855276,0.00843774068532194,-0.0546162484287586,-0.0215403049422967,6.4419411259981e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NRGN,Neurogranin,37445,-0.0406224046125273,0.00900773284791322,-0.0582775609944372,-0.0229672482306174,6.54550489822581e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CTRL,Chymotrypsin-like protease CTRL-1,37388,0.0290825097555868,0.00646035845611454,0.0164202071816023,0.0417448123295713,6.79793551700788e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",39809,-0.0287496228789292,0.00639705922221143,-0.0412878589544636,-0.0162113868033948,7.03253773689496e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ASGR2,Asialoglycoprotein receptor 2,37445,-0.0111767609434492,0.00248801201825198,-0.0160532644992231,-0.00630025738767535,7.10575140355893e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KIF1C,Kinesin-like protein KIF1C,37021,-0.0161176752866389,0.0035885587001494,-0.0231512503389318,-0.0090841002343461,7.13565656811509e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RAB37,Ras-related protein Rab-37,39587,-0.0365240013410733,0.00814122601097798,-0.0524808043225901,-0.0205671983595564,7.298348731692e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NARS1,"Asparagine--tRNA ligase, cytoplasmic",37411,-0.0207391538894973,0.00462806094040826,-0.0298101533326974,-0.0116681544462971,7.48411600972361e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,39585,-0.0159914325511586,0.00356943694018292,-0.0229875289539171,-0.00899533614840006,7.51342870994206e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SPP1,Osteopontin,40012,0.0196728611617877,0.0043948399979382,0.0110589747658288,0.0282867475577465,7.6447899615224e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,39788,-0.0414686011125208,0.0092777074079156,-0.0596529076320354,-0.0232842945930062,7.88684703283884e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KIF22,Kinesin-like protein KIF22,37021,-0.0531079960552433,0.0118956268234297,-0.0764234246291656,-0.0297925674813211,8.09243394512862e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TRAF3,"TNF receptor-associated factor 3, Isoform 2",37056,-0.015722575102582,0.00352371543147231,-0.0226290573482678,-0.00881609285689628,8.18965969399962e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GGACT,Gamma-glutamylaminecyclotransferase,37437,-0.0312501569261093,0.00700487066182511,-0.0449797034232866,-0.0175206104289321,8.21555677423353e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL22,Interleukin-22,37368,-0.0286289069480525,0.00642071212654756,-0.0412135027160857,-0.0160443111800193,8.30700848733481e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD70,CD70 antigen,39866,0.0184029391752976,0.00412782952237869,0.0103123933114354,0.0264934850391599,8.31891492004959e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ARID4B,AT-rich interactive domain-containing protein 4B,39489,-0.0176257514919576,0.00396329697143303,-0.0253938135559663,-0.00985768942794888,8.75785840278223e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MASP1,Mannan-binding lectin serine protease 1,39713,-0.0102071681107277,0.00230035839826928,-0.0147158705713355,-0.0056984656501199,9.17475863307137e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PTPRC,Receptor-type tyrosine-protein phosphatase C,37437,-0.00968155692293556,0.0021854072653523,-0.0139649551630261,-0.00539815868284507,9.49296341195704e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AHCY,Adenosylhomocysteinase,39868,-0.0293109828535712,0.00662415954611723,-0.042294335563961,-0.0163276301431815,9.7141866670295e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NFAT5,Nuclear factor of activated T-cells 5,37056,-0.0375168481933272,0.00847906710348979,-0.0541358197161671,-0.0208978766704872,9.73758811734382e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GZMH,Granzyme H,39585,-0.0323965149632162,0.00733949521956174,-0.0467819255935572,-0.0180111043328752,1.02154894991677e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,37382,0.0304760380377536,0.00691290331580296,0.0169267475387798,0.0440253285367274,1.04856456330323e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",37043,-0.039659756048735,0.00900476244433428,-0.0573090904396302,-0.0220104216578398,1.06957997241138e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRKG1,cGMP-dependent protein kinase 1,37124,-0.0546300179649183,0.0124353305181369,-0.0790032657804667,-0.03025677014937,1.12597226453771e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ABHD14B,Protein ABHD14B,39687,-0.0246595419917994,0.00561914775687851,-0.0356730715952813,-0.0136460123883176,1.1488205421083e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PADI2,Protein-arginine deiminase type-2,39587,-0.0244193022395922,0.00556699411975731,-0.0353306107143165,-0.0135079937648679,1.15968443474261e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SFTPD,Pulmonary surfactant-associated protein D,39868,-0.0282394232088311,0.00644139650273096,-0.0408645603541838,-0.0156142860634784,1.17233932076651e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IFNL1,Interferon lambda-1,39489,-0.0192255616247356,0.00438570804179812,-0.02782154938666,-0.0106295738628113,1.1745015385891e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DNLZ,DNL-type zinc finger protein,36991,0.0386972388064972,0.00883653755975766,0.0213776251893722,0.0560168524236222,1.2002087160542e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,39962,-0.0146978204443805,0.0033593257410701,-0.0212820988968779,-0.00811354199188305,1.22067623490486e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RNF43,E3 ubiquitin-protein ligase RNF43,37169,-0.0253215722993558,0.00579734181154773,-0.0366843622499894,-0.0139587823487223,1.26459072677686e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,COX6B1,Cytochrome c oxidase subunit 6B1,37437,-0.0137086163248486,0.00313991976580396,-0.0198628590658243,-0.00755437358387281,1.27529655994222e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CA1,Carbonic anhydrase 1,39531,-0.0253348072252732,0.00580766537986867,-0.0367178313698158,-0.0139517830807306,1.29521509433064e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PROCR,Endothelial protein C receptor,37021,0.0156088234064808,0.00358416131589381,0.00858386722732891,0.0226337795856326,1.34107066913074e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PBK,Lymphokine-activated killer T-cell-originated protein kinase,36962,0.0130135791490331,0.00299014481508948,0.00715289531145775,0.0188742629866085,1.35826158493481e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SF3B4,Splicing factor 3B subunit 4,39788,-0.0310229334283568,0.00712925125089128,-0.0449962658801037,-0.0170496009766099,1.3605138971366e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MAEA,E3 ubiquitin-protein transferase MAEA,39477,-0.0170313565663147,0.00391723687753536,-0.024709140846284,-0.00935357228634544,1.38381211474246e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDC26,Anaphase-promoting complex subunit CDC26,37362,-0.0302885713507084,0.00698115894267459,-0.0439716428783506,-0.0166054998230662,1.44424078890898e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SOD2,"Superoxide dismutase [Mn], mitochondrial",39858,-0.0157788964163114,0.00364497190974774,-0.022923041359417,-0.00863475147320586,1.50733216910205e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GUK1,Guanylate kinase,37021,0.0175330898919723,0.00406334254588854,0.00956893850203079,0.0254972412819139,1.60809600255757e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SLC12A2,Solute carrier family 12 member 2,37021,0.011776770880275,0.00273175124080459,0.00642253844829796,0.017131003312252,1.63648206699625e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RANBP1,Ran-specific GTPase-activating protein,37043,-0.0221722600303767,0.00514442801427799,-0.0322553389383616,-0.0120891811223919,1.64471367121585e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SUGT1,Protein SGT1 homolog,39477,-0.0340350486320008,0.0079273911405431,-0.0495727352674653,-0.0184973619965364,1.77060413299454e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,37306,-0.0127936173220153,0.00298615568082972,-0.0186464824564416,-0.00694075218758908,1.84581321568188e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PER3,Period circadian protein homolog 3,37056,-0.0493181875710518,0.0115345413755872,-0.0719258886672026,-0.0267104864749009,1.91880883804349e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DCLRE1C,Protein artemis,36962,0.0130147287121498,0.0030469103544021,0.00704278441752168,0.0189866730067779,1.95574889471831e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PTK7,Inactive tyrosine-protein kinase 7,39489,-0.0160387745102002,0.0037579230209217,-0.0234043036312067,-0.00867324538919362,1.98405156773545e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ABO,Histo-blood group ABO system transferase,37445,0.0601055683594345,0.0140887596836014,0.0324915993795758,0.0877195373392931,2.00170189659582e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CASP2,Caspase-2,39866,-0.0284868053415043,0.00667798076736005,-0.04157564764553,-0.0153979630374786,2.00347649132232e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SIGLEC9,Sialic acid-binding Ig-like lectin 9,40003,-0.0126084413264112,0.00295580004627771,-0.0184018094171155,-0.00681507323570693,2.00445665057749e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CX3CL1,Fractalkine,39749,0.0138213493546602,0.00324066059931585,0.00746965458000113,0.0201730441293192,2.01076561821579e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLEC7A,C-type lectin domain family 7 member A,40058,-0.0238471659235307,0.00559471432562235,-0.0348128060017505,-0.0128815258453109,2.03345444908949e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,39749,-0.0144027843164553,0.00338397157405934,-0.0210353686016116,-0.00777020003129895,2.09143978800985e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL3RA,Interleukin-3 receptor subunit alpha,39587,-0.012748791551809,0.00299535741342872,-0.0186196920821293,-0.00687789102148869,2.09150628186632e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CSF3,Granulocyte colony-stimulating factor,39587,-0.0199360488010736,0.00468477629028269,-0.0291182103300277,-0.0107538872721195,2.09793455364639e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AMOTL2,Angiomotin-like protein 2,37333,-0.0202008690884546,0.00474945804238259,-0.0295098068515245,-0.0108919313253847,2.12064667568119e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,37021,0.0108014891997994,0.00254196300522176,0.00581924170956475,0.0157837366900341,2.15943799570798e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DBH,Dopamine beta-hydroxylase,37430,0.0454270518823977,0.0107016104731271,0.0244518953550685,0.0664022084097269,2.20164723522597e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DEFB103A_DEFB103B,Beta-defensin 103,37000,-0.0167416688466658,0.00394624534389926,-0.0244763097207083,-0.00900702797262321,2.22627835426128e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,UXS1,UDP-glucuronic acid decarboxylase 1,39477,-0.0216704838992781,0.00511020908242018,-0.0316864937008217,-0.0116544740977346,2.24180080241983e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,39489,-0.0466543227468253,0.0110168347800995,-0.0682473189158202,-0.0250613265778303,2.30042095989076e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AMIGO2,Amphoterin-induced protein 2,39788,-0.00928600352387433,0.00219596799056235,-0.0135901007853765,-0.00498190626237214,2.36398529183204e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TPSAB1,Tryptase alpha/beta-1,40038,-0.0215860220691984,0.00510939096861325,-0.0316004283676804,-0.0115716157707164,2.4049022521963e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FXYD5,FXYD domain-containing ion transport regulator 5,39587,-0.0270013861585427,0.00639189586687815,-0.0395295020576239,-0.0144732702594615,2.41017219613619e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DBN1,Drebrin,37056,-0.0217251309806649,0.00514587718737264,-0.0318110502679153,-0.0116392116934146,2.43926250128832e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MMP3,Stromelysin-1,39858,0.0196240786393493,0.00465693485781023,0.0104964863180412,0.0287516709606573,2.52321634447174e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GP6,Platelet glycoprotein VI,39836,-0.0364829051925229,0.00866469983920764,-0.0534657168773698,-0.0195000935076759,2.56176380831303e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADGRE5,Adhesion G protein-coupled receptor E5,39962,-0.0122149572767832,0.00290418986357357,-0.0179071694093874,-0.00652274514417899,2.61361977557328e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,37043,-0.0251694765032166,0.00599853444381493,-0.0369266040130939,-0.0134123489933394,2.7352457495301e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SCGB2A2,Mammaglobin-A,37021,0.0129236925838858,0.00308074942515279,0.0068854237105863,0.0189619614571852,2.74680138976681e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MRI1,Methylthioribose-1-phosphate isomerase,37039,-0.0277658127048865,0.0066291597751509,-0.0407589658641822,-0.0147726595455907,2.8271072661126e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CYB5R2,NADH-cytochrome b5 reductase 2,37220,-0.0229179955554532,0.00547294059662298,-0.0336449591248343,-0.0121910319860722,2.8383961606496e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NAA10,N-alpha-acetyltransferase 10,37021,-0.0207721196317013,0.00496105076422276,-0.0304957791295779,-0.0110484601338247,2.84454539334603e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DCTD,Deoxycytidylate deaminase,37124,-0.0393703392514561,0.00940837231152176,-0.0578107489820387,-0.0209299295208734,2.87500232000411e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IGF1R,Insulin-like growth factor 1 receptor,39788,-0.00886543930133379,0.00212172265968354,-0.0130240157143135,-0.00470686288835405,2.95111979127272e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AKT2,RAC-beta serine/threonine-protein kinase,37411,-0.0520467386674179,0.012500615126732,-0.0765479443158127,-0.0275455330190232,3.15297170231271e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,39749,-0.0415798978968622,0.00999015069292407,-0.0611605932549934,-0.0219992025387311,3.17009847246144e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",39477,-0.0207961461842708,0.00500965602850326,-0.0306150720001371,-0.0109772203684044,3.32473118428744e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LXN,Latexin,39682,0.0271092817337042,0.00653269006581585,0.0143052092047051,0.0399133542627032,3.34522901169613e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NPTX2,Neuronal pentraxin-2,37437,0.0136638406970872,0.00330388762066122,0.00718822096059118,0.0201394604335831,3.56025844511021e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CRNN,Cornulin,39397,0.0261277235476835,0.00632274905374534,0.0137351354023427,0.0385203116930244,3.60976843572132e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EDA2R,Tumor necrosis factor receptor superfamily member 27,40030,-0.0143200327933294,0.00346974139180718,-0.0211207259212715,-0.00751933966538732,3.69178336699989e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IGFBP3,Insulin-like growth factor-binding protein 3,39931,-0.0111507060451174,0.00270841331245513,-0.0164591961375295,-0.00584221595270539,3.85649405810946e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PMS1,PMS1 protein homolog 1,37039,-0.0201187462078086,0.00489071081349197,-0.0297045394022529,-0.0105329530133644,3.91792022638036e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SLC39A14,Zinc transporter ZIP14,39489,-0.0131207831982364,0.00319033708958137,-0.0193738438938159,-0.00686772250265695,3.93121086290367e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PDIA3,Protein disulfide-isomerase A3,37124,-0.0102269853111692,0.00248892972378812,-0.0151052875697939,-0.00534868305254447,3.99782903990395e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,39749,-0.0241742307274556,0.005883922622568,-0.0357067190676889,-0.0126417423872223,4.00193872068738e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,POLR2A,DNA-directed RNA polymerase II subunit RPB1,37056,0.011970218601551,0.00292286024504812,0.00624141252125674,0.0176990246818454,4.23993584835139e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,37382,-0.00858978968452452,0.00209906395949998,-0.0127039550451445,-0.00447562432390456,4.29779646678954e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DTD1,D-aminoacyl-tRNA deacylase 1,37124,-0.035450592436242,0.00866842721141806,-0.0524407097706214,-0.0184604751018626,4.34626769058465e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KLK11,Kallikrein-11,39779,-0.011608305914152,0.00284140826221122,-0.017177466108086,-0.00603914572021799,4.42153181459983e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TXNDC15,Thioredoxin domain-containing protein 15,39913,-0.0107940246343313,0.00264960728492915,-0.0159872549127925,-0.00560079435587018,4.64703028637512e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ACOT13,Acyl-coenzyme A thioesterase 13,37382,-0.0456887617671889,0.0112182210612189,-0.0676764750471781,-0.0237010484871998,4.67305263439027e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PSAPL1,Proactivator polypeptide-like 1,37382,0.0198777042528228,0.00488377960435919,0.0103054962282788,0.0294499122773668,4.72504768438169e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PMVK,Phosphomevalonate kinase,39480,-0.0441826705873421,0.010856128177694,-0.0654606818156223,-0.022904659359062,4.7277501617662e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LPO,Lactoperoxidase,39344,-0.0237899965858012,0.00585039349541074,-0.0352567678368062,-0.0123232253347961,4.79826644039053e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GDF2,Growth/differentiation factor 2,39868,0.0140232739814295,0.00344915321826911,0.00726293367362205,0.020783614289237,4.81143829124205e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ITGA6,Integrin alpha-6,39866,-0.0210156594410111,0.00518496717296174,-0.0311781951000161,-0.010853123782006,5.07626266489298e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CEP170,Centrosomal protein of 170 kDa,37043,-0.0307579469940525,0.00758921794438887,-0.0456328141650547,-0.0158830798230503,5.08882316792988e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NRCAM,Neuronal cell adhesion molecule,39868,-0.010952952000098,0.00270580222787533,-0.0162563243667336,-0.00564957963346234,5.191116052127e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,39585,-0.0120598356353741,0.00298260667182337,-0.017905744712148,-0.00621392655860033,5.29354953734416e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RNF5,E3 ubiquitin-protein ligase RNF5,37043,-0.0291771678620595,0.0072329944069181,-0.043353836899619,-0.0150004988245,5.51681969524333e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NPR1,Atrial natriuretic peptide receptor 1,37021,0.0163656582853471,0.00407218978130211,0.00838416631399495,0.0243471502566992,5.88000039671832e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",37043,-0.0198455690168551,0.00494412479807314,-0.0295360536210785,-0.0101550844126318,6.00362316302053e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CILP,Cartilage intermediate layer protein 1,37437,-0.0211340128957458,0.00527069659168005,-0.0314645782154387,-0.0108034475760529,6.11162459519075e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PKLR,Pyruvate kinase PKLR,39881,-0.0250215273863766,0.00624486069428731,-0.0372614543471797,-0.0127816004255735,6.18410541409349e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TEK,Angiopoietin-1 receptor,39913,-0.00846691475652207,0.00211490084925554,-0.0126121204210629,-0.00432170909198122,6.27042336121175e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FN1,Fibronectin,37453,-0.0104654281595393,0.0026142238396982,-0.0155893068853477,-0.0053415494337308,6.28063288263948e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PPM1F,Protein phosphatase 1F,37437,-0.0209068372695632,0.00522616395925167,-0.0311501186296965,-0.0106635559094299,6.35661675237498e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DAPK2,Death-associated protein kinase 2,37056,-0.0208376558648216,0.00522792909438361,-0.0310843968898134,-0.0105909148398297,6.76054653041777e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",39984,-0.0274321357348975,0.00690367175917774,-0.0409633323828859,-0.0139009390869092,7.11152095414061e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BRSK2,Serine/threonine-protein kinase BRSK2,37411,-0.0150549957201895,0.00379178989322997,-0.0224869039109202,-0.00762308752945874,7.21167357032915e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SERPINA3,Alpha-1-antichymotrypsin,37407,0.00562809872244244,0.00142017257591179,0.00284456047365533,0.00841163697122955,7.44032895840535e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LAG3,Lymphocyte activation gene 3 protein,39788,0.0157214703666691,0.00397098620258288,0.0079383374096067,0.0235046033237316,7.55644578579166e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ATP6V1G2,V-type proton ATPase subunit G 2,37021,-0.0382817107507434,0.00967394707756924,-0.0572426470227791,-0.0193207744787077,7.62326534159984e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL13RA2,Interleukin-13 receptor subunit alpha-2,36991,0.0112025786173177,0.0028335998690616,0.00564872287395697,0.0167564343606784,7.74267802027066e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GP1BA,Platelet glycoprotein Ib alpha chain,39817,-0.0125994612192269,0.00318739585132106,-0.0188467570878162,-0.00635216535063766,7.75421455636076e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MANF,Mesencephalic astrocyte-derived neurotrophic factor,39931,-0.0464541251599077,0.0117863562212294,-0.0695553833535173,-0.023352866966298,8.13681583447106e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SCG3,Secretogranin-3,39885,0.0124814008303147,0.00316690130142456,0.0062742742795226,0.0186885273811069,8.14181326310338e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TBC1D17,TBC1 domain family member 17,39489,-0.0169253794742301,0.0042971282102772,-0.0253477507663734,-0.00850300818208682,8.22576505047352e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCL26,C-C motif chemokine 26,39866,-0.0328940657641291,0.00836212416290271,-0.0492838291234184,-0.0165043024048398,8.40020393865483e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,REG3G,Regenerating islet-derived protein 3-gamma,37368,-0.0150942585507139,0.00383834097377304,-0.0226174068593091,-0.00757111024211875,8.44884999856986e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ASRGL1,Isoaspartyl peptidase/L-asparaginase,37043,-0.0395931412039868,0.0100721618309551,-0.0593345783926587,-0.0198517040153149,8.50441315544887e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD33,Myeloid cell surface antigen CD33,39913,-0.0300523109991481,0.0076623741289012,-0.0450705642917945,-0.0150340577065018,8.81594056191152e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TXNL1,Thioredoxin-like protein 1,36971,-0.0377051312998847,0.00962181731958626,-0.0565638932462737,-0.0188463693534956,8.94755277058852e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FXN,"Frataxin, mitochondrial",40030,-0.0280811849089636,0.00717052133627149,-0.0421354067280557,-0.0140269630898715,9.03256071212326e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLEC10A,C-type lectin domain family 10 member A,39749,0.0137695117462249,0.00351894223131259,0.00687238497285219,0.0206666385195975,9.15480928702224e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TINAGL1,Tubulointerstitial nephritis antigen-like,39844,-0.00850580608360595,0.00217485551571901,-0.0127685228944152,-0.0042430892727967,9.23041693162023e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MEGF10,Multiple epidermal growth factor-like domains protein 10,39862,0.0153130807228017,0.00391832041261864,0.00763317271406913,0.0229929887315342,9.34184019738171e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,39984,-0.0129523359056127,0.00331916928741693,-0.0194579077089498,-0.00644676410227548,9.56770788102846e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HDGF,Hepatoma-derived growth factor,40014,-0.0356737637293361,0.00916802189487334,-0.0536430866432879,-0.0177044408153844,0.00010018783056127
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL10RA,Interleukin-10 receptor subunit alpha,39587,-0.0221845820228107,0.00570744135367142,-0.0333711670760067,-0.0109979969696147,0.000101925154324336
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,INPP1,Inositol polyphosphate 1-phosphatase,39788,-0.0204516244331077,0.00527504367539011,-0.0307907100368723,-0.010112538829343,0.000106153657600433
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",37411,-0.0347851104540715,0.00897547257116758,-0.05237703669356,-0.0171931842145831,0.000106874777756847
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SETMAR,Histone-lysine N-methyltransferase SETMAR,39699,-0.0112640582779407,0.00290798524346781,-0.0169637093551376,-0.00556440720074379,0.00010771836528002
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PDIA5,Protein disulfide-isomerase A5,36962,-0.0233219898981985,0.00603099055804817,-0.0351427313919729,-0.0115012484044241,0.000110703737641351
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TGOLN2,Trans-Golgi network integral membrane protein 2,37445,-0.00941372459039315,0.0024356947321797,-0.0141876862654654,-0.00463976291532093,0.000111650169199894
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,39477,-0.0177921051554728,0.00460592660849769,-0.0268197213081283,-0.00876448900281734,0.000112514156253879
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FRMD4B,FERM domain-containing protein 4B,37021,-0.0266454833050226,0.00690244675656843,-0.0401742789478967,-0.0131166876621485,0.000113791389617322
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CREBZF,CREB/ATF bZIP transcription factor,36962,0.00995228702705134,0.00257816267829143,0.00489908817760013,0.0150054858765026,0.000113826753984485
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DNAJA4,DnaJ homolog subfamily A member 4,37388,-0.0263506521338208,0.0068387874307986,-0.039754675498186,-0.0129466287694555,0.000117161870439071
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CA7,Carbonic anhydrase 7,37169,0.0127606067694959,0.00331337479471714,0.00626639217185033,0.0192548213671415,0.000118071095517969
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD101,Immunoglobulin superfamily member 2,37382,-0.0159386626009669,0.00413861891911708,-0.0240503556824364,-0.00782696951949742,0.000118080873232651
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AKT3,RAC-gamma serine/threonine-protein kinase,39391,-0.0219875347332451,0.00571034771343443,-0.0331798162515766,-0.0107952532149136,0.000118363186308508
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PLA2G4A,Cytosolic phospholipase A2,39931,-0.0331456845820809,0.00861813333451066,-0.0500372259177218,-0.0162541432464401,0.000120505482310856
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRDX6,Peroxiredoxin-6,40030,0.02220938352613,0.00577486391494521,0.0108906502528373,0.0335281167994226,0.000120585449641841
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,39866,-0.0560719245939056,0.0145881917594752,-0.0846647804424771,-0.0274790687453342,0.000121685718486856
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,39914,0.0112959874738997,0.0029406005205245,0.00553241045367173,0.0170595644941278,0.00012281103823202
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ARHGAP5,Rho GTPase-activating protein 5,36962,-0.0278972264267105,0.00726772128314419,-0.0421419601416732,-0.0136524927117479,0.000124364577436737
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BTC,Probetacellulin,39477,-0.0277228185585912,0.00723888674885604,-0.0419110365863491,-0.0135346005308334,0.000128797084444684
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FGF5,Fibroblast growth factor 5,39587,0.0123559577863078,0.00323510997877563,0.0060151422279076,0.0186967733447081,0.000134327786254765
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RAD23B,UV excision repair protein RAD23 homolog B,39477,-0.0175395518994562,0.0046110675737303,-0.0265772443439676,-0.00850185945494485,0.000143039416460978
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DPP6,Dipeptidyl aminopeptidase-like protein 6,39788,0.0122983652239575,0.00323430024361601,0.00595913674647011,0.0186375937014449,0.000143788592439867
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TSPYL1,Testis-specific Y-encoded-like protein 1,37056,-0.0151698022195572,0.00399285304591134,-0.0229957941895434,-0.00734381024957098,0.000145792719886872
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CASP9,Caspase-9,37056,-0.0235962884393598,0.00621849668931788,-0.0357845419504228,-0.0114080349282967,0.000148582758565114
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EPHA4,Ephrin type-A receptor 4,37124,-0.0104895212292332,0.00276557689728539,-0.0159100519479126,-0.00506899051055385,0.000149566618352095
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PREB,Prolactin regulatory element-binding protein,39587,-0.0105994766014384,0.0027956585993318,-0.0160789674561287,-0.00511998574674806,0.000150356585815592
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VCAN,Versican core protein,40009,0.0109413151218254,0.00288752154002569,0.00528177290337505,0.0166008573402757,0.000151699135627289
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SCARA5,Scavenger receptor class A member 5,40009,-0.0107679233789631,0.00285085410690707,-0.016355597428501,-0.00518024932942526,0.000159242634058341
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,37169,-0.02664483851491,0.00706181675253233,-0.0404859993498734,-0.0128036776799466,0.000161940186962636
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,39866,-0.0370853734568238,0.00984406054669196,-0.0563797321283401,-0.0177910147853076,0.000165624582538023
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NECTIN4,Nectin-4,39913,-0.0107967968738525,0.00287115890907591,-0.0164242683356413,-0.00516932541206376,0.000170222395431218
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SNX5,Sorting nexin-5,37043,-0.0112599308643331,0.00299603063875932,-0.0171321509163014,-0.00538771081236488,0.000171821322849966
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PNMA1,Paraneoplastic antigen Ma1,37043,-0.0210779470856586,0.00560853364472508,-0.0320706730293197,-0.0100852211419974,0.000171883608086384
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ELAVL4,ELAV-like protein 4,36991,-0.0312317184684953,0.00831520346211058,-0.047529517254232,-0.0149339196827585,0.000173412117477655
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CA12,Carbonic anhydrase 12,39788,-0.0116689678225128,0.00311418666012234,-0.0177727736763526,-0.00556516196867306,0.000179568303184201
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MSLN,Mesothelin,39766,-0.0191670047295358,0.0051326265403487,-0.0292269527486193,-0.00910705671045234,0.000188860099290615
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DAND5,DAN domain family member 5,37056,0.0196610969980472,0.00527032141527393,0.00933126702411031,0.0299909269719841,0.000191877427232215
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CUZD1,CUB and zona pellucida-like domain-containing protein 1,37039,-0.0133580608715455,0.00358457820175488,-0.0203838341469851,-0.00633228759610595,0.000194940409078224
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EGFLAM,Pikachurin,37382,-0.0111926052308859,0.00300992018747641,-0.0170920487983396,-0.00529316166343209,0.000201161607629348
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,37021,0.0210150898191066,0.00565239292389808,0.00993639968826634,0.0320937799499468,0.000201710930034565
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SERPINB9,Serpin B9,39749,-0.0121261574601155,0.00326670319094204,-0.0185288957143619,-0.0057234192058691,0.00020629150012373
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,F13B,Coagulation factor XIII B chain,37380,-0.00929334436588974,0.00250390518806835,-0.0142009985345037,-0.00438569019727578,0.000206828615417159
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,37021,0.0111939814663224,0.00301658027311189,0.00528148413102306,0.0171064788016217,0.000207441226214723
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SCN4B,Sodium channel subunit beta-4,37043,-0.0151138143168673,0.00407589153076549,-0.0231025617171677,-0.00712506691656697,0.000209676313883723
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HEPACAM2,HEPACAM family member 2,37388,0.0152386924831615,0.00411136492074257,0.00718041723850612,0.023296967727817,0.000210998109957594
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DCTPP1,dCTP pyrophosphatase 1,39868,-0.0114776827032763,0.00309874352818408,-0.0175512200185171,-0.00540414538803549,0.000212956952507355
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,39477,-0.0209143344212289,0.00564668724543524,-0.031981841422282,-0.00984682742017586,0.000213105634626614
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AOC3,Membrane primary amine oxidase,39931,0.0108641709317203,0.00294041701808091,0.00510095357628175,0.0166273882871589,0.000220814230787503
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LRRC25,Leucine-rich repeat-containing protein 25,39788,-0.0140089775474898,0.00379344243882197,-0.0214441247275808,-0.00657383036739872,0.000222411910914959
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PSPN,Persephin,39866,-0.0339590612664545,0.00920916985118765,-0.0520090341747823,-0.0159090883581267,0.000227192984910262
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DARS1,"Aspartate--tRNA ligase, cytoplasmic",39713,-0.0264422434362664,0.00717074793262589,-0.0404969093842131,-0.0123875774883196,0.000227210447429734
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MSTN,Growth/differentiation factor 8,39585,-0.0186333588402938,0.00505537665780959,-0.0285418970896006,-0.00872482059098705,0.00022870671632006
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ITGB1BP1,Integrin beta-1-binding protein 1,39477,-0.0145962855646266,0.00396854660689562,-0.022374636914142,-0.00681793421511123,0.000235865673725602
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PAEP,Glycodelin,39749,-0.0518968896812072,0.0141480087210829,-0.0796269867745297,-0.0241667925878848,0.000245118432063362
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ATXN10,Ataxin-10,39489,-0.0262094719157212,0.00714890492519663,-0.0402213255691066,-0.0121976182623358,0.000246976031313712
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HPCAL1,Hippocalcin-like protein 1,40058,-0.0265659468295488,0.00725041314270929,-0.040776756589259,-0.0123551370698386,0.000249040791783665
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLEC14A,C-type lectin domain family 14 member A,39858,-0.0108078029597527,0.00295212555338793,-0.016593969044393,-0.00502163687511231,0.000252017962312455
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNFSF12,Tumor necrosis factor ligand superfamily member 12,40058,0.0103139485821859,0.00281922417058082,0.00478826920784749,0.0158396279565243,0.000254564873288231
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD84,SLAM family member 5,39866,-0.0111302254629779,0.00304461184919166,-0.0170976646873935,-0.00516278623856224,0.000257289629339242
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NAPRT,Nicotinate phosphoribosyltransferase,37388,-0.0117234736768139,0.00320811207064077,-0.0180113733352698,-0.00543557401835799,0.000258838124562742
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL1B,Interleukin-1 beta,39478,-0.0198919799446229,0.00545415076081693,-0.0305821154358241,-0.00920184445342171,0.000266051283132415
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SEPTIN9,Septin-9,39788,-0.0100954749579581,0.00276880219905613,-0.0155223272681082,-0.00466862264780813,0.000267043944456478
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EPHX2,Bifunctional epoxide hydrolase 2,39585,-0.0217909665470554,0.00598258379721109,-0.0335168307895891,-0.0100651023045216,0.000270975421882103
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCS,Copper chaperone for superoxide dismutase,39749,-0.0167998358796708,0.00461330739989382,-0.0258419183834627,-0.0077577533758789,0.000271806339760603
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FADD,FAS-associated death domain protein,39868,-0.0273621684840438,0.00751678891241336,-0.042095074752374,-0.0126292622157136,0.000273347450994505
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,39881,-0.0173407956389865,0.00476545642133085,-0.026681090224795,-0.00800050105317801,0.000274715701384546
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RILPL2,RILP-like protein 2,37437,-0.035212261736722,0.00969037956663187,-0.0542054056873205,-0.0162191177861235,0.000280379601784497
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ANXA1,Annexin A1,37072,-0.0156062975270059,0.00429576623590127,-0.0240259993493724,-0.00718659570463942,0.000281262577259959
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PROK1,Prokineticin-1,39866,-0.0229384622684848,0.0063286318678495,-0.0353425807294698,-0.0105343438074998,0.000290358798033122
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MATN2,Matrilin-2,39885,-0.0105382331400248,0.00290768526967569,-0.0162372962685892,-0.00483917001146045,0.000290676966846453
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,39866,-0.0295515033911495,0.00816194741677384,-0.0455489203280263,-0.0135540864542728,0.00029477823712592
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AKR1B1,Aldo-keto reductase family 1 member B1,39477,-0.0272159877799358,0.00751982624812843,-0.0419548472262675,-0.0124771283336041,0.000296413452632897
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TPMT,Thiopurine S-methyltransferase,39477,-0.0257516293196216,0.00711638985123764,-0.0396997534280473,-0.0118035052111958,0.000297094237298267
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,39453,-0.0167714963932494,0.00464560381918774,-0.0258768798788574,-0.00766611290764142,0.000306936077753029
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,37437,-0.0259585519211312,0.00719889534382654,-0.0400683867950312,-0.0118487170472312,0.000312178887273412
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CELA2A,Chymotrypsin-like elastase family member 2A,37437,-0.0209217671679642,0.00581760992989358,-0.0323242826305556,-0.00951925170537281,0.000323943270703699
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MARCO,Macrophage receptor MARCO,39868,-0.00919392141268461,0.00256320395911335,-0.0142178011725468,-0.00417004165282243,0.000335647413413305
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PSMG4,Proteasome assembly chaperone 4,37056,-0.0195036278604599,0.00544177907664358,-0.0301695148506813,-0.0088377408702385,0.000339522384906462
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GP1BB,Platelet glycoprotein Ib beta chain,37021,-0.0238020187351394,0.00664694225072488,-0.0368300255465602,-0.0107740119237187,0.000343649809519478
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GAD1,Glutamate decarboxylase 1,36962,0.00910290401735001,0.00254671227920771,0.0041113479501029,0.0140944600845971,0.000352327870277143
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TMPRSS11D,Transmembrane protease serine 11D,37357,-0.0126686530995742,0.00354943968275188,-0.0196255548777679,-0.0057117513213805,0.00035931845167907
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BPIFB2,BPI fold-containing family B member 2,37405,-0.0215114300544684,0.00603025152457579,-0.033330723042637,-0.00969213706629987,0.00036198881298136
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,STK4,Serine/threonine-protein kinase 4,39868,-0.030386137647683,0.00852838165239241,-0.0471017656863721,-0.0136705096089939,0.000367786244198898
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,37021,0.01280883968968,0.00359774811397908,0.00575725338628104,0.0198604259930791,0.000371825232196717
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RBP7,Retinoid-binding protein 7,37382,-0.021070597628268,0.00592037825154516,-0.0326745390012965,-0.00946665625523948,0.000373552276574275
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CST1,Cystatin-SN,35640,-0.0352172690923571,0.00992371021923705,-0.0546677411220618,-0.0157667970626525,0.000388496424457792
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ANGPTL4,Angiopoietin-related protein 4,39908,0.0156753161816027,0.00441840540626506,0.00701524158532319,0.0243353907778822,0.000389672758084971
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TXN,Thioredoxin,37289,-0.0150343282090423,0.00424555533047427,-0.0233556166567718,-0.00671303976131268,0.000399672121041287
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SRC,Proto-oncogene tyrosine-protein kinase Src,39887,-0.0414445755514325,0.011718002411054,-0.0644118602770983,-0.0184772908257667,0.000406104900304626
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NPPB,Natriuretic peptides B,39585,-0.0435126883823385,0.0123419169775321,-0.0677028456583014,-0.0193225311063756,0.000423723203237631
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PAMR1,Inactive serine protease PAMR1,39858,-0.0095380272959477,0.00270762279592925,-0.014844967975969,-0.00423108661592638,0.000428434245867747
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CRIM1,Cysteine-rich motor neuron 1 protein,39931,0.00692740472917351,0.00196883519828363,0.0030684877405376,0.0107863217178094,0.00043514436063392
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SERPINA11,Serpin A11,40052,-0.0140552501172925,0.00399740775789655,-0.0218901693227698,-0.00622033091181529,0.000439148276544253
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TAFA5,Chemokine-like protein TAFA-5,39788,-0.011695170099788,0.00332713902268102,-0.0182163625842428,-0.0051739776153332,0.000440837325804887
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MFAP4,Microfibril-associated glycoprotein 4,37124,-0.0109930607418929,0.00312897762792705,-0.0171258568926299,-0.00486026459115588,0.000444038298274791
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KIAA0319,Dyslexia-associated protein KIAA0319,37388,0.0104468922599599,0.00297358947982362,0.00461865687950564,0.0162751276404142,0.000444145489872969
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BAG3,BAG family molecular chaperone regulator 3,39720,-0.013558517840337,0.00386350138636899,-0.0211309805576203,-0.00598605512305381,0.000450387622900835
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DIPK2B,Divergent protein kinase domain 2B,37124,0.00977437117856062,0.0027866542620286,0.00431252882498457,0.0152362135321367,0.000453724144857383
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PSMC3,26S proteasome regulatory subunit 6A,36962,0.0103193544340231,0.00294358640167546,0.00454992508673918,0.016088783781307,0.000456917037242155
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRSS53,Serine protease 53,37388,0.0127819675410737,0.00366090745474128,0.00560658892978081,0.0199573461523666,0.00048189301796331
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CASP8,Caspase-8,39984,-0.0210340948857974,0.00602488859997337,-0.0328428765417452,-0.00922531322984961,0.000482141039375798
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EVPL,Envoplakin,37169,0.0112985680639444,0.00323903166919214,0.00495006599232781,0.017647070135561,0.000487754986098945
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GIPC3,PDZ domain-containing protein GIPC3,37382,-0.0339281552149792,0.00972852470514738,-0.052996063637068,-0.0148602467928903,0.000489121936728558
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FLT3,Receptor-type tyrosine-protein kinase FLT3,39477,0.0103408126648863,0.00297905290301165,0.00450186897498345,0.0161797563547891,0.000519587534868496
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GLP1R,Glucagon-like peptide 1 receptor,36991,0.0129193593565939,0.00372995534613153,0.00560864687817607,0.0202300718350117,0.00053454584921111
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SAFB2,Scaffold attachment factor B2,37411,-0.00931885494523093,0.00269468827829701,-0.0146004439706931,-0.00403726591976879,0.000545405062781935
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LRRC37A2,Leucine-rich repeat-containing protein 37A2,37382,-0.0143755948739686,0.00415764677175168,-0.0225245825466019,-0.00622660720133533,0.000546630448547436
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,39858,-0.0121624458196963,0.00352779032275419,-0.0190769148522945,-0.00524797678709812,0.000567024420254202
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNC,Tenascin,39931,0.0158809962902726,0.00460641661902987,0.00685241971697408,0.0249095728635712,0.000567078156024498
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RGMB,RGM domain family member B,40009,-0.00851883520889082,0.00248960996540171,-0.0133984707410782,-0.00363919967670347,0.000623725195075987
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FAP,Prolyl endopeptidase FAP,40052,0.00911603809796452,0.00266635655600971,0.00388997924818549,0.0143420969477436,0.000630269664916192
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,THAP12,52 kDa repressor of the inhibitor of the protein kinase,36931,-0.029482023049619,0.00862495945507224,-0.0463869435815606,-0.0125771025176774,0.000632239969485414
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TYMP,Thymidine phosphorylase,39764,-0.0225793375323696,0.00662295579197668,-0.0355603308846439,-0.00959834418009534,0.000653025022624679
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NFIC,Nuclear factor 1 C-type,37411,-0.0140562659379148,0.00412531975957615,-0.0221418926666841,-0.00597063920914557,0.000657959612218044
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TK1,"Thymidine kinase, cytosolic",37169,-0.0154275469634108,0.00453413640692154,-0.0243144543209771,-0.00654063960584463,0.000669609748213384
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LYZL2,Lysozyme-like protein 2,36962,-0.0120463753701286,0.00354041900885277,-0.01898559662748,-0.00510715411277716,0.000669651724922278
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ARHGAP1,Rho GTPase-activating protein 1,39477,-0.0156047033166777,0.00458823662544221,-0.0245976471025444,-0.00661175953081093,0.000673020706993428
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SNU13,NHP2-like protein 1,37021,-0.0206229971360691,0.00607285447432329,-0.0325257919057428,-0.00872020236639547,0.000685976918783243
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FOSB,Protein fosB,39489,-0.0129613884999475,0.00381732564028741,-0.0204433467549108,-0.00547943024498417,0.000686961768272419
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PECR,Peroxisomal trans-2-enoyl-CoA reductase,37043,-0.00933009614020323,0.00275232845040217,-0.0147246599029915,-0.00393553237741497,0.000701251598874205
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLEC1A,C-type lectin domain family 1 member A,39585,-0.0105807546572084,0.0031226586167023,-0.0167011655459449,-0.00446034376847185,0.000704792240902416
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NGF,Beta-nerve growth factor,39749,0.00406783187160669,0.00120097321239146,0.00171392437531943,0.00642173936789395,0.000708035751654222
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,REXO2,"Oligoribonuclease, mitochondrial",37021,0.0158581785176159,0.00468620760712495,0.00667321160765096,0.0250431454275808,0.000716435505483878
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VASP,Vasodilator-stimulated phosphoprotein,37445,-0.024215853359916,0.00717058523346439,-0.0382702004175062,-0.0101615063023258,0.000734573061855135
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SCRN1,Secernin-1,39866,-0.0185557854806147,0.00549840888763659,-0.0293326669003824,-0.007778904060847,0.000740567372475595
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TLR3,Toll-like receptor 3,40058,-0.0200939892186781,0.00595716360344789,-0.0317700298814359,-0.00841794855592022,0.000745064479329292
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PODXL,Podocalyxin,39788,0.00495413330041449,0.00147000654761366,0.00207292046709172,0.00783534613373726,0.000753073544880533
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PNLIPRP2,Pancreatic lipase-related protein 2,39862,-0.0968008290110109,0.0287245153478645,-0.153100879092825,-0.0405007789291964,0.000753532755798835
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DDI2,Protein DDI1 homolog 2,37124,-0.0248394668321096,0.00738317490511025,-0.0393104896461257,-0.0103684440180935,0.000769459848175981
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",39585,-0.0290309063109401,0.00864456680085458,-0.0459742572406151,-0.0120875553812652,0.000786142669572708
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FGFR4,Fibroblast growth factor receptor 4,37124,-0.0173861509648393,0.00518356867930752,-0.027545945576282,-0.00722635635339658,0.000798497783886566
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TPK1,Thiamin pyrophosphokinase 1,37437,-0.00906814479658766,0.00270721496232328,-0.0143742861227413,-0.00376200347043404,0.000811424782840816
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LTBP3,Latent-transforming growth factor beta-binding protein 3,39477,-0.017952121279996,0.00537846495455781,-0.0284939125909293,-0.00741032996906272,0.000846485256372066
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,37039,-0.0172584364087832,0.00517650492004536,-0.0274043860520721,-0.00711248676549433,0.000858445282343858
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GC,Vitamin D-binding protein,37453,-0.00845720572178715,0.0025378838861272,-0.0134314581385965,-0.00348295330497783,0.000863348547007914
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",37043,-0.00846216528289899,0.00255627589491994,-0.0134724660369421,-0.0034518645288559,0.000934298559366101
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PROS1,Vitamin K-dependent protein S,37453,-0.00794669177470363,0.00240487469113396,-0.0126602461693262,-0.00323313738008108,0.000954226977591017
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GBP2,Guanylate-binding protein 2,39587,-0.0190905624585264,0.00579279053519181,-0.0304444319075024,-0.0077366930095505,0.000984386359885364
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DIABLO,"Diablo homolog, mitochondrial",39818,-0.035330736585888,0.0107344592393615,-0.0563702766950367,-0.0142911964767394,0.000999283570705076
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,37056,-0.010096458506969,0.00307580043264237,-0.016125027354948,-0.00406788965898996,0.00103141351853016
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",37437,-0.0198537011116537,0.00605323742967515,-0.031718046473817,-0.00798935574949044,0.0010412447289077
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RPS10,40S ribosomal protein S10,37021,0.0137945390501911,0.0042111296034001,0.00554072502752695,0.0220483530728553,0.00105660451531934
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RABEPK,Rab9 effector protein with kelch motifs,39477,-0.0192288481371524,0.00587807523210919,-0.0307498755920864,-0.00770782068221835,0.00107292824145052
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HSBP1,Heat shock factor-binding protein 1,37043,-0.0310751060497612,0.00950191552531279,-0.0496988604793743,-0.0124513516201482,0.00107669466247245
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IDI2,Isopentenyl-diphosphate delta-isomerase 2,39489,-0.0149749514260876,0.00457997959015493,-0.0239517114227913,-0.00599819142938395,0.00107911745885044
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL20RB,Interleukin-20 receptor subunit beta,37056,0.0138657799432856,0.00424099881267756,0.00555342227043762,0.0221781376161337,0.00108028587681421
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GGH,Gamma-glutamyl hydrolase,39573,-0.0108443077334868,0.00331985942111151,-0.0173512321988653,-0.0043373832681082,0.00109120714942856
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CEP350,Centrosome-associated protein 350,36962,0.0116024159303805,0.00355494403664828,0.00463472561854986,0.0185701062422111,0.00110233496992111
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TFPI2,Tissue factor pathway inhibitor 2,39864,-0.0127608591120469,0.00391281414517125,-0.0204299748365826,-0.00509174338751126,0.00111134821824006
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,37411,-0.0102088836470799,0.00313416253826112,-0.0163518422220717,-0.00406592507208813,0.00112757209691219
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLEC12A,C-type lectin domain family 12 member A,37056,-0.0064333424999589,0.00197753118429689,-0.0103093036211808,-0.00255738137873698,0.00114392332125763
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GSR,"Glutathione reductase, mitochondrial",37403,-0.00720111913616341,0.00221362829554747,-0.0115398305954365,-0.00286240767689037,0.00114439325658186
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EPCAM,Epithelial cell adhesion molecule,39867,-0.0302248905890327,0.00929230367359008,-0.0484378057892693,-0.0120119753887962,0.00114558949831637
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TUBB3,Tubulin beta-3 chain,36991,0.00900543363924315,0.00277028099737076,0.00357568288439645,0.0144351843940899,0.00115399443777557
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VEGFB,Vascular endothelial growth factor B,37056,-0.00903887920923448,0.00278402664310003,-0.0144955714297105,-0.00358218698875842,0.0011704574496898
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ART3,Ecto-ADP-ribosyltransferase 3,39931,0.0104892165566676,0.003231063731515,0.00415633164289821,0.016822101470437,0.00117127742945693
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FAM172A,Cotranscriptional regulator FAM172A,37043,-0.0197226313577951,0.0060851237557981,-0.0316494739191594,-0.00779578879643085,0.00119355586149568
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLU,Clusterin,37453,0.0101176277267367,0.00312712980860116,0.00398845330187845,0.016246802151595,0.00121747721698305
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,REST,RE1-silencing transcription factor,36962,0.0112867895514821,0.00350512475473328,0.00441674503220489,0.0181568340707593,0.00128466382101493
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SNX18,Sorting nexin-18,37382,-0.0142642987761997,0.00444167525592446,-0.0229699822778116,-0.00555861527458775,0.00132367536952653
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NAGA,Alpha-N-acetylgalactosaminidase,37037,-0.0190089050900755,0.00592237127079787,-0.0306167527808394,-0.0074010573993117,0.00133202081931757
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,37169,-0.0204051818119448,0.0063586156192716,-0.0328680684257172,-0.00794229519817252,0.00133485155793215
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CNTN2,Contactin-2,40030,0.0138431957420868,0.00432865897694884,0.00535902414726703,0.0223273673369065,0.00138634793605585
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",37411,-0.0220805820726754,0.0069143496635412,-0.0356327074132161,-0.00852845673213466,0.00140908500929032
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GSTT2B,Glutathione S-transferase theta-2B,37388,-0.0748725586523623,0.0234646236257622,-0.120863220958856,-0.0288818963458683,0.00142169105620533
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CEBPA,CCAAT/enhancer-binding protein alpha,37056,-0.01182989779812,0.00371294962908286,-0.0191072790711224,-0.00455251652511755,0.00144531204726991
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRAME,Melanoma antigen preferentially expressed in tumors,36962,0.00801069080674202,0.00251696234270387,0.00307744461504245,0.0129439369984416,0.00146258577093956
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SNX2,Sorting nexin-2,37368,-0.0251668912693362,0.00791122170455778,-0.0406728858102695,-0.00966089672840297,0.00147016436824868
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MYH4,Myosin-4,37021,0.0148887495433729,0.00468769814637763,0.00570086117647276,0.0240766379102731,0.00149597275511933
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,39866,-0.0375070542351377,0.0118116182128567,-0.0606578259323368,-0.0143562825379386,0.00149894411133523
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RANBP2,E3 SUMO-protein ligase RanBP2,36991,0.01054982695044,0.00332347645697924,0.00403581309476072,0.0170638408061193,0.0015052697981407
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FNDC1,Fibronectin type III domain-containing protein 1,37388,-0.0143282730156616,0.0045204850577389,-0.0231884237288298,-0.00546812230249336,0.00152972312821375
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SAT2,Thialysine N-epsilon-acetyltransferase,37169,-0.0221950019160369,0.00700449293529306,-0.0359238080692113,-0.00846619576286247,0.00153478923915782
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VWC2L,von Willebrand factor C domain-containing protein 2-like,37411,0.0148195367275817,0.00468086775883034,0.00564503592027419,0.0239940375348891,0.00154903409250383
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PCSK7,Proprotein convertase subtilisin/kexin type 7,37368,-0.013782407292134,0.0043543304425107,-0.022316894959455,-0.00524791962481307,0.00155310546352048
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CRH,Corticoliberin,39455,-0.0268963393714285,0.00850659650066951,-0.0435692685127408,-0.0102234102301163,0.00157085923377079
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DDX1,ATP-dependent RNA helicase DDX1,37382,-0.0155275922570878,0.00491689873731561,-0.0251647137822263,-0.00589047073194917,0.00159202004694989
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,37043,0.011190629621837,0.0035505229997117,0.00423160454240206,0.0181496547012719,0.00162616461976217
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LUZP2,Leucine zipper protein 2,37368,-0.0135011163382571,0.00428909549292189,-0.021907743504384,-0.00509448917213023,0.00164874990383063
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FMR1,Synaptic functional regulator FMR1,39477,-0.0109539775523044,0.00348162221025776,-0.0177779570844096,-0.00412999802019916,0.00165701569937103
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCND2,G1/S-specific cyclin-D2,37169,0.0113728631205046,0.003620453662985,0.00427677394105403,0.0184689522999552,0.00168578991762134
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RCC1,Regulator of chromosome condensation,37368,-0.0156084032071665,0.00496955204323834,-0.0253487252119136,-0.00586808120241934,0.00168846613172144
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NELL2,Protein kinase C-binding protein NELL2,39931,0.00861965261237218,0.00275117562251632,0.0032273483922402,0.0140119568325042,0.00173293284127959
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CRISP3,Cysteine-rich secretory protein 3,37325,0.00825307215876688,0.00264033157017913,0.00307802228121579,0.013428122036318,0.00177716655192344
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MOG,Myelin-oligodendrocyte glycoprotein,40030,0.00968986873886004,0.00310542689330933,0.00360323202797375,0.0157765054497463,0.00180983763509839
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDH22,Cadherin-22,37169,0.00889910335870216,0.00285236812155568,0.00330846184045303,0.0144897448769513,0.001812990009446
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SPINK5,Serine protease inhibitor Kazal-type 5,39858,0.0100899431103101,0.00324986849255302,0.00372020086490613,0.016459685355714,0.00190789485419544
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CORO1A,Coronin-1A,39520,-0.027026868333516,0.00873289271838011,-0.044143338061541,-0.00991039860549095,0.00197269073405834
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,39869,-0.0174165131589151,0.00562835366266407,-0.0284480863377367,-0.00638493998009352,0.00197535263541765
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PCSK9,Proprotein convertase subtilisin/kexin type 9,40052,-0.0118508745339318,0.00383205345909347,-0.019361699313755,-0.00434004975410864,0.00198772147212478
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",37124,-0.0272173519920423,0.00880184306019905,-0.0444689643900324,-0.00996573959405213,0.00199068888890765
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KLHL41,Kelch-like protein 41,37411,-0.0155042794224958,0.00502609374907477,-0.0253554231706824,-0.00565313567430926,0.00204128416561911
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BEX3,Protein BEX3,36962,0.014171126052213,0.00459664789521716,0.00516169617758739,0.0231805559268387,0.00205401865950003
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ODAM,Odontogenic ameloblast-associated protein,39456,-0.0153384056833924,0.00500363040659658,-0.0251455212803217,-0.00553129008646314,0.00217710295708122
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EIF5,Eukaryotic translation initiation factor 5,37021,-0.0132547206947149,0.00432535904922483,-0.0217324244311956,-0.00477701695823424,0.00218533063731128
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ANPEP,Aminopeptidase N,39891,0.00836875488454022,0.0027336571780576,0.00301078681554732,0.0137267229535331,0.00220686155209834
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRDX2,Peroxiredoxin-2,37249,-0.0182867898503937,0.00597883587154816,-0.0300053081586281,-0.00656827154215926,0.00222822644329784
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,APPL2,DCC-interacting protein 13-beta,37124,-0.0339386010417686,0.0111108601759663,-0.0557158869866626,-0.0121613150968746,0.00225850800216761
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MYL3,Myosin light chain 3,37043,-0.0217735364381276,0.00716291105844658,-0.0358128421126829,-0.00773423076357228,0.00237230359387109
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KIAA1549L,UPF0606 protein KIAA1549L,37169,0.00827013711773407,0.00272087848985661,0.00293721527761511,0.013603058957853,0.00237423526686931
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GSTP1,Glutathione S-transferase P,39393,0.0206039616811339,0.00678020295292952,0.00731476389339202,0.0338931594688757,0.0023788458189554
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,REG3A,Regenerating islet-derived protein 3-alpha,40052,-0.0174015668360517,0.0057350383522815,-0.0286422420065234,-0.00616089166557991,0.00241513171592679
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,39812,-0.0173591875561678,0.00573310829916904,-0.0285960798225392,-0.00612229528979652,0.00246665881519482
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,INSR,Insulin receptor,37056,-0.00494739587024999,0.00163404919910936,-0.00815013230050433,-0.00174465943999565,0.00246905786461114
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD5L,CD5 antigen-like,37380,-0.0138808462575032,0.00458848503231811,-0.0228742769208467,-0.00488741559415972,0.00248978344998811
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,C2orf69,UPF0565 protein C2orf69,37039,-0.0173890067746995,0.00574934434228125,-0.0286577216855707,-0.00612029186382824,0.00249507593370175
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ACTA2,"Actin, aortic smooth muscle",39585,-0.012729946425595,0.00421047425657565,-0.0209824759684833,-0.00447741688270674,0.00250354733324236
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RNASE10,Inactive ribonuclease-like protein 10,37043,-0.0139346652317136,0.00461039813796321,-0.0229710455821215,-0.00489828488130569,0.00251224870693597
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNFSF8,Tumor necrosis factor ligand superfamily member 8,37437,-0.0105513939414217,0.00349126310038931,-0.0173942696181848,-0.00370851826465868,0.00251389011923138
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BAMBI,BMP and activin membrane-bound inhibitor homolog,39477,-0.0088656686229219,0.0029341716797636,-0.0146166451152586,-0.00311469213058523,0.00251913346812449
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GBP6,Guanylate-binding protein 6,37021,0.0136655928954406,0.00453068256159337,0.00478545507471763,0.0225457307161637,0.00256425377742599
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LAMA4,Laminin subunit alpha-4,39931,-0.00990577484102861,0.00328586795578649,-0.0163460760343701,-0.0034654736476871,0.00257668855684943
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FGF9,Fibroblast growth factor 9,36931,0.0119885709700486,0.00397866113950141,0.0041903951366258,0.0197867468034713,0.00258988752047773
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SPINK8,Serine protease inhibitor Kazal-type 8,37021,0.0110027855760029,0.00366089700985809,0.00382742743668102,0.0181781437153247,0.00265653869779632
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CFP,Properdin,37453,-0.00680540840431458,0.00227280423191755,-0.011260104698873,-0.00235071210975618,0.00275589993370599
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,C1S,Complement C1s subcomponent,37453,-0.00613660565695107,0.00205541152418902,-0.0101652122443616,-0.00210799906954059,0.00283540554228583
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FST,Follistatin,39908,-0.0150002025750414,0.00502700753849128,-0.0248531373504843,-0.0051472677995985,0.00285006870313208
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NXPE4,NXPE family member 4,37021,0.0101803962306402,0.00342850900239988,0.00346051858593649,0.016900273875344,0.00298981869624982
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ITGB2,Integrin beta-2,39731,0.00830219294842933,0.00280951319975467,0.00279554707691018,0.0138088388199485,0.00313098916221276
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLASP1,CLIP-associating protein 1,36962,-0.0212565776538987,0.00719349574701444,-0.035355829318047,-0.00715732598975038,0.00313253958447039
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LRRC38,Leucine-rich repeat-containing protein 38,37039,-0.0140079121638996,0.00474857765136278,-0.0233151243605707,-0.00470069996722857,0.00318417616763462
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,37169,-0.0103996559547789,0.0035271139832335,-0.0173127993619165,-0.00348651254764124,0.00319886660397171
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KLKB1,Plasma kallikrein,37187,-0.00723634309578412,0.00245651087478157,-0.012051104410356,-0.00242158178121225,0.00322697550180664
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HBQ1,Hemoglobin subunit theta-1,40030,0.0172438359005156,0.00585873789838482,0.00576070961968138,0.0287269621813499,0.00325228599130092
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IFNW1,Interferon omega-1,37021,0.010212757305607,0.00347426969176381,0.00340318870974992,0.017022325901464,0.00329270315935458
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,STXBP1,Syntaxin-binding protein 1,37411,-0.0225825826688415,0.00769202107709087,-0.0376589439799396,-0.00750622135774343,0.00333199243489851
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",37056,-0.013137171516852,0.00447568740455701,-0.0219095188297838,-0.00436482420392029,0.00333875281668947
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,C5,Complement C5,37453,-0.00438334322851521,0.00149381689566421,-0.00731122434401706,-0.00145546211301335,0.00334833595397327
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IGHMBP2,DNA-binding protein SMUBP-2,37021,-0.0162202535254419,0.00553000002322703,-0.0270590535709668,-0.00538145347991688,0.00336133212933141
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ACP6,Lysophosphatidic acid phosphatase type 6,40011,-0.0187096617597249,0.00638255793654654,-0.0312194753153561,-0.00619984820409369,0.00337939748857725
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CPQ,Carboxypeptidase Q,37430,-0.0108402258500581,0.00370203458901319,-0.018096213644524,-0.00358423805559228,0.0034151859230357
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RAB2B,Ras-related protein Rab-2B,37368,-0.0180264271605531,0.00615677895379534,-0.030093713909992,-0.00595914041111427,0.00341830411006972
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ECM1,Extracellular matrix protein 1,37106,0.0103857903983092,0.00355591501314701,0.00341619697254101,0.0173553838240773,0.00349825800119381
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PSMD1,26S proteasome non-ATPase regulatory subunit 1,37411,-0.0138530814730142,0.00474627593857322,-0.0231557823126177,-0.00455038063341071,0.00352042514216366
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CA4,Carbonic anhydrase 4,40052,0.00666817065053982,0.00228887002789398,0.00218198539586763,0.011154355905212,0.00358116986199699
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CTSH,Pro-cathepsin H,39546,-0.0205322562316461,0.00705537248395942,-0.0343607863002066,-0.00670372616308567,0.00361752677619509
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TPSD1,Tryptase delta,37411,-0.0104095654492504,0.00359719976205021,-0.0174600769828689,-0.00335905391563202,0.00381221130753474
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TGFB2,Transforming growth factor beta-2 proprotein,37368,-0.0148786679398845,0.00516242056701871,-0.0249970122512412,-0.0047603236285278,0.00395643439394761
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HPGDS,Hematopoietic prostaglandin D synthase,39477,0.0104624316609535,0.00363455161560638,0.00333871049436498,0.017586152827542,0.00399982776024897
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SCP2,Non-specific lipid-transfer protein,39477,-0.0219405207961468,0.00762494037459147,-0.036885403930346,-0.00699563766194747,0.00401424055183536
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,39585,-0.00754177050652904,0.00262215978570807,-0.0126812036865169,-0.00240233732654122,0.00403077070380135
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,WAS,Wiskott-Aldrich syndrome protein,39587,-0.018926842359546,0.00658959477758307,-0.0318424481236088,-0.00601123659548316,0.00408129047246606
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,39788,-0.012432985198438,0.00433166288372381,-0.0209230444505366,-0.0039429259463393,0.00410678509586695
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,INHBB,Inhibin beta B chain,37124,-0.0139529380565941,0.00486223802815266,-0.0234829245917733,-0.00442295152141488,0.00411571219145658
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SLURP1,Secreted Ly-6/uPAR-related protein 1,37370,-0.0103234838307153,0.00360841219802829,-0.0173959717388508,-0.00325099592257988,0.004230228571
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",37368,-0.0102732837999328,0.00359112586797354,-0.0173118905011609,-0.00323467709870463,0.00423299566270884
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SMPD1,Sphingomyelin phosphodiesterase,39912,-0.0136958836248632,0.00479136560137064,-0.0230869602035496,-0.00430480704617671,0.00426262886740521
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MYH7B,Myosin-7B,36962,0.0123323327016534,0.00432120365567659,0.00386277353652724,0.0208018918667795,0.00432522807123989
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RLN1,Prorelaxin H1,37411,-0.0226190590035473,0.00793217378148371,-0.0381661196152554,-0.00707199839183923,0.0043571218329161
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCL28,C-C motif chemokine 28,39815,-0.0165995433457783,0.00582572391725922,-0.0280179622236064,-0.00518112446795026,0.00438643407819589
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,M6PR,Cation-dependent mannose-6-phosphate receptor,37043,-0.011494266603833,0.00405430384643068,-0.0194407021428372,-0.00354783106482891,0.0045884244447488
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL5RA,Interleukin-5 receptor subunit alpha,39866,-0.0150200495474276,0.00530495585728767,-0.0254177630277115,-0.00462233606714381,0.00464135294672925
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRKD2,Serine/threonine-protein kinase D2,37021,-0.0127022175878448,0.00448657029839238,-0.0214958953726938,-0.0039085398029957,0.00464492264478518
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,JUN,Transcription factor AP-1,39587,-0.0143413128072097,0.00507201422444808,-0.0242824606871279,-0.00440016492729146,0.00469667024243176
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ARFIP1,Arfaptin-1,37411,-0.0192627287011026,0.00681409811490723,-0.0326183610063208,-0.00590709639588447,0.00470708273965057
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD177,CD177 antigen,39844,-0.034139062800039,0.0121941853557138,-0.058039666097238,-0.01023845950284,0.00512244344839657
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RBPMS,RNA-binding protein with multiple splicing,37056,-0.0178210827005667,0.00637376644418542,-0.0303136649311701,-0.00532850046996327,0.00518134030794993
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SYT1,Synaptotagmin-1,37388,0.0101081997481524,0.00363509660438985,0.00298341040354825,0.0172329890927565,0.00543128463532756
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SCT,Secretin,37039,-0.012057574248603,0.00434443879945929,-0.0205726742955432,-0.00354247420166284,0.0055210827191195
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CALB1,Calbindin,39788,-0.0113662872841182,0.0040972651616979,-0.0193969270010461,-0.00333564756719035,0.00554164433786753
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADGRE2,Adhesion G protein-coupled receptor E2,39931,-0.00759658131835543,0.00274096498544336,-0.0129688726898244,-0.00222428994688644,0.00558630333463383
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NAAA,N-acylethanolamine-hydrolyzing acid amidase,39674,0.0159927383290889,0.00577821128468166,0.00466744421111286,0.0273180324470649,0.00565075568489892
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",37388,-0.015019902637717,0.00542863644763404,-0.0256600300750797,-0.00437977520035429,0.00566878975456115
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NPTN,Neuroplastin,39477,0.0226869422250282,0.00821051257618499,0.00659433757570565,0.0387795468743508,0.00573120863426219
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DSG4,Desmoglein-4,39725,0.0132544419003025,0.00480019983231526,0.00384605022896459,0.0226628335716404,0.00576508049861869
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NPTXR,Neuronal pentraxin receptor,39868,0.00917708367445477,0.00332439773101128,0.00266126412167266,0.0156929032272369,0.00577741844621456
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CA9,Carbonic anhydrase 9,40030,-0.0116210935451425,0.00422841642549981,-0.0199087897391221,-0.00333339735116284,0.00599656836317707
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,C1QL2,Complement C1q-like protein 2,37056,0.0113186682391163,0.00412086929073028,0.00324176442928494,0.0193955720489476,0.00602852982348302
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL1RL2,Interleukin-1 receptor-like 2,39587,-0.0106573216849262,0.00388367974479399,-0.0182693339847225,-0.00304530938513003,0.0060740318256048
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,36991,-0.016659727047514,0.00607369781639961,-0.0285641747676572,-0.00475527932737075,0.00609762613066677
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL17RA,Interleukin-17 receptor A,39858,-0.011808854726144,0.00430560311020885,-0.0202478368221534,-0.00336987263013471,0.0061009424894068
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SATB1,DNA-binding protein SATB1,37411,-0.00807934231984014,0.00295041917753214,-0.0138621639078031,-0.00229652073187715,0.00618250208043566
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RGS10,Regulator of G-protein signaling 10,37411,-0.016105558422303,0.00589454555328941,-0.0276588677067502,-0.00455224913785574,0.00629788483788141
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLIC5,Chloride intracellular channel protein 5,37039,0.00861420310218567,0.00315299854541225,0.00243432595317766,0.0147940802511937,0.00630221770707133
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HCG22,Protein PBMUCL2,37021,0.0145131645284247,0.00531628666809486,0.00409324265895881,0.0249330863978907,0.00634293454696154
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MKI67,Proliferation marker protein Ki-67,37056,-0.0104795753628439,0.00385778387234956,-0.0180408317526491,-0.0029183189730388,0.00660670585388184
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ENO2,Gamma-enolase,40009,-0.0175623693414845,0.00646649703230789,-0.030236703524808,-0.00488803515816101,0.00661658906575062
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LCN15,Lipocalin-15,37411,-0.0165207818450193,0.00609702435144868,-0.0284709495738587,-0.0045706141161799,0.00674396150928981
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SUSD4,Sushi domain-containing protein 4,37368,-0.0110782853191281,0.00409667204201567,-0.0191077625214788,-0.00304880811677738,0.00685515589061218
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",39489,-0.0144574680695591,0.00534640654016043,-0.0249364248882735,-0.00397851125084462,0.00685541519617384
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NTproBNP,N-terminal prohormone of brain natriuretic peptide,39868,-0.024453586109798,0.00906413982544003,-0.0422193001676605,-0.00668787205193554,0.00698644096477581
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD2,T-cell surface antigen CD2,37021,-0.0101582133626414,0.00376576099441449,-0.0175391049116938,-0.00277732181358903,0.00699472222644254
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDK1,Cyclin-dependent kinase 1,36962,-0.00957510658806901,0.00355561077839157,-0.0165441037137165,-0.00260610946242153,0.00709115178585011
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRL,Prolactin,40009,-0.0199105046632867,0.00740651251092456,-0.0344272691846988,-0.00539374014187457,0.00719027935520165
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TLR1,Toll-like receptor 1,37056,-0.00688274930304363,0.00256192676647582,-0.0119041257653362,-0.00186137284075102,0.00722841361106026
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LEO1,RNA polymerase-associated protein LEO1,37411,-0.00738953972752783,0.00275148121967742,-0.0127824429180956,-0.00199663653696009,0.00724751420165765
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,INSL4,Early placenta insulin-like peptide,37368,-0.0140746325223342,0.00524568528542254,-0.0243561756817624,-0.00379308936290601,0.0073034737368884
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NPHS1,Nephrin,37056,0.00900606271411398,0.00336382788987453,0.0024129600499599,0.0155991653782681,0.00743042655953195
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GFRA3,GDNF family receptor alpha-3,39709,0.00722967199331242,0.00270183742671331,0.00193407063695433,0.0125252733496705,0.00746198835748211
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SEMA3G,Semaphorin-3G,37124,-0.0114893260149313,0.00430525824153457,-0.0199276321683391,-0.00305101986152356,0.00762442091566598
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,37021,0.00875984695622379,0.0032824887177745,0.00232616906938578,0.0151935248430618,0.00762478193206123
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CBX2,Chromobox protein homolog 2,37021,0.0105825459342721,0.00396893984511754,0.0028034238378417,0.0183616680307024,0.00767756521690949
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CR2,Complement receptor type 2,39931,-0.0118053737193708,0.00443810241067434,-0.0205040544442925,-0.00310669299444909,0.00782170797024005
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,37021,0.0135153247298955,0.00508544586228471,0.00354785083981744,0.0234827986199735,0.00787831000516745
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ARG1,Arginase-1,39754,-0.0133969919921534,0.00505533987246686,-0.0233054581421885,-0.00348852584211837,0.00805553630752224
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,C9orf40,Uncharacterized protein C9orf40,37382,-0.0206352176494244,0.00779109808024762,-0.0359057698867097,-0.00536466541213907,0.00809285566631087
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SUSD5,Sushi domain-containing protein 5,37064,0.00880438367716224,0.00332794580876794,0.00228160989197707,0.0153271574623474,0.00816449415831319
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MIA,Melanoma-derived growth regulatory protein,39913,-0.00933669691942343,0.00353101374443392,-0.0162574838585139,-0.00241590998033294,0.00819645520371526
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ACHE,Acetylcholinesterase,37124,-0.00849165432675687,0.00321275620132805,-0.0147886564813599,-0.0021946521721539,0.00822459314475171
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,39904,0.016607755788733,0.00628665562263362,0.00428591076837111,0.0289296008090949,0.00825595519007755
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,THBS4,Thrombospondin-4,39892,-0.011552656466006,0.00437643433454008,-0.0201304677617045,-0.00297484517030744,0.00830495331392388
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,APOL1,Apolipoprotein L1,37445,0.0159024622306415,0.00603024195464146,0.00408318799954424,0.0277217364617387,0.00837088107083651
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,39868,0.00792347285875128,0.00300481889687708,0.0020340278208722,0.0138129178966303,0.00837428763545334
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GPR15L,Protein GPR15L,37382,-0.0158777094553945,0.00603098145151116,-0.0276984331003564,-0.00405698581043264,0.00848077218799351
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CYTL1,Cytokine-like protein 1,37437,0.00588158399545013,0.00224394827781498,0.00148344537093277,0.0102797226199675,0.00877475351078671
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,37124,-0.0165229836985512,0.00631505422976537,-0.0289004899888913,-0.00414547740821105,0.00889517418698998
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TDGF1,Teratocarcinoma-derived growth factor 1,39489,-0.0361269420062612,0.0138241832154406,-0.0632223411085248,-0.00903154290399769,0.00897545734385646
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRELP,Prolargin,39862,0.00565196021530949,0.00216705520156505,0.001404532020242,0.00989938841037698,0.00911231264043667
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,39682,-0.00811969148342298,0.00311459424519707,-0.0142242962040092,-0.00201508676283672,0.00914298208317185
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD3D,T-cell surface glycoprotein CD3 delta chain,36991,0.00884948439868883,0.00340022803636399,0.00218503744741542,0.0155139313499623,0.00926197441612732
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PCDH12,Protocadherin-12,37411,-0.00646653125776981,0.00248892035683617,-0.0113448151571687,-0.00158824735837092,0.0093835244254415
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ITGB7,Integrin beta-7,40030,0.0115242477566673,0.00444497181523479,0.00281210299880715,0.0202363925145275,0.00953258850999091
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MGMT,Methylated-DNA--protein-cysteine methyltransferase,39866,-0.0309970895389821,0.0119805564080948,-0.0544789800988479,-0.00751519897911624,0.00968234287516086
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,37368,-0.0171493229091782,0.00662899383091382,-0.0301421508177693,-0.00415649500058713,0.00969141876962839
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CALY,Neuron-specific vesicular protein calcyon,37021,0.00960275904157034,0.00371638816617983,0.00231863823585787,0.0168868798472828,0.00977981029761402
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,39862,-0.0074810424735355,0.00289951954058422,-0.0131641007730806,-0.00179798417399043,0.00988607843929255
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD93,Complement component C1q receptor,39238,0.00775358708976083,0.00301556276120086,0.00184308407780714,0.0136640901017145,0.0101442612243366
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,QSOX1,Sulfhydryl oxidase 1,37186,-0.0106025669224909,0.00412496416955351,-0.0186874966948158,-0.002517637150166,0.0101705890123421
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CADPS,Calcium-dependent secretion activator 1,37039,0.0109435550802216,0.00426174292693075,0.00259053894343737,0.0192965712170059,0.0102437973650743
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,36991,0.00810595378196692,0.00317101570139405,0.00189076300723458,0.0143211445566993,0.0105914294378103
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GHRL,Appetite-regulating hormone,39868,-0.0191505773907466,0.00750169601992948,-0.0338539015898084,-0.00444725319168485,0.0106942653064268
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDHR1,Cadherin-related family member 1,39489,-0.0105865872931191,0.0041734425552806,-0.018766534701469,-0.00240663988476909,0.0112013374273451
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,37368,-0.0133062372964997,0.00524990257544177,-0.0235960463443656,-0.00301642824863386,0.0112697869644755
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,37124,-0.0166523037098087,0.00657077250283137,-0.0295310178153582,-0.00377358960425919,0.0112786508035932
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MRPL46,"39S ribosomal protein L46, mitochondrial",39489,-0.006741256396132,0.00266441204729439,-0.011963504008829,-0.001519008783435,0.0114124039164534
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,APOB,Apolipoprotein B-100,37445,0.00557922155568904,0.00222644325325134,0.00121539277931642,0.00994305033206166,0.0122259645145427
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SPINT1,Kunitz-type protease inhibitor 1,39794,-0.00636073930665912,0.0025388501240305,-0.0113368855497589,-0.00138459306355935,0.0122424985296914
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DLL4,Delta-like protein 4,37043,-0.0211522991270252,0.00846845186833534,-0.0377504647889624,-0.00455413346508791,0.0125095895658679
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,37021,0.0124336821586039,0.00498135592266622,0.00267022455017809,0.0221971397670297,0.0125708516413923
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ARTN,Artemin,39587,-0.010848862000562,0.00437873522556463,-0.0194311830426687,-0.00226654095845536,0.0132364451903838
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AMBN,Ameloblastin,39587,0.00690451677884738,0.00278847816978851,0.0014390995660619,0.0123699339916329,0.0132935351742258
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,UPK3A,Uroplakin-3a,36991,0.0116097247415018,0.00469846093185954,0.00240074131505708,0.0208187081679465,0.0134875609554253
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VIPR1,Vasoactive intestinal polypeptide receptor 1,37043,0.00631613275009234,0.00255691608573645,0.0013045772220489,0.0113276882781358,0.0135157438283127
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NUP50,Nuclear pore complex protein Nup50,37021,0.00801156574415345,0.0032441380277082,0.00165305520984538,0.0143700762784615,0.0135408502093437
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LIFR,Leukemia inhibitory factor receptor,39866,-0.00588294683560479,0.00238457682178779,-0.0105567174063089,-0.00120917626490071,0.0136323012554842
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,37169,-0.0203188024546787,0.00824990885312306,-0.0364886238067999,-0.00414898110255754,0.0137939266884862
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NPTX1,Neuronal pentraxin-1,39858,0.00979296361059524,0.00399189975446107,0.00196884009185154,0.0176170871293389,0.0141694049212099
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VCPKMT,Protein-lysine methyltransferase METTL21D,36962,-0.0208296025129394,0.00849240301133737,-0.0374747124151606,-0.00418449261071813,0.0141904701026738
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD1C,T-cell surface glycoprotein CD1c,39913,0.00561575279172109,0.00229107392557192,0.00112524789760013,0.010106257685842,0.0142508707427528
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNFSF11,Tumor necrosis factor ligand superfamily member 11,39866,-0.0147435005951575,0.00601707170499676,-0.0265369611369512,-0.00295004005336386,0.0142852102033229
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SPON2,Spondin-2,39775,-0.00801280185468406,0.00327982283985596,-0.0144412546208017,-0.00158434908856637,0.0145741354249553
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NRTN,Neurturin,39587,-0.0118272874319806,0.00485115066751274,-0.0213355427403055,-0.00231903212365559,0.0147782359227
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PCDH1,Protocadherin-1,40018,-0.00494833332012756,0.00203328997500534,-0.00893358167113803,-0.000963084969117093,0.0149578562803751
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,40030,0.00598751931631105,0.00246185818524659,0.00116227727322774,0.0108127613593944,0.0150217675883785
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL36A,Interleukin-36 alpha,37056,0.0140247898765551,0.0057776584420001,0.0027005793302349,0.0253490004228753,0.0152200296434741
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GP5,Platelet glycoprotein V,37124,-0.00862114955835405,0.00355625462133477,-0.0155914086161702,-0.00165089050053789,0.0153545142935713
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AGER,Advanced glycosylation end product-specific receptor,39817,-0.00936355510730209,0.00386924149878367,-0.0169472684449181,-0.0017798417696861,0.0155317066418406
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,COPB2,Coatomer subunit beta',37021,-0.0101351809374175,0.00419591909616641,-0.0183591823659037,-0.00191117950893135,0.01572778990837
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MATN3,Matrilin-3,39720,0.00737978606348197,0.00306130421658164,0.00137962979898196,0.013379942327982,0.0159346653631729
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DPEP2,Dipeptidase 2,39788,0.00685310071449863,0.0028431855221083,0.00128045709116636,0.0124257443378309,0.0159480419692792
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MUCL3,Mucin-like protein 3,36962,0.0106105303244486,0.00441775629976736,0.00195172797690458,0.0192693326719926,0.0163288323135069
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,37056,-0.014255607510563,0.00593615952967974,-0.0258904801887353,-0.00262073483239071,0.0163423500776134
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",39699,0.00942588689338942,0.00393577781346563,0.00171176237899678,0.017140011407782,0.0166353769042576
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PMM2,Phosphomannomutase 2,37021,-0.0141009278312178,0.00590677006054784,-0.0256781971498916,-0.00252365851254405,0.0169890434662794
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FES,Tyrosine-protein kinase Fes/Fps,39477,-0.0110487327570315,0.00463213382515735,-0.02012771505434,-0.00196975045972314,0.0170800168051201
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DTX2,Probable E3 ubiquitin-protein ligase DTX2,37039,0.014632767624569,0.00617043910803487,0.00253870697282063,0.0267268282763173,0.0177336667385739
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CREB3,Cyclic AMP-responsive element-binding protein 3,36962,0.0130796201734042,0.00551764275607732,0.00226504037149262,0.0238941999753157,0.0177780149447215
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,40052,-0.006341725460116,0.00267690421192741,-0.0115884577154937,-0.00109499320473827,0.0178454064542465
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",37382,-0.0239990746861533,0.0101544351055243,-0.0439017674929808,-0.00409638187932567,0.0181217789083141
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CA13,Carbonic anhydrase 13,39657,-0.0243220255125078,0.0103280768795585,-0.0445650561964425,-0.00407899482857315,0.0185377433265961
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,YY1,Transcriptional repressor protein YY1,37056,0.00639865742727966,0.00272603114167823,0.00105563638959033,0.011741678464969,0.0189276138559084
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AFAP1,Actin filament-associated protein 1,37124,-0.019529755446868,0.00833846577719504,-0.0358731483701703,-0.00318636252356576,0.0191888408967768
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNNI3,"Troponin I, cardiac muscle",39585,-0.0191774295301821,0.00820275575623883,-0.0352548308124102,-0.00310002824795397,0.0194035985349685
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ACP1,Low molecular weight phosphotyrosine protein phosphatase,37056,-0.00994892787995514,0.0042625759482812,-0.0183035767385863,-0.00159427902132399,0.0196097228991778
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RTKN2,Rhotekin-2,37021,0.0118436963271204,0.00509916758987628,0.00184932785096285,0.0218380648032779,0.0202119229083553
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLINT1,Clathrin interactor 1,36962,0.0111314704116997,0.00480530515012283,0.00171307231745897,0.0205498685059405,0.0205465478672584
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LY6D,Lymphocyte antigen 6D,39761,-0.00814136776260399,0.00352989983757503,-0.0150599714442511,-0.00122276408095692,0.0211009786401803
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ATF2,Cyclic AMP-dependent transcription factor ATF-2,39489,-0.0154328949079838,0.0067414231431707,-0.0286460842685984,-0.00221970554736927,0.0220773099076685
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SAT1,Diamine acetyltransferase 1,37021,0.0111367543880792,0.00487399641504298,0.00158372141459497,0.0206897873615635,0.0223326034771706
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CHRM1,Muscarinic acetylcholine receptor M1,37039,0.00825177321716255,0.0036114859244116,0.00117326080531581,0.0153302856290093,0.0223363101580558
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LRG1,Leucine-rich alpha-2-glycoprotein,37453,0.00569260214884939,0.00249543822497169,0.000801543227904871,0.0105836610697939,0.0225518106646492
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BRME1,Break repair meiotic recombinase recruitment factor 1,36991,0.00911511428481358,0.00400777416097096,0.0012598769293105,0.0169703516403167,0.0229605137900069
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RAB6B,Ras-related protein Rab-6B,39489,-0.0104242239125251,0.00459651282846023,-0.0194333890563072,-0.00141505876874309,0.0233516434025021
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,REPS1,RalBP1-associated Eps domain-containing protein 1,37056,-0.0085523252675609,0.00377138740299944,-0.0159442445774398,-0.001160405957682,0.0233644025696521
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,STX3,Syntaxin-3,37388,-0.00845542279733717,0.00373195811095709,-0.0157700606948131,-0.00114078489986127,0.0234867200068795
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TGM2,Protein-glutamine gamma-glutamyltransferase 2,39835,-0.0161219779341326,0.00711593457608447,-0.0300692097032582,-0.00217474616500703,0.0234882077672761
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,37437,0.0056682324973606,0.00250263629010063,0.000763065368763367,0.0105733996259578,0.0235342257120956
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MYBPC2,"Myosin-binding protein C, fast-type",37043,-0.0187151655182593,0.00837546990443741,-0.0351310865309567,-0.00229924450556203,0.0254654875172091
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,36962,0.0094952973068627,0.0042743378955402,0.00111759503160391,0.0178729995821215,0.0263364220999149
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FZD8,Frizzled-8,36991,-0.00929429798028949,0.00419028668617889,-0.0175072598852001,-0.00108133607537888,0.02656793748414
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL4,Interleukin-4,39587,-0.0195265249753228,0.00882138838236834,-0.0368164462047647,-0.00223660374588083,0.0268745088627538
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PTX3,Pentraxin-related protein PTX3,39866,0.010755356507973,0.00485919103673431,0.00123134207597372,0.0202793709399722,0.0268838024792379
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CGN,Cingulin,37039,-0.00843937821364943,0.00382245699801152,-0.015931393929752,-0.000947362497546861,0.0272725003430084
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD82,CD82 antigen,37169,0.00912856104312929,0.0041479392107573,0.000998600190044982,0.0172585218962136,0.0277711148325327
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CENPJ,Centromere protein J,37169,-0.0157221403123611,0.00714807504004249,-0.0297323673908444,-0.00171191323387782,0.0278600261900688
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HSD17B3,Testosterone 17-beta-dehydrogenase 3,37021,-0.0102670033973901,0.00467828441237059,-0.0194364408456365,-0.00109756594914375,0.0282090924948906
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SERPINC1,Antithrombin-III,37424,0.00313563932512934,0.00142977332102159,0.000333283615927033,0.00593799503433165,0.0283169180549481
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RYR1,Ryanodine receptor 1,37021,0.00727523774381878,0.00332132087583786,0.000765448827176567,0.013785026660461,0.028507997360826
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KLK8,Kallikrein-8,39315,-0.00740900281073423,0.00339225668596338,-0.0140578259152224,-0.000760179706246008,0.0289704205984077
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL2RG,Cytokine receptor common subunit gamma,37368,-0.00807135624391007,0.00369842466756507,-0.0153202685923376,-0.000822443895482533,0.0290988997060152
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SCN2B,Sodium channel subunit beta-2,37039,0.00617624447075579,0.00283505780661352,0.000619531169793285,0.0117329577717183,0.0293846284349685
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IGFBP7,Insulin-like growth factor-binding protein 7,40052,-0.0062419201927458,0.00286587589406824,-0.0118590369451195,-0.000624803440372053,0.0294193132057803
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADGRV1,Adhesion G-protein coupled receptor V1,36991,0.0148612431249022,0.00682487103940695,0.00148449588766452,0.0282379903621398,0.0294600793240934
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TERF1,Telomeric repeat-binding factor 1,37056,0.00624465031095825,0.00286903917169707,0.000621333534431986,0.0118679670874845,0.0295307073256919
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,39877,-0.0121312129154866,0.00557942247406836,-0.0230668809646605,-0.00119554486631257,0.0296988885043579
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HLA_A,,37411,-0.0069027488677759,0.00317567051294216,-0.0131270630731425,-0.00067843466240926,0.0297498062106223
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,37382,-0.00823191569389493,0.00379814227033429,-0.0156762745437501,-0.000787556844039717,0.0302253309305764
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RGMA,Repulsive guidance molecule A,40009,0.00655329063308709,0.00302493918904374,0.000624409822561372,0.0124821714436128,0.0302936383778705
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CABP2,Calcium-binding protein 2,37039,-0.0140138803426702,0.00647124575806598,-0.0266975220284795,-0.00133023865686092,0.0303625937822376
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KEL,Kell blood group glycoprotein,39489,-0.00748566578523578,0.00346814787159513,-0.0142832356135622,-0.000688095956909329,0.0309115778162712
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ATXN2,Ataxin-2,36991,-0.0235887011821518,0.0109584879154991,-0.0450673374965301,-0.00211006486777355,0.0313721674682182
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IFNGR1,Interferon gamma receptor 1,39931,-0.00422206723835516,0.0019727184435027,-0.00808859538762046,-0.000355539089089858,0.0323513544240919
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KIRREL1,Kin of IRRE-like protein 1,36991,0.012673666476366,0.00592938561562933,0.0010520706697325,0.0242952622829995,0.0325811781116726
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ANXA5,Annexin A5,39415,-0.0063046401198027,0.00295673933115016,-0.012099849208857,-0.000509431030748383,0.032998230795907
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD55,Complement decay-accelerating factor,39315,-0.00529493185338584,0.00248594731183045,-0.0101673885845735,-0.000422475122198155,0.0331918792681929
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ANXA4,Annexin A4,39783,-0.0150888287196932,0.00709003157320922,-0.0289852906031833,-0.00119236683620316,0.033337880493201
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,37411,-0.024159066022345,0.0113756737056227,-0.0464553864853654,-0.00186274555932456,0.0337092724612996
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,36709,-0.0228502320716335,0.0107659625810439,-0.0439515187304795,-0.0017489454127874,0.0338189246732374
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",39489,-0.00626573342128296,0.00296133643623895,-0.0120699528363113,-0.000461514006254613,0.0343736332005806
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CRYGD,Gamma-crystallin D,37388,-0.0200043666924995,0.00945775925551689,-0.0385415748333126,-0.00146715855168637,0.0344373137184309
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,36991,0.0126429158391533,0.00602818785461723,0.000827667644103519,0.0244581640342031,0.035986136230207
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CTLA4,Cytotoxic T-lymphocyte protein 4,37437,0.00608019049645221,0.00290353620208382,0.000389259540367923,0.0117711214525365,0.0362727793278453
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NME1,Nucleoside diphosphate kinase A,37056,0.0044766234204706,0.00214367896370079,0.00027501265161706,0.00867823418932415,0.0367908013304117
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SERPINB5,Serpin B5,39585,-0.00989319203116417,0.00474263350643043,-0.0191887537037678,-0.000597630358560522,0.0369935815618746
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,39587,-0.00848467318983051,0.00407092864240301,-0.0164636933289404,-0.000505653050720617,0.037157100844382
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MYL6B,Myosin light chain 6B,37039,-0.0189360599916067,0.00909328024828841,-0.036758889278252,-0.0011132307049614,0.0373230479577275
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SH3GL3,Endophilin-A3,37083,-0.0169136617488844,0.00812670082842903,-0.0328419953726053,-0.000985328125163509,0.0374306096074386
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL3,Interleukin-3,36962,0.0120901898346909,0.00585700945073929,0.000610451311241924,0.0235699283581399,0.0390159544566263
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TTN,Titin,37021,-0.0138534487852392,0.00671165611921431,-0.0270082947788992,-0.000698602791579137,0.0390289276894684
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PSMA1,Proteasome subunit alpha type-1,39477,-0.00937993305125557,0.00454521914122556,-0.0182885625680577,-0.000471303534453476,0.0390633975451909
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ANK2,Ankyrin-2,37021,0.0143633240245208,0.00697004806886871,0.000702029809538162,0.0280246182395035,0.0393492758976974
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SIGLEC15,Sialic acid-binding Ig-like lectin 15,39489,-0.0159468886647716,0.00777030364490789,-0.031176683808791,-0.000717093520752117,0.0401584536171263
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MZT1,Mitotic-spindle organizing protein 1,39477,-0.0107063689885672,0.0052207147290302,-0.0209389698574663,-0.000473768119667978,0.0403081696260656
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ART5,Ecto-ADP-ribosyltransferase 5,36991,0.0124157527258708,0.00606379679587368,0.000530711005958348,0.0243007944457832,0.0406267872648198
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ACSL1,Long-chain-fatty-acid--CoA ligase 1,37021,0.00730400719476899,0.00358611115659597,0.00027522932784088,0.0143327850616971,0.0416952042911884
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SCARF2,Scavenger receptor class F member 2,40009,0.00559867415032313,0.00274905603782779,0.000210524316180659,0.0109868239844656,0.0417083684108473
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL34,Interleukin-34,39456,-0.00711536894288238,0.00349664487822077,-0.0139687929041951,-0.000261944981569672,0.0418764806387133
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,WASF3,Wiskott-Aldrich syndrome protein family member 3,39489,-0.0166785442348006,0.00821989455775749,-0.0327895375680053,-0.000567550901595913,0.0424705194866578
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CTNNA1,Catenin alpha-1,36991,0.00698266099398266,0.00345770544931582,0.000205558313323664,0.0137597636746417,0.0434608132017577
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,S100A16,Protein S100-A16,39456,-0.0122563800032468,0.00607243425443559,-0.0241583511419405,-0.000354408864553001,0.043570496305051
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PALM3,Paralemmin-3,37021,-0.0149314086965657,0.00742427489166391,-0.029482987484227,-0.000379829908904462,0.0443288533220521
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL20RA,Interleukin-20 receptor subunit alpha,39587,-0.00895532416262041,0.00445421398096072,-0.0176855835653034,-0.000225064759937397,0.0443923208793061
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CHRDL1,Chordin-like protein 1,39908,-0.00599411830467537,0.00299628757496021,-0.0118668419515974,-0.000121394657753362,0.0454614955774257
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,39477,-0.0145924959096148,0.00729944973244006,-0.0288994173851973,-0.000285574434032267,0.0456123729490785
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",37043,-0.0153005384040622,0.00765714423086659,-0.0303085410965607,-0.000292535711563648,0.0457150212451625
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PITHD1,PITH domain-containing protein 1,36931,0.0155181312051769,0.00776802534412483,0.000292801530692204,0.0307434608796616,0.0457706217105499
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MNAT1,CDK-activating kinase assembly factor MAT1,37169,-0.00856137103912239,0.00430867625252769,-0.0170063764940767,-0.000116365584168117,0.0469420582360539
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",37411,0.00843699817175112,0.00426160666640585,8.42491055956605e-05,0.0167897472379066,0.0477496541981436
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,COMMD9,COMM domain-containing protein 9,37368,-0.00761401426949597,0.00385237073628379,-0.0151646609126122,-6.33676263797475e-05,0.0481242563454595
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GZMB,Granzyme B,39866,-0.0123568808390934,0.00626444603419933,-0.0246351950661241,-7.85666120627412e-05,0.048564988267337
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL11,Interleukin-11,39587,-0.0119923120393572,0.00608103383917971,-0.0239111383641494,-7.3485714564947e-05,0.0486174652490874
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TP73,Tumor protein p73,37039,0.00669812491737344,0.00340460122224392,2.51065217753647e-05,0.0133711433129715,0.0491610168285369
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EDDM3B,Epididymal secretory protein E3-beta,37368,0.00992327007980352,0.00505292216079818,1.95426446390964e-05,0.019826997514968,0.0495659262903914
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ATP1B4,Protein ATP1B4,36962,0.0080412618226236,0.00411403612748153,-2.22489872401983e-05,0.0161047726324874,0.0506524917401793
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,OBP2B,Odorant-binding protein 2b,39701,0.0119701837547967,0.00615762608405494,-9.87633699509813e-05,0.0240391308795444,0.0519178600053574
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DTX3,Probable E3 ubiquitin-protein ligase DTX3,39788,-0.00442803300388602,0.00228055906060645,-0.00889792876267466,4.18627549026171e-05,0.0521978661170935
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,37445,0.00892065742922401,0.00459435855462548,-8.42853378419436e-05,0.01792560019629,0.052199575865086
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SCIN,Adseverin,36991,-0.0141159034190781,0.00727760664193325,-0.0283800124372672,0.00014820559911112,0.0524454044422396
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRR5,Proline-rich protein 5,37056,0.00905720596716505,0.00467456669552902,-0.000104944756071835,0.0182193566904019,0.0526994765147751
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRKCQ,Protein kinase C theta type,39587,-0.00819309871828855,0.00423846726136456,-0.0165004945505631,0.000114297113985992,0.0532500141859274
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SLC4A1,Band 3 anion transport protein,37437,-0.00883588977774274,0.00457452028777633,-0.0178019495417843,0.00013016998629887,0.0534365309575276
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",37021,0.0116944450502997,0.00607064809941356,-0.000204025224550871,0.0235929153251503,0.0540770142226826
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",37056,0.00867921442733397,0.00450626517941566,-0.000153065324320722,0.0175114941789887,0.0541217384366533
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TSPAN15,Tetraspanin-15,37021,0.00930925335037716,0.00484508856529858,-0.000187120237608049,0.0188056269383624,0.0547054665158045
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRDX5,"Peroxiredoxin-5, mitochondrial",40058,-0.0129917060157598,0.00676682166541594,-0.0262546764799751,0.0002712644484554,0.0548864858700038
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TPSG1,Tryptase gamma,37056,0.00504776294009298,0.00264137774162811,-0.000129337433498116,0.0102248633136841,0.0560218421061285
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DNAJA1,DnaJ homolog subfamily A member 1,36962,0.00864844480923383,0.00453703049454045,-0.000244134960065451,0.0175410245785331,0.0566473416279149
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRUNE2,Protein prune homolog 2,37169,-0.00534514989693236,0.00280565312444943,-0.0108442300208533,0.000153930226988524,0.0567839662530428
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ATF4,Cyclic AMP-dependent transcription factor ATF-4,36962,0.00627381558105216,0.00329992490793877,-0.000194037238507829,0.0127416684006121,0.057297805563329
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",37169,-0.0131258370994717,0.00691531569677007,-0.026679855865141,0.000428181666197666,0.0577068795754513
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CNTF,Ciliary neurotrophic factor,36991,0.00632669251737557,0.00334063125633351,-0.000220944745038104,0.0128743297797892,0.0582653701487835
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CBLN4,Cerebellin-4,40030,0.00573724186536532,0.0030297207120675,-0.000201010730286973,0.0116754944610176,0.0582888226586571
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,39788,-0.00706878148565818,0.00373481085597338,-0.014389010763366,0.00025144779204965,0.058419275611978
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CFD,Complement factor D,37453,-0.00338988630961427,0.00179276411633011,-0.00690370397762128,0.000123931358392748,0.0586627653425204
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GAS6,Growth arrest-specific protein 6,39947,0.00471042820498077,0.00249260188466607,-0.000175071488964736,0.00959592789892627,0.0588075522089698
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NMRK2,Nicotinamide riboside kinase 2,36962,0.00757884239597938,0.00401078167122589,-0.000282289679623364,0.0154399744715821,0.0588312198751383
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DPP10,Inactive dipeptidyl peptidase 10,39866,0.00639569280697033,0.00338692914793137,-0.000242688322975144,0.0130340739369158,0.0589976344992859
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NDRG1,Protein NDRG1,39489,-0.0127749129245232,0.00677038948931577,-0.0260448763235821,0.000495050474535736,0.0591949771554018
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",37388,0.00469293721517926,0.00248878332301837,-0.000185078097936736,0.00957095252829527,0.0593655502073503
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRND,Prion-like protein doppel,37388,-0.00937242548835959,0.00498675165944059,-0.0191464587408632,0.000401607764143972,0.0602024971847285
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ESPL1,Separin,36962,0.00993197819156975,0.00528535694019526,-0.00042732141121295,0.0202912777943525,0.0602462009686427
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DRAXIN,Draxin,39749,-0.00770504843691086,0.00410906229001186,-0.0157588105253341,0.000348713651512383,0.0607924154344746
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GPC1,Glypican-1,40030,0.00530423646033351,0.00283302142556578,-0.000248485533775411,0.0108569584544424,0.0611845870035483
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,METAP1,Methionine aminopeptidase 1,39489,-0.00557800902766711,0.00297926261190806,-0.0114173637470069,0.000261345691672687,0.0611867559701173
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NOP56,Nucleolar protein 56,37021,-0.0202746417890393,0.0108287428850906,-0.0414989778438168,0.000949694265738217,0.0611874401062227
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TP53INP1,Tumor protein p53-inducible nuclear protein 1,39585,0.00580419096781112,0.00310247192459622,-0.000276654004397467,0.0118850359400197,0.061387499969674
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CA3,Carbonic anhydrase 3,40017,-0.0109802639142118,0.00588787682952249,-0.0225205025000759,0.000559974671652266,0.0622144326844448
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PCNA,Proliferating cell nuclear antigen,36962,0.0117099789267221,0.00628003491912579,-0.000598889514764485,0.0240188473682086,0.0622547912487196
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EFHD1,EF-hand domain-containing protein D1,37411,-0.00632895414578706,0.00339480573887148,-0.0129827733939752,0.00032486510240104,0.0623004560374424
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GNPDA2,Glucosamine-6-phosphate isomerase 2,37124,-0.00677620825327315,0.00363676372572898,-0.013904265155702,0.000351848649155658,0.0624488668929745
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GLI2,Zinc finger protein GLI2,37056,0.00629243117762497,0.00337785917584635,-0.000328172807033874,0.0129130351622838,0.0625061501912397
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ENOPH1,Enolase-phosphatase E1,37368,0.0101669591228302,0.00547650518457132,-0.000566991038929562,0.02090090928459,0.0634085725200551
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LMOD1,Leiomodin-1,37411,0.0064252625254426,0.00346459973789659,-0.000365352960834712,0.0132158780117199,0.063682672577569
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,39214,0.00685022504351038,0.00369513282788816,-0.000392235299150404,0.0140926853861712,0.0637796702701691
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GAMT,Guanidinoacetate N-methyltransferase,37021,0.00667987995376027,0.00361481942276218,-0.000405166114853609,0.0137649260223742,0.0646370254976973
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DHODH,Dihydroorotate dehydrogenase,37021,-0.00840736883473138,0.00455485674050956,-0.0173348880461301,0.000520150376667361,0.0649432400485412
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RICTOR,Rapamycin-insensitive companion of mTOR,37056,0.00867389052880531,0.00470367025642285,-0.000545303173783476,0.0178930842313941,0.065195549105693
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,STAM,Signal transducing adapter molecule 1,37368,-0.00655967402063935,0.00357406224342589,-0.0135648360177541,0.000445487976475402,0.0664750374249926
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CHGA,Chromogranin-A,37437,-0.0140830533605335,0.0076858588358089,-0.0291473366787189,0.000981229957651965,0.0669237027225107
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,C1R,Complement C1r subcomponent,37453,-0.00347368353332058,0.00189905772658729,-0.00719583667743167,0.000248469610790518,0.0673972936493909
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,37021,0.00738027563778042,0.00403962096461874,-0.000537381452872314,0.0152979327284332,0.0677265691129191
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ERCC1,DNA excision repair protein ERCC-1,36962,0.00589272793117454,0.0032309871637916,-0.000440006909856993,0.0122254627722061,0.0682025769032332
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CBLN1,Cerebellin-1,36991,0.0172467935723242,0.00946572093148054,-0.00130601945337763,0.0357996065980261,0.0684737141471067
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TAGLN3,Transgelin-3,36962,0.0106832941146915,0.00587467001387129,-0.000831059112496174,0.0221976473418793,0.0690051948951141
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL36G,Interleukin-36 gamma,37021,-0.0120271961808424,0.00661948739555582,-0.0250013914761318,0.000946999114447039,0.0692493875108943
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NEDD9,Enhancer of filamentation 1,37056,-0.00594507459418122,0.0032797600154195,-0.0123734042244034,0.000483255036041001,0.0699077066148617
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LMNB1,Lamin-B1,37348,-0.0103060204892657,0.00569545455464256,-0.0214691114163651,0.000857070437833759,0.0703930094606187
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FDX2,"Ferredoxin-2, mitochondrial",37021,-0.0100068109383668,0.00553010898387611,-0.020845824546764,0.000832202670030386,0.0703939544049529
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MMP13,Collagenase 3,39489,0.00566613644348045,0.00313634725312991,-0.00048110417265418,0.0118133770596151,0.0708433233946174
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BRDT,Bromodomain testis-specific protein,37021,-0.0064820121114757,0.00358929675340474,-0.013517033748149,0.000553009525197584,0.0709523978627386
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",37021,0.0114356640625863,0.0063400435841437,-0.000990821362335345,0.0238621494875079,0.0712980542213034
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL6R,Interleukin-6 receptor subunit alpha,39805,-0.0059379064009036,0.00329339415664129,-0.0123929589479205,0.000517146146113315,0.0714110576200186
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDAN1,Codanin-1,37388,0.00398868608513816,0.00221284247117889,-0.000348485158372463,0.00832585732864877,0.0714863569962703
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SSB,Lupus La protein,39489,-0.0106856298630161,0.00593333640896846,-0.0223149692245943,0.000943709498562069,0.0717303585043414
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDH23,Cadherin-23,37388,0.00471604204233921,0.00263669375036156,-0.000451877708369454,0.00988396179304788,0.0736984726250168
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,36991,0.00993098240525265,0.00555323885529842,-0.000953365751132258,0.0208153305616375,0.073747027412222
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FOLH1,Glutamate carboxypeptidase 2,37056,-0.0191774048480888,0.0107618238130819,-0.0402705795217293,0.00191576982555173,0.0747747230301358
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CNDP1,Beta-Ala-His dipeptidase,39931,-0.00794413441729026,0.00445890242455067,-0.0166835831694096,0.00079531433482905,0.0748277317865046
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MST1,Hepatocyte growth factor-like protein,37271,-0.0110287020985353,0.00620269455951984,-0.0231859834351942,0.00112857923812361,0.0754182679296443
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MCTS1,Malignant T-cell-amplified sequence 1,37382,-0.00434590798610386,0.00245095507723897,-0.00914977993749223,0.000457963965284514,0.0762265635422785
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FGF20,Fibroblast growth factor 20,37056,0.00747792298878098,0.00421959745835144,-0.000792488029587851,0.0157483340071498,0.0763863058987556
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DGKZ,Diacylglycerol kinase zeta,39587,-0.00623278642164512,0.00351762891372249,-0.0131273390925412,0.000661766249250957,0.0764352490407655
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLMP,CXADR-like membrane protein,40030,-0.00354303364861815,0.00200100822159727,-0.0074650097629488,0.000378942465712505,0.0766420460432714
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TSHB,Thyrotropin subunit beta,39868,-0.0129373419382365,0.00732206836580941,-0.0272885959352229,0.00141391205874998,0.0772645014923387
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ENG,Endoglin,40052,0.0029085804887758,0.00165603255638575,-0.000337243321740273,0.00615440429929187,0.0790467724809621
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,COL9A2,Collagen alpha-2(IX) chain,37169,-0.00796954136166006,0.00454114918472644,-0.0168701937637239,0.000931111040403772,0.0792889239642549
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CEP112,Centrosomal protein of 112 kDa,37021,-0.00802151651459758,0.00457856304022399,-0.0169955000734366,0.000952467044241437,0.0798018257627538
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LTO1,Protein LTO1 homolog,39587,0.0069045492881142,0.00394328918978692,-0.000824297523868172,0.0146333961000966,0.0799719611063049
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRG3,Proteoglycan 3,37437,0.00857364171472199,0.00489940923946063,-0.00102920039462085,0.0181764838240648,0.0801523308704085
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AXL,Tyrosine-protein kinase receptor UFO,39931,-0.00466426750629981,0.00266832630563743,-0.00989418706534917,0.000565652052749551,0.0804809732460509
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GALNT7,N-acetylgalactosaminyltransferase 7,39788,-0.00353698927884665,0.002024960253855,-0.00750591137640245,0.000431932818709145,0.0807094190631631
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ITGB6,Integrin beta-6,39587,0.00506189052434824,0.00289935280495173,-0.000620840973357142,0.0107446220220536,0.0808532233003776
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ERVV_1,,37021,0.00822522492333412,0.00472086101139149,-0.00102766265899321,0.0174781125056614,0.0814767739486118
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TEX33,Testis-expressed protein 33,37169,0.00679416480857406,0.00390875782705787,-0.00086700053245937,0.0144553301496075,0.0822004212697832
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NPHS2,Podocin,37056,0.0174089705698549,0.0100198362140759,-0.00222990840973382,0.0370478495494437,0.082330994997596
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,37453,0.00444403651128374,0.00256437023589196,-0.000582129151064504,0.00947020217363198,0.0831195336109381
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",36991,-0.00543333195945187,0.00314142608506752,-0.0115905270861842,0.000723863167280462,0.0837297394646079
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HNF1A,Hepatocyte nuclear factor 1-alpha,37039,-0.0120759208001768,0.00698513633818691,-0.0257667880230231,0.00161494642266956,0.0838678775423304
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DEFB118,Beta-defensin 118,36991,-0.00988236231748412,0.00571931469946372,-0.021092219128433,0.00132749449346476,0.0840309683854525
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNN,Tenascin-N,37437,-0.00727979882854115,0.00421468022283313,-0.0155405720652941,0.000980974408211796,0.0841458408396497
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SFTPA2,Pulmonary surfactant-associated protein A2,39477,-0.00832238579740187,0.00482089740241945,-0.017771344706144,0.00112657311134025,0.0843105991041353
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CRTAP,Cartilage-associated protein,37039,-0.00832375730577203,0.00486026167552971,-0.0178498701898103,0.0012023555782662,0.0868069046065572
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SOX2,Transcription factor SOX-2,37391,0.00399476873795481,0.00233603919054882,-0.000583868075520877,0.00857340555143049,0.0872775805522763
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RASA1,Ras GTPase-activating protein 1,39489,-0.00542748448886573,0.0031912460056916,-0.0116823266600213,0.000827357682289808,0.0890114340017538
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DNAJB8,DnaJ homolog subfamily B member 8,39585,-0.00939668714293064,0.0055546372627178,-0.0202837761778575,0.00149040189199624,0.0907261863139406
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SEMA6C,Semaphorin-6C,37056,0.0043399086365562,0.00257049858029895,-0.000698268580829747,0.00937808585394215,0.0913671416720959
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ID4,DNA-binding protein inhibitor ID-4,37169,0.00732216881730234,0.00435739278013989,-0.00121832103177184,0.0158626586663765,0.0929027162417463
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",37411,-0.0107057712501003,0.00637715790668407,-0.0232050007472011,0.00179345824700046,0.0932202432209424
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,39749,0.0114734405488893,0.00685011323077358,-0.00195278138342691,0.0248996624812055,0.0939682069308107
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,36675,-0.00804793727110032,0.00480555382652179,-0.017466822771083,0.00137094822888238,0.0940143916660854
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TJP3,Tight junction protein ZO-3,36991,0.00715180414304782,0.00427790536304148,-0.00123289036851348,0.0155364986546091,0.0945875029802503
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SLC34A3,Sodium-dependent phosphate transport protein 2C,36962,0.00795137891675606,0.00476929114777343,-0.00139643173287986,0.017299189566392,0.0954978459456249
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,37368,-0.00783329431142539,0.00471195353318143,-0.017068723236461,0.00140213461361022,0.0964497299899069
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MFAP3,Microfibril-associated glycoprotein 3,39585,-0.00793023002436552,0.0047819673366867,-0.0173028860042715,0.00144242595554041,0.0972644883702264
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ICAM3,Intercellular adhesion molecule 3,40052,-0.00410428391803441,0.00247537862503975,-0.00895602602311232,0.000747458187043494,0.0973281810892495
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCAR2,Cell cycle and apoptosis regulator protein 2,37388,-0.009312820695378,0.00564193269194673,-0.0203710087715936,0.0017453673808376,0.0988345617843553
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,37021,-0.00755584592934855,0.0045824066035981,-0.0165373628724008,0.00142567101370373,0.0991957606211937
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LAMA1,Laminin subunit alpha-1,37021,0.00876449310802471,0.00532081880343322,-0.00166431174670439,0.0191932979627538,0.0995392579195321
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MRPL24,"39S ribosomal protein L24, mitochondrial",37021,-0.00640284808944185,0.0038954136975996,-0.0140378589367371,0.00123216275785337,0.100264374625908
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FBN2,Fibrillin-2,37039,-0.00970862924200158,0.00591144422632088,-0.0212950599255905,0.00187780144158734,0.100542441105653
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BSND,Barttin,36962,0.00543272030914619,0.00331246274177483,-0.00105970666473247,0.0119251472830249,0.101011509896318
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SHPK,Sedoheptulokinase,37169,-0.006733957499021,0.00412244861520552,-0.0148139567848238,0.00134604178678182,0.102390711023038
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SULT1A1,Sulfotransferase 1A1,40009,0.0205755208363125,0.0126055147436976,-0.00413128806133484,0.0452823297339598,0.102643498917389
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DKKL1,Dickkopf-like protein 1,39788,-0.0133928769584805,0.0082291414162357,-0.0295219941343025,0.00273624021734143,0.10365203531262
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EVI2B,Protein EVI2B,36962,0.00658878690288887,0.00405085924535536,-0.00135089721800763,0.0145284710237854,0.103864005709212
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TFAP2A,Transcription factor AP-2-alpha,36991,-0.00947591193464677,0.0058374756036807,-0.0209173641178609,0.00196554024856739,0.104551571026616
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD109,CD109 antigen,39858,0.00533391656436159,0.00329696662691714,-0.00112813802439601,0.0117959711531192,0.105719931273128
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,UHRF2,E3 ubiquitin-protein ligase UHRF2,37021,0.00548057595544992,0.00339137695350286,-0.00116652287341569,0.0121276747843155,0.106111218152587
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PDGFRB,Platelet-derived growth factor receptor beta,40052,0.00548855011642258,0.00340812018805723,-0.00119136545216958,0.0121684656850147,0.10732279617411
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TPPP3,Tubulin polymerization-promoting protein family member 3,39489,-0.00607326427619914,0.00379960578380902,-0.0135204916124648,0.00137396306006655,0.109975698492819
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VIM,Vimentin,39585,-0.0182468057972468,0.0114305755598687,-0.0406507338945894,0.00415712230009581,0.11043844890741
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PDGFRA,Platelet-derived growth factor receptor alpha,39868,0.00437153038755291,0.00274386694053436,-0.00100644881589444,0.00974950959100025,0.111134945615152
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ATP6V1D,V-type proton ATPase subunit D,39788,-0.00404960536504942,0.00254635109614269,-0.00904045351348909,0.000941242783390244,0.111774373430417
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SERPINI1,Neuroserpin,37088,0.00481451804843639,0.00302822084609379,-0.00112079480990744,0.0107498309067802,0.111884988059141
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LTB,Lymphotoxin-beta,37368,-0.00532726974987843,0.00335355792964239,-0.0119002432919775,0.00124570379222066,0.112187092146045
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PALLD,Palladin,37056,0.0063486384068993,0.00399974483487087,-0.00149086146944762,0.0141881382832462,0.112477536082859
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ACTN4,Alpha-actinin-4,39587,-0.00485763478849273,0.00306849807865823,-0.0108718910226629,0.00115662144567741,0.113426543895096
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ANGPTL3,Angiopoietin-related protein 3,39892,0.00545812641052021,0.00345005973351483,-0.00130399066716885,0.0122202434882093,0.113660568337284
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL18RAP,Interleukin-18 receptor accessory protein,39639,0.0265081908405426,0.0167739746601611,-0.00636879949337325,0.0593851811744584,0.114054420839004
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GAD2,Glutamate decarboxylase 2,37056,0.00722083636664198,0.00457430938902367,-0.00174481003584442,0.0161864827691284,0.114460255213912
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,THPO,Thrombopoietin,39585,-0.00586105945858164,0.00371822910193062,-0.0131487884983657,0.00142666958120238,0.114975873014468
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RBP1,Retinol-binding protein 1,37039,-0.0108816273816126,0.00690830526950679,-0.0244219057098459,0.00265865094662074,0.115245482996732
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ATP5PO,"ATP synthase subunit O, mitochondrial",39489,-0.00670173071514742,0.00425785143118379,-0.0150471195202676,0.0016436580899728,0.115514610252325
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AIDA,"Axin interactor, dorsalization-associated protein",37039,-0.0130776232384368,0.00832731942357106,-0.0293991693086361,0.00324392283176248,0.116334898747529
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FRMD7,FERM domain-containing protein 7,37039,0.00517366815722954,0.00330636836000188,-0.00130681382837414,0.0116541501428332,0.117663544139591
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,COL4A4,Collagen alpha-4(IV) chain,37147,0.00802767339375612,0.00515816362664039,-0.00208232731445905,0.0181376741019713,0.119659512741542
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KLK1,Kallikrein-1,39720,0.0191083586481369,0.0122798690208704,-0.00496018463276918,0.0431769019290429,0.119710958249088
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RAD51,DNA repair protein RAD51 homolog 1,37169,-0.00806277832937794,0.00518943746724524,-0.0182340757651786,0.00210851910642274,0.120282100531984
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,37368,-0.014853238231057,0.00957826805743823,-0.0336266436236359,0.00392016716152195,0.120991566041715
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TDO2,"Tryptophan 2,3-dioxygenase",37039,-0.00594974841446408,0.00385233907432406,-0.0135003330001392,0.00160083617121108,0.122503156251688
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LYPD1,Ly6/PLAUR domain-containing protein 1,39489,-0.0097429285457054,0.00631552179757833,-0.0221213512689589,0.00263549417754813,0.122924863001995
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,36931,0.00797502660128399,0.00517581119764885,-0.00216956334610775,0.0181196165486757,0.123383246406859
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,37039,0.00480591684557229,0.00312344289395548,-0.00131603122658045,0.010927864917725,0.123911314121259
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CYB5A,Cytochrome b5,36962,-0.0108316756106412,0.00704029837227045,-0.0246306604202913,0.00296730919900885,0.123944429916489
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MAPRE3,Microtubule-associated protein RP/EB family member 3,36962,-0.0217281727657119,0.0141444989757724,-0.0494513907582258,0.00599504522680209,0.124523997648857
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TIE1,Tyrosine-protein kinase receptor Tie-1,40052,-0.00616666264204535,0.00401482873726835,-0.0140357269670913,0.00170240168300062,0.124564901663415
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SCN3B,Sodium channel subunit beta-3,36991,0.00670813187222918,0.00437904011471306,-0.00187478675260842,0.0152910504970668,0.125577949205679
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BABAM1,BRISC and BRCA1-A complex member 1,37056,-0.00445568336138959,0.00291667677185273,-0.0101723698342209,0.00126100311144176,0.126621546584752
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SIRT1,NAD-dependent protein deacetylase sirtuin-1,37056,-0.0134830543756364,0.00882642945654375,-0.0307828561104621,0.00381674735918934,0.126641457973882
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LYPLA2,Acyl-protein thioesterase 2,36991,-0.0157577669902934,0.0103527924279066,-0.0360492401489902,0.00453370616840351,0.128013390073149
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MUC16,Mucin-16,39788,-0.0275893615028961,0.0181925112218081,-0.0632466834976399,0.00806796049184775,0.12940700674427
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",37043,-0.0104701249090378,0.00690582552151053,-0.0240055429311984,0.00306529311312286,0.129510619236598
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,UGDH,UDP-glucose 6-dehydrogenase,37021,-0.01481399624625,0.00982785373207976,-0.0340765895611263,0.00444859706862632,0.131745466853943
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,UBE2B,Ubiquitin-conjugating enzyme E2 B,37368,-0.0041840669451268,0.0027906276548805,-0.00965369714869259,0.00128556325843899,0.133811860400772
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EPB41L5,Band 4.1-like protein 5,37039,-0.00946743554582744,0.00631674934868208,-0.0218482642692443,0.00291339317758944,0.13395392871044
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BCL7B,B-cell CLL/lymphoma 7 protein family member B,37368,-0.00666569951957758,0.00444762656894271,-0.0153830475947053,0.00205164855555014,0.133972418500223
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,STOML2,"Stomatin-like protein 2, mitochondrial",36962,-0.013563129087759,0.00910700349941016,-0.031412855946603,0.00428659777108487,0.136430469669759
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FZD10,Frizzled-10,37039,-0.00876531802835898,0.00589070999517459,-0.0203111096189012,0.00278047356218321,0.136777435780084
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SEMA4C,Semaphorin-4C,39788,0.00411633427034108,0.00277024835744626,-0.00131335251025359,0.00954602105093574,0.137323241966628
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MSLNL,Mesothelin-like protein,37039,0.00527772061242045,0.00356871786823998,-0.00171696640932991,0.0122724076341708,0.139195156139431
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,C1GALT1C1,C1GALT1-specific chaperone 1,37021,0.00474445867000288,0.00321261257467474,-0.00155226197635961,0.0110411793163654,0.139747138694137
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TSLP,Thymic stromal lymphopoietin,39585,-0.008581287897016,0.00585480466172097,-0.0200567050339891,0.00289412923995711,0.142754650998579
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ARHGEF5,Rho guanine nucleotide exchange factor 5,36991,-0.0107596075314435,0.00735737676692493,-0.0251800659946163,0.00366085093172941,0.143648871067808
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LIPF,Gastric triacylglycerol lipase,37043,0.00858357032831588,0.00589102816451694,-0.00296284487413733,0.0201299855307691,0.14512415979941
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ERC2,ERC protein 2,37039,-0.0107162271175759,0.00737507759791005,-0.0251713792094795,0.00373892497432783,0.146238551911829
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GPHA2,Glycoprotein hormone alpha-2,37382,0.0066078679102604,0.0045712568244978,-0.00235179546575529,0.0155675312862761,0.148333534715313
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BATF,Basic leucine zipper transcriptional factor ATF-like,37039,-0.0118961728941972,0.00825623419522684,-0.0280783919168418,0.00428604612844736,0.149644734446055
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TLR2,Toll-like receptor 2,37169,-0.0032180527726432,0.00223428178860018,-0.00759724507829955,0.00116113953301314,0.149803948736161
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NGFR,Tumor necrosis factor receptor superfamily member 16,37437,-0.00419839559948657,0.00292903130239523,-0.00993929695218122,0.00154250575320807,0.151774178614081
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IMPA1,Inositol monophosphatase 1,39749,-0.00856048712003093,0.00599473709295752,-0.0203101718222277,0.00318919758216581,0.153311390399481
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AGBL2,Cytosolic carboxypeptidase 2,36991,0.0128792932456303,0.00902520524845373,-0.00481010904133903,0.0305686955325996,0.153593281437097
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NENF,Neudesin,37368,-0.0153713039642096,0.0107761858956853,-0.0364926283197527,0.00575002039133349,0.153771944676944
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BHLHE40,Class E basic helix-loop-helix protein 40,36991,0.0100048080034564,0.00702927974992989,-0.00377258030640619,0.023782196313319,0.154671558187626
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DUSP29,Dual specificity phosphatase 29,37039,-0.00927216780511488,0.00653639600093829,-0.0220835039669539,0.00353916835672418,0.156055538180253
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CSH1,Chorionic somatomammotropin hormone 1,37445,-0.00484601892613747,0.00342047133093351,-0.0115501427347671,0.0018581048824922,0.156573305650778
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KIAA1549,UPF0606 protein KIAA1549,37169,-0.00955867691603207,0.00676627119960552,-0.0228205684672589,0.00370321463519475,0.157768831070927
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RGS8,Regulator of G-protein signaling 8,39587,-0.00902258189913904,0.00642869481818473,-0.0216228237427811,0.00357765994450304,0.160491766718474
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PMCH,Pro-MCH,37021,0.0113886480644392,0.0081331033231217,-0.00455223444887934,0.0273295305777577,0.161452098953058
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MPRIP,Myosin phosphatase Rho-interacting protein,37338,-0.00616819823909311,0.00440608408392952,-0.014804123043595,0.00246772656540874,0.161558049646308
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PODXL2,Podocalyxin-like protein 2,39913,0.00375544599055001,0.00268351154607935,-0.00150423663976552,0.00901512862086554,0.161696761772754
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ICAM5,Intercellular adhesion molecule 5,39868,-0.00603249349432511,0.00431465990958089,-0.0144892269171036,0.00242423992845343,0.162090756120733
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MAMDC2,MAM domain-containing protein 2,37437,0.00453217214457667,0.0032445320194168,-0.00182711061348025,0.0108914549026336,0.162477101783454
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VWA5A,von Willebrand factor A domain-containing protein 5A,36962,-0.0111708774907439,0.00799887691682216,-0.0268486762477154,0.00450692126622751,0.162570863614401
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,USP47,Ubiquitin carboxyl-terminal hydrolase 47,37021,-0.011887486919114,0.00855047794956267,-0.0286464237002568,0.00487144986202883,0.164469919580695
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,39887,-0.00320168166041126,0.00230904742498394,-0.0077274146133798,0.00132405129255727,0.165588802272004
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CRHR1,Corticotropin-releasing factor receptor 1,39585,-0.00837291493974487,0.00604912809513885,-0.020229206006217,0.00348337612672727,0.166331449613202
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PPM1A,Protein phosphatase 1A,39477,-0.00411919249556585,0.00298714270176482,-0.00997399219102489,0.0017356071998932,0.167922480595202
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CSRP3,Cysteine and glycine-rich protein 3,37021,-0.0131718589756026,0.00955770114642456,-0.0319049532225947,0.00556123527138953,0.168183214655281
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FBLN2,Fibulin-2,37437,0.00408927178737661,0.00296853420181517,-0.00172905524818112,0.00990759882293434,0.168368356467072
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EPN1,Epsin-1,37169,-0.00581315502155147,0.0042396967201805,-0.0141229605931052,0.0024966505500023,0.170359048493474
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,37021,-0.0054367535051853,0.0039715871639009,-0.0132210643464311,0.00234755733606045,0.171050132622992
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MORC3,MORC family CW-type zinc finger protein 3,37388,-0.00375204009822157,0.00274741510708082,-0.00913697370809997,0.00163289351165683,0.172067817478472
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDSN,Corneodesmosin,39992,0.00564393736041155,0.00413475770423482,-0.0024601877398887,0.0137480624607118,0.17227261110322
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SCARB1,Scavenger receptor class B member 1,39489,-0.00760255093533876,0.00557009321704339,-0.0185199336407438,0.00331483177006628,0.172308041092058
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADRA2A,Alpha-2A adrenergic receptor,37021,0.00958794928906072,0.00703153185036194,-0.00419385313764869,0.0233697517157701,0.172727900919233
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,S100A3,Protein S100-A3,37368,0.00603124228891224,0.00442979407377752,-0.0026511540956917,0.0147136386735162,0.173372905633664
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PTPRR,Receptor-type tyrosine-protein phosphatase R,37388,0.00476085649110276,0.00350507955589124,-0.00210909943844407,0.0116308124206496,0.174399582968491
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",37021,0.00578698985039998,0.00426140085578101,-0.0025653558269308,0.0141393355277308,0.174486406538917
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TMEM25,Transmembrane protein 25,37411,0.00596689059971519,0.00440211915040684,-0.00266126293508222,0.0145950441345126,0.175294056435031
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KCNC4,Potassium voltage-gated channel subfamily C member 4,36991,0.00747864715853361,0.00552101857948568,-0.00334254925725832,0.0182998435743255,0.175575534690722
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DDX39A,ATP-dependent RNA helicase DDX39A,37056,0.00299386671398068,0.0022122979716139,-0.00134223731038255,0.00732997073834392,0.175988205961153
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TMED1,Transmembrane emp24 domain-containing protein 1,37169,0.0071955885774951,0.00531772607431788,-0.00322715452816794,0.0176183316831581,0.176036251794699
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GBA,Lysosomal acid glucosylceramidase,37039,-0.00701046397969091,0.00518184760180776,-0.0171668852792341,0.00314595731985231,0.176114341618691
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SLC13A1,Solute carrier family 13 member 1,37368,-0.00789659094981358,0.00586916505641755,-0.019400154460392,0.00360697256076482,0.178506785603124
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RALB,Ras-related protein Ral-B,37056,-0.00386047984220351,0.00287230016149075,-0.00949018815872538,0.00176922847431836,0.178959286933135
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PPT1,Palmitoyl-protein thioesterase 1,37039,-0.0103152061168796,0.00768501907095304,-0.0253778434959475,0.00474743126218838,0.179538523413283
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IFNAR1,Interferon alpha/beta receptor 1,37382,-0.00335331576762602,0.00250626530439856,-0.0082655957642472,0.00155896422899517,0.180927678476611
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IGFL4,Insulin growth factor-like family member 4,37056,-0.0100861775592628,0.00754513054186514,-0.0248746334213185,0.00470227830279287,0.181317593419551
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GRIK2,"Glutamate receptor ionotropic, kainate 2",37411,0.00517862629732819,0.00388112350465216,-0.00242837577179005,0.0127856283664464,0.182124331883352
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TPRKB,EKC/KEOPS complex subunit TPRKB,36962,0.00862411404256537,0.00647316778497908,-0.00406329481599363,0.0213115229011244,0.182789233813801
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,37039,-0.0131151033661972,0.00986819878445048,-0.0324567729837202,0.0062265662513257,0.183862045264294
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TCN2,Transcobalamin-2,40012,-0.00379714405935488,0.00285787217162909,-0.00939857351574789,0.00180428539703813,0.18397851948315
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LCP1,Plastin-2,37437,-0.00609950871909115,0.00460343574812278,-0.0151222427854118,0.00292322534722951,0.185196594450618
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",36991,0.00698156243522642,0.00530786051823548,-0.00342184418051511,0.017384969050968,0.188423615776944
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PKD1,Polycystin-1,37437,-0.00337767804898817,0.00257195187034246,-0.00841870371485939,0.00166334761688306,0.189112760785034
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IGSF21,Immunoglobulin superfamily member 21,37043,0.0051050761715788,0.00389332224349064,-0.00252583542566285,0.0127359877688204,0.18979984978731
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,36991,0.00621930679184785,0.00474410306931142,-0.00307913522400253,0.0155177488076982,0.18989581066478
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,37124,-0.00498437381635527,0.00382328758263565,-0.0124780174783211,0.0025092698456106,0.192362637536953
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RNF31,E3 ubiquitin-protein ligase RNF31,37056,-0.00479521328497715,0.00368051620386407,-0.0120090250445507,0.00241859847459642,0.192643817434122
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL33,Interleukin-33,39587,-0.00498192367400292,0.00382542334451941,-0.012479753429261,0.00251590608125512,0.192826236737019
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GGA1,ADP-ribosylation factor-binding protein GGA1,39489,-0.00887139832066589,0.00684682106213599,-0.0222911676024524,0.00454837096112066,0.195099392587946
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GPR158,Probable G-protein coupled receptor 158,37411,0.00454436129899813,0.00350917525930585,-0.00233362220924134,0.0114223448072376,0.195344323407251
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CFHR5,Complement factor H-related protein 5,37267,0.00523104024134018,0.00406019817607686,-0.00272694818377047,0.0131890286664508,0.197639197017815
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD276,CD276 antigen,39862,-0.00442792349329787,0.00343860933100682,-0.0111675977820712,0.00231175079547549,0.197866376594334
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GPC5,Glypican-5,39749,0.007034095464783,0.00546509038347443,-0.00367748168682689,0.0177456726163929,0.198079611197691
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EIF5A,Eukaryotic translation initiation factor 5A-1,39587,0.00378581809767658,0.00294534331182064,-0.00198705479349187,0.00955869098884504,0.198686433563379
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,39477,0.0151153811959957,0.0117710538416352,-0.00795588433360932,0.0381866467256008,0.199120936701755
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KLK7,Kallikrein-7,36818,0.00492007290344438,0.00384055567377923,-0.00260741621716291,0.0124475620240517,0.200187228396912
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,WNT9A,Protein Wnt-9a,39587,-0.00352103153081615,0.00274882771978596,-0.00890873386159663,0.00186667079996433,0.200240255635839
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,F2,Prothrombin,37453,0.001846342580068,0.00144214693232479,-0.000980265407288584,0.00467295056742458,0.200470791669047
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,37411,-0.00300549068406279,0.00234939741989371,-0.00761030962705445,0.00159932825892887,0.200827336445169
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PGM2,Phosphoglucomutase-2,37039,-0.0076103905511399,0.00595538629101715,-0.0192829476815335,0.00406216657925372,0.201307053226187
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL12RB2,Interleukin-12 receptor subunit beta-2,37056,0.00520458544441525,0.00409055285250561,-0.00281289814649574,0.0132220690353262,0.20327376896538
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,37437,-0.0167511232166387,0.013190035023406,-0.0426035918625144,0.00910134542923703,0.204112370364634
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,39247,-0.00764839012149615,0.0060225299453504,-0.0194525488143829,0.00415576857139064,0.204117018996118
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LAMTOR5,Ragulator complex protein LAMTOR5,37368,0.00513931330942222,0.00406193463390207,-0.00282207857302583,0.0131007051918703,0.205807914576697
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SAG,S-arrestin,36991,0.0065974597697967,0.00523219143568916,-0.00365763544415405,0.0168525549837475,0.207354224721684
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BMP4,Bone morphogenetic protein 4,39720,0.00563264522480217,0.00449134892152146,-0.0031703986613799,0.0144356891109842,0.209820539581732
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,37169,-0.00837065225741459,0.006688362362101,-0.0214798424871325,0.00473853797230337,0.210765019422272
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HSP90B1,Endoplasmin,39405,-0.0082053447293486,0.00658459512265418,-0.0211111511697508,0.00470046171105359,0.212730813251594
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CEP164,Centrosomal protein of 164 kDa,39587,-0.00730175548977341,0.00591815174308292,-0.0189013329062159,0.00429782192666912,0.217299664062766
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ACRV1,Acrosomal protein SP-10,37056,-0.00882013669412404,0.00716509195783659,-0.0228637169314838,0.00522344354323568,0.218349580387462
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GABARAP,Gamma-aminobutyric acid receptor-associated protein,37368,-0.00589955194155616,0.00479457688709454,-0.0152969226402615,0.00349781875714913,0.218545007052969
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TGFBR3,Transforming growth factor beta receptor type 3,40052,0.00379635758410217,0.00308946110019979,-0.00225898617228942,0.00985170134049375,0.219161287163311
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MEP1B,Meprin A subunit beta,39868,-0.0137568225581255,0.0112647851197759,-0.0358358013928862,0.00832215627663529,0.222019318832176
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SPRING1,SREBP regulating gene protein,36962,-0.00715657978844955,0.00588268395228196,-0.0186866403349222,0.00437348075802309,0.223797350588692
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CINP,Cyclin-dependent kinase 2-interacting protein,37169,-0.00517919308262492,0.0042810512613795,-0.0135700535549287,0.0032116673896789,0.226379172129175
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IFNL2,Interferon lambda-2,36991,-0.00737920816813674,0.00610029811254332,-0.0193357924687216,0.00457737613244816,0.226436098243184
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BLMH,Bleomycin hydrolase,40052,-0.0037723651802832,0.00312789771231559,-0.00990304469642175,0.00235831433585536,0.227820253771641
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SLC1A4,Neutral amino acid transporter A,37039,-0.00608729063171838,0.00504912849092528,-0.0159835824739319,0.00380900121049516,0.227988719082725
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CELA3A,Chymotrypsin-like elastase family member 3A,40034,-0.00651146125975443,0.00544845109470651,-0.0171904254053792,0.00416750288587032,0.232064240711714
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NMI,N-myc-interactor,37311,0.00845921595259809,0.00707974893942304,-0.00541709196867106,0.0223355238738672,0.232167926178893
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TREML1,Trem-like transcript 1 protein,37445,-0.00622598895690047,0.00521124099678442,-0.0164400213105979,0.003988043396797,0.232216169872654
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AMY2A,Pancreatic alpha-amylase,39246,-0.00548821711256924,0.00460124590631236,-0.0145066590889415,0.00353022486380298,0.232978789625305
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SSH3,Protein phosphatase Slingshot homolog 3,36962,-0.00346854011682878,0.002912251231347,-0.00917655253026891,0.00223947229661135,0.233668569276716
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL17D,Interleukin-17D,39587,-0.00392927193418857,0.00331122000928115,-0.0104192631523796,0.0025607192840025,0.235382115162048
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,37021,-0.00761945789310551,0.00643919182610822,-0.0202402738722776,0.00500135808606659,0.236713971575808
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ARG2,"Arginase-2, mitochondrial",37368,0.00508592816359687,0.00430485073774577,-0.00335157928238484,0.0135234356095786,0.237448285367857
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,37021,-0.00745907162060029,0.00632181219461751,-0.0198498235220506,0.00493168028085003,0.238063492324007
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AMY2B,Alpha-amylase 2B,38832,-0.00554075813646665,0.00470205430348942,-0.0147567845713059,0.00367526829837261,0.238667995140936
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GNLY,Granulysin,39858,-0.00586171990230729,0.00497982918671657,-0.0156221851082718,0.00389874530365719,0.239176075102966
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SDC4,Syndecan-4,39868,-0.00521434366246103,0.00443662899088689,-0.0139101364845993,0.00348144915967727,0.239894573826939
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DUSP13,Dual specificity protein phosphatase 13 isoform A,37368,-0.00483773107010197,0.00412641972442026,-0.0129255137299657,0.00325005158976174,0.241065287112803
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,37437,0.00392210435523382,0.00334617800992724,-0.00263640454422357,0.0104806132546912,0.241171584949901
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ARNT,Aryl hydrocarbon receptor nuclear translocator,39587,-0.00431907567670576,0.00368675326936689,-0.0115451120846649,0.00290696073125335,0.241410787228446
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ENO1,Alpha-enolase,39830,0.00900219469666895,0.00771422207273858,-0.00611768056589867,0.0241220699592366,0.243243628165819
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PLXDC2,Plexin domain-containing protein 2,37388,0.00307118464709366,0.00263231640521157,-0.00208815550712103,0.00823052480130834,0.24334273268243
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GSTM4,Glutathione S-transferase Mu 4,37021,0.00816884761863762,0.00702848211405416,-0.00560697732490854,0.0219446725621838,0.245155335762774
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HBZ,Hemoglobin subunit zeta,37437,0.0119700251864258,0.0103542552382459,-0.00832431508053613,0.0322643654533878,0.247681505438429
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,JCHAIN,Immunoglobulin J chain,39587,-0.0068376651145731,0.00591714274358221,-0.0184352648919942,0.00475993466284803,0.247875160651712
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",37021,0.00959275898567018,0.00834409133747385,-0.00676166003577856,0.0259471780071189,0.250310211382591
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADGRB3,Adhesion G protein-coupled receptor B3,39720,0.00370729594290866,0.00322744694399885,-0.00261850006732908,0.0100330919531464,0.250706277835636
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADAMTSL5,ADAMTS-like protein 5,37437,-0.00441316012997012,0.00384918011960114,-0.0119575531643884,0.00313123290444811,0.251600461938081
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PDRG1,p53 and DNA damage-regulated protein 1,37039,-0.00595037715428992,0.00522109746089679,-0.0161837281776476,0.00428297386906779,0.254440610712938
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GUCY2C,Heat-stable enterotoxin receptor,37169,0.00957304254496547,0.00843037108864668,-0.00695048478878201,0.026096569878713,0.256168638852027
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLSPN,Claspin,39453,-0.00381832472792205,0.00336696755191371,-0.0104175811296729,0.00278093167382882,0.256789118811344
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CXCL14,C-X-C motif chemokine 14,39587,-0.00682601312667479,0.0060387207233624,-0.0186619057444651,0.00500987949111552,0.258335887437748
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL2,Interleukin-2,39587,0.00342706734846572,0.00304536719763043,-0.00254185235888992,0.00939598705582136,0.260463017643763
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDC25A,M-phase inducer phosphatase 1,36962,0.00460450787273821,0.00409407840528524,-0.00341988580162085,0.0126289015470973,0.260747357655223
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLEC2L,C-type lectin domain family 2 member L,37039,-0.00561275326180152,0.00502201548128725,-0.0154559036051245,0.00423039708152148,0.263745585276107
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,39885,-0.00290255202657737,0.00260865986510058,-0.00801552536217452,0.00221042130901977,0.26587108230847
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,39477,0.00377546339260887,0.00341202443123988,-0.00291210449262129,0.010463031277839,0.268519809028478
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCL24,C-C motif chemokine 24,39908,-0.00890980715153224,0.00805906036857521,-0.0247055654739397,0.00688595117087517,0.268931845436681
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",39587,-0.0130453929516938,0.0118425307183901,-0.0362567531597383,0.0101659672563508,0.270664912994735
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,STEAP4,Metalloreductase STEAP4,36991,0.00814612466567998,0.00739875110644956,-0.00635542750296116,0.0226476768343211,0.27091097457909
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,37169,-0.00563057432486732,0.00512626902257382,-0.015678061609112,0.00441691295937738,0.272059913004905
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EDNRB,Endothelin receptor type B,37056,-0.00501886275805667,0.00458009773785874,-0.0139958543242598,0.00395812880814646,0.273187104023737
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KIRREL2,Kin of IRRE-like protein 2,39489,-0.00423575448226781,0.00387080022594129,-0.0118225229251127,0.00335101396057712,0.273847335477542
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,37453,0.00199908002306958,0.00182919465277886,-0.00158614149637698,0.00558430154251614,0.274468314076309
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",37043,0.00347775651977139,0.00319375942683969,-0.00278201195683439,0.00973752499637718,0.276207965868617
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SRPX,Sushi repeat-containing protein SRPX,37437,0.00364268352898839,0.00335001903856354,-0.00292335378659615,0.0102087208445729,0.276896144158203
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CNPY2,Protein canopy homolog 2,39585,-0.0063895843758329,0.00587634047160541,-0.0179072117001795,0.0051280429485137,0.276902917636065
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ZCCHC8,Zinc finger CCHC domain-containing protein 8,37021,-0.00628116779435926,0.00577701168089607,-0.0176041106889156,0.00504177510019704,0.276937696909701
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,COL15A1,Collagen alpha-1(XV) chain,37437,0.00265066939677082,0.00245326231414193,-0.00215772473894737,0.00745906353248901,0.279953389347855
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VIT,Vitrin,37437,-0.00389212238923003,0.00361065357880374,-0.0109690034036854,0.0031847586252253,0.28107295167256
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EXTL1,Exostosin-like 1,37021,-0.00504951755042462,0.00468548377194637,-0.0142330657434395,0.00413403064259026,0.281190108122693
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LYPD3,Ly6/PLAUR domain-containing protein 3,39794,0.0036161563642666,0.00336498771923571,-0.0029792195654354,0.0102115322939686,0.282551415110707
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MEGF11,Multiple epidermal growth factor-like domains protein 11,37021,0.00333389443972971,0.00310797539637896,-0.00275773733717305,0.00942552621663248,0.283429851834583
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RSPO1,R-spondin-1,39749,-0.00368407641684743,0.00344809327006647,-0.0104423392261777,0.00307418639248286,0.285338883377554
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CEP290,Centrosomal protein of 290 kDa,37169,-0.00545498241558555,0.0051080327309161,-0.0154667265681811,0.00455676173701,0.2855749010387
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,37021,0.00494422690169933,0.00464275698118519,-0.00415557678142364,0.0140440305848223,0.286925613411978
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,36991,0.0033951428046914,0.00319131198667736,-0.00285982868919622,0.00965011429857902,0.28740691389408
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CNTNAP4,Contactin-associated protein-like 4,37039,-0.0108096511644806,0.0101726293085934,-0.0307480046093237,0.00912870228036238,0.287973257487429
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FRZB,Secreted frizzled-related protein 3,39695,0.00273757793820439,0.0025763789555401,-0.00231212481465421,0.00778728069106298,0.287994091063993
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL31RA,Interleukin-31 receptor subunit alpha,37015,0.004146273494746,0.00392116086573911,-0.00353920180210266,0.0118317487915947,0.290344067942745
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MORN4,MORN repeat-containing protein 4,36962,-0.00827290843819223,0.00783530001121827,-0.02363009646018,0.00708427958379559,0.291055815326197
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NEB,Nebulin,37021,-0.00388800947521541,0.00368438648794061,-0.011109406991579,0.00333338804114819,0.291322848504912
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,STX5,Syntaxin-5,37056,-0.00421754913433078,0.00399880007296062,-0.0120551972773336,0.00362009900867204,0.29158018025418
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KRT6C,"Keratin, type II cytoskeletal 6C",37021,-0.00415280445180752,0.00395461700266956,-0.0119038537770399,0.00359824487342481,0.293684313544231
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FGF6,Fibroblast growth factor 6,37056,0.00422470136929263,0.00402455492914026,-0.00366342629182227,0.0121128290304075,0.293860882409684
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MRPL52,"39S ribosomal protein L52, mitochondrial",36942,0.00260833065674501,0.00248525260806337,-0.00226276445505919,0.00747942576854922,0.293956699576878
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,37022,0.00400881667099002,0.00382372719045687,-0.00348568862230545,0.0115033219642855,0.29447106474017
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,WFDC12,WAP four-disulfide core domain protein 12,39990,-0.00636861993606368,0.00607714973097665,-0.0182798334087779,0.00554259353665055,0.294671972584434
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ZNF174,Zinc finger protein 174,37056,0.0039208050596432,0.00374977516260314,-0.00342875425905895,0.0112703643783453,0.295759956198281
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SEPTIN3,Neuronal-specific septin-3,37411,-0.00783888431401226,0.00750717425429374,-0.022552945852428,0.00687517722440347,0.296418089070388
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL24,Interleukin-24,39587,-0.00480100354104639,0.0046146129755244,-0.0138456449730742,0.00424363789098142,0.298174100604529
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KLK4,Kallikrein-4,40030,0.00611534316611047,0.00587931415173558,-0.00540811257129126,0.0176387989035122,0.298287779674376
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NTF3,Neurotrophin-3,39866,0.00341988280368776,0.00329119632334093,-0.00303086199006046,0.00987062759743598,0.298773827668291
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AFP,Alpha-fetoprotein,39699,0.00685335175715839,0.00660514888190066,-0.00609274005136689,0.0197994435656837,0.299482785447196
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,THSD1,Thrombospondin type-1 domain-containing protein 1,36975,0.00350395685356516,0.00338909600787054,-0.0031386713218611,0.0101465850289914,0.301206049715379
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CHIT1,Chitotriosidase-1,39906,-0.0152096606155401,0.0147214272850369,-0.0440636580942124,0.0136443368631321,0.301542349206759
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCDC28A,Coiled-coil domain-containing protein 28A,37039,-0.00298900926069712,0.00289703757230839,-0.00866720290242157,0.00268918438102734,0.302209677827564
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FCRL3,Fc receptor-like protein 3,39587,-0.00525336323973359,0.00509597814989007,-0.0152414804135181,0.00473475393405094,0.302610990636267
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HTR1B,5-hydroxytryptamine receptor 1B,36991,0.00433527707026665,0.00421622526802729,-0.00392852445506684,0.0125990785956001,0.303857492798785
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NECTIN1,Nectin-1,37056,-0.00323915454322936,0.00315097566802377,-0.00941506685255595,0.00293675776609723,0.303975901660522
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DCUN1D2,DCN1-like protein 2,36962,0.00810915291229703,0.00789979880543457,-0.00737445274635473,0.0235927585709488,0.304674351316011
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LELP1,Late cornified envelope-like proline-rich protein 1,36991,0.00735987700581347,0.00721702882100844,-0.00678549948336307,0.02150525349499,0.307845331065003
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ENSA,Alpha-endosulfine,37368,-0.0052579671448269,0.00515788117408176,-0.0153674142460272,0.00485147995637336,0.308029239984737
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MLLT1,Protein ENL,36962,0.00714010694394318,0.00701211858453682,-0.00660364548174899,0.0208838593696353,0.308576800066981
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TPM3,Tropomyosin alpha-3 chain,37021,0.00441288561797764,0.00435542198861564,-0.00412374147970901,0.0129495127156643,0.310986330125655
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,36962,-0.0083052393075447,0.00820128856445507,-0.0243797648938766,0.00776928627878724,0.311234157701622
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,37039,-0.00514081234249202,0.00507783997809241,-0.0150933786995531,0.00481175401456911,0.311364751737748
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LRP2,Low-density lipoprotein receptor-related protein 2,37039,0.00355405252685024,0.00352182694919391,-0.00334872829356982,0.0104568333472703,0.3129211116721
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,36991,0.00654197782931569,0.006497658932942,-0.00619343367925063,0.019277389337882,0.31403947439256
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KHDC3L,KH domain-containing protein 3,36962,0.00655299215038491,0.00653149152611036,-0.00624873124079139,0.0193547155415612,0.31573860071042
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CHP1,Calcineurin B homologous protein 1,36991,-0.0071482874622436,0.00714547853734744,-0.0211534253954446,0.00685685047095738,0.317138739678552
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MYOM3,Myomesin-3,37124,0.00920152871524467,0.00920528216184245,-0.00884082432196653,0.0272438817524559,0.317526109722603
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL6ST,Interleukin-6 receptor subunit beta,39868,-0.00171221743800378,0.00171891849273718,-0.00508129768376865,0.00165686280776109,0.319215845357928
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,OMP,Olfactory marker protein,36991,0.00476494949243946,0.0047862647052344,-0.00461612932981996,0.0141460283146989,0.319488842743896
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,39351,0.00826112718871271,0.00830394096797659,-0.0080145971085214,0.0245368514859468,0.319827603152784
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FGA,Fibrinogen alpha chain,37149,0.00301200045016002,0.00302769016793286,-0.00292227227898839,0.00894627317930843,0.319842940023478
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CEND1,Cell cycle exit and neuronal differentiation protein 1,36991,0.00572059108542066,0.00578214087528219,-0.00561240503013243,0.0170535872009738,0.322507620115214
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LRP2BP,LRP2-binding protein,37039,-0.00775673888802143,0.0078432700642747,-0.0231295482139998,0.00761607043795697,0.322697218013379
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MDM1,Nuclear protein MDM1,37039,-0.00303953603513268,0.00307791539473993,-0.00907225020882295,0.00299317813855758,0.32340065561952
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ANKRA2,Ankyrin repeat family A protein 2,36962,0.0052240646630758,0.00534037329160758,-0.00524306698847506,0.0156911963146267,0.327983152839946
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CPLX2,Complexin-2,36962,0.00287968740534629,0.00294703553713971,-0.00289650224744753,0.00865587705814012,0.328514344278745
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",37039,-0.00463655335639323,0.00474926666899802,-0.0139451160276294,0.00467200931484289,0.328949980166769
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PPIE,Peptidyl-prolyl cis-trans isomerase E,37169,0.00598398661934141,0.00615061394667675,-0.00607121671614502,0.0180391899548278,0.330616297652552
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HDDC2,5'-deoxynucleotidase HDDC2,37382,0.00403348539177918,0.00424874280559204,-0.00429405050718121,0.0123610212907396,0.342466609026563
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FAM171A2,Protein FAM171A2,37411,-0.0146591745296189,0.0154558463836667,-0.0449526334416056,0.0156342843823679,0.34291479301143
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRTG,Protogenin,40030,-0.00230421604326284,0.00243266181930458,-0.00707223320909982,0.00246380112257413,0.343551287860331
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BGLAP,Osteocalcin,37437,-0.00803344198864638,0.00848232416270884,-0.0246587973475557,0.00859191337026293,0.343614725272323
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FGF3,Fibroblast growth factor 3,37056,0.00285205189432267,0.00302268068167381,-0.003072402241758,0.00877650603040334,0.345416667455401
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TIMP2,Metalloproteinase inhibitor 2,37437,-0.00236041411508105,0.00250278352970519,-0.00726586983330322,0.00254504160314112,0.345638573970259
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MB,Myoglobin,40052,-0.00477722891984105,0.00506837608890957,-0.0147112460541038,0.00515678821442171,0.345922053758757
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",39489,-0.00454359876497664,0.00483721187031774,-0.0140245340307994,0.00493733650084612,0.347590654533949
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LMOD2,Leiomodin-2,36991,-0.00591010726476786,0.00631460619879827,-0.0182867354144125,0.00646652088487675,0.349320091140107
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",37056,-0.00462393357981404,0.00494460781934973,-0.0143153649057395,0.00506749774611142,0.34972982530805
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,39585,0.00290689529782246,0.0031110649102361,-0.00319079192624029,0.00900458252188521,0.350125827100285
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MYOM2,Myomesin-2,37021,-0.00470937931879561,0.00505594396456588,-0.0146190294893447,0.00520027085175351,0.351635845424577
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLEC11A,C-type lectin domain family 11 member A,39822,0.00429256799122701,0.0046253163100379,-0.00477305197644727,0.0133581879589013,0.353390823556139
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TP53BP1,TP53-binding protein 1,37056,-0.00801150494411985,0.00863803003176872,-0.0249420438063865,0.00891903391814684,0.353700050669121
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LEG1,Protein LEG1 homolog,36703,0.00637070238253775,0.00688146097441892,-0.00711696112732334,0.0198583658923988,0.354578968911285
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CSPG5,Chondroitin sulfate proteoglycan 5,36991,0.00444756018822625,0.00481411637662207,-0.004988107909953,0.0138832282864055,0.355577200666737
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,37437,-0.00357857383024544,0.00389372955140371,-0.0112102837509967,0.00405313609050584,0.358080147926161
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SKIV2L,Helicase SKI2W,37021,0.00361354751169801,0.00395099305076808,-0.00413039886780743,0.0113574938912035,0.360422499230156
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SAP18,Histone deacetylase complex subunit SAP18,37169,-0.00656805997246775,0.00719021888276917,-0.0206608889826953,0.00752476903775981,0.361011167562025
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TEX101,Testis-expressed protein 101,37039,0.00436657439387393,0.00478306417305194,-0.00500823138530787,0.0137413801730557,0.361299179050079
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,37411,-0.00266687415130723,0.00292776607724308,-0.00840529566270367,0.00307154736008921,0.362369301961397
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CHEK2,Serine/threonine-protein kinase Chk2,39585,-0.00297361443756732,0.00326617770467417,-0.0093753227387287,0.00342809386359405,0.362611630519136
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NT5C3A,Cytosolic 5'-nucleotidase 3A,39829,-0.00787142127866857,0.00864774991530477,-0.0248210111126659,0.00907816855532879,0.362716191492785
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DEFB104A_DEFB104B,Beta-defensin 104,36991,0.00521012790923985,0.00574957156980273,-0.00605903236757351,0.0164792881860532,0.364858950010686
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CPTP,Ceramide-1-phosphate transfer protein,37021,-0.00352729217676365,0.00389736802781942,-0.0111661335112897,0.00411154915776242,0.365458287487749
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLSTN3,Calsyntenin-3,37388,-0.00268408495876339,0.0029699898337382,-0.00850526503289026,0.00313709511536349,0.36615181423022
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HMOX1,Heme oxygenase 1,39691,0.00419619246087367,0.00465773159810118,-0.00493296147140465,0.013325346393152,0.367650393895483
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,INSL3,Insulin-like 3,37388,0.00640406373683159,0.00711804991069617,-0.0075473140881329,0.0203554415617961,0.368299360482815
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CALCB,Calcitonin gene-related peptide 2,37388,0.00347622095010244,0.0038646221026095,-0.00409843837101217,0.0110508802712171,0.368403319975231
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RANGAP1,Ran GTPase-activating protein 1,39477,0.0043433134331347,0.00484296750990543,-0.00514890288627993,0.0138355297525493,0.369824025489447
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ZPR1,Zinc finger protein ZPR1,36991,-0.00844739465995077,0.00945514241831282,-0.0269794737998439,0.0100846844799424,0.371649727203991
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,37411,0.00320513126992979,0.00361798891770511,-0.00388612700877223,0.0102963895486318,0.375693855809966
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MEPE,Matrix extracellular phosphoglycoprotein,39862,0.00213514633976944,0.00241130981382139,-0.00259102089532049,0.00686131357485937,0.37591564002621
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL9,Interleukin-9,37169,0.00497661756177106,0.00563761676596878,-0.00607311129952774,0.0160263464230699,0.377386215384415
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MYO6,Unconventional myosin-VI,37411,-0.0033008068361944,0.00375377709496296,-0.0106582099423218,0.00405659626993301,0.379238252114159
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BRK1,Protein BRICK1,39489,-0.00382468645681885,0.00435181643310069,-0.0123542466656962,0.0047048737520585,0.379484586670247
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RRP15,RRP15-like protein,36991,-0.00780061027189062,0.00890150745456884,-0.0252475648828455,0.00964634433906431,0.3808696069121
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SCN3A,Sodium channel protein type 3 subunit alpha,37039,-0.00329359409320292,0.00377413950445183,-0.0106909075219285,0.00410371933552266,0.3828565946146
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNPO1,Transportin-1,37169,0.00302679445388376,0.00348609335253839,-0.00380594851709147,0.009859537424859,0.38527410076036
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CHGB,Secretogranin-1,39952,0.00334294081872227,0.00385773569934585,-0.00421822115199559,0.0109041027894401,0.386198705089637
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,UNG,Uracil-DNA glycosylase,37368,0.00294755383459693,0.00340437188011569,-0.00372501505042981,0.00962012271962368,0.386607386462598
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RBM19,Probable RNA-binding protein 19,37021,0.00402549025768728,0.00466572000381989,-0.00511932094979971,0.0131703014651743,0.388274117039034
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",37056,0.0029892006669084,0.003477944476666,-0.00382757050735695,0.00980597184117376,0.390095017618106
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NFKB2,Nuclear factor NF-kappa-B p100 subunit,37169,0.00493227527220548,0.00574637106175732,-0.00633061200883887,0.0161951625532498,0.390726436724872
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LSM8,U6 snRNA-associated Sm-like protein LSm8,37169,0.00730964148925812,0.00851797560178723,-0.00938559069024485,0.0240048736687611,0.390828936678018
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RELB,Transcription factor RelB,37056,0.00414089930686485,0.00483012079409239,-0.00532613744955624,0.0136079360632859,0.391290473776109
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLNS1A,Methylosome subunit pICln,37039,-0.0028389387844146,0.00331283587899545,-0.00933209710724568,0.00365421953841649,0.391487419738559
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ATP2B4,Plasma membrane calcium-transporting ATPase 4,37021,0.00534864948896036,0.00624772955089546,-0.00689690043079474,0.0175941994087155,0.391960867870213
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,WASL,Neural Wiskott-Aldrich syndrome protein,37056,0.00500134913937326,0.00590723592463679,-0.00657683327291486,0.0165795315516614,0.397206736426628
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TCP11,T-complex protein 11 homolog,37169,-0.00495730148407661,0.00586227740808117,-0.0164473652039157,0.00653276223576248,0.39777592511277
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RAB39B,Ras-related protein Rab-39B,37021,-0.00736022019932707,0.00870716270032432,-0.0244262590919627,0.0097058186933086,0.397955165606406
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,37453,0.00158580099380292,0.00188140263324512,-0.00210174816735751,0.00527335015496335,0.399309099864684
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SHD,SH2 domain-containing adapter protein D,37002,-0.00683662688319117,0.00816140825388122,-0.0228329870607984,0.00915973329441601,0.40222716806508
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TG,Thyroglobulin,37368,0.00888178881326265,0.0106655435096246,-0.0120226764656016,0.0297862540921269,0.404997423109336
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NLGN2,Neuroligin-2,36991,0.00386209989633205,0.00464073784609152,-0.00523374628200734,0.0129579460746714,0.405301729901722
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",37021,-0.00333236687737381,0.00400610517331376,-0.0111843330170688,0.00451959926232117,0.405524451226931
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PALM,Paralemmin-1,37299,0.00231323690027888,0.00279342708429836,-0.00316188018494592,0.00778835398550367,0.407628588635943
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CRX,Cone-rod homeobox protein,39585,-0.00870296639088249,0.010548202125809,-0.0293774425574681,0.0119715097757031,0.409346450945887
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FGFBP2,Fibroblast growth factor-binding protein 2,37437,0.00401583670145617,0.00487069973938482,-0.00553073478773807,0.0135624081906504,0.409676440751024
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RAP1A,Ras-related protein Rap-1A,37056,0.0054998924560194,0.00667711133931357,-0.0075872457690352,0.018587030681074,0.410128683905772
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MAPK13,Mitogen-activated protein kinase 13,36962,-0.00342428092721476,0.00419057296957999,-0.0116378039475915,0.00478924209316201,0.413863811822863
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CYTH3,Cytohesin-3,36962,-0.00580440094244538,0.00710481506864443,-0.0197298384769885,0.00812103659209771,0.413962021553068
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TMED4,Transmembrane emp24 domain-containing protein 4,37021,0.00448191987049915,0.00552393015907052,-0.00634498324127906,0.0153088229822774,0.41717115226242
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DNM1,Dynamin-1,37382,-0.00912755452439104,0.0112671607663338,-0.0312111896264052,0.0129560805776231,0.417895553108791
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GSAP,Gamma-secretase-activating protein,39477,-0.00695734064892392,0.00860647003263596,-0.0238260219128904,0.00991134061504256,0.41888134008942
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,39489,-0.00387049896356524,0.00478924412379679,-0.0132574174462069,0.00551641951907646,0.419007965472326
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ARHGAP30,Rho GTPase-activating protein 30,37169,-0.00312858741623818,0.0038724276797383,-0.0107185456685252,0.00446137083604888,0.419154697513667
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TPPP2,Tubulin polymerization-promoting protein family member 2,37169,-0.00622824003011365,0.00771162598466725,-0.0213430269600615,0.00888654689983417,0.419310612936257
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BTNL10,Butyrophilin-like protein 10,36962,0.00312908627016209,0.00387848688691226,-0.00447274802818594,0.0107309205685101,0.419807796076408
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,COL4A1,Collagen alpha-1(IV) chain,39868,0.00308030374983593,0.00382063958235413,-0.00440814983157816,0.01056875733125,0.420123804789768
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NTF4,Neurotrophin-4,39477,-0.00313011864460049,0.00388996574987151,-0.0107544515143486,0.00449421422514766,0.421025367103054
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PCDHB15,Protocadherin beta-15,37368,-0.0031163182299207,0.00390058244917405,-0.0107614598303018,0.00452882337046043,0.424341199876159
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MORF4L2,Mortality factor 4-like protein 2,36962,0.00291316592369861,0.00364907764269733,-0.00423902625598815,0.0100653581033854,0.42469383749101
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GPR101,Probable G-protein coupled receptor 101,36991,0.00492075582237209,0.0061696189528644,-0.00717169732524215,0.0170132089699863,0.425129517108516
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,37169,-0.00514304303127565,0.00644939575106309,-0.0177838587033593,0.00749777264080799,0.425206442584226
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SERPINA6,Corticosteroid-binding globulin,37453,-0.00136741235847175,0.00172838365159035,-0.00475504431558882,0.00202021959864533,0.428869717491479
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,37368,0.00590617421843897,0.00752718455668855,-0.00884710751267058,0.0206594559495485,0.432674992379568
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ARID3A,AT-rich interactive domain-containing protein 3A,36991,-0.00306847628886464,0.00391996867954365,-0.0107516149007702,0.00461466232304091,0.433769950251252
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,OSBPL2,Oxysterol-binding protein-related protein 2,37388,-0.00295649891456806,0.00378110803683386,-0.0103674706667624,0.00445447283762631,0.434279173782495
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PEAR1,Platelet endothelial aggregation receptor 1,40052,-0.00172689556104258,0.00221284421395116,-0.00606407022038685,0.00261027909830169,0.435169019932436
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VSIG10,V-set and immunoglobulin domain-containing protein 10,37368,-0.0027813210806281,0.00357312715090417,-0.00978465029640029,0.00422200813514407,0.436347053507244
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DLGAP5,Disks large-associated protein 5,37411,0.00401101005430535,0.00516081100148875,-0.00610417950861261,0.0141261996172233,0.437051178153216
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD164L2,CD164 sialomucin-like 2 protein,37039,-0.0028065865982356,0.00362205417758088,-0.00990581278629412,0.00429263958982292,0.438436015091791
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AIF1L,Allograft inflammatory factor 1-like,37043,0.00444089475238204,0.0057679136658846,-0.00686421603275178,0.0157460055375159,0.441354700311569
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PFDN6,Prefoldin subunit 6,37039,0.00498247412737274,0.00649146542812055,-0.00774079811174355,0.017705746366489,0.442772920362747
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,39749,0.00210357359361046,0.00275038899882748,-0.00328718884409139,0.00749433603131232,0.444385531162995
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,36962,-0.00421259001535024,0.00553996108542475,-0.0150709137427828,0.00664573371208226,0.447028817495427
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,37382,-0.00626719469605197,0.00826377376611072,-0.022464191277629,0.00992980188552504,0.448228492893769
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,XG,Glycoprotein Xg,39985,0.00221945745844049,0.00293669472856606,-0.00353646420954899,0.00797537912642998,0.449799844438899
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TCL1B,T-cell leukemia/lymphoma protein 1B,39585,-0.00577626068501106,0.00764607616350354,-0.020762569965478,0.00921004859545588,0.449987791976804
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PAPPA,Pappalysin-1,39587,0.00348205100051467,0.0046379726396699,-0.00560837537323835,0.0125724773742677,0.452802283064256
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PSMD5,26S proteasome non-ATPase regulatory subunit 5,37039,-0.00408837042783372,0.00544925837449157,-0.0147689168418372,0.00659217598616975,0.453110434993288
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ARMCX2,Armadillo repeat-containing X-linked protein 2,36991,0.00462064210910894,0.00616169695820597,-0.00745628392897477,0.0166975681471926,0.453329781193993
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TFRC,Transferrin receptor protein 1,39918,0.00285542209418776,0.00382562708178754,-0.00464280698611582,0.0103536511744913,0.455440844017259
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SMC3,Structural maintenance of chromosomes protein 3,36962,-0.00387422331033977,0.00519715159980987,-0.0140606404459671,0.00631219382528757,0.456012326143169
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL5,Interleukin-5,39587,-0.0104425230164233,0.0141014431833904,-0.0380813516558684,0.0171963056230218,0.458990324540554
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CRTAM,Cytotoxic and regulatory T-cell molecule,39749,-0.00357166052965963,0.00483342329736493,-0.0130451701924949,0.00590184913317564,0.459947975267467
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SLC28A1,Sodium/nucleoside cotransporter 1,36962,-0.00428531840985863,0.00585544255360189,-0.0157619858149183,0.00719134899520109,0.464271884899676
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,37021,-0.00351567859478163,0.00480610985794052,-0.0129356539163451,0.00590429672678179,0.464485655343997
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MMP15,Matrix metalloproteinase-15,37437,0.00355254725696389,0.00486219112698425,-0.00597734735192523,0.013082441865853,0.465007165534891
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DDA1,DET1- and DDB1-associated protein 1,37021,0.00282808287344383,0.00389918883694534,-0.00481432724696903,0.0104704929938567,0.468280711019881
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SERPINA1,Alpha-1-antitrypsin,37247,-0.000574996284843377,0.000794180032803877,-0.00213158914913898,0.000981596579452223,0.469070702038821
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,COPE,Coatomer subunit epsilon,39489,-0.00334553976559683,0.00462483163077019,-0.0124102097619064,0.00571913023071275,0.469453421735722
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL31,Interleukin-31,37056,0.00407124999162539,0.00564201572659824,-0.00698710083250716,0.0151296008157579,0.470556336881858
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TYRO3,Tyrosine-protein kinase receptor TYRO3,39868,0.00198399958021212,0.00275380862787924,-0.00341346533043118,0.00738146449085542,0.471254436479749
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LY75,Lymphocyte antigen 75,39866,-0.00271629206930644,0.00377860024104394,-0.0101223485417526,0.00468976440313968,0.472236455340181
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IMPG1,Interphotoreceptor matrix proteoglycan 1,36991,0.00211137032706195,0.00295612056449946,-0.00368262597935698,0.00790536663348089,0.475093411606875
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ISM2,Isthmin-2,37437,0.00305286679788116,0.00436369079558819,-0.00549996716147169,0.011605700757234,0.484185017363544
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,37043,0.00280679386470302,0.00401343545002486,-0.0050595396173457,0.0106731273467517,0.484346010790454
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MN1,Transcriptional activator MN1,37039,0.00406870805155215,0.00582116117111683,-0.00734076784383684,0.0154781839469411,0.48459481294019
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SLITRK6,SLIT and NTRK-like protein 6,39585,0.00226155708277064,0.00323988166844594,-0.00408861098738341,0.00861172515292469,0.48516441483508
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL1RL1,Interleukin-1 receptor-like 1,40002,-0.00317270501324015,0.0045757813310827,-0.0121412364221622,0.00579582639568195,0.48808797578493
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PGLYRP4,Peptidoglycan recognition protein 4,37021,0.0042301105783506,0.006127217644067,-0.00777923600402071,0.0162394571607219,0.489967213473366
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TRPV3,Transient receptor potential cation channel subfamily V member 3,37021,0.00349957639034037,0.00507856251971927,-0.0064544061483094,0.0134535589289901,0.490780051114055
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,39908,0.00602245859344835,0.00876391054598991,-0.0111548060766919,0.0231997232635886,0.491973876893787
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SERPINF2,Alpha-2-antiplasmin,37224,-0.000909606926081562,0.00132538356722662,-0.00350735871784573,0.00168814486568261,0.492537670804496
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BCAM,Basal cell adhesion molecule,39858,0.00155957773289974,0.00230102971270745,-0.00295044050400686,0.00606959596980635,0.497924905141127
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,40058,-0.002268895332458,0.00335772019028721,-0.00885002690542094,0.00431223624050494,0.499224933937032
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TMED10,Transmembrane emp24 domain-containing protein 10,37021,0.00332367124296028,0.00498573762399577,-0.00644837450007144,0.013095716985992,0.505016474921043
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EFNB2,Ephrin-B2,37039,-0.00393756858688821,0.00592515557854608,-0.0155508735208385,0.0076757363470621,0.50634928959608
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GKN1,Gastrokine-1,39123,-0.00182111855889711,0.00274620042848585,-0.00720367139872937,0.00356143428093515,0.50725016139822
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,40009,0.00173372687525509,0.00261860984758938,-0.00339874842602009,0.00686620217653026,0.50792997103507
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NRXN3,Neurexin-3,37039,-0.00228219667192924,0.00345106343211803,-0.00904628099888058,0.00448188765502209,0.508429936979701
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCNE1,G1/S-specific cyclin-E1,37056,-0.00620306440470914,0.00939427826904088,-0.0246158498120293,0.012209721002611,0.509071321238795
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GHRHR,Growth hormone-releasing hormone receptor,39489,-0.00348058430084051,0.00527621029286034,-0.0138219564748468,0.00686078787316575,0.509472099955766
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HMCN2,Hemicentin-2,37100,-0.00367706805338942,0.00558248373708373,-0.0146187361780735,0.00726460007129469,0.510113001188476
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DDX4,Probable ATP-dependent RNA helicase DDX4,37056,0.00355118130410907,0.00541437045208718,-0.0070609847819818,0.0141633473901999,0.511912295685266
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PFDN2,Prefoldin subunit 2,39489,-0.00352106340655634,0.00545619298331475,-0.0142152016538533,0.00717307484074058,0.518720645153967
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,36991,-0.00457224630777974,0.00710725071342013,-0.0185024577060832,0.00935796509052372,0.520026822994627
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ITGAX,Integrin alpha-X,37169,-0.00334101182230914,0.00520480552385063,-0.0135424306490564,0.0068604070044381,0.520943286631124
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PNMA2,Paraneoplastic antigen Ma2,36991,-0.00274053730689922,0.00427526625734577,-0.0111200591712969,0.00563898455749848,0.521519944395204
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SFTPA1,Pulmonary surfactant-associated protein A1,39477,-0.00359166091436828,0.00565567847513711,-0.014676790725637,0.00749346889690046,0.525402538003693
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,37169,0.00317554130639532,0.0050103793499295,-0.00664480221946651,0.0129958848322572,0.526227081391287
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IZUMO1,Izumo sperm-egg fusion protein 1,36962,0.0031204469642876,0.00492464597974367,-0.00653185915600998,0.0127727530845852,0.526327608221745
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,37043,0.00164770443115605,0.00261384829143296,-0.00347543822005255,0.00677084708236465,0.528460236462753
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,37368,-0.00516791529796785,0.00821804735854121,-0.0212752881207086,0.0109394575247729,0.529458197406086
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,39587,0.00219756136033178,0.00350345041829169,-0.00466920145951993,0.00906432418018349,0.530500347286146
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NLGN1,Neuroligin-1,37039,-0.00414652774023042,0.00661768965186083,-0.0171171994578776,0.00882414397741681,0.530943873289921
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SCN2A,Sodium channel protein type 2 subunit alpha,36991,-0.00299258770561828,0.00477899404758104,-0.0123594160388771,0.00637424062764056,0.531197172453465
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CORO6,Coronin-6,36991,-0.00233550107389201,0.00373186495948067,-0.00964995639447412,0.0049789542466901,0.531439434108828
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AMIGO1,Amphoterin-induced protein 1,37039,-0.00306820465062395,0.00491280973025705,-0.0126973117219278,0.00656090242067988,0.532289371746949
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VGF,Neurosecretory protein VGF,37411,-0.00179072051618438,0.00287703436513258,-0.00742970787184423,0.00384826683947547,0.533676939865924
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SCGB1A1,Uteroglobin,39903,0.0032979484853604,0.00534719840997628,-0.0071825603981931,0.0137784573689139,0.537400508915441
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SMAD5,Mothers against decapentaplegic homolog 5,39788,-0.00123628942275708,0.00200504423825243,-0.00516617612973184,0.00269359728421768,0.53751426902257
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DDX25,ATP-dependent RNA helicase DDX25,37039,0.00226529583595204,0.00368710151014169,-0.00496142312392567,0.00949201479582975,0.538972272689565
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,XPNPEP2,Xaa-Pro aminopeptidase 2,39913,0.00593691504257138,0.00966891697472673,-0.013014162227893,0.0248879923130358,0.539210358266908
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",36962,0.00328484223188381,0.00537668090203468,-0.00725345233610417,0.0138231367998718,0.541248324550977
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BRD2,Bromodomain-containing protein 2,36991,0.00203067107802876,0.00333310120765345,-0.004502207288972,0.00856354944502951,0.542373425959078
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MORF4L1,Mortality factor 4-like protein 1,37169,-0.00241682900830662,0.00397065440394671,-0.0101993116400422,0.00536565362342893,0.542751782021643
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CSF2RB,Cytokine receptor common subunit beta,37056,0.0025843051164193,0.00425874647627436,-0.00576283797707845,0.0109314482099171,0.543978853146198
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RAC3,Ras-related C3 botulinum toxin substrate 3,37039,0.00403675730720817,0.00670091533885978,-0.00909703675695701,0.0171705513713733,0.546905770468574
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",37039,0.00455377249601752,0.0075631849439046,-0.0102700699940355,0.0193776149860705,0.547119794770756
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,THRAP3,Thyroid hormone receptor-associated protein 3,37021,-0.00674799252671062,0.0113689227772884,-0.0290310811701959,0.0155350961167747,0.552825190632422
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FLT1,Vascular endothelial growth factor receptor 1,39755,0.00133820053689146,0.00226123331904344,-0.00309381676843368,0.0057702178422166,0.553992152577645
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DPT,Dermatopontin,40052,0.00154770093125004,0.00262011271514159,-0.00358771999042747,0.00668312185292755,0.554729602792146
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TMOD4,Tropomodulin-4,36962,0.00235401559995226,0.00400781141443073,-0.00550129477233197,0.0102093259722365,0.556974170095004
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LHB,Lutropin subunit beta,39477,-0.0050792467859985,0.00865537033731978,-0.0220437726471453,0.0118852790751483,0.557325141975598
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,40052,-0.00399579863454432,0.00682032532210958,-0.0173636362658791,0.00937203899679045,0.557973543631092
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CA8,Carbonic anhydrase-related protein,37056,0.00149850109494545,0.00256148931407358,-0.00352201796063875,0.00651902015052966,0.558549884610204
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DOC2B,Double C2-like domain-containing protein beta,37039,0.00206916472825253,0.00357437465188567,-0.00493660958944338,0.00907493904594845,0.562674237882658
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,37382,0.00960680411080275,0.0167302202729676,-0.0231844276242138,0.0423980358458193,0.565829417690372
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,37039,0.00235510250809902,0.00411633717596363,-0.00571291835678969,0.0104231233729877,0.567239958905863
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,OTOA,Otoancorin,36991,0.0029711788159909,0.00521634188579684,-0.00725285128017091,0.0131952089121527,0.568965212620099
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CXCL12,Stromal cell-derived factor 1,39587,-0.00220351432063904,0.00389636969787517,-0.00984039892847437,0.00543337028719629,0.571721328928623
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,COL28A1,Collagen alpha-1(XXVIII) chain,37039,-0.0042875562376715,0.00763022895980348,-0.0192428049988863,0.0106676925235433,0.574182048689191
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EPGN,Epigen,37368,0.00273938413768115,0.00489841786083719,-0.00686151486955974,0.012340283144922,0.576008193526109
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,OFD1,Oral-facial-digital syndrome 1 protein,37169,0.00373922783494468,0.00669250336838518,-0.00937807876709027,0.0168565344369796,0.576363007548678
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ITGB5,Integrin beta-5,39913,0.00205185128640286,0.00370643856924923,-0.00521276830932564,0.00931647088213136,0.57986645023969
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RUVBL1,RuvB-like 1,39477,-0.0054532443303548,0.00993416055901936,-0.0249241990260327,0.0140177103653231,0.583055425411771
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RNF168,E3 ubiquitin-protein ligase RNF168,37056,-0.00222983806616989,0.00406910093419565,-0.0102052758971934,0.00574559976485357,0.58370610710265
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SMPD3,Sphingomyelin phosphodiesterase 3,37056,-0.00323251282156257,0.00590346739357226,-0.0148033089129642,0.00833828326983906,0.584002133627805
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,OSMR,Oncostatin-M-specific receptor subunit beta,39949,0.00107931306585533,0.00197779153471897,-0.00279715834219384,0.0049557844739045,0.58526853586369
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GH2,Growth hormone variant,39477,0.00876333878554956,0.0160761597487575,-0.0227459343220152,0.0402726118931143,0.585682940051653
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,37124,-0.00198740302499703,0.00368834289001233,-0.00921655508942119,0.00524174903942714,0.59001072988209
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SFRP1,Secreted frizzled-related protein 1,39689,0.00223090418616872,0.0041519163649462,-0.00590685188912582,0.0103686602614633,0.591054730382651
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KDM3A,Lysine-specific demethylase 3A,37056,0.00489410366579405,0.0091436209204826,-0.0130273933383518,0.0228156006699399,0.592487484746066
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,40052,-0.0014076408581626,0.00263477717430608,-0.00657180411980251,0.00375652240347731,0.59317298686684
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRC1,Protein regulator of cytokinesis 1,37368,0.00240754720029812,0.00452948952630213,-0.00647025227125407,0.0112853466718503,0.595062189835206
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PFDN4,Prefoldin subunit 4,36962,-0.00283855359285909,0.00534563299617885,-0.0133159942653696,0.00763888707965144,0.595424866929072
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ZNF75D,Zinc finger protein 75D,37169,-0.00308922680538393,0.0058276442418377,-0.0145114095193858,0.00833295590861796,0.596052323663741
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DUOX2,Dual oxidase 2,39585,-0.00368134405513821,0.00695120436949516,-0.0173057046193487,0.00994301650907231,0.596398145501332
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CASQ2,Calsequestrin-2,37021,-0.00252940497757016,0.00478567114755207,-0.0119093204267722,0.00685051047163191,0.597135483463785
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FABP9,Fatty acid-binding protein 9,39866,0.00280857663835504,0.0054085636990536,-0.00779220821179001,0.0134093614885001,0.603570398975808
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MANSC1,MANSC domain-containing protein 1,39913,-0.00137035972156456,0.00263905232561321,-0.00654290227976644,0.00380218283663732,0.60358517230695
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ITM2A,Integral membrane protein 2A,39866,0.0029884391008012,0.0057796781931248,-0.00833973015772341,0.0143166083593258,0.605121577543759
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HDAC8,Histone deacetylase 8,37056,-0.00320754699504158,0.00620535073899206,-0.015370034443466,0.00895494045338285,0.605234495701587
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FOS,Proto-oncogene c-Fos,36931,-0.00178953041508591,0.00347141835525955,-0.00859351039139463,0.00501444956122282,0.606209519676602
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ENDOU,Poly(U)-specific endoribonuclease,36430,-0.00260678009820602,0.00508762903229787,-0.0125785330015099,0.00736497280509781,0.608396737720575
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CPB2,Carboxypeptidase B2,37424,-0.00113059688652622,0.00221744863946108,-0.00547679621986994,0.00321560244681751,0.61015514961719
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TOP1,DNA topoisomerase 1,37382,-0.00567833384454527,0.0111835291647009,-0.027598051007359,0.0162413833182685,0.611643425476611
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ZP4,Zona pellucida sperm-binding protein 4,36962,-0.00159598646466064,0.00316263378860241,-0.00779474869032135,0.00460277576100007,0.613821318536615
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MTR,Methionine synthase,37021,0.00318531612506253,0.00632061797983401,-0.00920309511541213,0.0155737273655372,0.614300424538867
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,STX1B,Syntaxin-1B,37039,-0.00208651030697438,0.00418051883045993,-0.0102803272146758,0.00610730660072709,0.617715017377384
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ZNF830,Zinc finger protein 830,37368,-0.00393060573277219,0.00791004726598843,-0.0194342983741095,0.0115730869085651,0.619258453603408
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CAPS,Calcyphosin,37388,-0.00423523995195869,0.00854315725524353,-0.020979828172236,0.0125093482683186,0.62008135788469
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,C7,Complement component C7,37149,-0.00155515574912413,0.00315202575803464,-0.00773312623487203,0.00462281473662377,0.621750184458775
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,36962,-0.0027811947046782,0.00565839924832163,-0.0138716572313886,0.0083092678220322,0.623069654702419
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PLXDC1,Plexin domain-containing protein 1,39477,-0.00164120053644632,0.00336588777962788,-0.00823834058451697,0.00495593951162433,0.625841375632114
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FASLG,Tumor necrosis factor ligand superfamily member 6,40058,0.00174821810998206,0.00358817024914302,-0.00528459557833826,0.00878103179830237,0.62611104075548
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PLA2G2A,"Phospholipase A2, membrane associated",39826,-0.00258960130817192,0.00532405442104851,-0.013024747973427,0.00784554535708315,0.626692764712539
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CNTNAP2,Contactin-associated protein-like 2,39866,0.0019473462657735,0.00400562935750419,-0.00590368727493471,0.00979837980648172,0.626865783361473
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,37368,0.00211557873399807,0.00435826862404361,-0.0064266277691274,0.0106577852371235,0.627388277035058
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLEC4C,C-type lectin domain family 4 member C,39866,0.00217376813076916,0.00449727994651353,-0.00664090056439736,0.0109884368259357,0.628852613234676
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TSPAN7,Tetraspanin-7,36991,0.00446911318566375,0.00927706104147367,-0.0137139264556246,0.0226521528269521,0.63000007927257
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BTLA,B- and T-lymphocyte attenuator,36962,-0.00408617376756023,0.00852208046202953,-0.0207894514731381,0.0126171039380176,0.631604642929613
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDH6,Cadherin-6,39868,0.00177324544298329,0.00371964244511778,-0.00551725374944756,0.00906374463541414,0.63356467641844
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MRPS16,"28S ribosomal protein S16, mitochondrial",37056,-0.00138391432301725,0.00291956692699404,-0.00710626549992557,0.00433843685389108,0.63549807764099
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL1A,Interleukin-1 alpha,39587,0.00245084933642802,0.00521854145956868,-0.00777749192432659,0.0126791905971826,0.638616900769819
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NEO1,Neogenin,37411,-0.000986857602912849,0.00212540891458952,-0.00515265907550831,0.00317894386968261,0.642430089644359
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,39477,-0.00576526344983698,0.0124168794988383,-0.03010234726756,0.018571820367886,0.642433163682839
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PPM1B,Protein phosphatase 1B,37056,-0.00290295754889049,0.00626066641639826,-0.0151738637250311,0.00936794862725011,0.642883332008711
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SPON1,Spondin-1,39885,-0.00144235778359547,0.00311351673847503,-0.00754485059100654,0.00466013502381559,0.643186602237207
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,37039,-0.00212240998883153,0.00464319118882416,-0.0112230647189269,0.00697824474126382,0.647605575094854
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GNPDA1,Glucosamine-6-phosphate isomerase 1,37043,-0.00146343156424459,0.00322960491715678,-0.00779345720187188,0.0048665940733827,0.650462438389763
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HRG,Histidine-rich glycoprotein,37380,-0.00140468057262325,0.00310890581622618,-0.00749813597242657,0.00468877482718007,0.651402490973862
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ATP5F1D,"ATP synthase subunit delta, mitochondrial",37021,0.00224601908264054,0.00498581952573951,-0.00752618718780889,0.01201822535309,0.652370765695671
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",37139,-0.00284424914590527,0.00634635315987486,-0.01528310133926,0.00959460304744946,0.654037363310634
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AHNAK2,Protein AHNAK2,37043,-0.00128704350761573,0.00288706510467034,-0.0069456911127696,0.00437160409753814,0.655751574011139
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KIF20B,Kinesin-like protein KIF20B,36991,0.00326626276651776,0.00739517438331064,-0.0112282790247711,0.0177608045578066,0.658731762047713
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CPA4,Carboxypeptidase A4,36868,0.0018895483243982,0.00428234007768152,-0.00650383822785758,0.010282934876654,0.659045139884078
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PHLDB2,Pleckstrin homology-like domain family B member 2,36962,0.00396020541687586,0.00897855326620285,-0.0136377589848817,0.0215581698186335,0.659166782956091
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KLK3,Prostate-specific antigen,37437,0.00339856439436795,0.00771880129069816,-0.0117302861354004,0.0185274149241363,0.659729084247017
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NXPH1,Neurexophilin-1,39489,-0.00161319535313856,0.00367029272817893,-0.00880696910036927,0.00558057839409215,0.660285286148619
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EPHA10,Ephrin type-A receptor 10,39489,0.00273515219864689,0.00627039881244537,-0.00955482947374603,0.0150251338710398,0.662697162806516
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MED21,Mediator of RNA polymerase II transcription subunit 21,37021,-0.00209026165011335,0.00481915036708006,-0.0115357963695903,0.00735527306936357,0.664483857721781
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HIP1,Huntingtin-interacting protein 1,37021,-0.00140307792589668,0.00329189751259172,-0.00785519705057644,0.00504904119878309,0.669953327761291
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CNGB3,Cyclic nucleotide-gated cation channel beta-3,36991,-0.0022721229652364,0.00538544656302404,-0.0128275982287635,0.00828335229829072,0.673104502108274
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DCUN1D1,DCN1-like protein 1,36991,-0.00309649136704506,0.00738178233848997,-0.0175647847504854,0.0113718020163953,0.674874080503809
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BRD1,Bromodomain-containing protein 1,37169,0.0012555266712105,0.00302950691162923,-0.00468230687558278,0.00719336021800379,0.678563938222133
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",36991,-0.00188354706007573,0.00456435291834693,-0.0108296787800357,0.00706258465988425,0.679859071415292
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,37169,0.00293395230179672,0.00712285662360998,-0.0110268466804789,0.0168947512840723,0.680414450000759
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HIF1A,Hypoxia-inducible factor 1-alpha,37056,-0.00275191753376772,0.0067167443521276,-0.0159167364639378,0.0104129013964024,0.682025321574642
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLPS,Colipase,39836,0.00276921841218576,0.0067640993628207,-0.0104884163389428,0.0160268531633143,0.682252047666243
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TPT1,Translationally-controlled tumor protein,39587,0.00257619825248888,0.00637677079184232,-0.00992227249952207,0.0150746690044998,0.686220189802152
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GJA8,Gap junction alpha-8 protein,36962,-0.00236620005252421,0.00586882149504142,-0.0138690901828054,0.00913669007775697,0.686821312343594
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,37368,-0.00241714618396334,0.00600882230345065,-0.0141944378987266,0.00936014553079994,0.687494483400966
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MANSC4,MANSC domain-containing protein 4,37021,-0.00244328483454887,0.00611413248747947,-0.0144269845100086,0.00954041484091089,0.689448304551324
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TRIM26,Tripartite motif-containing protein 26,36962,-0.0021535346396628,0.00548806037348369,-0.0129101329716908,0.00860306369236523,0.694766410686391
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HMMR,Hyaluronan mediated motility receptor,36942,0.00182868551168924,0.0046641669976292,-0.00731308180366399,0.0109704528270425,0.695011999666932
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ICOSLG,ICOS ligand,39788,0.000720427469454468,0.00184371134392911,-0.0028932467646466,0.00433410170355553,0.695988360414804
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NCLN,Nicalin,39587,-0.00198716906482451,0.00515178614912396,-0.0120846699171075,0.00811033178745844,0.6997060872985
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HK2,Hexokinase-2,39585,-0.00101912835044123,0.00266563070894168,-0.00624376453996692,0.00420550783908447,0.702227959261709
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RBM25,RNA-binding protein 25,36962,0.00170926940878753,0.00448707403759955,-0.00708539570490758,0.0105039345224827,0.703259995330406
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GART,Trifunctional purine biosynthetic protein adenosine-3,37411,0.00099921596457078,0.00263053031131994,-0.0041566234456163,0.00615505537475786,0.704060170192319
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL25,Interleukin-25,36903,0.00128027621593524,0.00337146316090798,-0.0053277915794444,0.00788834401131488,0.704145313004163
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GIPR,Gastric inhibitory polypeptide receptor,37056,-0.00170002500904753,0.00448668594909358,-0.0104939294692709,0.00709387945117588,0.704764959119602
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IKZF2,Zinc finger protein Helios,39477,-0.00348483123950064,0.00919811564376527,-0.0215131379012806,0.0145434754222793,0.704794303392797
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PCARE,Photoreceptor cilium actin regulator,36991,0.00315875705214608,0.00839627550059478,-0.0132979429290197,0.0196154570333119,0.706767369129751
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRG2,Bone marrow proteoglycan,37437,-0.00187010905201128,0.0049735888961493,-0.0116183432884639,0.00787812518444136,0.706916847624752
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MELTF,Melanotransferrin,37437,0.00106100226800525,0.00285187670392555,-0.00452867607168884,0.00665068060769933,0.709871469386943
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ACE,Angiotensin-converting enzyme,37445,-0.000936733444959991,0.00252023210892809,-0.00587638837845904,0.00400292148853906,0.710132903644864
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SPRR1B,Cornifin-B,37169,-0.00318289432779528,0.00862969280100639,-0.0200970922177678,0.0137313035621772,0.712259900152479
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CPVL,Probable serine carboxypeptidase CPVL,39990,-0.00142034822158978,0.00392963917184824,-0.00912244099841233,0.00628174455523276,0.717771587172032
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ACTN2,Alpha-actinin-2,37021,-0.00209145837274669,0.00579685843531427,-0.0134533009059627,0.00927038416046928,0.71826096324591
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GAGE2A,G antigen 2A,36962,-0.00216063139084393,0.00599288537973989,-0.0139066867351341,0.00958542395344627,0.718454589013382
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL21R,Interleukin-21 receptor,37056,0.00188376950045576,0.00533844025855414,-0.00857957340631036,0.0123471124072219,0.724192368971454
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EDAR,Tumor necrosis factor receptor superfamily member EDAR,39866,-0.00317795754426307,0.00905573108319038,-0.0209271904673162,0.0145712753787901,0.72564301118541
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LTA4H,Leukotriene A-4 hydrolase,40030,0.00199803104556496,0.00572867584735282,-0.00923017361524658,0.0132262357063765,0.727261185061214
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KLK15,Kallikrein-15,37351,-0.00171493634571392,0.0049453270371051,-0.0114077773384399,0.00797790464701208,0.728762644836556
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KIAA2013,Uncharacterized protein KIAA2013,37368,0.00195085644690626,0.00562575910287009,-0.00907563139471912,0.0129773442885316,0.728767920858128
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD3E,T-cell surface glycoprotein CD3 epsilon chain,37169,0.00116282362990421,0.00337352591187615,-0.00544928715737304,0.00777493441718146,0.730332218378689
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GID8,Glucose-induced degradation protein 8 homolog,37411,0.00113379249708732,0.00329374080043814,-0.00532193947177143,0.00758952446594607,0.730681380528319
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLC,Galectin-10,39841,0.00221923998690486,0.00651395848474829,-0.0105481186432018,0.0149865986170115,0.733341507163711
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LBP,Lipopolysaccharide-binding protein,39931,0.00190503702979404,0.00567100402190341,-0.00921013085313665,0.0130202049127247,0.736931144178268
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SPESP1,Sperm equatorial segment protein 1,37437,0.000932911624942693,0.00286389675285606,-0.00468032601065518,0.00654614926054057,0.744619255801007
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DDX53,Probable ATP-dependent RNA helicase DDX53,37039,-0.00111643944354496,0.00346158351013623,-0.00790114312341198,0.00566826423632205,0.747061819622221
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TBR1,T-box brain protein 1,37039,-0.001528933666707,0.00474161131157318,-0.0108224918373904,0.00776462450397642,0.747116749972697
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CST6,Cystatin-M,39524,0.00146391370488232,0.00458647144703538,-0.00752557033130704,0.0104533977410717,0.749593658591971
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRRT3,Proline-rich transmembrane protein 3,37043,-0.00113384136091845,0.00356730527916134,-0.00812575970807468,0.00585807698623777,0.750609416720508
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,37437,-0.000833244205315378,0.00262607524602355,-0.00598035168752154,0.00431386327689079,0.751023592514612
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,40009,0.00219504540374873,0.00693075015903728,-0.0113892249079643,0.0157793157154618,0.751466930554319
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CRYBB2,Beta-crystallin B2,37388,-0.00175792843677032,0.00557545414589102,-0.0126858185627167,0.00916996168917608,0.75254041715157
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],39788,0.00174239026372791,0.00563096746148864,-0.00929430596078982,0.0127790864882456,0.75699849998016
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL17F,Interleukin-17F,39587,-0.00233422502489052,0.00757440337894305,-0.0171800556476189,0.0125116055978379,0.757954937038858
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FGF16,Fibroblast growth factor 16,37056,-0.00146101353095079,0.00474339049250229,-0.0107580588962553,0.00783603183435369,0.758079291695408
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",36962,-0.00151708536711204,0.0049865804655012,-0.0112907830794944,0.00825661234527031,0.76095475363499
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FGF7,Fibroblast growth factor 7,36962,-0.00236199903885642,0.00781898400012848,-0.0176872076791082,0.0129632096013954,0.762591939189727
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CTAG1A_CTAG1B,Cancer/testis antigen 1,37135,0.00150118088302551,0.00498792869152789,-0.00827515935236915,0.0112775211184202,0.763447590514644
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SUMF1,Formylglycine-generating enzyme,37056,-0.00201004924796083,0.00671395083838274,-0.015169392891191,0.0111492943952693,0.764651807605634
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KLK12,Kallikrein-12,39477,0.00396196118801488,0.0134728853627352,-0.0224448941229462,0.0303688164989759,0.768708901637609
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,36991,0.00169859780591737,0.00578820011392506,-0.00964627441737574,0.0130434700292105,0.769176184306703
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDKL5,Cyclin-dependent kinase-like 5,36991,0.00150627743674287,0.0051875803798169,-0.00866138010769824,0.011673934981184,0.771543716586762
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PSCA,Prostate stem cell antigen,37382,-0.00719992919335623,0.0249330923094717,-0.0560687901199207,0.0416689317332083,0.772761813681733
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DIPK1C,Divergent protein kinase domain 1C,37039,0.00119591363936599,0.00420851218176102,-0.00705277023688561,0.00944459751561759,0.776288077314113
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PDIA2,Protein disulfide-isomerase A2,36962,-0.00110858402452637,0.00390128541544498,-0.00875510343879852,0.00653793538974579,0.776293287342895
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,COL24A1,Collagen alpha-1(XXIV) chain,37382,-0.00153686752825471,0.00544303710188371,-0.0122052202479468,0.00913148519143736,0.777675808765771
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RPGR,X-linked retinitis pigmentosa GTPase regulator,37039,0.00108459463810369,0.0040193181616012,-0.00679326895863467,0.00896245823484204,0.787283395561165
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TCN1,Transcobalamin-1,37235,0.000896017087575865,0.00335984522380369,-0.00568927955107936,0.00748131372623109,0.78971655690424
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FHIP2A,FHF complex subunit HOOK interacting protein 2A,37021,-0.00119731598725761,0.00454528066946143,-0.010106066099402,0.0077114341248868,0.79223131400003
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GPNMB,Transmembrane glycoprotein NMB,39444,0.000724312782225296,0.00276381231381406,-0.00469275935285026,0.00614138491730085,0.793270802517998
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PVALB,Parvalbumin alpha,39971,-0.00289324347660322,0.0111551877209219,-0.0247574114096102,0.0189709244564037,0.795358452464347
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CA11,Carbonic anhydrase-related protein 11,39477,-0.000784838884158777,0.00306852017857026,-0.00679913843415649,0.00522946066583894,0.798130933367068
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,37169,-0.00158606983270446,0.00622481833905409,-0.0137867137772505,0.0106145741118415,0.798883234393159
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FGF12,Fibroblast growth factor 12,37056,-0.00116494076724892,0.00460180031116484,-0.010184469377132,0.00785458784263416,0.800157082328157
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TMEM132A,Transmembrane protein 132A,37043,-0.00155138026658407,0.00616929862763596,-0.0136432055767505,0.0105404450435824,0.801456334719392
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,OSTN,Osteocrin,37039,-0.00102633269346527,0.00411383197108239,-0.00908944335678675,0.0070367779698562,0.802990785679114
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,37039,-0.00133257452189769,0.00535050078634703,-0.0118195560631379,0.0091544070193425,0.803321316570133
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",36962,-0.001377057932698,0.00557752911401301,-0.0123090149961635,0.00955489913076749,0.804994203110502
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CAPN3,Calpain-3,37368,-0.000906970700880276,0.00369517168801641,-0.00814950720939245,0.00633556580763189,0.806113672608403
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EP300,Histone acetyltransferase p300,37056,0.000696521475841735,0.00290630534619472,-0.00499983700269992,0.00639287995438339,0.81059854619927
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HEBP1,Heme-binding protein 1,39585,-0.00121444403655785,0.00523836416477374,-0.0114816377995144,0.00905274972639868,0.816668019690556
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HTR1A,5-hydroxytryptamine receptor 1A,36991,-0.00170869309168519,0.00747910344559003,-0.0163677358450416,0.0129503496616713,0.819290427630416
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VWF,von Willebrand factor,40052,-0.0016300422344897,0.00714320922386321,-0.0156307323132616,0.0123706478442822,0.819497790409613
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KCNIP4,Kv channel-interacting protein 4,39489,-0.00117010201721944,0.0051286004847348,-0.0112221589672997,0.00888195493286077,0.819530824123771
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MTPN,Myotrophin,39585,-0.000719102029992724,0.00316362447158832,-0.00691980599430583,0.00548160193432038,0.820190924210295
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HLA_DRA,,39799,0.000780394590665482,0.00346986007296823,-0.00602053115235226,0.00758132033368322,0.822054782210203
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FH,"Fumarate hydratase, mitochondrial",36991,0.00181717969655628,0.00814372610447242,-0.0141445234682097,0.0177788828613222,0.823431102825244
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ROBO4,Roundabout homolog 4,37043,-0.000391521649774362,0.00175494499609743,-0.00383121384212533,0.00304817054257661,0.823464052442488
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ESR1,Estrogen receptor,37056,0.00128662750434671,0.00583770791437146,-0.0101552800078214,0.0127285350165148,0.825563497829911
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RNF4,E3 ubiquitin-protein ligase RNF4,37169,0.00141228989071956,0.00645945748194823,-0.011248246773899,0.0140728265553381,0.826934554222116
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,POMC,Pro-opiomelanocortin,37043,0.00152691978175339,0.00698525104618001,-0.0121641722687594,0.0152180118322662,0.826971292843674
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AOC1,Amiloride-sensitive amine oxidase [copper-containing],39587,0.00116708694688301,0.00534579939346139,-0.00931067986430133,0.0116448537580673,0.827183787709205
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL2RB,Interleukin-2 receptor subunit beta,39587,-0.00072760512652613,0.00354796189766677,-0.007681610445953,0.00622640019290074,0.837514676176313
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SNAP25,Synaptosomal-associated protein 25,36991,0.000930611725047407,0.00465532872106334,-0.00819383256823674,0.0100550560183316,0.841559951661601
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SOX9,Transcription factor SOX-9,37039,0.000525105815119733,0.00265794261236801,-0.00468446170512157,0.00573467333536103,0.843391593311576
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",37021,0.000959136905749964,0.00492205509285936,-0.00868809107625437,0.0106063648877543,0.84550154093002
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD3G,T-cell surface glycoprotein CD3 gamma chain,37056,-0.00173203314909753,0.00893418251538112,-0.0192430308792445,0.0157789645810495,0.846283885159996
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LSM1,U6 snRNA-associated Sm-like protein LSm1,39477,-0.00101494973971805,0.00534896814390674,-0.0114989273017753,0.00946902782233916,0.849509989726754
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DEFB116,Beta-defensin 116,36991,0.0014350549173557,0.00761989928449469,-0.0134999476802539,0.0163700575149653,0.850620953306367
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DOCK9,Dedicator of cytokinesis protein 9,36991,-0.00215481537318909,0.0114705823704834,-0.0246371568193365,0.0203275260729583,0.850992598694173
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,S100A13,Protein S100-A13,37056,-0.000635747495146473,0.00341450256954536,-0.00732817253145538,0.00605667754116243,0.852298337881182
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PXDNL,Peroxidasin-like protein,37368,-0.00108319108179299,0.00584158186352032,-0.0125326915342928,0.0103663093707068,0.852896368721383
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TPBGL,Trophoblast glycoprotein-like,37039,0.00072664462186213,0.00398765379250894,-0.00708915681145539,0.00854244605517965,0.855410057139847
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NRN1,Neuritin,37411,-0.000627088146021653,0.00346325940846389,-0.00741507658661087,0.00616090029456757,0.856316299647556
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL13,Interleukin-13,39587,-0.000843065275984709,0.00476420170220522,-0.0101809006123069,0.00849477006033751,0.859543383206794
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KLK6,Kallikrein-6,39889,-0.000510544052759783,0.00288752083947651,-0.00617008489813375,0.00514899679261418,0.85965946163704
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HRAS,GTPase Hras,37161,0.0016993658737418,0.00962069562149944,-0.0171571975443971,0.0205559292918807,0.859796621791424
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TOP1MT,"DNA topoisomerase I, mitochondrial",36962,-0.000846412304619591,0.00479321214716659,-0.0102411081130661,0.00854828350382692,0.859836625093255
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,UBQLN3,Ubiquilin-3,37021,0.000813271477945118,0.00461184830124066,-0.00822595119248657,0.00985249414837681,0.860026460811279
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BTN1A1,Butyrophilin subfamily 1 member A1,37348,-0.000703753084949055,0.00402532856594677,-0.00859339707420472,0.00718589090430661,0.86121488398726
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DUSP3,Dual specificity protein phosphatase 3,39489,-0.00144453916024706,0.00829342208664736,-0.0176996464500759,0.0148105681295818,0.861727121117385
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SHH,Sonic hedgehog protein,37056,0.000733205284497271,0.00428590427030112,-0.00766716708529291,0.00913357765428746,0.864168478091736
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EXOSC10,Exosome component 10,37021,-0.00101942188242388,0.0059828535780926,-0.0127458148954854,0.0107069711306376,0.864705600178856
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TAP1,Antigen peptide transporter 1,37169,-0.000980238791565222,0.00579126429748091,-0.0123311168146278,0.0103706392314974,0.865593433536936
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,37021,0.00111267337271257,0.00662904069392186,-0.0118802463873743,0.0141055931327994,0.866705183406928
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SLK,STE20-like serine/threonine-protein kinase,37169,0.0012566576841363,0.00755273825325989,-0.0135467092922531,0.0160600246605257,0.867856991762924
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SHC1,SHC-transforming protein 1,36962,-0.00188667753204394,0.0113556737065662,-0.0241437979969136,0.0203704429328258,0.868046158703102
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,UPK3BL1,Uroplakin-3b-like protein 1,37149,-0.000870532475036023,0.00534326210073926,-0.011343326192485,0.00960226124241293,0.870582690450679
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MSMB,Beta-microseminoprotein,39780,-0.00105751271164983,0.00655322947264747,-0.0139018424780389,0.0117868170547392,0.87180186941085
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",37056,0.000421034331438281,0.00272811142785479,-0.00492606406715711,0.00576813273003367,0.877350489625456
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KRT17,"Keratin, type I cytoskeletal 17",37021,0.000567601640486692,0.00382750461627802,-0.00693430740741822,0.0080695106883916,0.882111852964774
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RPA2,Replication protein A 32 kDa subunit,37056,0.000438781355455044,0.00313646104967624,-0.00570868230191039,0.00658624501282048,0.888743540953974
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TLR4,Toll-like receptor 4,37056,0.00037247462184662,0.00270756089363804,-0.00493434472968393,0.00567929397337717,0.890583687892977
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",36991,0.000755445518688191,0.00552707127949862,-0.0100776141891291,0.0115885052265055,0.891285059634046
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCDC50,Coiled-coil domain-containing protein 50,37411,0.00102312798972608,0.00760176669832398,-0.0138763347389889,0.0159225907184411,0.892937401465776
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DSG3,Desmoglein-3,39964,-0.000436996942830017,0.00325768719772249,-0.00682206385036609,0.00594806996470606,0.893290929171622
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ITGA2,Integrin alpha-2,37124,0.000442705201714481,0.00330639648400283,-0.00603783190693107,0.00692324231036003,0.893488772795395
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MAGEA3,Melanoma-associated antigen 3,37169,0.00103414557477791,0.00824688279707445,-0.015129744707488,0.0171980358570438,0.900210080711175
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TSC1,Hamartin,37056,0.000931643851393414,0.00750479054484599,-0.0137777456165047,0.0156410333192916,0.901206407793398
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL20,Interleukin-20,39587,-0.000584196479893916,0.00477211454233846,-0.0099375409828773,0.00876914802308946,0.902568923683517
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KRT14,"Keratin, type I cytoskeletal 14",39064,0.000327973711822459,0.00283782980099214,-0.00523417269812214,0.00589012012176706,0.907993268346666
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DCC,Netrin receptor DCC,37039,-0.000240733240157008,0.00222454886039149,-0.00460084900652433,0.00411938252621031,0.913825479884786
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MUC2,Mucin-2,37437,0.000925827310960605,0.00884743465317018,-0.0164151446092529,0.0182667992311742,0.916660171690284
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDC123,Cell division cycle protein 123 homolog,36962,0.000653520731581197,0.00625100832433797,-0.0115984555841212,0.0129054970472836,0.916737308421054
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MRPL28,"39S ribosomal protein L28, mitochondrial",37411,0.00036383133776684,0.00354626273382035,-0.00658684362052104,0.00731450629605472,0.91828536705743
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TMPRSS11B,Transmembrane protease serine 11B,36991,0.000754215033589828,0.00755722031829174,-0.014057936790262,0.0155663668574416,0.920504164532971
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MFAP3L,Microfibrillar-associated protein 3-like,37039,-0.000625031172958482,0.00633984069153643,-0.0130511189283699,0.0118010565824529,0.921467027971721
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NOTCH1,Neurogenic locus notch homolog protein 1,40052,-0.000147097361699551,0.00153175418414981,-0.00314933556263318,0.00285514083923408,0.923496375210555
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MYOM1,Myomesin-1,36991,0.00044678936874521,0.00466638045930024,-0.00869931633148326,0.00959289506897367,0.923723408727748
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,APOH,Beta-2-glycoprotein 1,39858,0.000325737524290554,0.0034699846611733,-0.00647543241160911,0.00712690746019022,0.9252112967178
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VSTM2B,V-set and transmembrane domain-containing protein 2B,37169,-0.000380805785102199,0.00408568860931282,-0.00838875545935532,0.00762714388915092,0.925742264974992
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TET2,Methylcytosine dioxygenase TET2,37161,-0.000893219396392864,0.00973404278413981,-0.0199719432533069,0.0181855044605212,0.926888178365899
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,37021,-0.000445670148993313,0.00496233317060921,-0.0101718431633874,0.00928050286540075,0.928439086554659
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BRD3,Bromodomain-containing protein 3,37021,-0.000402161372223129,0.00455293597278902,-0.00932591587888961,0.00852159313444335,0.929615645645115
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MAG,Myelin-associated glycoprotein,37039,-0.000376893103658497,0.00453876092378879,-0.00927286451428453,0.00851907830696754,0.933821976823538
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GFRA2,GDNF family receptor alpha-2,39788,0.000164208573907541,0.00203567929453265,-0.00382572284337646,0.00415413999119154,0.935709188738516
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CASP4,Caspase-4,37169,0.00129241850109149,0.0162294174430149,-0.0305172396872176,0.0331020766894006,0.936529301691132
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TGFBR1,TGF-beta receptor type-1,37056,0.000168865114901623,0.0021384491343013,-0.00402249518832892,0.00436022541813216,0.937060737329726
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VTCN1,V-set domain-containing T-cell activation inhibitor 1,39477,0.000239792252181776,0.00316146630597384,-0.00595668170752695,0.0064362662118905,0.939540657966584
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DENND2B,DENN domain-containing protein 2B,37021,0.000370490765570145,0.00506045727226551,-0.00954800548807025,0.0102889870192105,0.941637811707109
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TXK,Tyrosine-protein kinase TXK,37169,-0.000517640471295719,0.00730466581564275,-0.0148347854699555,0.0137995045273641,0.94350677302064
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,37039,-0.000325554846033392,0.00475376450647515,-0.00964293327872469,0.00899182358665791,0.94540172387689
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,39881,0.000297859545982543,0.00481802566411775,-0.00914547075568824,0.00974118984765333,0.950705426878899
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SLC44A4,Choline transporter-like protein 4,37039,0.000412268009054978,0.0066696444086651,-0.0126602350319286,0.0134847710500386,0.950713012985756
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CR1,Complement receptor type 1,37420,-0.000197682277018932,0.00350402282032553,-0.00706556700485698,0.00667020245081912,0.955011395622103
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ECE1,Endothelin-converting enzyme 1,39489,-0.000191048636712797,0.00341841324164376,-0.00689113859033457,0.00650904131690897,0.955431661596201
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PDCL2,Phosducin-like protein 2,36962,-0.00028371155063217,0.00521812743368923,-0.0105112413206631,0.00994381821939872,0.956640909425489
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ECSCR,Endothelial cell-specific chemotaxis regulator,36991,0.000249625500586668,0.00483764929179869,-0.00923216711133877,0.0097314181125121,0.958847743509313
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,39801,0.000915600253171228,0.0182691621907667,-0.0348919576407315,0.036723158147074,0.96002957772233
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FAM171B,Protein FAM171B,37368,-0.000134453683567613,0.00272047099782489,-0.00546657683930439,0.00519766947216916,0.960582975188232
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,36962,-0.000117676269043409,0.00257830148518533,-0.00517114718000665,0.00493579464191983,0.963597082119944
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HDAC9,Histone deacetylase 9,36991,0.000276978980447878,0.00632393590640021,-0.0121179353960965,0.0126718933569923,0.965065679449356
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,40009,-0.000197593199806629,0.00454214769170245,-0.00910020267554343,0.00870501627593017,0.965301786851943
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DCDC2C,Doublecortin domain-containing protein 2C,36962,0.000269039158025216,0.00623577388180605,-0.0119530776503146,0.0124911559663651,0.965587027951589
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",37056,0.000243035948175223,0.00588188307487428,-0.0112854548785784,0.0117715267749288,0.967041883120405
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SEPTIN7,Septin-7,37169,-0.000205227485984548,0.00505200564651257,-0.0101071585531492,0.0096967035811801,0.967597079277702
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SPINT3,Kunitz-type protease inhibitor 3,37382,-0.000579036026446756,0.0143169056743614,-0.028640171148195,0.0274820990953015,0.967739576845921
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PTTG1,Securin,37169,-0.00015581732659756,0.00410847376297934,-0.00820842590203707,0.00789679124884195,0.969747377793247
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MAPT,Microtubule-associated protein tau,39489,0.000193843235125667,0.00514691751521297,-0.00989411509469176,0.0102818015649431,0.96995765082083
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ALMS1,Alstrom syndrome protein 1,37169,0.000159864539340109,0.00440935156826595,-0.00848246453446115,0.00880219361314137,0.97107894227078
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PYDC1,Pyrin domain-containing protein 1,37043,0.000134246310926059,0.0040629503030223,-0.00782913628299764,0.00809762890484976,0.973641927262339
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,36991,0.000178159913760643,0.005680462939973,-0.0109555474485864,0.0113118672761077,0.974980025984084
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BCL7A,B-cell CLL/lymphoma 7 protein family member A,36962,0.000189559072187429,0.00625826372676693,-0.0120766378322758,0.0124557559766506,0.975836709213895
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,40052,-6.68636481602874e-05,0.00221823827018007,-0.00441461065771322,0.00428088336139265,0.975953633307124
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KCNH2,Potassium voltage-gated channel subfamily H member 2,37039,0.000221781983913075,0.00766532749958427,-0.0148022599152721,0.0152458238830982,0.976918353896041
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDH4,Cadherin-4,36991,-0.00011743411053698,0.00460822155344612,-0.00914954835529138,0.00891468013421742,0.979669610594784
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FOLR3,Folate receptor gamma,39858,0.000457841999983386,0.018477384336956,-0.0357578313004505,0.0366735153004172,0.980231943644407
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLSTN1,Calsyntenin-1,39489,0.000109097237173338,0.0049220849906718,-0.00953818934454339,0.00975638381889006,0.98231674550137
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CEP152,Centrosomal protein of 152 kDa,36962,8.75057316009762e-05,0.00410068013434636,-0.00794982733171788,0.00812483879491984,0.982975301932519
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ZP3,Zona pellucida sperm-binding protein 3,37043,0.000532883428496042,0.0254042146563507,-0.0492593772979514,0.0503251441549435,0.983264973015333
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,H2AP,Huntingtin-interacting protein M,36962,0.000100098361416898,0.00492185987097487,-0.00954674698569384,0.00974694370852764,0.98377444509963
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IGLON5,IgLON family member 5,36962,0.00017763309156904,0.00906049109960407,-0.0175809294636549,0.017936195646793,0.984358583220837
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ENPEP,Glutamyl aminopeptidase,37021,-7.56485042503225e-05,0.00411111094749295,-0.00813342596133651,0.00798212895283587,0.985319242999408
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NINJ1,Ninjurin-1,39477,8.97539262032614e-05,0.00552050487062027,-0.0107304356202125,0.010909943472619,0.98702854678924
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FABP6,Gastrotropin,39564,-6.73236412316979e-05,0.00527492122894067,-0.0104061692499554,0.010271521967492,0.989817064923982
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PGR,Progesterone receptor,37056,8.93799105424185e-05,0.0103148222654005,-0.0201276717296425,0.0203064315507274,0.993086394968024
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TEF,Thyrotroph embryonic factor,37021,-1.4618575405365e-05,0.00416258024844395,-0.0081732758623555,0.00814403871154477,0.997197966313462
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRR4,Proline-rich protein 4,37031,1.20658077175511e-05,0.00686433213764939,-0.0134420251820753,0.0134661567975104,0.998597542512649
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NOS2,"Nitric oxide synthase, inducible",37021,8.30922886110168e-07,0.00388335036628201,-0.00761053579502664,0.00761219764079886,0.999829279389981
